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Abstract.
Renal papillary necrosis (RPN) and upper urothelial carcinoma (UUC) 
can both be caused by the long-term abusive consumption of analgesics 
and non-steroidal anti-inflammatory drugs (NSAID). A "cause-and- 
effect" relationship between RPN and UUC has been proposed. However, 
despite a considerable amount of clinical data and experimental 
evidence this relationship has not been proven nor is it widely 
accepted.
Experimental models of RPN and UUC have been difficult to establish 
using analgesics and NSAID because of the chronic periods of dosing 
required with these compounds which frequently have extra-renal 
toxicities and there is a large biological variation in response. 
These problems have lead to the use of alternative models using 
chemicals with known papillotoxic potential such as 2-bromoethanamine 
(BEA) hydrobromide. This compound will induce a dose related RPN in 
the rat in 24-48 hr.
Studies to determine which was the earliest cellular change occurring 
as a consequence of BEA-induced RPN were performed in a number of 
different species (rat, mouse, marmoset and pig), and to determine 
whether this acute RPN lesion was relevant to the chronic clinical 
situation in man. High resolution light microscopy using semithin 
glycolmethacrylate sections in conjunction with routine and enzyme 
histochemical staining was used throughout these studies to assess the 
histopathological changes. Comparison with renal tissue obtained from 
human analgesic abusers was also performed.
The results from these investigations show for the first time that the 
earliest cell type affected, in BEA-induced RPN in the rat and mouse 
is the medullary interstitial cell in the renal papilla. These cells
(i)
were also affected in the marmoset and pig where only terminal studies 
were undertaken. A degenerative cascade results affecting the medulla, 
cortex (in rats and nude mice) and a pronouced hyperplasia of the 
urothelium of the pelvis and ureter occurs in the rat and pig. Long­
term changes in the rat closely resembled the changes observed in 
tissues from human analgesic abusers.
A series of investigations was performed to try and establish the link 
between RPN and UUC using the classical 2-stage "initiation-promotion" 
model for experimental carcinogenesis.
A specific urothelial carcinogen N-butyl-N-(4-hydroxybutyl)-nitros- 
amine (BBN) was used to initiate the urothelium of Wistar rats, 
followed by an acute BEA-induced RPN. The development of pre­
neoplastic papillary and nodular hyperplasias (within 13 weeks of this 
regimen) and macroscopic transitional cell tumours in the renal 
pelvis and upper ureter (at 30-40 weeks) suggests that the localised 
injury associated with an acute RPN can "promote" an already initiated 
urothelium to induce pre-neoplastic and neoplastic changes. Studies 
where single analgesics were superimposed on to this BBN/BEA regimen 
produced results that suggest that analgesics may exacerbate these RPN 
related changes to induce more severe pre-neoplastic and neoplastic 
changes earlier than with BBN/BEA alone.
A number of possible mechanisms are discussed the light of the data 
from these investigations to link RPN and UUC. Peroxidative 
metabolism of potential carcinogenic compounds seems to be the most 
likely mechanism although the actual mechanistic process is probably 
a complex one with a multifactorial basis.
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CHAPTER 1
INTRODUCTION TO NEPHROTOXICITY AND SUMMARY OF INVESTIGATIONS 
UNDERTAKEN
1.1 NEPHROTOXICITY.
Many chemicals target for specific organs, e.g. kidney, and cause a 
lesion. Organs such as the liver, kidney and lung (which are important 
sites for xenobiotic metabolism and elimination) are, frequent targets 
for chemical toxicity. Targeting may be specifically located to a 
single or discrete cell types within that organ, and could possibly 
be related to the specific functional or metabolic processes within 
these organs or cells.
Nephrotoxicity has been defined as adverse functional and structural 
changes induced directly or indirectly in the kidney by chemical and 
biological agents (or their metabolites) that are inhaled, ingested or 
otherwise absorbed (CEC-IPCS, 1989).
1.2 THE KIDNEY AND NEPHROTOXICITY.
Anatomically and functionally the kidney is an extremely complicated 
organ and these aspects, and many others, have formed the basis for a 
vast amount of literature. For a basic introduction and comprehensive 
reviews on the kidney and nephrotoxicity see Brenner & Rector, (1981), 
Bach et al, (1982), Bach & Lock, (1985, 1987, 1989), Hook & Hewitt, 
(1986) and CEC-IPCS (1989). The primary role of the kidney is the 
regulation of total body homeostasis, particularly the water-solute 
balance, but it also plays a significant role in the excretion of 
metabolic wastes and xenobiotics. The basic functional unit of the 
kidney is the nephron (see Figure 1.1). Any chemical toxicity which 
affects the kidney as a whole will often be initiated at a specific
1
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FIG. 1. This scheme depicts a short-looped and a lon^'-looped neph­
ron together with the collecting system. Not drawn to scale. Within  
the cortex a medullary ray is delineated by a dashed line. 1, Renal 
corpuscle including Bowman’s capsule and the glomerulus (glomerular 
tuft); 2, proximal convoluted tubule; 3, proximal straight tubule; 4 , 
descending thin limb; 5, ascending thin limb; 6, distal straight tubule 
(thick ascending limb); 7, macula densa located within the final portion 
of the thick ascending limb; 8, distal convoluted tubule; 9 , connecting 
tubule; 9 \  connecting tubule of the juxtamedullary nephron that forms 
an arcade; 10, cortical collecting duct; 11, outer medullary collecting 
duct; 12, inner medullary collecting duct.
Figure 1.1 Diagram illustrating the anatomical subdivisions and 
arrangement of different nephrons within the kidney. From Kriz & 
Bankir (IUPS), (1988).
2
region of the nephron. The nephron is a heterogenous structure and is 
divided into several regions: glomeruli, proximal tubule, loops of
Henle, distal tubule, collecting duct. Some of these i.e. P.^, P2 and 
Pg regions of the proximal tubule may be further subdivided. Some 20 
morphologically distinct cell types are found along the length of the 
nephron, there is also heterogeneity between nephrons (Figure 1.1). 
This cellular hetereogeneity exists at the biochemical and functional 
levels, hence it is not surprising to find chemical toxins often 
target for particular groups of cells or specific cells and do not 
affect the adjacent cells. This target cell specificity of different 
chemical nephrotoxins can be seen schematically in Figure 1.2.
There are several reasons for renal sensitivity to chemicals. The 
kidneys comprise only 0.4% of the total body weight in most mammals 
(Rush et al, 1984), but receive 20% of the resting cardiac output. 
This high blood flow dictates that large quantities of systemically 
circulating xenobiotics will be delivered to the kidneys, especially 
in the cortex which receives over 90% of the renal blood flow. The 
kidneys are metabolically very active, performing many important 
biochemical and functional processes and they have the second highest 
oxygen consumption rate per gram/tissue of the large parenchymal 
organs (Cohen & Kamm, 1981). These are some of the factors that 
predispose the kidney to damage by potential nephrotoxic substances. 
The renal medulla receives approximately 10% of the total renal blood 
flow, thus the total amount of chemicals reaching the region may be 
significantly less than the cortex. However this region of the kidney 
is concerned with water and salt reabsorption via the counter current 
mechanism. This may lead to "trapping" of chemicals in the medulla,
3
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Figure 1.2 From Darmady & Mclver, (1980).
which results in a high and potentially toxic concentration of 
certain chemicals.
A chemical may act directly or indirectly on the kidney cells to 
produce a toxic response. A schematic representation of three
possible mechanisms for renal damage from chemical toxicity (Figure
1.3) has been suggested (Rush et al, 1984). First, a chemical may 
enter renal cells and interfere directly with an essential metabolic 
or functional process, resulting in cellular damage (Scheme I) . 
Second, a chemical may be metabolised to a highly reactive 
intermediate that may bind covalently to protein or initiate active 
oxygen species or lipid peroxidation and thus cause cellular damage 
(Scheme II) . Finally, a chemical may be metabolised extra-renally 
to a stable metabolite that may enter the systemic circulation (Scheme 
III) and be transported to the kidney to cause toxicity via either 
scheme I or II (Rush et al, 1984) .
1.2.1 Consequences of Nephrotoxicity.
Over the last decade, the number of toxic nephropathies resulting as 
a direct consequence of exposure to therapeutic agents or 
environmental chemicals has become increasingly discernible.
The cellular response to a toxic insult may vary from a subtle 
biochemical aberration to cell death, resulting in necrosis, fibrosis 
and end stage renal disease. Functionally, toxicity may be reflected 
as a minor alteration in transport capability (eg. transient 
glucosuria, aminoaciduria), as polyuria with decreased concentrating 
capacity, or as frank renal failure with anuria and elevated blood 
urea nitrogen. Depending on the magnitude of the insult, these 
changes may be reversible, permanent or lethal. One renal cell type
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FIGL’RE 1*3 Schematic representation of mechanisms of toxic injury induced by 
xenobiotics.
Figure 1.3 From Rush et al, (1984).
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may be the primary site of nephrotoxic damage, but the consequence of 
the loss of this cell may lead to a change in the maintenance of 
normal renal function resulting in a cascade of degenerative changes. 
These eventually result in secondary effects, many of which may affect 
other distant areas of the kidney and/or cause extra-renal 
abnormalities (Gregg et al, 1990a). Chemically induced acute renal 
papillary necrosis (RPN) is a good example of this nephrotoxic 
sequence of events. The medullary interstitial cell has been 
suggested to be the primary site of damage (Bach & Bridges, 1985), the 
structural and functional loss of which is thought to lead to a total 
medullary necrosis with cortical changes only developing later (Gregg 
et al, 1990a). In patients with analgesic associated RPN there is a 
high incidence of upper urothelial carcinoma (UUC) which is thought to 
be the secondary consequence of RPN and analgesic abuse. This high 
association between analgesic induced RPN and UUC suggests a "cause- 
and-effect" relationship (Bengtsson et al, 1978; McCredie et al, 
1982a,b; Prescott, 1982), but this has not been proven (Bach & 
Bridges, 1985).
1.2.2 Socioeconomic consequences of Nephrotoxicity.
The gravity of the socioeconomic impact of end-stage renal disease 
(ESRD) has just begun to be documented in terms of the annual addition 
of more than 500 000 patients worldwide (CEC-IPCS, 1989). Thus, an 
average of 50-100 new patients are added per million population per 
year in the developed world. There is a scarcity of information from 
developing countries, however it is known that they have a lack of 
treatment facilities. Individual haemodialysis patients presently 
cost the EEC 50,000 European Currency Units (ECU) (£33,000) annually.
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By the end of 1986 there were 65 000 haemodialysis patients in the 
EEC, giving an annual bill of 3,250,000,000 ECU (£2200 million). 
Peritioneal dialysis for 7500 patients costs amounted to 165,000,000
ECU (£99 million) and the costs of transplantation has been calculated
at 127,300,000 ECU for the first year of treatment. These sums
include all hospitalisation periods, medication, but does not account 
for the loss of economic contribution of each patient. It is
envisaged that the numbers of patients will continue to increase, thus 
increasing the already large burden on the medical and health
services. Up to 20% of ESRD has been estimated to have a drug or
chemical aetiology with 50% of all ESRD having no known aetiology it
has been suggested that some of this unknown aetiology is probably due 
to chemical associated nephropathies (Dieperink, 1989) . Analgesic 
associated RPN is a serious nephrotoxic condition, which may lead to 
end-stage renal disease requiring long-term dialysis treatment. It 
is, however, one of a few toxic related nephropathies which is
preventable. An understanding into the mechanism of pathogenesis, 
identifying all possible causative agents, any risk factors that may 
predispose a patient to developing analgesic-associated RPN could help 
reduce the numbers of patients presenting with analgesic-associated 
RPN and the necessity to provide costly health care measures.
1.3 RELEVANCE OF ANIMAL MODELS TO MAN IN TOXICOLOGICAL STUDIES.
Animal models are utilised in toxicological studies in two ways:-
I. To evaluate the general overall effects of compounds on the 
animals, and within the category of acute, subchronic and chronic 
period of administration to determine the order of safety of a 
particular compound i.e. pharmaceutical drugs for therapeutic use.
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II. To elucidate toxicity mechanism(s) at a molecular level in order 
to help provide a rational basis for risk asssessment, methods to 
improve effiacy or safety and also to understand disease processes.
The following guidelines have been suggested by Weil, (1972) for the 
use of experimental animals with regard to toxicological evaluaton 
with relevance to man.
a. The use of one or more species that biologically handle the
material qualitatively as similarly as possible to man.
b. Use several dose levels on the principle that all types of
toxicologic and pharmacologic actions in man and animals are dose 
related.
c. Choose administration routes to test animals which are the same 
as those to which man will be exposed if possible.
There are few recommendations regarding the selection of specific 
species of animals for toxicologic tests but much has been shaped by 
economics, practicality and tradition. In the absence of some specific 
reason for the use of exotic or expensive species such as non-human 
primates, and large animals such as pigs, most toxicity studies are 
performed on rats, mice, (and some on guinea pigs and rabbits and at 
least one non-rodent species such as the dog) . . These species are
relatively inexpensive, easily obtainable, easily handled and there 
is a considerable amount of base-line biological and toxicological 
information available regarding their handling of many classes of 
chemical compounds. The use of genetically identical (inbred) animals 
in toxicology has been strongly advocated as a means of minimising the 
experimental variance attributed to the animals used (Festing, 1979). 
The use of strains which are sensitive or resistant to particular 
drugs or chemicals may offer valuable information about the mechanism
of toxicity which could be relevant to man (Festing, 1981) . The 
region of the nephron affected by the'nephrotoxin may have a bearing 
on the choice of species since the structural and functional 
characteristics of the nephron may prove to be a more suitable in a 
particular species to investigate the mechanism of nephrotoxicity 
(Schmidt-Nielsen, 1989).
The rat has several advantages which make it the primary choice of 
animal model for nephrotoxicity studies. It has a relatively simple 
renal morphology (unipapillate kidney compared to the multipapillate 
kidneys of man and pig) and several nephrotoxicity models are already 
well established and widely reported. The evaluation of the effects 
of a chemical on normal renal function can be determined using a 
broad spectrum of experimental investigative techniques. 
Abnormalities of total renal function can be determined using a 
battery of tests (all used clinically) on collected urine samples such 
as measurement of urine volume, urinary pH, urinary osmolality, 
electrolyte excretion, sugar excretion, protein excretion, and the 
appearance of enzymes in urine. Enzymuria can pinpoint a specific 
site of injury (eg trehalase, maltase identifying proximal tubular 
damages) but one must be aware of possible extra-renal sources of any 
enzymes. Specific effects on the kidney function can be determined on 
anaesthetised animals such as the assessment of glomerular filtration
rate using inulin or ^^Tc-DTPA renography, and renal blood flow using
, 1 3 1
para-ammohippurate clearance or I-hippuran renography.
Histopathological examination of renal tissues after terminal
sacrifice can provide vital information with regard to renal integrity
and where the site of damage occurred. Histopathology may often
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identify a lesion where no apparent functional changes were observed 
from functional tests. In renal papillary necrosis, histopathological 
examination currently offers the best means of identifying the early 
onset of this lesion, due to the focal nature of this lesion and the 
lack of any specific functional changes.
In a review concerned with the relevance of animal models to 
analgesic-associated renal papillary necrosis in humans, Bach & Hardy 
(1985), suggest "Animal models offer a potentially important means by 
which to understand the pathomechanism of RPN and provide a model 
system to improve the early diagnosis of the lesion to identify which 
analgesic(s) have the greatest papillotoxic potential and what factors 
exacerbate its development or contribute to the secondary consequences 
of papillary damage".
Analgesic abuse leads to the development of RPN (see Chapter 2, 
section 2.1) and may cause upper urothelial carcinoma (UUC) (see 
Chapter 2, section 2.2), the mechanisms of the pathogenic changes are 
not fully understood. Medical ethics dictate against the use of man. 
The answer is, therefore, to study reproducible animal models of RPN 
in the laboratory situation which can be utilised to determine the 
mechanism of the lesion. There are many questions to be evaluated such 
as: -
I. The pathogenic changes occurring during the onset of RPN.
a) what are the earliest necrotic changes?
b) is RPN initiated by similar mechanisms in different species?
c) what other factors affect the progression of RPN?
II. The relationship between RPN and UUC.
a) Does RPN progress to UUC?
b) is it possible to produce a model of UUC from an RPN model?
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III. Is it possible to evolve preventive and therapeutic procedures? 
These questions have formed the focus of investigations described 
below.
1.4 SUMMARY OF INVESTIGATIONS.
1.4.1 Chemically induced RPN in the rat
A time course study of a 2-bromoethanamine (BEA) hydrobromide induced 
RPN lesion in the Wistar rat (see Methods section 3.6.1), was 
conducted to answer some of these questions.
Previous studies on the development of BEA-induced RPN used relatively 
few time points and routine wax embedded tissue sections (> 5um) often 
precluded a detailed morphological evaluation. There is also a 
paucity of data on enzyme histochemical changes associated with the 
development of RPN.
This time course study has allowed the re-evaluation of an acute 
papillary necrosis using glycolmethacrylate embedded sections to 
provide unprecedented detail of the pathological changes. 
Furthermore, the ability to combine 'routine' staining with selective 
enzyme histochemistry on serial semi-thin (lum) sections enhances the 
ability to inter-relate changes in different cell types during the 
course of the development of degenerative processes that lead to RPN. 
The earliest histopathological changes (see Results section 4.1.1) 
occurred in the medullary interstitial cells in the papilla tip, and 
in the interstitial matrix. A cascade of necrotic changes followed; 
producing frank RPN. Hyperplasia of the pelvic and ureteric 
urothelium occurred as a secondary consequence of this lesion.
1.4.2 Chemically induced RPN in the mouse.
For experimental details see Methods sections 3.6.2.1 and 3.6.2.3.
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C57B1/6 mice have been reported to metabolise phenacetin via a similar 
pathway as in man, and are also prone to developing renal papillary 
necrosis (RPN) after dosing with phenacetin (Macklin & Szot, 1980) . 
An investigation into whether this mouse strain was sensitive to the 
papillotoxin, 2-bromoethanamine (BEA), was undertaken to determine if 
it would be a suitable animal model for studies into the pathogenetic 
mechanism of analgesic nephropathy. Obese mice (ob/ob) are a random 
bred mouse strain derived from C57B1/6 mice which have the genetic 
potential to become obese, and they may also develop diabetes (Flatt & 
Bailey, 1981). Diabetics are prone to developing a number of 
nephropathies (including RPN). It was of interest to use the ob/ob 
strain to see whether they were more sensitive to BEA and whether 
there was any difference in sensitivity between the random outbred 
strain (ob/ob) and the inbred parent strain (C57B1/6).
In the mouse (see Results section 4.2.2) BEA caused necrosis of renal 
medullary interstitial cells associated with increased staining for 
interstitial cell matrix. Frank RPN was not observed at the time 
points studied. However, cortical changes not normally observed in 
the Wistar rat until after the onset of total RPN were evident in the 
mouse strains. A strain difference in susceptibility to BEA was seen: 
C57BL/6 > Obese > BALB/c. These strain differences in BEA toxicity
are suggested to be due to metabolic differences between the strains. 
Genetic differences may also influence this sensitivity; obese mice 
are derived from the C57B1/6 strain so out-breeding may confer some 
protection possibly due to hybrid vigour.
1.4.3 Chemically induced RPN in nude mice.
For experimental details see Methods section 3.6.2.2 and Results
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section 4.2.3. By contrast the nude mouse showed the potential of the 
role of the immune system in renal papillary necrosis. Unexpectedly 
the Nude mouse develops both an RPN and a cortical necrosis of the P2 
and Pg segments. This unique response could be exploited to better 
understand the role of biochemical charactersitics along the nephron 
in the targeting of BEA, and the role of the immune system in 
nephrotoxicity.
1.4.4 Chemically induced RPN in the marmoset.
The marmoset is the smallest living primate and has a unipapillate 
kidney. It combines the attributes of having a simple kidney 
structure to examine pathologically and also being a primate therefore 
being distantly related to man. As such it offers the potential to be 
a novel animal model on which to investigate acutely induced RPN in an 
attempt to extrapolate the findings to the clinical condition 
analgesic nephropathy. The administration of BEA (see Methods 
section 3.6.3) at doses of 50 and 100 mg/kg did not induce frank RPN 
(see Results section 4.3), only minimal changes in the capillaries and 
matrix which would be concomittant with an early RPN lesion in the 
rat. The most prominent change was a hyperplasia of the covering
epithelium of the papilla ridge. With only two animals in this study
the results are interesting but without control data one cannot 
postulate too strongly on the significance of these few results.
1.4.5 Chemically induced RPN in the pig.
1.4.5.1 BEA induced RPN.
These studies (see Methods sections 3.6.4.2-3.6.4.5) showed that BEA 
caused a sub-acute RPN in the pig (see Results section 4.4.3) which 
took 7-14 days to develop compared to 24-48 hr in the rat. Moreover
the lesion did not progress to frank necrosis as in the rat.
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1.4.5.2 Effect of superimposing analgesic dosing on a BEA 
induced RPN lesion.
RPN was induced acutely in pigs using BEA, and these animals were 
dosed for 28 days with paracetamol (acetminophen) to assess the 
effect of superimposing this analgesic drug on porcine renal function 
(see Methods section 3.6.4.6).
Necrosis of interstitial cell nuclei, interstitial matrix and thick 
ascending limb together with hyperplasia of the pelvic and ureteric 
urothelia with extensive vacuolation was observed (see Results section
4.4.3) after BEA and BEA/paracetamol treatment. These animals also 
exhibited a significant increase in effective renal plasma flow 
compared with that observed in the age-matched controls. There was no 
significant difference in the overall response in glomerular flow rate 
between the groups. These findings suggest that subsequent 
paracetamol dosing does not enhance BEA-induced RPN in the pig. BEA 
induces urothelial hyperplastic changes despite the lack of a gross 
RPN lesion. The pig is thus less sensitive to papillotoxins than the 
rat. The multipapillate pig kidney is more similar to that of man, 
implying that the use of acute RPN rodent "models" for analgesic 
nephropathy may not be justified.
1.5 EXPERIMENTAL UPPER UROTHELIAL CARCINOGENESIS STUDIES.
Studies (see Methods 3.6.5) into how RPN progresses to UUC, were based 
on the 'classical' 2-stage initiation-promotion protocol used in skin 
and bladder experimental carcinogenesis (see section 2.3.4). A marked 
hyperplasia of the pelvic and ureter urothelium occurs after BEA 
induced RPN, atypical urothelium may persist up to 40 weeks after BEA 
but UUC does not develop. Results (Chapter 5, section 5.1-5.5) showed
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that 6 weeks after this protocol papillary/nodular hyperplasia 
occurred in the ureteric urothelium, this had progressed by 13 weeks 
to include 'invasive' foci which were lacking alkaline phosphatase 
(which is reported to be a preneoplastic 'marker' change in urothelium 
(Kunze, 1979) . By 21 weeks bladder tumours were present, and pelvic 
tumours with dyplasia and upper urothelial tumours were observed at 40 
weeks.
These results suggest that an acute RPN lesion can promote urothelial 
malignant changes including full blown tumours. This system has been 
used to evaluate the effects of chronic dosing of analgesics on the 
development of upper urothelial tumours (see Methods sections 3.6.5.3 
and 3.6.5.5) .
Early results (see Results section 5.3) with paracetamol and aspirin 
dosing suggest that subsequent analgesic dosing exacerbates the 
progression of UUC.
Attempts to increase the yield of tumour tissue by xenografting into 
nude mice (see Methods section 3.6.6) or growing tumour cells in 
culture from tumour explants were undertaken. Tumours were 
successfully transplanted (see Results section 5.6) and growth of the 
tumours occurred in 2/21 animals transplanted, but failed to progress 
beyond one passage step. Tumours were slow growing but identical to 
the donor tumours with respect to morphology (at the light and 
ultrastructural level) and histochemistry. Although tumour cells 
initially grew successfully in culture, bacterial contamination meant 
that no cells survived to establish a tumour cell line.
Chapter 2 reviews the literature on analgesic associated renal 
papillary necrosis and upper urothelial carcinoma, and chemical 
carcinogenesis.
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CHAPTER 2
RENAL PAPILLARY NECROSIS, UPPER UROTHELIAL CARCINOMA AND CHEMICAL 
CARCINOGENESIS
2.1 RENAL PAPILLARY NECROSIS (RPN).
2.1.1 Introduction.
Renal papillary necrosis (RPN) is a clinicopathological syndrome which 
was first described over one hundred years ago by von Friedriech 
(1877) and Turner (1888). Subsequently RPN was also frequently 
associated with diabetes mellitus and obstructive uropathy (Gunther, 
1937) .
Mandel (1952) reviewed 180 cases of RPN and agreed with the findings 
of Gunther and Froboese, but also suggested that bacterial toxins 
released into the urinary tract may have a significant role to play in 
cell death and necrosis. RPN may have a number of other possible 
different causes (Table 2.1).
However, since then it has become clear that the abusive intake of 
mixed analgesics is by far the most frequent cause of RPN. Spuhler & 
Zollinger (1953) first drew attention to this when they reported on 
the increased incidence of chronic interstitial nephritis associated 
with an abusive intake of mixed analgesics. Phenacetin was found to 
be common to all these mixed analgesics and similar findings by other 
researchers led the condition to be dubbed "phenacetin kidney". The 
assumption that phenacetin was the single common denominator that 
caused RPN was a concept that was to retard research into RPN for 
many years.
It soon became apparent that other analgesics had the potential to 
cause RPN (Gilman, 1964). Together with the suggestion that the
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Frequently reported
Diabetes mellitus 
Analgesic abuse
High dose nonsteroidal anti-inflammatory drug therapy therapy 
Upper urinary tract obstructive uropathy (may be of consequence) 
Recurrent urinary tract infection (may be of consequence)
Sickle cell hemoglobinopathy
Acute pyelonephritis (may be superimposed)
Dehydrated newborn infants (frequently jaundiced)
Less frequently reported
Renal vein thromboses 
Chronic alcoholism
Dehydration in children (diarrhea loss of Cl , also K+)
Severe jaundice 
Calyceal arthritis 
Glomerulonephritis 
Systemic candidosis 
Trauma
Prolonged hypotension 
Dapsone
Table 2.1 Factors relating to the development of RPN. From Bach & 
Bridges, (1985).
initial lesion was in the papilla and the so called "interstitial 
nephritis" was due to the atrophy of nephrons affected by RPN 
(Kincaid-Smith, 1967). The concept that the primary lesion
associated with analgesic abuse is RPN, and interstitial nephritis is 
a secondary conseqeuence has now been widely accepted (Burry et al, 
1977; Burry, 1978; Gloor, 1978).
The identification of the causative agent for RPN has been complicated 
by the fact that patients abused and/or were prescribed mixed 
analgesics and a number of non steroidal anti-inflammatory drugs 
(NSAID) (Cove-Smith & Knapp, 1973; Nanra & Kincaid-Smith 1975; Nanra 
et al, 1980). A reduction in the availability of phenacetin in mixed 
analgesics occurred in Finland, Sweden and Denmark from 1961 and other 
countries followed suite over the next 25 years. In the Federal 
Republic of Germany,^  for example, phenacetin has only just been banned
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in 1986. However as Prescott (1982) points out the withdrawal of 
phenacetin did not significantly reduce the number of deaths from RPN 
either early or advanced, where analgesic abuse continued on a large 
scale, also withdrawing a drug would not change the course of a 
disease already well advanced towards chronic renal failure. 
Paracetamol (acetaminophen) has largely replaced phenacetin in anal­
gesic mixtures and several studies have implicated this compound as 
the initiating agent in the pathogenesis of RPN (Krikler, 1967; 
Axelsen, 1975; Masters & Krikler, 1973; Rosner, 1976; Duggin, 1977; 
Molland, 1978; Nanra et al, 1978; Dubach et al, 1983). Rosner (1976) 
formed the opinion that paracetamol was the inital link, because it is 
a major metabolite of phenacetin and concentrated in the medulla 
(where the first pathological changes appear) whereas phenacetin is 
not concentrated in the medulla to the same extent (Gault, 1971) .
To date at least thirty-six (36) therapeutically used agents (see 
Table 2.2) have been implicated in causing RPN in animals and man.
This list is likely to be larger as each year a few new classes of
papillotoxins are reported eg 1-Napthol (Poole & Buckley, 1989) and L- 
triidothyronine (L-Tg) (Kennedy & Jones, 1989) and there are examples 
of new therapeutic agents currently undergoing toxicity screening 
which must remain confidential. Evidence also points to other
extremely common (and easily available) drugs such as aspirin, also 
having the potential to be papillotoxic. Rheumatic patients find this 
drug a good pain reliever which can be purchased over the counter and 
is therefore easily open to 'abuse'. Abuse in context with
rheumatoid arthritic sufferers is a bit of a misnomer, as large
quantities of analgesics are often prescribed and may have to be
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consumed to combat the pain. Nanra & Kincaid-Smith, (1975), found
that 60% of rheumatic 
autopsy tissue.
patients had RPN in a retrospective study oJ
Acetaminophen 4-Isopropylbiphenyl
Aclofenac Ketophenbutazone
Aminopyrine Ketoprofen
5-Aminosalicylic acid Meclofenamic acid
Antipyrine Mefanamic acid
Aspirin Mono-N-methylaniline
Aspirin, phenacetin and codeine Naproxen
Aspirin, phenacetin and caffeine Niflumic acid
Aspirin and pentazocine Oxyphenbutazone
Bucloxic acid Phenacetin
Cyclophosphamide Phenothiazine
Dapsone Phenylalkanoic acid
Dextropropoxyphene Phenylbutazone
Fenoprofen Sudoxicam
Flufenamic Sulfinpyrazone
Glaphenine Tetrahydroxyquinoline
Ibruprofen Tolfenamic acid
Indomethacin Tolmetin
Table 2.2 Therapeutically administered analgesics, NSAID, and other 
drugs and chemicals implicated with a direct papillotoxic potential. 
From Bach & Bridges, (1985)
Aspirin has also been implicated in causing RPN in arthritic children 
together with administered paracetamol and NSAID (Wortman et al, 
1980; Allen et al, 1986; Bailie, 1986). Long-term feeding studies 
with aspirin and aspirin-containing compounds by (Nanra & Kincaid- 
Smith, 1970; Molland, 1978) showed that aspirin did cause RPN in rats 
and suggested it may be an important aetiological factor in the 
clinical syndrome. Prescott (1982) also concluded that aspirin caused 
RPN in experimental animals and despite the considerable of evidence 
available for the role of aspirin as a causative agent of RPN in man 
"there is a curious reluctance to accept the nephrotoxicity of 
aspirin" especially based.on a NIH consensus conference (NIH, 1984). 
The contribution of therapeutic doses of NSAID to the development of
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RPN has been increasingly apparent over the years, with a considerable 
amount of evidence that now supports this hypothesis (Shelley, 1978; 
Prescott, 1979, 1982; Robertson et al, 1980; Erwin & Boulton-Jones,
1982; Mitchell et al, 1982; Bach & Bridges, 1985).
Attempts have been made to explain the reasons behind analgesic abuse 
(Prescott, 1982). It was originally linked with the misguided use of 
these drugs in an attempt to increase productivity and reduce strain 
in working environments such as watch factories (Gsell, 1974; 
Kielholz, 1957), heavy industry in Sweden (Grimlund, 1963) and the 
textile mills of Atlanta where analgesics were also distributed free 
to the workers (Fellner & Tuttle, 1969).
Only a minority of patients with analgesic nephropathy have taken the 
drugs for genuine indications such as arthritis, headaches or migraine 
in most other cases, however, analgesics have been taken because of 
their "pick me up" value and frequently used inappropriately. 
However, the stigma of being identified as an abuser have often 
resulted in the patients providing unreliable or misleading data 
(Murray, 1974, 1978; Schwarz et al, 1988). The success of several
of the recent epidemiological investigations has, in fact, depended 
on the close association between a sympathetic history taker and 
patients who did not feel threatened by being identified as an 
analgesic abuser (Sandler et al, 1989; Schwarz et al, 1984, 1988;
Elseviers & De Broe, 1987, 1988). The origins of analgesic abuse are 
usually psychosocial and patients have been variously described as 
neurotic, dependant, immature, introverted, anxious or depressed. 
Many have been said to have personality disorders and up to 20% may 
have psychiatric illness. Other addictive habits such as smoking 
(Fellner & Tuttle, ,1969; Clarkson & Lawrence, 1970; Murray, 1974),
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alcoholism (Clarkson & Lawrence, 1970; Murray, .1974) and use of 
psychotrophic drugs and sleeping tablets have been associated with 
analgesic abuse. Women in their middle age years (40 - 50) are
predominantly the largest group in populations who abuse analgesics 
and suffer RPN. Studies from DeBroe and coworkers in Belgium are 
unique in that they have a large group of co-operative analgesic 
abusers contributing to a prospective case control study. The
patients are generally females of the lower socio-economic group, 60% 
of whom complained of headaches, although they admitted using these 
analgesic mixtures (especially powders) inappropriately, for 4-56 
years. In 1983 the total sales volume of analgesic compounds in 
Belgium amounted to 2 6 million packages. On average this
represents 2.6 packages or approximately 25 g per capita per year. 
While single analgesics were sold mostly in the south of the 
country, analgesic mixtures comprised 63% of the total sales and were 
largely formulated as tablets. These were sold almost equally 
throughout the country, whereas analgesic mixture powders were the 
most commonly abused product, especially in the north of the country 
(Elseviers & De Broe, 1987, 1988) . Since 1972 the sales of analgesics 
containing phenacetin reduced progressively to 21% (in 1976), 9% (in
1983) and less than 3% in 1987. Nevertheless, the prevalence of
analgesic nephropathy in dialysis patients in Belgium remained at
the same level (18-20%) between 1979 and 1984. These data strongly
support the concept that phenacetin was not the most important 
aetiological factor in the genesis of the lesion (Elseviers & De Broe 
1987, 1988).
Environmental factors have also been implicated in RPN such as
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dehydration, high temperatures, bacterial infection and diet (Burry et 
al, 1977; Eknoyan et al, 1982; Molland, 1982; Thomas & Tange, 1985) it 
is clear that RPN is a complex disease state the pathogenic mechanism 
of which can only be postulated on and will be discussed later. 
Clinical evidence shows that the prognosis for patients who continue 
to abuse analgesics (after RPN has been diagnosed) is very poor. This 
rapidly' leads to end-stage renal disease (Nanra & Kincaid-Smith, 1972; 
Murray & Goldberg, 1975; Burry et al, 1977; Bach & Bridges, 1985) .
2.1.2 Analgesic Associated RPN in Han.
2.1.2.1 Epidemiological evidence on RPN.
The national prevalence of analgesic-associated end stage renal 
disease can be grouped into 3 classes: low < 5% (USA, Canada, France,
Great Britain, Italy, Scandinavia, Spain); moderate 11-15% (Australia, 
Federal Republic of Germany) and high > 16% (Belgium, Switzerland). 
The occurrence of this condition may, however, be severely under­
estimated (Cove-Smith & Knapp, 1978, Bucchianti et al, 1987; Wing et 
al, 198 9) in those countries where the prevalence is reported to be 
low. There is also a marked regional heterogeneity in the documented 
prevalence in some countries. For example, in the Federal Republic 
of Germany abuse is highest in Berlin and lowest in Bavaria (Pommer 
et al, 1986, 1989a,b; Schwarz, 1987) (Figure 2.1), whereas in Belgium 
dialysis units report the maximum frequency as 51% in the north of 
the country (Figure 2.2), but < 4% in some part of the south, giving a 
national average figure of about 20% (Elseviers & De Broe, 1987, 
1988). Thus the national average does not reflect the pockets of high 
frequency.
Over the last decade there have been a number of carefully controlled
23
Schletwig - Holstein
6.08 pmp
Hamburg 
26.2b pmpBremen
20.0 pmp Niedersachsen 
17.95 pmp
Berlin (W) 
37.37 pmp
Nordrhein - Westfalen
13.5® pmp A
Hessen
14.64 prrp
Bayern 
5.55 pmp
Rheinland - Pfalz
7.22 pmp
Saarland
0.00 pmp
Baden • Wurttemberg 
10.22 pmp
Fjg. 2. Prevalence o f terminal analgesic nephropathy in the Federal Republic o f Germanv (1986) 
Reproduced, with permission, from Ref. 12; pmp, per million population.
Figure 2.1 From Pommer et al, (1986) .
Brugge Gent 
“  ^ '0 6
'  Hcsselt
Mors
'Arlon
Fig. 1. Analgesic nephropathy as a cause o f end-stage renal failure in Belgium (1984). From Ref. 11. 
Population. 10 m illion; area, 30 513 k n r; chronic dialysis units ( • ) ,  54; total numbers o f patients under 
chronic dialysis, 2334; (O )  and number, patients with end-stage renal failure caused by analgesic 
nephropathy expressed as o f patients treated in the dialysis unit(s).
Figure 2.2 From Elseviers & De Broe, (1988).
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epidemiological investigations that have supported some of the "gut 
feelings" about the condition, but there does appear to be important 
national differences that may well occur in other parts of the world. 
For example, case-control studies from Germany (Pommer et al, 1989a,b) 
have confirmed an increased risk associated with the abusive 
consumption of either phenacetin or paracetamol in mixed analgesics or 
with phenacetin alone, but there was no data on NSAID. By contrast 
in Australia (McCredie & Stewart, 1988) found only phenacetin- 
containing mixed analgesics increased risk. Regular heavy use of 
analgesics is reported to be common in the Southeastern USA, 
especially North Carolina, where analgesic abuse has been implicated 
in at least 10% of end stage renal disease (Gonwa et al, 1981), which 
is much greater than the national prevalence for the United States. 
The reasons for such abuse included increased workplace and social 
environments which encourages heavy use of analgesics.
Recently published data from Sandler et al, (1989) reported on over 
500 patients (30-79 years), 28% of whom had chronic renal disease, as 
assessed by a sustained elevation in serum creatinine (>1.5 mg/dl or 
130 umol). The diagnosed cause of the chronic renal disease was 
hypertensive nephrosclerosis - 19%, diabetic nephropathy - 20%, 
glomerulonephritis - 14%, and interstitial nephritis - 19%. These 
patients were compared to an age, race and sex matched control group 
(> 500) who were telephone screened to obtain information about
specific analgesic and NSAID use. Daily users were defined as those 
who took analgesics for > 360 consecutive days and weekly users took 
pain reliever at least once a week for as long as a year. There was 
no reported consideration of either the quantity of analgesic consumed 
or the duration of abuse. Odds ratios were used to assess the
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relative risk associated with daily or weekly use compared to 
infrequent use of a particular product. Daily use of any analgesic 
increased relative risk to 2.8. The relative risk was 3.2 with
paracetamol, 5.1 with phenacetin, but only 1.3 for aspirin. Daily 
NSAID use in men showed a relative risk of 4.6, which increased to
16.6 if they were aged > 65 years. The risk associated with NSAID 
use was higher for interstitial nephritis 3.9, renal insufficiency 
2.5. If daily NSAID use was sub-stratified to males the risk of 
interstitial nephritis was 13.0. For the whole group the risk of 
chronic renal disease was 3.6 for daily users of ibuprofen, but only
1.6 for indomethacin despite the fact that it was more commonly used. 
Stratifying for the male sub-group, ibuprofen users had a relative 
risk of 9.0 compared to 3.7 for indomethacin. These data highlight 
older men as the population at greatest risk, but gives no indication 
of why this should be. The increased risk associated with NSAID 
consumption is consistent with a number of case-reports and with 
animal studies (Brandstetter & Mar, 1978; Kimberly et al, 1978; 
Wiseman & Reinert, 1975; Nanra et al, 1978; Wortman et al, 1980; 
Gunson, 1983; Adams et al, 1986; Allen et al, 1986; Bailie, 1986). 
The greater risk for interstitial nephritis is consistent with several 
proposed mechanisms for renal injury from NSAID (Clive & Stoff, 1984; 
Bender et al, 1984; Orme 1986), especially those that believe that the 
reduction of renal blood flow leads to ischaemic injury in the 
medulla. The increasing availability of over-the-counter NSAID will 
probably lead to markedly higher and inappropriate use of these drugs. 
At present there is no clear way of knowing if such excessive use of 
these compounds in the general population will cause renal papillary
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necrosis, exacerbate existing renal disease or have no effect on it. 
Analgesic nephropathy accounts for 44% of patients in some German 
outpatient clinics where 21% of patients had paracetamol metabolites 
in their urine. Groups of patients who discontinued or continued 
analgesic abuse were followed for > 50 months (Pommer et al, 1986, 
1989a,b; Schwarz, 1987) . Renal function declined more rapidly in
those who continued to abuse, they had recurrent urinary tract 
infection, severe hypertension was more common, and mortality was 
greater. Individuals who stopped abusing showed improved renal
function (Cove-Smith & Knapp, 1978; Kimberly et al, 197 8; Schwarz, 
1987), but because of an increased survival these patients may be at 
greater risk of developing upper urothelial carcinoma.
2.1.2.2 Clinical symptoms and diagnosis of RPN.
The diagnosis of RPN is difficult because of the insidious nature in
its development; it progresses silently, over prolonged long time
periods (Gault et al, 1968; Duggin, 1977, 1980; Kincaid-Smith, 1979;
Bach & Bridges, 1985) the clinical situation. One early clinical sign
of analgesic nephropathy is the loss of urine concentrating capacity
(Bengtsson, 1962; Dubach et al, 1975; Nanra et al, 1978; Nanra,
1980). Polyuria may, however, be a consequence of several
nephropathies, and loss of the concentrating mechanism may have a
number of renal and extra-renal causes. RPN is also associated with
electrolyte disturbances. Cove-Smith & Knapp, (1973) reported a
high incidence of sodium wastage and Jaeger et al, (1982) showed that
patients were hypocalcaemic as a result of a urinary calcium ion 
2 +(Ca ) loss. Patients with analgesic nephropathy have a pronounced 
defect in the urinary acidification mechanism following ammonium
chloride administration (Bengtsson, 1962; Steele et al, 1969; 
Krishnaswamy et al, 1976; Nanra et al, 1978; Nanra, 1980) suggesting 
that damage to the medulla might be synonymous with loss of effective 
urinary acidification and altered electrolyte balance. Other classical 
clinical biochemical parameters used to diagnose renal disease (such 
as creatinine, blood urea nitrogen) only identify incipient renal 
failure, by which time papillary necrosis has long since occurred and 
the secondary degenerative change that follow this lesion have 
progressed towards end-stage renal disease. There are few tell-tale 
clinical symptoms, (Table 2.3), none of which are pathognomonic of the 
condition.
Degenerative renal changes may^be identified by radiology (Lindvall, 
1978), but these are essentially indicative of an advanced lesion, and 
they may miss early, but frank RPN. The most dependable method of 
assessing analgesic related disease is by detailed patient histories, 
but the stigma of analgesic abuse normally leads to patients giving 
unreliable or misleading data on their drug usage (Murray, 1974,
1978) .
New techniques such as ultrasound scanning and nuclear magnetic 
resonance (NMR) imaging and ^H-NMR spectroscopy of urine samples which 
are also non-invasive techniques may in the future broaden our 
persepective on RPN and lead to earlier diagnosis.
Pathology remains the most reliable method to diagnose RPN 
unfortunately it is generally performed at post mortem, and only 
serves to confirm that RPN-related end-stage-renal disease was the 
cause of death. However, the renal papillae are often inadequately 
sampled and examined since a coronal section of the kidney may only 
reveal a few papillae.
Clinical features associated with RPN Incidence
Early symptoms
Females predominate 3:1 to 8:1; most common 40 to 60 yr; 
Psychiatric abnormalities: immaturity, dependence,
emotional instability, anxiety, headaches3, introversion 
and neurosis.
U
Upper gastrointestinal disease: peptic ulceration of
stomach or duodenum and dyspepsia.
Anaemia: gastrointestinal b l e e d i n g * 3 ,  haemolysis, iron
deficiency and cyanosis*3.
Intermediate symptoms
Urinary tract disease: bacteriuria, sterile pyuria, 
nocturia, dysuria, microscopic haematuria, ureteral 
colic, and lower back pains.
Urinanalysis: defect in ability to concentrate and
acidify urine, proteinuria, nocturia and uraemia.
Late symptoms
Hypertension
Cardiovascular manifestations, ischaemic heart disease 
and peripheral vascular disease 
Renal caliculi and bladder stones
Renal malfunction: decreased GFR, increased BUN, renal
tubular manifestion and ESRD 
Renal osteodystrophy and bone pain 
Carcinoma of renal pelvis
Acute renal failure: especially after renal surgery
a: possibly caffeine withdrawal related; b: direct secondary
consequence of high dose analgesic intake; GFR: glomerular filtration 
rate; BUN: blood urea nitrogen; ESRD: end stage renal disease.
Table 2.3 Clinical features associated with RPN.
Lomax-Smith & Seymour, (1980a) recommend taking transverse sections 
also to expose the hidden papillae (see Figure 3.2, in Methods, 
section 3.6.4.2). To identify the focal lesions within the papillae 
it is necessary to take histological sections which include the 
papilla tip (with ducts of Bellini) in addition to the cortex and 
outer medulla, this makes the cutting of sections for the diagnosis of 
RPN very time consuming.
2.1.2.3 The Pathology of RPN in Man.
The pathological course of RPN has been well documented (Gloor, 1978;
Very high
Up to 8 6% 
Up to 60%
Up to 100%
Up to 70% 
High
High
High
High
High
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Burry et al, 1977; Burry, 1978) and confirms that the lesion is 
primarily one which begins at the apex or tip of the papilla. Burry 
(1968) defined these pathological changes in terms of early, 
intermediate and total RPN.
a). Early RPN: is evident as necrotic/degenerative changes to
interstitial cell nuclei, loops of Henle and capillaries in the 
papilla tip. Changes in staining intensity of matrix ground
substance of the interstitium have been described; in terms of an 
increase in intensity (Burry, 1968; Burry et al, 1977) whereas Gloor 
(.1978) reported a loss of this matrix ground substance. Accumulation 
of lipid material was also evident at this stage in collecting duct 
cells (see Figure 2.3a).
b). Intermediate RPN: occurs when more anatomical elements of the 
medulla become necrosed as the lesion progresses into the outer 
medulla, which may show signs of atrophy, sclerosis and inflaxnmatory 
response. Calcium deposits become extensive in the necrotic tip areas 
which may lead to bone formation. The papilla is often termed a 
'ghost papilla' because of the increasing loss of tissue integrity. 
The ghost papilla may slough, reside in the pelvic space and be 
subsequently calcified to become a pelvic calculi, or be excreted and 
found in the urine. Whether the papilla remains attached or sloughs, 
a re-epithelialisation at the junction of viable and necrosed tissue 
frequently occurs which is comprised of transitional epithelium (see 
Figure 2.3b)
c). Total RPN: these changes progress to affect the outer medulla 
often up to the cortico-medullary junction on a crescentric line. 
Cortical changes become apparent when the papilla is totally necrosed
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and depends on the degree of fibrosis and sclerosis at the line of 
sequestration (if the papilla is sloughed). A loss of proximal 
tubular enzymes are often detectable in the cortex, but these changes 
only occur late in the development of RPN. Histologically the 
cortical and medullary changes are characterized as "chronic 
interstitial nephritis" (see Figure 2.3c). Tubular dilatation, 
atrophy, basement membrane thickening, sclerosis, fibrosis, 
inflammatory cell infiltration and vascular degeneration are the 
typical histological changes associated with chronic interstitial 
nephritis in the cortex as a consequence of the underlying RPN.
In addition, histological changes in the pelvic, ureteric and bladder 
urothelium have been reported (Johansson et al, 1976; Gloor, 1978; 
Mihatsch et al, 1978, 1984; Fourie et al, 1982; Johansson et al, 1986) 
which supports the hypothesis that RPN and UUC are linked by a common 
initiating factor of analgesic abuse (see Section 3.3). These 
changes include thickening of capillary walls (Mithatsch et al, 1978,
1979), sclerosis of lamina propria together with an altered fat and 
collagen deposition. A range of disordered epithelial states from 
hyperplasia through to malignancy and tumour growth have been 
described (Erikson & Johansson, 1976; Johansson et al, 1976; Bengtsson 
et al, 1978; Lomax-Smith & Seymour, 1980a,b; Hicks, 1980, 1983a,b; 
Blohme & Johansson, 1981) - these are considered below (see section 
2 .2).
2.1.3 Animal models of RPN.
2.1.3.1 Spontaneous models of RPN.
RPN occurs spontaneously. in animals as a result of a variety of 
conditions. These include age (Gorer, 1940) and amyloid .(Dunn, 1944;
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Cornelius, 1970) related changes in mice, and changes that are a 
consequence of medullary bilirubin deposition (and perhaps other 
biochemical effects) in the Gunn rat (Axelsen & Burry, 1972; Axelsen, 
1973; Henry & Tange, 1982) In addition, systemic candidosis also 
causes necrosis of the medulla (Tomashefski & Abromowsky, 1981) . It 
has previously been reported that vascular occlusion (Beswick & 
Schatzki, 1960), ureteral obstruction (Dziukas et al, 1982) and the 
injection of heterologous serum into rats (Ljungqvist et al., 1966, 
1967) also cause RPN. A critical analysis of these data (Bach & 
Bridges, 1985), however, suggests that the medullary infarct 
associated with all of these models differs from the chemically 
induced RPN, and is more comparable to the 'warm ischaemic' renal 
lesion (Mason & Thiel, 1982). It would still be valuable for these 
lesions to be more fully studied by histochemical methods, at both the 
light and ultrastructural levels, to establish the nature of the 
changes, and where they may be similar to the chemically induced 
lesion. The long-term feeding of rats with a diet deficient in
essential fatty acids (Molland, 1982) also causes RPN, but the 
widespead degenerative changes in most of the major organ systems 
makes this a most complex experimental model.
2.1.3.2 Experimental models of RPN.
2.1.3.2.A Analgesic and non-steroidal anti-inflammatory induced RPN.
When analgesics such as aspirin, phenacetin and paracetamol were 
administered to rats, RPN was often induced, but only after prolonged 
inappropriately high non-clinical doses (Prescott, 1982). Many 
months of dosing may be required to induce the lesion (Rosner, 1976) 
and even then biological variation within the groups resulted in 
animals being affected to different degrees (Table 2.4). High doses
of these drugs often resulted in fatalities in experimental animals 
due to extra-renal toxicity such as gastric ulceration and perforation 
(Kaump, 1966).
Preparation Oral daily dose 
(mg/kg)
Duration
(weeks)
RPN (%)
Compound analgesics
A + P + C/A + P 280- 900 8-72 37.5-100a
A + NAPA + C/A + NAPA 500- 900 12-72 56.3-100a
A + salicylamide + C 840 12-72 53.9
Antipyrine + P + C 840 12-72 36.4
Single analgesics
Aspirin 200- 700 SD ++
200 10-66 55.0a
318- 500 8-20 33.0-100
Phenacetin 137-3000 4-36 37.5-80
Paracetamol 894-3000 8-36 42.9-60
Antipyrine 1000 12-30 12 .5
Amidopyrine 500-1200 5 83.3
Phenylbutazone 50 SD Majority
400 SD Majority
10 8-20 11.1
Indomethacin 50 SD 60.0
75 SD 60.0
12 12-30 28.6
Indeacetic acid ** ★ * +
Mefanamic acid 100 8-20 66.7
Flufenamic acid 50- 100 * * +
Meclofenamic acid ** ** +
N-phenylanthranilic * * ** +
acid
Naproxen ** * ★ +a
Fenoprofen 40- 305 72 +a
Sudoxicam 2 * ★ +
A, aspirin; P, phenacetin; NAPA, paracetamol; C, caffeine; SD, single 
dose; ** no data; +,++, RPN produced, no quantitative data; a, chronic 
interstitial nephritis.
Table 2.4 Variable incidence of experimental renal papillary necrosis 
induced by single analgesics, analgesic mixtures and NSAID. From 
Nanra & Kincaid-Smith, (1986).
For a concise review and discussion of experimental analgesic- 
associated RPN see Nanra & Kincaid-Smith, (1986). There are reports 
of RPN occurring in horses (Gunson, 1983; Faulkner et al, 1984), sheep
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and cattle (Salisbury et al, 1969) after veterinary administration of 
NSAID particularly phenylbutazone, and also after phenothiazine and 
flunixin meglumine. In these veterinary reports RPN was exacerbated in 
these animals in hot dry weather resulting in a dehydrated state.
The Gunn rat is a mutant Albino strain which lacks the hepatic enzyme 
uridine diphosphate glucoronyl transferase resulting in a 
hyperbilirubinemia. A spontaneous RPN develops progressively with age 
in homozygous rats (Axelsen, 1973; Henry & Tange, 1982) . The 
incidence of RPN in this strain of rats has been found to increase 
with the administration of analgesic (APC) mixtures; 90% in treated 
rats compared to 12% in control rats (Axelsen & Burry, 1972, Axelsen, 
1975,) see Table 2.5.
Preparation Oral daily dose 
(mg/kg)
Duration
(weeks)
RPN (%)
Aspirin 175-1150 SD 46.7
250 4 45.0
Phenacetin 175-1150 SD 6.7
320- 500 4 7.0
Paracetamol 268- 420 4 37.0
A+P+C 38- 500 1-5 70-100
A, aspirin; P, phenacetin; C, caffeine; SD, single dose
Table 2.5 Experimental renal papillary necrosis in homozygous Gunn 
rats. From Nanra & Kincaid-Smith, (1986).
Axelsen (1975) reported that paracetamol produced RPN at a higher 
frequency than phenacetin alone. Aspirin alone (Henry & Tange, 1983a) 
and NSAID have also been reported to induce a RPN in this strain of 
rats (Axelsen, 1980; Harper & Axelsen, 1982).
This strain of rat has been proposed as a new reproducible model of
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analgesic nephropathy (Henry & Tange, 1983b). However, a number of 
extra-renal lesions also occur due to the inability of these rats to 
conjugate bilirubin which makes it inappropriate in the long-term 
study of NSAID and analgesic associated RPN. Despite this the Gunn 
rat probably has an important role to play in the study of RPN and 
factors which affect the initiation of the lesion. Recent studies by 
Thomas & Tange (1985) have shown the relationship between 
experimentally induced urinary tract infection (with Proteus 
mirabilis), pyelonephritis and RPN.
2.1.3.2.B Non-analgesic chemical induced RPN.
The difficulties with the use of spontaneous animal models of RPN and 
analgesic/NSAID induced models of the lesion led to the use of 
alternative approaches using chemicals which had a marked papillotoxic 
potential although they may not be therapeutically used 
analgesics/NSAID. The most commonly used chemical agents fall into 
two categories - i) NSAID analogues and/or metabolites, ii) non­
analgesic compounds.
In the first group N-phenylanthranilic acid (NPAA) an analogue of the 
fenamic acid NSAID has been most extensively studied. (Hardy, 
1970a,b, 1974; Hardy & Bach, 1984). A dose related apex limited 
lesion can be produced by oral gavage administration with 1-2 mmol/kg 
for 14 consecutive days, diphenylamine gives similar results 
(Powell et al, 1983). The morphological changes due to NPAA are 
similar to those reported for analgesic associated RPN with the 
interstitial cells, microvasculature and loops of Henle affected first 
(at doses of 0.5-1.0 mmol/kg), with a progressive destruction of of 
the collecting ducts and covering epithelium of the papilla (at doses
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of 1.0-2.0 mmol/kg) and the outer medulla and cortex affected (at 
doses of 3.0-5.0 mmol/kg). There is a loss of the mucopolysaccharide 
interstitial matrix staining following NPAA (Powell et al, 1983). 
Functional changes include an increased proteinuria, decrease in urine 
osmolality, diuresis, decrease in chloride ion (Cl-) excretion (Hardy 
& Bach, 1984; Powell et al, 1985).
In the non-analgesic group there are two related compounds 
ethylenimine (El) and 2-bromoethanamine (BEA) hydrobromide which 
induce RPN in 24-48 hours after a single dose (Bach & Bridges 1985).
2.1.3.2.C Ethylenimine-induced RPN.
Ethylenimine (El) has been studied extensively (Mandel & Popper, 1951; 
Davies, 1968, 1970; Davies et al, 1968; Ham & Tange, 1969; Sherwood et 
al, 1971; Ellis et al, 1973; Ellis & Price, 1975; Axelsen, 1978a; 
Davies & Tange, 1982) since it was first used by Levaditi in 1901. 
It causes a dose related necrosis (Axelsen, 1978a; Davies & Tange, 
1982), first affecting the interstitial cells of the papilla tip 
which then progresed to affect the other fine anatomical elements of 
papilla and medulla (Ham & Tange, 1969). A number of pertinent 
functional changes have also been described including marked polyuria, 
low specific gravity and enzymuria (Mandel & Popper, 1951; Ellis et 
al, 1973; Ellis & Price, 1975). Unfortunately a number of problems 
are associated with the use of El; i) it is a powerful alkylating 
agent and proven mutagen (Ninan & Wilson, 1969), ii) chemically 
unstable and may be explosive (Dermer & Ham, 1969) iii) it is no 
longer commercially available.
2.1.3.2.D 2-Broxnoethanamine hydrobromide-induced RPN.
Oka (1913) showed that 2-bromoethanamine (BEA) hydrobromide produced 
lesion that was histologically almost indistinguishable to that
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induced by El. BEA has largely replaced El as the model optimal 
papillotoxin for the following reasons i) it is commercially 
available, ii) is a stable, water soluble crystalline solid material 
(though unstable in solution - light sensitive). BEA-induced RPN is 
dose related (Bach et al, 1983) and the lesion has been characterised 
in a variety of species and strains of laboratory animal (see Table 
2 .6) .
The route of administration of BEA alters the intensity of the lesion 
relative to the dose. Intravenous administration produces the most 
intense response with intraperitoneal and subcutaneous injection being 
approximately equal, but with oral dosing producing the weakest 
response (Burnett, 1982; Bach et al, 1983). In vitro BEA cyclizes 
to El under strongly alkaline conditions (Dermer & Ham, 1969), but 
although this has been proposed as a mechanism of BEA-induced RPN 
(Murray et al, 1972) there is no evidence to support this by urinary 
excretion of El (Bach & Gregg, 1988; Bach & Gregg, 1990).
The choice of an animal model system for the investigation of a human 
clinical disease condition has to fulfill certain criteria. The 
generally accepted axiom in experimental medicine is that "the greater 
the concurrence between the pathophysiology of a model lesion and that 
which occurs in humans the more likely will experimental observations 
be related to an interpretation of clinical significance" (Bach & 
Hardy, 1985) .
Table 2.7 shows the comparison of pathological changes in 
experimentally induced RPN and the analgesic induced lesion in humans 
to be very strong and correlates well.
The greatest advantage attributed by the use of BEA is the rapid
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Species/strain Reference.
RAT Battleboro Sabatini et al, (1981)
Donjru Murray & von Stowasser, (1976)
Fischer 344 Shimamura, (1972, 1975, 1976) 
Shimamura et al, (1974) 
Cuppage & Tate, (1975) 
Shimamura & Bonk, (1976)
Gunn Harper & Axelsen, (1982)
Holtzmann Hill et al, (1972)
Murray et al, (1972)
Wylie et al, (1972)
Solez et al, (1974) 
Heptinstall et al, (1975) 
Cuttino et al, (1981)
Munich-Wistar Reineck et al, (1980)
Sprague-Dawley Axelsen, (1978)
Arruda et al, (1979)
Sabatini et al, (1978, 1981, 1982, 1983) 
Burnett, (1982)
Wistar Bach et al, (1980, 1983) 
Vanholder et al, (1981) 
Bing et al, (1983)
Wilks et al, (1986)
Gregg et al, (1990a & b)
MICE Tatonic Farm Thiele, (1974)
Balb/c ) 
C57B1/6) - 
Obese )
Scarlett et al, (1990)
Nude Gregg & Bach, (1989)
HAMSTER Syrian Carlton & Englehardt, (1989)
PIG Large White Gregg et al, (1989)
Table 2.6 List of published papers which used BEA to induce an 
acute RPN in different species and strains.
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Type of rcnul papillary necrosis
Morphological and functional changes 
Early*
pcx primary site oflcsion
hin loop of Henle and interstitial cells
•asa recta
to include outer medulla but not beyond 
medullary junction 
scular occlusion 
concentrating mechanism
Intermediate*
collecting ducts and covering cpilhclia 
staining of cxttaccllular matrix
anges    -
■itory response 
I hyperplasia
ition and re*cpithcliaIi/ation 
tion
d bladder calculi 
tract infection
asia of transitional urothclia of pelvis, meter, and‘or 
r '*
tion defect 
te wastage
Total or l -ttc* 
ry cortical changes overlying neciosed papilla, for 
le. scarring 
ilatalion
ra o f transitional urolhelia of pelvis, meter, and Madder 
nsion
Chronically induced 
Acutely induced (Analgesics. N SAIDs. and Analgesic-associated 
(DEA and El) N S A ID  analogues) lesion in humans
Yes
Yes
Yes
Yes
No
Yes ‘
Yes
Increase then loss
Yes
No
Yes
Yes
Yes
No data
Yes
Yes
No
Yes
Yes
Yes
No
After salt loading or 
aitcrial clipping
Yes
Yes
Yes
Yes
Yes
Yes
Yes
I .OSS
Yes
Yes
Yes
Yes
Yes
No data
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Increase or loss
Yes ____
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Common
Common
Table 2.7 Comparison of pathological changes in experimentally 
induced RPN and the lesions found in humans. From Bach & Hardy, 
(1985) .
induction of a dose related reproducible RPN within 48 hr. The 
tremendous reduction in time needed to produce this lesion, compared 
to those induced using analgesics, NSAID or their analogues, (which 
may take weeks or months), has several logistically important 
advantages. Also BEA affects the medulla only first, whereas 
analgesics, NSAID often affect the cortex, stomach and spleen.
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Type of renal papillary necrosis
Chronically induced
Acutely induced (Analgesics. N S A lD s . and Analgesic-associate
Morphological and functional changes (B E A  and EL) N S A ID  analogues) lesion in humans
Early*
;
Papilla apex primary site o f lesion Yes Yes Yes
Loss o f  thin loop o f Henle and interstitial cells Yes Yes Yes
Loss o f vasa recta Yes Yes Yes
Extends to include outer medulla but not beyond Yes Yes Yes
corlicom cdullary junction
. Yes YesM icrovascular occlusion N o '■
Loss o f concentrating mechanism Yes ‘ . Yes Yes
Intermediate*
Loss o f collecting ducts and covering cpithclia Yes Yes Yes
Changed staining of extracellular matrix Increase then loss Loss Increase or loss
Fatty  changes .............................. - Yes Yes . . . Yes
Inflam m atory response No Yes Yes
Epithelial hyperplasia Yes Yes Yes
Regeneration and re-cpitheliali/ation Yes Yes Yes
Calcification Yes Yes Yes
Renal and bladder calculi N o data N o  data Yes
U rin ary  tract infection Yes Yes Yes
Hyperplasia of transitional urothelia o f pelvis, m eter. atnl-W Yes Yes Yes
bladder *
YesAcidification defect No Yes
E lectroU tc wastage Yes Yes Yes
Total or Late*
Secondary cortical changes overlying neciosed papilla, for Yes Yes Yes
exam ple, scarring
Yes YesCystic dilatation Yes
Carcinom a o f transitional urothelia o f pelvis, m eter, and bladder No N o Com m on
Hypertension A fter salt loading or Yes Com m on
aiterial clipping
Table 2.7 Comparison of pathological changes in experimentally 
induced RPN and the lesions found in humans. From Bach & Hardy, 
(1985) .
induction of a dose related reproducible RPN within 48 hr. The 
tremendous reduction in time needed to produce this lesion, compared 
to those induced using analgesics, NSAID or their analogues, (which 
may take weeks or months), has several logistically important 
advantages. Also BEA affects the medulla only first, whereas 
analgesics, NSAID often affect the cortex, stomach and spleen.
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2.1.3.2.D .i Functional changes associated with BEA.
There are marked similarities between the renal functional changes and 
the pathomorphological progression of the lesion following BEA 
administration and those reported for the analgesics associated lesion 
in both experimental animals and man (Bach & Bridges, 1982; Bach & 
Bridges, 1985; Bach & Hardy, 1985). Prominent among these is the 
loss of urinary concentrating ability (Fuwa & Waugh, 1968; Wyllie et 
al, 1972; Murray et al, 1972; Shimamura, 197 6; Sabatini et al, 1981, 
1983; Vanholder et al, 1981; Bach et al, 1983), loss of nephron 
function and severe cortical degeneration (Sabatini et al, 1981, 1983; 
Bach & Bridges, 1982) .
An increased medullary plasma flow 6hr after BEA. administration has 
been reported by Solez et al, (1974) and an increased filling of the 
medullary microsvasculature using colloidal carbon (Bach et al, 1983) . 
Sabatini et al, (1981) reported a decrease in the number of filtering 
and thus presumably functioning juxtamedullary nephrons assessed by 
the Hansen technique after BEA induced RPN.
Immunohistochemical demonstration of Tamm-Horsfall glycoprotein (THG) 
by Bach & Bridges, (1982) after BEA-induced RPN showed a total loss 
from distal tubules and accumulation in collecting ducts and ducts of
Bellini. The loss of THG corresponded with onset of early polyuria.
+  —  2—  2 +Loss of other urinary electrolytes (Na , Cl , PO^ and Ca ) has also
been reported following BEA-induced RPN (Arruda et al, 1979; Sabatini
et al, 1981) . The measurement of urinary acidification capacity and
electrolyte handling could therefore offer a simple way of monitoring
for RPN in toxicology screening programs. Arruda et al, (1979)
however failed to find any differences between control and BEA treated
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rats studied 24 hr after dosing, and Sabatini et al, (1982) found 
neither an acidosis nor a defective urinary acidification in response 
to ammonium chloride loading one month after dosing with BEA. Wilks 
et al, (1986) studied the renal functional changes within 3 hr of BEA 
administration. Their data showed that the excretion of urea 
increased (from 30 min) osmolality decreased from 90 min and sodium 
excretion increased at 3 hr, but potassium excretion was unchanged. 
Glomerular filtration rate and the clearance of the organic ion p- 
aminohippurate decreased over the period of investigation. These data 
reflect early functional abnormalities, and suggest that BEA may be 
less target selective for the medullary interstitial cells than has 
previously been thought. Alternatively, these changes may represent 
aspects of the complexity in the renal response to injury. They may 
reflect a rapid homeostatic consequence caused by the perturbation of 
the medullary cells.
Recently the application of ^H-NMR spectroscopy to urine samples from 
animals treated with BEA has elucidated some metabolic disturbances 
which are unique to RPN (Gartland et al, 1989). There was an early 
elevation of trimethylamine N-oxide and dimethylamine, then a later 
increase in acetate and succinate occurs together with a minor 
increase in the excretion of lactate and alanine 24-48 hr after the 
administration of BEA which may herald secondary cortical changes.
2.1.3.2.D .ii Histopathological changes associated with BEA.
The histopathological changes induced by BEA during development of 
RPN have been described at the light microscopic level (Murray et al, 
1972; Axelsen, 1978b; Bach et al, 1983; Mattingley et al, 1985) and 
the ultrastructural level (Shimamura, 1972; Hill et al, 1972, Sabatini 
et al, 1982). These changes follow the same pattern of early,
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intermediate and total RPN described by Burry, (1968) and are dose and 
time dependant. With low doses <50 mg/kg in female and male Wistar 
rats, interstitial cells, loops of Henle and blood vessel walls were 
necrosed corresponding to 'intermediate' RPN. At higher doses of 100 
mg/kg collecting duct epithelia and cuboidal covering epithelium 
undergo necrosis too, resulting in 'total' RPN. The lesion frequently 
extended into outer medulla with papilla tip becoming a sloughing 
'ghost' with re-epithelialisation of exposed viable tissue after 5
days (Axelsen, 1978b). Histochemical staining changes in
interstitial matrix of papilla occurs with BEA-induced RPN (Bach et 
al, 1983). At 2 and 4 hr an increased intensity with pronounced 
granular appearance of the matrix at the papilla tip. These changes 
were more marked at 8 hr and at 12-24 hr areas of intermediate
necrosis coincided with a decrease in matrix staining in papilla tip.
Casts within lumen of necrosed collecting ducts and loops of Henle 
showed extensive deposition of mucopolysaccharides (assessed by
colloidal iron staining). The medullary interstitial cells have a 
very high lipogenic potential and contain numerous lipid droplets rich 
in long-chain polyunsaturated fatty acids (Bojesen, 1974). Oil red 0 
stains the lipid droplets in these cells heavily, but not other parts 
of the kidney (Bach & Gregg, 1988) ORO positive lipid material 
accumulates in kidneys of analgesic abusers (Munck et al, 1970; Burry 
et al, 1977; Burry, 1978) and similar changes occur in aspirin-induced 
(Molland, 197 6) and essential fatty acid-deficient diet-induced RPN 
(Molland, 1982) . Recent studies have shown that in an acutely induced 
papillary necrosis, early .lipid changes take place in the capillaries 
followed by a marked accumulation of lipid in the epithelial cells.
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Normally there is no Oil red 0 positive lipid material in these cells. 
The epithelial accumulation of lipid material extends into those 
areas of the outer medulla which were not affected by the papillotoxin
and appeared to be normal by routine H&E staining (Bach et al, 1987).
Other chemically induced lesions, such as those caused by 
hexachlorobutadiene, aminoglycosides, cis-platin and polybrene, do not 
produce these Oil red 0 lipid changes (Bach et al, 1987), which
suggests that the capillary and epithelial deposits of lipid material 
may be pathognomonic of RPN.
Biochemically the lipid changes in the BEA-induced RPN represent a 
phospholipidosis, in which phosphatidyl- and lysophosphatidyl- 
choline, -inositol and -ethanolamine were increased (Duffy and Bach, 
unpublished data). The increase in urinary free polyunsaturated fatty 
acids with C18, C20 and C22 suggests a large precursor pool for the
synthesis of eicosanoid related products (Scholey and Bach, 
unpublished data). These changes are histochemically the same as
those reported by Burry, (1978) and Gloor, (1978) in man.
Hyperplasia of the pelvic and ureteric urothelium after BEA 
administration has also been reported (Bach & Bridges, 1985; 
Mattingley et al, 1985).
2.2 UPPER UROTHELIAL CARCINOMA (UUC).
2.2.1 Introduction.
Upper urothelial carcinoma (UUC) is a pathological condition which has 
been associated with RPN and analgesic abuse. This relationship was 
first reported by Hultengren et al (1965), subsequently Johansson et 
al, (1974) reported a 92% association between RPN, UUC and mixed 
analgesic abuse involving phenacetin, phenazone and caffeine. Since
44
then epidemiological evidence has shown a strong association between 
RPN and UUC particularly in those countries such as Switzerland, 
Scandanavia and Australia where analgesic abuse is more commmon. 
(Bengtsson et al, 1968, 1978; Dubach, 1971; Johansson et al, 1974,
1976; Mahony et al, 1977; Mihatsch et al, 1979; Mihatsch & Knusli, 
1982; McCredie et al, 1982a,b, 1983a), often after a latent period of
10-20 years after initiating analgesic abuse (Bach & Bridges, 1985).
As yet there is no proof for a "cause-and-effeet" relationship between 
analgesic abuse associated RPN and UUC (Bach & Bridges, 1985).
Patients who discontinue the abuse of analgesic generally allay renal 
failure and stabilise (Bell et al, 1969; Dubach, 1975) . These
patients are, however, the ones who may, due to their prolonged 
survival time be at a greater risk of developing UUC. Greatly 
improved dialysis techniques have meant the survival of analgesic 
abusing patients who would otherwise have developed end stage renal 
disease, and subsequently died (Mihatsch et al, 1980) . It has
therefore been suggested that the incidence of UUC will increase.
2.2.2 Incidence of UUC.
Urothelial carcinoma is one of the class of epithelial malignancies 
which accounts for 90% of deaths due to carcinoma. (Bach & Bridges, 
1985). UUC in the general population accounts for a relatively 
limited proportion of the total number of human malignancies with a 
background incidence of between 1:156,000-180,000 in Sweden 
(Bengtsson et al, 1978). UUC has usually been described as a 
predominantly male disease with a ratio of 2:1. In contrast the 
incidence of UUC among analgesic abusers is as high as 92% (Johansson 
et al, 1974) and females predominate in analgesic-associated UUC with
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a ratio of 2.5 to 1 (Bengtsson et al, 1978), in keeping with the 
predominantly female ratio of analgesic abusers. In addition, 
analgesic abusers develop UUC at a younger age than non-analgesic 
abusers (Mihatsch & Knusli, 1982). The distribution of urothelial 
carcinomas in analgesic abusers also has a distinct pattern compared 
to non-analgesic abusers. Tumours of renal pelvis, ureter and 
bladder are respectively induced 77 times, 8 9 times and 7 times more 
frequently, than non-analgesic abusers. Also the tumours are 
typically multiple, diffuse, poor differentiated and rapidly spreading 
(Lomax-Smith & Seymour, 1980a,b; Mihatsch & Knusli, 1982) . Typically 
UUC occurs following a latency of 20 - 30 years from the time the 
individual started to abuse analgesics (Bengtsson et al, 1978). 
However as pointed out in section 2.2.1 patients who discontinue to 
abuse analgesics frequently develop UUC. This fact confuses the 
already difficult diagnosis of UUC with patients having a stable renal 
function and not being documented as previous analgesic abusers (Bach 
& Bridges, 1985).
There are a number of well documented factors in addition to analgesic 
consumption which affect the incidence of UUC including cigarette 
smoking (McCredie et al, 1983b). Recently Ross et al (1989) performed 
a population-based case-control study by telephone interview on how 
analgesic consumption, cigarette smoking and caffeine consumption 
posed risk factors for the induction of UUC. The major risk factor 
was found to be cigarette smoking with a relative risk factor of 4.5, 
compared to nonsmokers. Mixed analgesic compounds (aspirin, 
acetaminophen and caffeine) had a relative risk factor of 2.0 for 
subjects who used the compounds for periods of 30 consecutive days or 
more. Caffeine alone was found to have a relative risk factor of 1.8
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which dropped to 1.3 if the contribution of smoking was removed. 
Other factors which had identifiable risks, but were not statistically 
significant were: 1.5 for alcohol consumption (2 drinks/day), 1.6 for
urinary tract stones, 1.2 for urinary tract infection. This latter 
factor has also been reported by Johansson & Walhquivst, (1977) who 
found that 80% of patients presenting with UUC had an association with 
recurrent urinary tract infection. Ross et al, (1989) also looked at 
other commonly used drugs and found that thyroid hormone 
supplementation and Milk of Magnesia presented a minor risk. The 
finding that thyroid hormone supplementation presents a small but 
identifiable risk is interesting because these compounds have also 
been found to induce RPN experimentally in rats (Kennedy & Jones, 
1989).
RPN is not the only disease condition associated with UUC; the 
highest incidence of pelvic tumours (1:200) is in those patients with 
Balkan nephropathy (BEN) in certain endemic areas of Yugoslavia, 
Bulgaria and Romania (Chemozemsky et al, 1977; Sattler et al, 1977). 
Clinically BEN represents a slow progressive renal degeneration 
including anaemia, concentrating defect, proteinuria and ureamia, 
leading to end stage renal disease, which occurs more commonly in 
females than males. Pathologically tubular and/or glomerular lesions 
are the earliest changes and cortical tissue loss is greatest opposite 
the hilum (Hall & Dammin, 1978). Thus clinically BEN is similar to 
RPN, but pathological early changes of BEN are only evident (usually) 
in late stages of RPN.
Various environmental factors such a fungal toxin, plant toxins have 
been implicated in BEN (Krogh & Elling, 1976; Krogh, 1978; Austwick,
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1983), together with a high familial incidence which may suggest a 
genetic disposition or susceptibility to cancer. This "cancer family 
syndrome" with transitional cell carcinoma of the renal pelvis has 
been reported in USA (Frischer et al, 1985; Orphali et al, 1986). 
Although a genetic factor has not been implicated in analgesic- 
associated RPN, it cannot as yet be discounted as a possible 
influential factor. It may be that a pathological/metabolic change 
common to BEN and RPN could result in the alterations in the urothelia 
environment which initiates the onset of UUC.
2.2.3 Clinical Symptoms and Diagnosis of UUC.
The diagnosis of UUC is difficult in the clinical situation because 
UUC (as with RPN) progesses silently with few clinical symptoms to 
indicate the early development of the malignant changes in the ureter 
and pelvis (Bengtsson et al, 1968, 1978; Dubach et al, 197,1;
Johansson et al 1974, 1976; Mahony et al, 1977; Mihatsch et al,
197 9, 1982; Bach & Bridges, 1985). The main symptom is usually a 
haematuria, occassionally accompanied by pain in the flank (Nielsen & 
Ostri, 1988).
Diagnosis is more likely where analgesic abuse is common and the 
patient is being monitored for the condition and receiving treatment. 
Retrograde ureteropyelography has been used to diagnose 69.5% of 
ureteral carcinoma and 82% of pelvic carcinoma in a retrospective 
study of 40 patients (Oschner et al, 1974). Urinary cytology can be a 
useful diagnostic technique; Eriksson & Johansson (197 6) found a 83% 
predictive correlation between histological findings and cytology with 
94% of most advanced tumour grades being identified as being advanced 
malignancies. Computerised tomography is another diagnostic
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procedure which has been shown to be advantageous over radiographic 
procedure (Gatewood et al, 1982; Nielsen & Ostri, 1988). New 
techniques such as nuclear magnetic resonance imaging and ultrasound 
scanning may, in the future, improve the early diagnosis of UUC. 
Recently, DNA ploidy by flow cytometry has been used retrospectively 
to identify abnormal DNA nuclear patterns in low grade tumours (which 
normally would be associated with good prognosis) which seem to 
indicate poor prognosis (Blute et al, 1988) .
The urothelium of renal pelvis, ureter and bladder are all derived 
from the same embryological structure; the ureteric bud. They have 
a similar histological appearance although they do differ in thickness 
(Melicow, 1945) and also in cell surface characteristics (Newman and 
Hicks,1981). It is therefore common to grade UUC tumours at the gross 
and histological levels on the same basis as is internationally used 
for bladder carcinoma (Berquikst et al, 1965; Mostofi et al, 1973; 
Helpap et al, 1985) .
2.2.4 Treatment of UUC.
The prognosis for the patients with UUC is poor, and only have a mean 
survival time of 22 months (Mihatsch et al, 1980) due to difficulty in 
diagnosis, compromised renal function of patients with RPN (Clark, 
1961) and multifocal sites of invasion and metastases (Johansson et 
al, 1974, 1976). The survival rate appears to be dependant on the
grade of tumour and degree of invasion, with patients with low grade 
tumours generally having a better survival rate (Nielsen & Ostri, 
1988). UUC does not respond readily to chemo- or radio-therapy 
(Johansson & Wahlquivst, .1977), and re-occurrence with invigorated 
metastases often occurs after surgery (Hultengren et al, 1965;
49
Johansson et al, 1976). Blohme & Johansson (1981) recently 
suggested the radical surgical procedure of prophylatic bilateral 
nephrouretectomy, but the survival rate was only 51% after 2 years in 
a series of surgically treated patients reported by Mahony et al 
(1977). Other studies recommend the use of conservative surgical 
measures, however, only patients who have a good prognosis (those with 
low grade tumours) should be considered for conservative parenchymal 
sparing surgery (Reitelman et al, 1987) .
2.2.5. Experimentally induced UUC.
Various animal experiments have been performed to elucidate whether 
the relationship between analgesic consumption, RPN and UUC in 
particular does phenacetin induce tumours in the urinary tract. 
Urothelial hyperplasia and microvasculature changes were the most 
prominent morphological changes (87%) in female Sprague-Dawley rats 
fed on 0.535% phenacetin in their daily diet for 96-110 weeks 
(Johansson & Angervall, 1976a,b). These changes have been associated 
with RPN in human situation (Burry et al, 1978; Mihatsch et al, 1979; 
Mihatsch & Knusli, 1982) Animals fed 2.5% phenacetin in their daily 
diet for 18 months developed transitional cell hyperplasia and UUC 
with a ratio of 3:1 male to female (Isaka et al, 1979). Similar 
experiments in B6C3F1 mice failed to induce RPN or pelvic tumours, but 
did increase bladder hyperplasia (Nakanishi et al, 1982).
Mixed analgesics were implicated in development of RPN (Spuhler & 
Zollinger, 1953) thus Johansson (1981) studied the effects of co­
formulated phenacetin, phenazone, caffeine and paracetamol. 
Phenacetin and phenazone either alone or in combination induced renal 
pelvic tumours and bladder tumours. Mixtures . of phenazone or
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phenacetin with caffeine induced comparable numbers of bladder tumours 
and a lower number of pelvic tumours. Paracetamol alone induced 
comparable numbers of bladder tumours and 3/13 rats with pelvic
tumours were found to have RPN also. Many other tumour types were
also induced of the phenacetin studies including ear, nasal, liver 
mammary bladder and renal parenchymal tumours (Isaka et al, 1979; 
Johansson, 1981). Thus phenacetin does not on its own or in 
combination appear to produce a target-specific carcinogenic 
metabolite.
Phenacetin is an aromatic amide with N-hydroxylated or N-nitrosated 
metabolites which are potent carcinogens (Nery, 1971; Lijinsky, 1984). 
The wide spectrum of possible N-nitroso compounds produced by
phenacetin or phenacetin containing mixtures would explain this wide 
range of tumour target sites. Ham & Calder (1983) found that
phenacetin was carcinogenic but paracetamol was not, they also 
suggested that the metabolism of phenacetin to N-hydroxyphenacetin 
was the reason for the carcinogenecity of phenacetin. A 2 year 
feeding study with paracetamol by Hiragi & Fuji, (1985) also found 
that paracetamol was not carcinogenic. Nakanashi et al, (1978) dosed 
rats with N-butyl-N-(4-hydroxybutyl)nitrosamine together with 
phenacetin and caffeine either alone or in combination. A 
significantly higher frequency of bladder tumours was induced in the 
phenacetin alone group and papillary hyperplasias were observed in the 
pelvis. Table 2.8 shows the incidence of experimentally induced 
urothelial hyperplasias and tumours using analgesics and NSAID. 
Patierno et al (1989) have investigated in vitro the cytotoxicity, 
mutagenocity potential of phenacetin, acetaminophen and aspirin in
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Preparation Oral daily 
dose (mg/kg)
Duration
(weeks)
Hyperplasia Tumour
Compound 
analgesics 
A + P + C 900 12-72 +
A + NAPA + C 900 12-72 + • +
A + salicyl- 840 12-72 + -
amide
Single
analgesics
Aspirin 250 36 + -
Phenacetin 2.5% 110 + + (29.1%)
1.25% 110 + + ( 2.1%)
Flufenamic ★ ★ * *** + -
acid
N-PAA 228-600 8 + -
Ideneacetic *** ★ * * + -
acid
Abbreviations: A, aspirin; P, phenacetin; NAPA, paracetamol; C, 
caffeine; N-PAA, N-phenylanthranilic acid; ***, data not available
Table 2.8 Experimental uroepithelial hyperplasia and tumours induced 
by single analgesics and analgesic mixtures. From Nanra & Kincaid- 
Smith, (1986).
C3H/10T1/2 Clone 8 mouse embryo cells. Both acetaminophen and 
phenacetin induced a low but dose-dependant number of morphologically 
transformed foci. None of the compounds caused base substitutions to 
ouabain resistance at highly toxic concentrations. Patierno et al, 
(1989) suggest that if acetaminophen and phenacetin are carcinogenic 
in humans and animals then other cocarcinogenic factors are required 
and/or metabolism to carcinogenic metabolites.
2.2.6 Relationship between RPN and UUC.
Although the relationship between RPN and UUC has not been proven 
there is substantial clinical and experimental evidence connecting 
the abuse of analgesics and the development of urothelial tumours 
(Johansson & Angervall, 1976; Bengtsson et al, 1978; Bach' & Bridges, 
1985). Phenacetin has been implicated in the induction of urothelial
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malignancies from studies of Hultengren et al (1965) described renal 
pelvic tumours in six . patients five of whom were known to abuse 
phenacetin containing drugs. In an autopsy study covering 25 years 
8.6% of phenacetin abusers had urothelial tract tumours which was 
statistically significant compared to control groups (Mihatsch & 
Knusli, 1982) . Compounds containing phenacetin, phenazone and 
caffeine were found to produce renal pelvis and bladder tumours 
(Bengtsson et al, 1968; Angervall et al, 1969).
The progression of hyperplasia, through dysplasia to malignancy is now 
widely accepted; a series of changes in the development of carcinoma 
in epithelial cells in a number of different organs (Farber, 1976; 
Sporn, 1976) . Such events may occur in the genesis of analgesic- 
associated carcinoma. There are well documented foci of hyperplastic 
ureteric epithelia, in addition to malignancies in patients with UUC 
(Lomax-Smith & Seymour, 1980a,b) and in analgesic abusers with RPN, 
but no diagnosed malignancies (Blohme & Johansson, 1981) .
Urothelial hyperplasia frequently occurs as a secondary associated 
morphological change as a consequence of RPN and has been observed in 
animals given N-phenylanthranilic acid (Hardy, & Bach, 1984), aspirin 
(Molland, 1976), BEA (Bach & Bridges,1985; Bach & Gregg, 1988) and L- 
triidotyronine (Kennedy & Jones, 1989) but there was little published 
on how this hyperplasia could progress to upper urothelial tumours in 
the long-term or with repeated dosing. Using these compounds in 
conjunction with chemical carcinogens it may be possible to develop 
"models" of UUC.
These data taken in the light of the already very established high 
incidence of UUC in analgesic abusers (Bengtsson et al, 1968, 1978)
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and the strong association between RPN and UUC (McCredie et al, 
1982a,b, 1983a) highlights the possibility of these proliferative 
changes in the pelvic and .ureter epithelial cell are premalignant.
2.3 CHEMICALLY INDUCED CARCINOGENESIS.
2.3.1 Introduction to Carcinogens and Carcinogenesis.
The literal definition of carcinogenesis is the development of cancer 
or carcinoma (which is a specific type of cancer). A more complete 
definition is that of Friedberg (1985) who defines the carcinogenic 
process as: "Neoplasia is a process by which the normal controlling
mechanisms that regulate cell growth and differentiation are impaired, 
resulting in progressive growth".
The majority of human cancers are suspected to be caused by 
"environmental factors" (Williams & Weisburger, 198 6). This term is 
fairly loosely defined in this context, and may apply to a wide range 
of agents encompassing the food chain, geographical location, social 
habits, (e.g. smoking, drug abuse), therapeutic agents and 
occupational exposure to hazardous chemicals and/or products. 
Chemicals are the common denominator that underly the majority of 
these environmental factors, occurring naturally in the environment 
and diet, or synthetically as specific products (see Table 2.9).
For a basic comprehensive introduction to some of the pertinent areas 
in carcinogenesis see Becker, (1982); Friedberg, (1985); Williams & 
Weisburger, (1986) and Tannock & Hill, (1988) .
2.3.2 Mode o£ action of carcinogens.
Chemical carcinogens are defined operationally by their ability to 
induce tumours. Evidence of tumourigenicity have been classified by 
four responses as follows:
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Table 2.9
Chemical Origin Exposure Type of Cancer
Benzene Synthetic Occupational Marrow (leukemia)
2-Naphthylamine Synthetic Occupational Bladder
Oestrogens Natural Hormonal
defect
Breast, uterus
Diethylstyl-
bestrol
Synthetic Drug consump­
tion
Vagina, breast
Androgens Natural/ Hormonal/drug Liver
Anabolic
steroids
Synthetic consumption
Polycyclic hydro­
carbon in tar, 
soot and oil
Synthetic Occupational Skin, scrotum
Polycyclic hydro­
carbon in 
tobacco smoke
Synthetic Social - 
smoking
Lung
Aflatoxins Natural Food consump­
tion
Liver
Cholesterol Natural Food consump­
tion
Colon, breast
Data from Doll, (1977).
1. An increased incidence of the tumour types compared to controls
2. The earlier occurrence of tumours than in controls
3. The development of types of tumours not seen in controls
4. An increased multiplicity of tumours in individual animals 
Carcinogens interact with numerous tissue constituents and produce a 
number of effects. A number of considerations derived from a vast 
body of experimental evidence supports the view that DNA is a critical 
target of carcinogens (see Table 2.10), either by direct (genotoxic) 
interaction with molecules of DNA, or by indirect (nongenotoxic or
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epigenetic) mechanism through cellular protein or RNA interaction 
(Williams & Weisburger, 198 6).
1. Many carcinogens are or can be metabolized to electrophiles 
that react covalently with DNA.
2. Many carcinogens are also mutagens
3. Defects in DNA repair such as in xeroderma pigmentosum 
predispose to cancer development
4. Several heritable or chromosomal abnormalities predispose to 
cancer development
5. Initiated dormant tumour cells are persistent, consistent 
with a change in DNA
6. Cancer is heritable at the cellular level and, therefore, may 
result from an alteration of DNA
7. Most if not all, concern display chromosomal abnormalities
8. Many concern display aberrant gene expression
Table 2.10: Considerations indicating that DNA is a critical target
for carcinogens. From Weisburger & Williams, (1986).
Chemical carcinogens can be classified according to their proposed 
mode of action which result in eight classes (see Table 2.11), but 
they fall into 2 broad classes according to whether they are are 
genotoxic or nongenotoxic.
Genotoxic carcinogens comprise those chemicals that function as 
electrophilic■reagents and alkylate DNA and alter directly the process 
of DNA replication.
Nongenotoxic carcinogens comprise of those substances for which there 
is no evidence for a direct interaction with DNA. Their
carcinogenic effects often occur only with high and sustained levels 
of exposure that lead to prolonged physiological abnormalities, tissue 
injury or hormonal imbalances, e.g. changes in cellular processes and
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structures may (through the action of nongenotoxic carcinogens) lead 
to the onset of carcinogenesis in the cell.
Type Mode of action Example
Genotoxic
1 Direct-acting or 
primary carcinogen
Electrophile,organic compound, 
genotoxic,interacts with DNA.
Ethyleneimine 
bis(chloromethyl)ether
2 Procarcinogen or 
secondary carcino­
gen
Requires conversion through 
metabolic activation by host 
or in vitro to type 1
Benzo(a)pyrene,
2-napthylamine 
•dimethylnitrosamine
3 Inorganic 
carcinogen
Not directly genotoxic, leads 
to changes in DNA by selective 
alteration in fidelity of DNA 
replication
Nickel, chromium
Epigenetic 
4 Solid-state 
carcinogen
Exact mechanism unknown; 
usually affects only mesenchy­
mal cells and tissues; 
physical form vital
polymer or metal foils 
asbestos
5 Hormone Usually not genotoxic; alters 
endocrine system balance and 
differentiation; often acts 
as promoter
Oestradiol, diethyl- 
stilbestrol
6 Immunosuppressor Not usually genotoxic;mainly 
stimulates "virally induced" 
transplanted or metastatic 
neoplasms
Azathioprine, antilym- 
phocytic serum
7 Cocarcinogen Not genotoxic or carcinogenic 
enhances effect of type 1 or 
type 2 agent when given at 
same time, may modify type 2 
conversion to type 1
Phorbol esters, pyrene 
catechol, ethanol, SO2 
n-dodecane
8 Promoter Not genotoxic or carcinogenic 
but enhances effect of type 1 
or type 2 agent when given 
subsequently
Phorbol esters, phenol 
anthralin, bile acids 
trytophan metabolites 
saccharin
Table 2.11 Classes of carcinogenic chemicals. From Weisburger & 
Williams, (1986).
Alterations in surface membrane recognition antigens that . prevent 
autonomous growth due to contact inhibition may be changed so that the
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cell continues to grow despite encroaching on its neighbours. (Lock- 
Caruso & Trosko, 1985). Switching on the cell cycle of growth mitosis 
by removing 'stop' chemicals (chalones) or allowing oncogenes to exert 
their effect are all potential modes of action by nongenotoxic 
carcinogens.
Pre-neoplastic changes (ie changes which occur in cell or tissue which 
are indicative of transformation to a neoplastic state later) have 
been recorded and include cellular hyperplasia (Farber & Sporn, 1976), 
functional changes indicative by loss of enzymes (Tsuda et al, 1985) 
and an increase in mitotic index (Sporn, 1976) .
2.3.3 Experimental Carcinogenesis.
2.3.3.1 Justification for use of animals.
At present there seems to be no alternative to the use of animals as a
means of screening for the long-term chronic exposure hazard of 
chemicals. The short-term in vitro assays using bacteria or mammalian 
cell lines may help intially to screen out some compounds for 
mutagenic potential. However, there are some limitations to these in 
vitro assays which make them inappropriate to long-term studies and 
extrapolation of the results to the in vivo and the clinical 
situation. Controversy exists as to whether there is any meaningful 
relationship between short-term tests as against long-term chronic 
studies. This is very relevant to the whole question of using
animals to test for the carcinogenesis potential of chemicals. The 
fact that rats and mice have more similarities than differences to 
humans in terms of anatomy, physiology and biochemistry would seem to 
satisfy the assumption that one is justified in extrapolating from
rodent species to man.
The purpose of carcinogenicity studies are to screen chemicals or 
other exposures (radiation) for carcinogenicity potential, elucidate 
the mechanism of known cancer-causing agents and are frequently 
performed as part of risk assessment to satisfy legislative 
requirements on new chemicals and drugs (IARC, 1986). Scientists are 
compelled to use experimental animals to screen for potential human 
carcinogens since the vast array of existing (and continual 
development of new) chemicals coupled with the longevity of man means 
a database derived from environmental and occupational exposure to 
these agents could never be completed (Moore, 1988).
Certain properties of tumours can only be studied in animals, for 
instance, metastasis is as common a cause of death in humans as 
primary cancers and at present the study of tumour metastasis is only 
possible in experimental animals (Lijinsky, 1988). Time course 
studies in animals allow the study of progression of the tumour, its 
biological and behavioural properties. Animal experiments also allow 
the study of multiple exposure to different compounds to examine 
additive, synergistic or antagonistic interactions. Such experiments 
are difficult to perform adequately but probably are very relevant to 
carcinogenesis processes occurring in humans exposed to multiple 
potential carcinogens in their occupation or enviroment (Lijinsky, 
1988). Short term in vitro assays by their very nature preclude 
against chronic multiple chemical exposure. They are, however, useful 
in providing mechanistic information about the carcinogenic process at 
the cellular level (Moore, 1988) . Laboratory animals can predict 
human carcingenecity, this has been shown by the years of 
toxicological testing and health and safety screening. Of the 23
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chemicals classified by IARC as definite human carcinogens (see Table 
2.12), 21 of these chemicals have produced cancer in animals with 18
causing cancer in an identical site to that seen in humans (Moore, 
1988) .
1. 4-aminobiphenyl
2. analgesic mixtures containing phenacetin
3. arsenic and arsenic compounds
4. asbestos
5. azathioprine
6. benzene
7. benzidine
8. N,N-bis(2-chloroethyl)-2-napthylamine (Chlornaphazine)
9. bis(chloromethyl)ether and technical-grade chloromethyl-methyl-ether
10. 1,4-butanediol dimethanesulphonate (Myleran)
11. certain combined chemotherapy for lymphomas
12. chlorambucil
13. chromium and certain chromium compounds
14. conjugated oestrogens
15. cyclophosphamide
16. diethylstilboestrol
17. melphalan
18. methoxsalen with ultra-violet A therapy
19. mustard gas
20. 2-napthylamine
21. soots,tars and oils
22. treosulphan
23. vinyl chloride
Table 2.12 Twenty-three chemicals identified as definite human 
carcinogens. From IARC, (1982).
It is possible to compare the potency of carcinogens with similar 
target organs and to determine species differences in their response 
to certain carcinogens (Lijinsky, 1988) . Species differences can be 
very useful in providing a means to identify mechanisms by comparing 
the differing metabolic pathways within cells/tissues/organs in 
susceptible and resistant species (Rice & Frith, 1981). There are 
many other aspects of carcinogenesis; role of genetics, age, sex, 
diet, hormones, homeostasis, and environment which can only be 
studied in experimental animals (Lijinsky, 1988) .
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2.3.3.2 Practical criteria for experimental carcinogenesis. 
2.3.3.2.A Choice of Species.
The purpose of a long-term carcinogencity experiment is to determine 
if administration of a test substance to animals alters the normal 
pattern of tumour development in that species (IARC, 1986). 
Accordingly the primary criteria in determining the choice of test 
animal is that there should be a low spontaneous rate of tumour 
induction. Since a low spontaneous incidence means a small increase 
in tumour development will be statistically significant (IARC, 198 6). 
Economy and the short natural life span of the rat and mouse (2-3yrs) 
as against the dog (9-12yrs) and monkey (20-30 yrs) means these two 
species are chosen for all long-term studies, since the spontaneous 
natural occurring tumour incidence has to be determined. Obviously it 
is more economical and easier to determine spontaneous tumour 
incidence (type and numbers) in the rat or mouse than in the dog or 
monkey. Practically it is also easier to maintain the large numbers 
of rats and mice required in these long-term studies.
2.3.3.2.B Choice of carcinogen.
The criteria which have been recommended as applicable to all 
toxicological studies are namely the route, dose, duration of exposure 
should be as similar to that for human exposure. Hence, chronic 
studies of 2 years are typically 2/3 of the natural life span of rats 
and mice which represents the typical working life (and occupational 
exposure) of humans (Kluwe et al, 1984).
The chemical should obviously induce tumours in the desired organ in 
the species chosen so that the experiment provides a "model" of the 
clinical situation eg bladder tumours.
N-nitroso compounds, (including nitrosamines) which are some of the
simplest in terms of structure of all groups of. carcinogens have 
opened up the field of experimental carcinogenesis (Lijinsky, 1987). 
These compounds have been found to induce cancer in all laboratory 
species so far tested and as such are unique among chemicals 
carcinogens. The same compound will often induce tumours in different 
organs in different species (Lijinsky, 1981) . Perhaps the most 
important factor influencing the use of N-nitroso compounds in 
experimental carcinogenesis is that simple . changes in chemical 
structure of the compound can have a pronounced effect on the target 
site of action (Lijinsky, 1984; Preussman & Wiessler, 1987) . This has 
allowed the mechanism of action of these potent carcinogens to be 
evaluated in different species using the structure-activity and 
metabolism relationship (Lijinsky, 1984, 1987; Okada, 1984).
2.3.3.2.C Experimental Design.
A comprehensive review of various aspects of long-term carcinogenicity 
experiments, with particular reference to statistical considerations 
is discussed in IARC publication N° 79, (IARC, 1986). Many long­
term carcinogenicity studies use the time for visible tumours to 
appear, time of animal death, cause of death, histopathological 
diagnoses of affected organs as end point determinations for the 
induction of carcinogenic potential for a chemical. There are many 
variables which can be limiting factors affecting the interpretation 
of experimental studies. These include variable tumour latency, 
induction of lethal tumours, dormant tumour cells, occult tumours 
(non-visible tumours) and experimental observations (Rice & Frith, 
1981). McKnight (1988) suggests that the development of practical 
non-invasive methods to diagnose internal tumours in live, animals or
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protocols that can assure comparable tumour-free death rates in all 
groups are possible methods when occult tumours are found/expected as 
in experimental bladder carcinogenesis studies. Alternatively one can 
use the incidence of preneoplastic lesions (identified by morphology 
and histochemistry in time course studies) as end points in 
carcinogenesis studies (Bannasch, 1986a,b). These methods have 
limitations in that they may not be predictive and require a vigorous 
experimental design and appropriate statistical tests for occult non- 
lethal tumours (preneoplasia) such as the Cochran-Mantel-Haenzel test 
should be performed (IARC, 1986; McKnight, 1988).
2.3.4 Two Stage (Initiation and Promotion) Carcinogenesis. 
Carcinogenesis experiments using rodents as the model animal have 
utilised particularly the "two-stage" initiation and promotion model 
of cancer (Boutwell, 1964; Scribner & Suss, 1978) originally developed 
from experimental skin cancer. This designation of a two step 
mechanism is a convenient way of indicating the usual number of 
experimental manipulations performed by the operator. It is an 
'operational' definition and not related to the actual number of 
biological and chemical interactions which occur in the cell during 
transformation to a cancerous cell. Since the in vivo carcinogenic 
process is a multistep pathway with many stages and end points 
including cell death, regression and the induction of benign lesions 
(Shubik, 1984).
The criteria for a two stage initiation-promotion experiment according 
to Berenblum (1974) are:
1. The design should ensure that the initiation and promotion stages 
do not overlap in time.
2. Neither the initiating or promoting agents should be carcinogenic
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alone.
3. Tumours should be induced when the initiator is followed by the 
promotor but not vice versa.
4. Increasing the interval between the administration of the 
initiation and promotion stages should not decrease the tumour yield.
5. Ultimately the tumour yield should be quantitatively related to 
the dose of the initiating agent whereas the tumour latency time 
should be determined by the promotor.
2.3.4.1 Definitions of Initiation and Promotion.
Initiation: is a change in target tissue or organ induced by
exposure to a carcinogen that can be promoted or selected to develop 
local proliferations, one or more of which can act as sites of origin 
for the ultimate development of malignant neoplasia (Farber, 1982). 
Initiation is associated with a change in DNA and activation of one or 
more oncogenes and requires one complete cell cycle to "lock in" 
these changes (Farber, 1984).
Promotion: is the process whereby an initiated tissue or organ
develops focal proliferations, one or more of which may act as 
precursors for subsequent steps in the carcinogenic process, (see 
Figure 2.4), resulting in hyperplasia, increased or decreased enzyme 
induction and many other biochemical changes.
Cohen, (1985) has the following definition: an initiator is a
"subcarcinogenic" dose of a chemical administered singly or for a 
short period of time. The promoting agent is administered multiple 
times after the initiating agent. These definitions are based on the 
experimental administration of chemical carcinogens and still require 
the basic criteria of Berenblum (1974) to be followed.
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Figure 2.4 Diagrammatic representation of initiation and promotion, 
as viewed with the rare event-selection hypothesis. The different 
symbols represent different types of functionally altered cells. 
According to this hypothesis amplification (or expansion) of 
appropriately altered cells is the first pre-requisite of promotion of 
an initiated cell. From Farber, (1982).
2.3.5 Bladder carcinogenesis.
Occupational bladder cancer was first noticed in the Aniline dye 
industry in Germany in the early 1900's (Rehn, 1895), but it was only 
some years later that 2-naphthylamine was found to be a potent bladder 
carcinogen (Hueper, 1934; Hueper et al, 1938). Later benzidine was 
also implicated (Case et al, 1954; Meigs et al, 1986).
Aetiologically a single compound such as 2-naphthylamine may be 
sufficient to induce cancer, but it is more probable that multiple 
exposure to a variety of agents and factors is responsible for most 
cases of human bladder cancer that are encountered today (Cohen,
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1985) .
Risk factors that have been identified to significantly increase the 
incidence of bladder carcinoma are: smoking (Mommsen & Aagaard, 1983;
McCredie et al, 1983b; Koch et al, 1986), consumption of alcohol 
(Kunze et al, 1986), and genetic factors (Berger et al, 1986; Mommsen 
& Aagaard, 1986).
The majority of exogenous chemicals implicated in bladder cancer are 
related to aniline dyes and 2-naphthylamine, i.e aromatic amines. 
This gave a chemical structure base from which to produce carcinogens 
with which to develop experimental animal models in order to study the 
pathogenesis of bladder cancer.
2.3.5.1 Spontaneous animal models of bladder cancer.
Experimental research on urinary bladder cancer is performed mainly on 
chemically induced tumours due to the rare incidence of spontaneous 
tumours in laboratory animals. There are, however, certain strains 
of rat that do have a high incidence of urothelia carcinomas (see 
Table 2.13) .
The Brown Norway (BN/BiRij) rat strain have a high incidence (28%-35% 
male 2% female rats) of urinary bladder tumours, (Boorman & Hollander, 
1974; Bolhuis et al, 1978; Burek, 1978), and have been suggested as a 
suitable model for the human disease (Boorman et al, 1977). Deerburg 
et al, (1985) reported on another strain incidence of spontaneous 
urinary bladder tumours in DA/Han rats 53.9% male and 14.4% female of 
this inbred strain developed bladder tumours with the peak incidence 
occurring between 25 and 39 months of the animals life span. All 
neoplasms (90%) were of epitheloid origin being papillomas or 
papillary transitional cell carcinomas in the BN/BiRij strain with
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Strain Sex No. of No, of rats with
rats tumours
Sprague-Dawley/ 
Charles River (CD)
Fischer-344
Fischer-344
Fischer-344
Fischer-344
Wistar
ACI/segHapBR
ACI/N
ACI/N
BN/BiRj
BN/BiRj
M/F
M
M
M
F
M
M
F.
M
535
144
1794
1754
994
457
216
55
209
104
265
2 - papillomas
1 - transitional cell 
papilloma
1 - transitional cell 
papilloma
1 - carcinoma,undiffer­
entiated
2 - transitional cell
papilloma 
2 - transitional cell 
carcinoma
1 - papilloma
1 -
leiomyoma 
squamous cell 
carcinoma
transitional cell 
carcinoma
2 - papilloma
29 -
6 -
papilloma 
transitional cell 
carcinoma
transitional cell 
carcinoma
transitional cell 
carcinoma
M, male; F, female.
Table 2.13 Incidence of 
adult rats. From Stula,
naturally occurring urinary bladder tumours in 
(1986).
squamous differentiation and keratinization occurring in presence of 
bladder stones. In the DA/Han strain transitional cell carcinomas 
were the predominant tumours induced, incidence in male rats were: 
papillary (16.8%), solid (56.7%) and mixed types of transitional cell
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carcinoma (15.1%). In the female rats tumour incidences were: 
papilloma (38.4%), papillary transitional cell carcinomas (30.1%), 
solid (9.6%) and squamous cell carcinoma (9.6%) with 60% associated 
with bladder stones (Deerberg et al, 1985). Some tumour types such 
as inverted papillomas have only been previously reported in humans.
It is suggested that these rat strains could be suitable models for 
human urinary bladder cancer. Deerberg et al, (1985) suggests that 
the DA/Han strain possesses a genetic predisposition for these 
neoplasms, and as such would be highly appropriate for the study of 
genetic, hormonal and occupational influences on urinary bladder 
carcinogenesis.
There are, however, problems with spontaneous models:
i) less than 50% incidence and long latent period of development is 
waste of resources.
ii) variable development of tumours produces difficulty in staging 
tumours.
2.3.5.2 Experimentally induced urothelial cancer.
Experimental chemical carcinogenesis in the urinary bladder has helped 
our understanding of the development of such lesions in animals. 
These models have provided the basis for extrapolating the molecular 
concepts involved in the mechanism of pathogenesis to the development 
of the human cancer (Ito & Fukushima, 1986). There are several animal 
models of bladder and renal parenchymal carcinoma (Hicks & Chowaniec, 
1978; Cohen & Friedell, 1979; Cohen 1983, 1985; Hard, 1986; Ito &
Fukushima, 1986), but to date there has been relatively little 
development of an experimentally induced model of upper urothelial 
carcinoma. A selection of the chemicals which have been used 
successfully to induce urinary bladder tumours is shown in Table 2.14.
Strain Sex Lesions Chemical
Wistar F HY,
AC,
TC,
UC
SC N-butyl-N-(4-hydroxybutyl)- 
nitrosamine (BBN)
Wistar M TC, SC, UC BBN
Wistar M HY, TP, TC BBN
Fischer-344 M/F HY,
SC,
TP,
AC
TC Methylalkylnitrosamines
Norwegian albino M/F TP, TC Bracken fern
Sprague-Dawley/ 
Charles River CD
M/F TP, TC Bracken fern
Norwegian albino M/F TP, TC Quercetin
Sprague-Dawley F HY, TC, SC N-[4-(5-nitro-2-furyl)-2- 
thiazolyl]formamide (FANFT)
Wistar F HY, TC 2-Napthyamine
Fischer-344 F TP, TC, SC p-Quinone dioxime
Fischer-344 M/F TP, TC o-Anisidine
Fischer-344 M/F HY, TC Nitrilotriacetic acid
Fischer-344 F TC o-Toluidine hydrochloride
Fischer-344 M/F HY, TP, TC 4-Amino-2-nitrophenol
Fischer-344 M/F HY, TC N-N it ro s odiphenylamine
Fischer-344 M TP Allyl isothiocyanate
Fischer-344 M HY, TC Me lamine
AC, adenocarcinoma; HY, hyperplasia; SC, squamous cell carcinoma; TC, 
transitional cell carcinoma; TP, transitional cell papilloma; UC, 
undifferentiated carcinoma; M, male; F, female.
Table 2.14 Various chemicals reported to induce bladder cancer in 
rats. From Stula, (1986).
Two of these chemicals; N [4-(5-nitro-2-furyl)-2 thiazolyl]formamide 
(FANFT) and N-Butyl-N-(4-hydroxbutyl)-nitrosamine (BBN) are probably 
the most widely used carcinogens that induce experimental models of
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urinary bladder tumours in animals.
2.3.2.2.A N[4-(5-nitro-2-furyl)-2-thiazolyl]forxnamide (FANFT).
Formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl] hydrazide, a nitro- 
furan derivative was reported to induce carcinomas of kidney, breast, 
intestine and ear duct, but not the urinary bladder (Price et al, 
1966). Nitrofurans can be reduced to aminofurans and possibly hydro- 
xylamine derivatives in vivo (Taylor et al, 1951) which, being 
aromatic amines, would be expected to induce bladder neoplasms.
Erturk et al, (1967) used FANFT, (Figure 2.5a) dosed as a 0.188% mix 
(by weight) in the diet for 4 6 weeks in 30 female Sprague Dawley rats 
to specifically induce urothelial carcinomas.
Of the animals that lived 34 weeks or more, 29 developed gross bladder 
tumours and 3 animals developed carcinoma of the renal pelvis which 
invaded the kidney. Benign mammary tumours also developed in 15/30 
animals. Further studies feeding 35 male Sprague Dawley rats on a 
0.188% FANFT diet for 26 or 46 weeks by Erturk et al, (1969) resulted 
in a 100% incidence of gross bladder carcinomas.
Over half the 35 rats developed severe pelvic hyperplasia and 4 cases 
of renal pelvic carcinomas were reported which invaded the kidney. 
Seventy female Sprague Dawley rats were also fed for 26 or 46 weeks on 
a 0.188% FANFT diet and groups were autopsied at periodic intervals. 
The following histological changes were noted by Erturk et al (1969), 
during the carcinogenesis of bladder. Hyperplasia at 3 weeks was 
followed by mitotic activity and squamous metoplasia at 8 weeks. 
Microscopic papillae lesions throughout the bladder occurred at 9 
weeks and progressed to small tumours at 12 weeks. By 25 weeks gross 
tumours were 2 cm in diameter and had enlarged to 3-7 cm by 45 weeks.
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Figure 2.5a N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT).
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Figure 2.5b N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)
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Metastases occurred late in the process and were very rare. Cohen & 
Friedell (1979) produced a succinct and comprehensive review of the 
FANFT induced animal model of bladder carcinoma. FANFT reproducibly
induces 100% tumour incidence in the urinary bladder of rats, mice,
hamsters and dogs without sex predominance. The pathogenesis
develops through mild hyperplasia to invasive cancer. Hyperplasia is 
present in all rat strains at 2/3 weeks Sprague-Dawley (Erturk et al, 
1969), Fischer (Tiltman & Friedell, 1971) and F344 (Jacobs et al, 
1976)), which increases in severity and by 8 weeks nodular and 
papillary hyperplastic lesions have developed. These lesions
gradually enlarge, protrude into the lumen, and downward into stroma. 
By 25-30 weeks cellular and nuclear atypia are present together with 
invasion of the basement membrane which by 45-50 weeks is through to 
the muscle layer. Late development of ureter and renal pelvis 
tumours with obstruction of ureter and subsequent hydronephrosis 
occurs in Sprague Dawley but not Fischer rats. Since these early 
reports there has been little attempt to increase either the incidence 
or severity of upper urothelial tumours as a model of UUC. 
FANFT-induced bladder carcinomas resemble the human disease in several 
ways; most of the lesions are papillary transitional cell carcinomas. 
As with human disease the FANFT-induced lesion progresses from 
epithelial hyperplasia to non-invasive carcinoma, invasive carcinoma
and eventually distant metastases. The progress of the lesion can be 
followed by urinary cytology and haematuria is a frequent early sign 
of disease as with humans.
FANFT is often used as the initiator.in two stage carcinogenesis 
experiments in order to evaluate potential promoter agents in bladder 
carcinogenesis. Table 2.15 shows a selection of agents which have
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been "screened" using FANFT initiated bladder urothelium for promotor 
activity by determining an increase in tumour incidence, or decrease 
in tumour latency, or alteration in target specificity.
There are several disadvantages of using FANFT in a diet mix:
i) increased exposure risk to personnel
ii) level of dosing to animals is unknown
iii) it is an expensive chemical to use in the quantities required 
over the effective period
iv) it is very difficult to get supplies in the United Kingdom. It is 
only synthesised in the USA, but due to problems with synthesis from 
time to time, there has been a failure of the companies who produce 
it to keep up to the demand for supplies used by researchers.
v) finally big spenders seem to get first choice! as we have had an 
order for 200 g outstanding for 5 years.
Agent Promoter Action Reference
DL-Tryptophan Y (1) Cohen at al, 1978
Saccharin Y (1) Cohen et al, 1978 
Hicks, 1978 
Cohen, 1982 
Schoenig et al, 1985
Phenacetin Y (2) Anderstrom et al, 1983
Mechanical
perforation
Y (2) Anderstrom et al, 1983
E.Coli (06K131) Y (2) Johansson et al, 1987
(1)-increased incidence of bladder tumours
(2)-increased incidence of pelvic tumours
Table 2.15: some agents screened for promoting potential in urothelium 
initiated with FANFT.
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2.3.5.2.B N-Butyl-N-(4-hydroxybutyl)-nitrosamine (BBN).
N-Butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) (Figure 2.5b) was first 
reported to be a specific urinary bladder carcinogen by Druckey et al, 
(1964). It is a metabolite of N-nitrosodi-n-butylamine (IARC, 1978) 
which itself is a potent carcinogen inducing tumours in liver, 
forestomach, lung, bladder and oesophagus. BBN has become widely used 
as a chemical carcinogen to induce urinary bladder tumours in 
experimental animal models (Becci et al, 1981; Cohen, 1985) . Oral 
doses of 40 and 20 mg/kg b.w. of BBN given in the drinking water 
selectively induced multiple carcinomas of the urinary bladder in all 
animals in three different rat strains; Wistar (Ito et al, 1969; Kunze 
& Schauer, 1977), ACI/N (Herman et al, 1985) and Fischer 344 (King 
et al, 1984). Wistar rats were found to be more susceptible to BBN 
when compared with mice, hamsters and guinea-pigs (Hirose et al, 
197 6, Ito, 197 6). However, mice developed a higher incidence of 
invasive carcinomas than rats (Ohtani et al, 198 6).
A 100% incidence of urinary bladder carcinomas is induced in rats by 
continuous, prolonged administration of BBN in the drinking water (Ito 
& Fukushima 1986, see Table 2.16 and Figures 2.6a,b) which is dose 
related. The incidence of carcinomas is proportional to the total 
dose consumed (Ito & Fukushima, 1986), after a period of 40 weeks. 
Intravesicular instillation of a 2% BBN solution directly into the 
bladder of female ACI/N rats, three times weekly for a period of 20 
weeks, resulted in 70% incidence of urinary bladder papilloma and 57% 
incidence in carcinomas (Hashimoto et al, 1974) thus showing the 
direct carcinogenic action of BBN on bladder urothelial cells.
The detailed morphology, classification and histogenesis of urinary
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ja u ie  _ Lesions 01 m e u r in a ry  b la d d e r in  m ale  rats trea t­
ed with 0.05% BBN fo r  d iffe re n t periods
Period Effec- Lesions o f  the urinary bladder*
\ in  wc
W ith
BBN
XKSJ
W ith­
out
BBN
tivc 
No. o f 
rats
PN
hyper­
plasia
Papilloma Carci­
noma
2 38 18 12 (66.7) 6 (333) 0
4 36 11 11 (100) 8 (72.7) 2 (18.2)
6 34 17 16 (94,1) 15 (SS.2) 11 (64.7)
8 32 10 10(100) 9 (90) 9 (90)
12 28 9 9(100) 9(100) 9(100)
20 . 20 20 20(100) 20(100) 20(100)
* Percentages are given in parentheses.
Table 2.16 Lesions of the urinary bladder in male rats treated with 
0.05% BBN for different periods. From Ito & Fukushima, (1986).
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Figure 2.6a Occurence of lesions in the urinary bladder of rats given
0.05% BBN. PN, papillary or nodular. From Ito & Fukushima, (1986).
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Figure 2.6b Occurence of papillary or nodular hyperplasia in the 
urinary bladder of rats given BBN. From Ito & Fukushima, (1986).
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bladder carcinomas induced by BBN in female Wistar rats (Kunze &
Schauer, 1977; Kunze, 1979) showed 88% of the tumours to be papillary
and non-papillary transitional cell carcinomas. Fukishima et al 
(1976) concluded that 95% of BBN-induced bladder tumours were
transitional cell carcinomas in origin, the remainder being squamous 
cell carcinomas, undifferentiated carcinomas and carcino-sarcomas, and 
similar to characteristic tumours described for human bladders.
A series of studies by Becci et al (1979) established a quantitative 
dosing regime for the administration of BBN. Previous studies had 
almost exclusively used oral administration in the drinking water of 
varying concentrations of BBN, usually between 0.05% and 0.5%
solution. This method of dosing has three main disadvantages: i)
there is no means by which the quantity of BBN consumed by each animal 
can be controlled ii) there is a large exposure risk to technical 
staff in mixing and handling the large volumes of carcinogenic 
solutions iii) sawdust is contaminated with water spillage.
Oral administration of BBN (in a 20:80 ethanol:water solution so that 
each volume is contained in a 0.5 ml volume) using intubation directly 
into stomach has been successfully utilised to induce transitional 
cell carcinomas in female Fischer 344 rats (Becci et al, 1979) and 
male B6D2F1 mice (McCormick et al, 1981a). Oral gavage allowing 
quantification of administered BBN has allowed aspects of chemical 
carcinogenesis of urinary bladder tumours to be investigated such as 
dose schedule and total dose. McCormick et al, (1981a) determined 
that BBN induces bladder tumours in a dose related manner, with high 
organ specificity, short tumour latency. Frequent smaller doses 
induced a higher incidence of tumours than fewer large doses up to the 
same total dose (McCormick et al, 1981a).
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The experimental procedures in administering BBN by oral gavage make
it preferable to use than other carcinogens in diet and via drinking
water.
Unilateral ureter ligation in male Wistar rats treated with 0.025% BBN 
in drinking water for 20 weeks induced a greater incidence of pelvic 
and ureteric papillomas and carcinomas together with enhanced
hyperplasia of the pelvic and ureteric urothelium above the ligation 
(Ito et al, 1971).
BBN-induced bladder tumours in experimental animals have been 
frequently used to assess chemotherapeutic agents for possible
clinical use. Retinoids, natural and synthetic, analogues of vitamin 
A have been used frequently to inhibit bladder cancer in experimental 
animals (Grubbs et al, 1977; Becci et al, 1981; Fukishima et al, 1981; 
McCormick et al, 1981b; Moon et al, 1982,1983). However the 
inhibition of carcinogenesis is not complete (McCormick et al, 1981b) 
and the use of BBN-induced tumours to investigate different chemo­
therapeutic protocols is continuing.
BBN is now used frequently as a bladder urothelium initiator to screen 
potential bladder urothelium promoters since bladder carcinogenesis is 
known to be a multifactorial process with many potential causative 
agents (Anderson et al, 1986; Fukushima et al, 1985; Miyata et al, 
1985; Kitahori et al, 1985; La Voie et al, 1985). Table 2.17 shows a 
selection of chemicals which have been screened by this short term in 
vivo assay system. The marker change which is used to determine 
whether there is a promoting or carcinogenic potential is the 
development of pre-neoplastic (papillary/nodular) hyperplasia.
The pathogenetic pathway of experimental bladder carcinogenesis
77
Table 2.17: Some chemicals screened for promoting potential in the
urinary bladder after BBN initiation.
AGENT PROMOTER(Y/N) ACTION
5% sodium saccharin Y (1)
2% sodium-O-phenylphenate Y (1) + (2)
2% butylated hydroxyanisole Y (1) + (2)
5% sodium-L-ascorbate Y (1) + (2)
5% ascorbic acid N —
5% ascorbic stearate N —
5% sodium erythorbate Y (1) + (2)
0.8% ethoxyquin Y (1) + (2)
0.02% N-nitrospyrrolidine Y (2)
0.2% methylhydroquinone N —
0.2% hydroquinone N —
0.2% resorcinol N —
0.8% catechol N —
0.5% pyrogallol N —
0.6% carbozole Y (1)
0.1% quinoline N —
1% uric acid N —
2% trisodium nitrilotri- Y (1) + (2)
acetate monohydrate 
5% sodium citrate Y (1) + (2)
0.5% diphenyl Y (1) + (2) + (3)
0.2% allopurinol Y (1)
1.3% acetaminophen N -
(1)-Increased incidence papillary/nodular hyperplasia
(2)-Increased incidence papillomas in urinary bladder
(3)-Increased incidence carcinoma in urinary bladder 
% -percentage of test chemical in diet
Data from Kurata et al,1986; Miyata et al,1985; Fukushima et al, 
1985,1986a.
(induced by chemical carcinogens such as FANFT and BBN) is 
schematically represented in Figure 2.7 with simple hyperplasia being 
the inital response to variety of carcinogens.
Research into experimental bladder tumours using chemical carcinogens 
such as BBN and FANFT has elucidated pre-malignant changes in normal 
histological urothelial cells which subsequently become hyperplastic 
then malignant. Kunze (1979) showed the loss of alkaline phosphatase 
to be a marker change for pre-neoplastic cells after BBN treatment.
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Normal urothelium.
Atypical hyperplasia. Papillary hyperplasia. Nndniar hvn^piasia.
Simple h erplasia.
Non invasive 
carcinoma.
Invasive carcinoma.
T
Metastatic carcinoma. (Modified from Cohen, 1983).
Figure 2.7 Schematic representation of the mechanism of pathogenesis 
of urothelial carcinoma, derived from experimental urinary bladder 
carcinogenesis studies.
The increase in gamma-glutamyl transpeptidase (GGT) has been well 
established as a pre-malignant marker for hepatomas (Hanigan & Pitot, 
1985) and Ozono et al (1985) has found similar changes in the 
urothelium of BBN treated animals.
The urothelia that lines the bladder, ureter, renal pelvis and that 
covers the renal papillae are all derived from the same embryological 
structure; (the ureteric bud) and have a similar histological 
appearance although they do differ in thickness (Melicow, 1945) and 
also in cell surface characteristics (Newman & Hicks, 1981) .
This 'common embryological genesis' concept is the basis of the choice 
of BBN as the "initiating" carcinogen in developing an experimental 
model of UUC and its relationship to RPN (see Methods, section 3.6.5).
Several other factors biased the choice of BBN against FANFT: i) oral
dosing regimes evolved allow "control" over frequency and total dose 
administered to animals ii) BBN has a greater specificity than FANFT 
with no benign "extra-urothelial" tumours induced e.g. mammary 
tumours iii) a supplier was found who could supply the necessary 
quantities required for the experimental procedures at a reasonable 
cost.
2.3.5.2.B.1 Metabolism, pharmokinetics and cellular changes induced 
by BBN.
BBN undergoes omega-oxidation by P-450 dependant monooxygenases 
(Gottfried-Anacker et al, 1985) to produce a number of metabolites the 
major one is N-nitroso-butyl-(3-carboxypropyl)amine (BCPN) which 
comprises 40% of the administered dose (Okada, 1984) . The presence of 
the 4-hydroxybutyl group has been found to be necessary for selective 
bladder carcinogenesis (Okada, 1984). Suzuki & Okada, (1980) found 
that 80% of the N-nitroso moieties produced as a consequence of BBN 
metabolism were excreted within 48 hr. The hydroxylated metabolites 
are mainly excreted as beta-glucoronides (BBN-Gluc) according to 
Gottfried-Anacker et al, (1985) , and the two metabolites BCPN and 
BBN-Gluc are detectable in the serum within 2 min after an intravenous 
injection of BBN (Bonfanti et al, 1988) . BBN was found to disappear 
completely from the circulating blood 90 min, BBN-Gluc was detectable 
up to 40 min and BCPN was detectable up to 120 min after initial BBN 
injection. The body and renal clearance rates of BBN were 8 6.1 and
0.22 ml/min/kg respectively (Bonfanti et al, 1988). When either BCPN 
or BBN-Gluc were administered each on their own, only 41% and 50% 
respectively of these compounds were recovered in the urine suggesting
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that they undergo further biotransformation to potential proximate 
carcinogens (Bonfanti et al, 1988). It has, however, been suggested 
that the species/strain differences reported by (Hirose et al, 1976; 
Ohtani et al, 1986; Okada, 1984) may be due to genetically determined 
differences in metabolic enzyme systems (Mori et al, 1987) which 
affects the metabolism of BBN and hence the potentially carcinogenic 
metabolites.
2.4 THE NUDE MOUSE AND EXPERIMENTAL CARCINOGENESIS.
2.4.1 History of Nude Mouse.
The nude mouse is a spontaneous hairless mutant which was discovered 
in a closed albino mouse colony in 1964 and first reported in the 
literature by Flanagan (1966). Flanagan showed that the mutation was 
due to a single autosomal recessive gene, to which he assigned the 
symbol nu. In studies where homozygous (nu/nu) male mice were mated 
with heterozygous (nu/+) female mice with resultant 1:1 ratio of nude 
to normal offspring (Flanagan, 1966).
In addition to hairlessness the nude mouse also has a short life span 
and lacks a complete thymus (Hansen, 1978). The "athymic" nature of 
the nude mouse meant that initially it became an important tool in 
immunological research, since the thymus plays a primary role in the 
immune response. However, the fact that homozygous (nu/nu) mice 
accepted transplants (xenografts) of tumour tissues (Rygaard & 
Polvsen, 1969) opened up a new era in cancer research. The lack of 
an immune 'host-graft' tissue rejection response allowed the use of 
tissue from human tumours to be used rather than spontaneous animal 
tumours or chemically induced "model" tumours. For reviews discussing 
the use of the nude mouse in cancer research see Sharkey & Fogh
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(1984), and Fogh & Giovanella (1978, 1982).
The factors which makes the nude mouse an ideal host for tumour 
xenografts (namely, athymic, lack of a host-graft rejection) also 
leaves the animal prone to bacterial and viral pathogens (Ediger & 
Giovanella, 1978) . Although the nude mouse is not immunologically 
neutral, it can produce immunoglobulins and display Natural Killer 
(NK) cell reactivity (Sharkey & Fogh, 1984).
As a result of this susceptibility special precautions:and maintenance 
facilities have to be provided in order to obtain and maintain 
healthy animals and consistent results. It is necessary to keep 
these animals in a gnotobiotic (germ-free) environment such as a 
bacteria-free isolators (see section 3.6.6) and ensure they remain 
isolated from other laboratory animal species (especially mice). Nude 
mice are especially susceptible to the murine hepatitis virus (which 
is lethal in nude mice, but not apparent in normal mice) and the 
Sendai virus; producing a fatal pneumonia rather than the mild "cold" 
syptoms induced in normal mice (Ediger & Giovanella, 1978) . Personnel 
in contact with nude mice should not be working with other rodents 
(Sharkey & Fogh, 1984) .
Nude mice are available from several commercial sources. The nude 
gene (nu) has been bred into a variety of background strains (Hansen, 
1978; Sparrow, 1980). In order to assure a consistency of results, a 
minimum of 5 backcrosses should have been performed (Festing, 197 9) . 
A simple mean of assuring genetic consistency is to transfer skin 
grafts among heterozygous litter mates, which are often available as a 
by product of breeding heterozygous females to homozygous males 
(Ediger & Giovanella, 1978). If the skin grafts take then the colony 
is genetically homozygous, if not the animals may have to be subjected
to further husbandry.
2.4.2 Growth of Human Tumours in Nude Mice.
The athymic characteristics of the nude mouse has made it a frequently 
used vehicle for growing human and other tumour cells. The growth of 
human tumours was first reported by Rygaard & Polvsen (1969) after 
transplantation into nu/nu mice. Innoculation of cultured human cells 
was also successful (Giovanella et al, 1972). During the past 20 
years many variables that affect the frequency and speed of growth of 
tumour xenografts have been identified including tumour origin, age, 
sex and genetic background of nude mouse host and site of tumour 
innoculation, see Table 2.18.
Table 2.18: Variables that affect transplantation.
Host Tumour
Species Tumour type
Age Origin (primary, metastatic,
recurrent)
Sex Preparation of tumour tissue
Health of the animal Histology
Transplant site Differentiation
Life span of the animal Proliferation
From Mattern et al, 1988.
Approximately 50% of malignant transplantations are successful. The 
"take" rate is dependant on many variables including those listed 
above, and in addition, the degree of malignancy, and the degree of 
differentiation of the original tumour (Polvsen et al, 1982) . 
Metastases grow considerably better than primary site tumours, and 
tumour-derived cell line innoculations do considerably better than 
surgically derived tissue specimens (Fogh et al, 1977).
Reed & Manning (1978) report a metastatic bladder carcinoma xenograft 
which was extremely rapidly growing and required 6 passages in 29
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weeks that then yielded 10Og of tumour tissue from 18 mice where lg 
of original tumour tissue had been implanted. This example 
illustrates how the nude mouse xenograft procedure can be utilised to 
increase the mass of malignant tissue from a rare or uncommon tumour 
(occurring in humans) and thus allow a variety of experimental 
procedures to be performed.
2.4.3 Nude Mouse in Urothelial and Renal Carcinoma Research.
Nude mice have been used to research into growth, histological, 
biochemical characteristics of urothelial and renal malignancies 
tumours to chemotherapeutic agents, cytotoxic drugs and novel cancer 
treatments using monoclonal antibodies as targeting molecules (Huland 
et al, 1985, 1986; Kyriazis et al 1985).
2.4.4 Stability of Xenograft Tumours.
To be of use the mouse grown tumour (MGT) must retain and display all 
biological characteristics found in the original human tumour (OHT). 
This question is an important argument for assessing the reliability 
of nude mouse tumour models particularly in drug sensitivity testing. 
Several structural, biochemical and functional criteria play an 
important part in the evaluation of any differences that occur between 
the OHT and MGT (Table 2.19) . The choice of which criteria to use to 
evaluate the differences may explain the discrepencies among published 
observations (Sharkey & Fogh, 1984).
The inherent hazard in pathological/histological grading is that each 
pathologist has their own idea of what constitutes a particular 
pathological lesion; "one man's carcinoma is another man's 
hyperplasia", thus their observations are qualitative and subjective.
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Similarities Differences
Histology, ultrastructure Cell cycle parameters
Hormone production Growth rate
Production of tumour marker Metastatic spread
Chromosomes Invasive properties
DNA content Stroma and vascularization of
mouse origin
Chemotherapeutic sensitivity Metabolism, pharmacokinetics
Table 2.19: Criteria which may be evaluated to establish 
similarities or differences between the donor tumour and the 
xenografted tumour. From Mattern et al, 1988.
Quantitative morphormetic analyses has revealed that significant 
changes have occurred in histological differentiation when no changes 
were reported based on a purely subjective grading scheme (Sharky & 
Fogh, 1984).
Knofel et al (1987) studied 30 human renal cell carcinomas after 
several passages (10-50) in NMRI/nu/nu mice, and found that the 
majority remained stable with regard to histopathology, nuclear grade. 
Only one sixth (5 out of 30) altered their mitotic rate and DNA 
content (which was in fact increased). Fogh et al, (1978) compared a 
number of parameters for a melanoma tumour before (MeWo) and after 
growth (NuCuMeWo) in the nude mouse. They compared histological and 
ultrastructural morphology, in vitro growth rates, chromosomal 
analysis (human chromosome presence showed tumour cells derived from 
original tumour rather than mouse tissues), immune adherence tests and 
isoenzyme analysis: differing mobililty patterns of human and mouse
enzymes on starch gel electrophoresis of polymorphic human enzymes 
were used to show that NuCuMeWo cells were derived from original MeWo 
tumour and not mouse tissues.
A general summary is that tumours are stable after many passages at 
histological and biochemical levels, tumour cell kinetics tend to
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increase and it is necessary to monitor phenotypic and genotypic 
tumour features throughout the experimental period.
2.5 INVESTIGATIONS UNDERTAKEN.
A series of investigations were initiated based on these data reported 
on RPN, UUC in the literature (described above). It was of interest 
to determine: i) which was the earliest change occurring as a
consequence of BEA-induced acute RPN, ii) how relevant is the acute 
RPN model in the unipapillate of the rat to the chronic clinical 
lesion in the multipapillate human kidney; could it be reproduced in a 
multipapillate animal species ie the pig, iii) using a classical 
two-stage carcinogenesis model was it possible to induce UUC in an 
initiated urothelium with an acute RPN injury as the "promoting" step, 
iv) could this UUC lesion be affected by subsequently dosing with 
analgesics and v) was it possible to develop an "in-vitro" cell line 
of any chemically-induced UUC tumours or a passable tumour in Nude 
mice. The methods, results and discussions of these investigations 
undertaken form the remainder of this thesis: Methods (Chapter 3),
Results and Discussions of RPN studies (Chapters 4), Results and 
Discussions of UUC studies (Chapter 5).
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CHAPTER 3
MATERIALS AND METHODS
3.1 MATERIALS AND INSTRUMENTATION.
3.1.1 Chemicals.
All the chemicals used in these studies were of analytical grade and 
of the highest purity that was commercially available unless otherwise 
stated. Chemicals are listed according to supplier.
Aldrich, Gillingham, Dorset, UK.: 2-Bromoethanamine hydrobromide 
British Drug Houses Ltd (BDH), Eastleigh, Hampshire, UK.: acetic acid, 
ammonium sulphide, calcium chloride, calcium nitrate, cobalt chloride, 
cobalt nitrate, disodium hydrogen orthophosphate, formaldehyde (40 v/v 
solution), Haemotoxylin (Harris'), n-hexane* hydrochloric acid, 
Giemsa, magnesium chloride, manganese chloride, methanol, N- 
phenylanthranilic acid, sodium acetate, sodium chloride, sodium 
hydrogen carbonate, sodium dihydrogen orthophosphate, sodium-beta- 
glycerophosphate, sodium hydroxide .
Intertox Chemicals, Cheshire, UK.: peracetic acid.
James Burroughs (FAD) Ltd., Witham, Essex, UK.: ethanol (100%) 
Koch-Light Ltd., Haverhill, Suffolk, UK.: N-gamma-L-glutamyl-beta-
napthylamide
May and Baker, Dagenham, U.K.: Diethylether, 98%, Sagatal.
Midwest Research Institute (MRI), Kansas City, Missouri, USA.: N-
butyl-N-(4-hydroxybutyl)-nitrosamine (BBN), purity: 97% +, molecular
weight: 174.3, CAS No.: 924-16-3.
Raymond A Lamb Ltd, London, UK: Methyl-green pyronin, Oil red O,
Toluidine blue .
Roche Products Ltd, Welwyn, Herts, UK.: Vitamin K supplement (KOnatin 
10)
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Sigma Chemical Company Ltd, Poole, Dorset, UK. : adenosine triphospha-
tate, aspirin, carboxy-methylcellulose, Cyancobalamin, Eosin, Fast 
garnet red, glycylglycine, napthol-AS-Bl-phosphate, Paracetamol (4- 
acetomidophenol), periodic acid, Red violet LB, Schiff's reagent, 
sodium barbitone, TRIS (Tris(hydromethyl)aminomethane), Triton X- 
100 .
3.1.1.1 Synthesis of sodium salt of N-phenylanthranilic acid 
Procedure.
1. Add the minimum volume of 1.0 M NaOH (pH > 8.0) sufficient to 
dissolve 15 g of NPAA (Aldrich), typically 60-70 ml.
2. Evaporate solution using a rotary evaporator at 65°C and at 30 mm 
Hg vacuum pressure until grey-white sludge is obtained.
3. Product is then removed from the vessel and redissolved in minimum 
volume of 96% ethanol and crystallised at 60°C in an oven. 
Purification is performed by redissolving in minimum volume of 1:1 
(v/v) ethanol:ether solution and recrystallize again.
4. Crystals can be ground to a fine powder using a mortar and pestle. 
[Caution: The product is a fine particulate compound that irritates 
the nasal and oral epithelia, necessitating the use of face mask and 
goggles.]
5. Compound can readily be dissolved in aqueous solutions which is the 
great advantage over the insoluble parent compound.
3.1.2 Materials.
H.A. Coombs Ltd, Wiltshire, UK.: 2.54 cm wide rubber band.
Filter Supply Company, London, UK.: 4 urn pore glass fibre wool.
Flow Laboratories Ltd, Rickmansworth, Herts, UK.: Multiwell plates. 
Gibco, Paisley, Scotland, UK.: RPMI-1640 media [lOx], L-glutamine (200
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mM) [lOOx], Foetal calf serum (heat inactivated), antibiotic- 
antimycotic solution [10,000 units/ml], NUNC cryotubes.
Gillette Surgical, Isleworth, Middlesex, UK.: Needles (Luer fitting, 
23G (0.6 x 30 mm), 25G (0.5 x 16 mm)).
Histolab & Cytolab, Hemel Hempstead, Hertfordshire, UK.: Histomount 
mounting medium (D.P.X), tissue stubs.
AR Horwell Ltd, West Hampstead, London, UK.: Microscope slides (single 
frosted end).
ICI, Macclesfield, Cheshire, UK.: Dry Ice (solid CC^).
Ilford Ltd, Mabberley, Cheshire, UK.: Black and White photograhic film 
- Ilford FP4 [ISO 125].
Kodak Ltd, Liverpool, UK. : Colour photographic films : Kodak
EKTACHROME [Daylight, ISO 100] .
Raymond A. Lamb Ltd, London, UK.: Coverslips (22 x 22 mm, 22 x 40 mm, 
22 x 50 mm,), coplin staining jars, staining racks, slide storage 
trays, slide storage boxes, adhesive slide labels.
LRC Products Ltd, Malaysia.: Industrial Rubber gloves (Marigold).
Meno Ltd, London, UK.: rubber "0” rings.
3M UK Ltd, Bracknell, Berkshire, UK.: 3M dust masks, scotch tape,
white pressure sensitive tape, glass fibre tape.
Polysciences Ltd, Northampton, Northants, UK.: JB-4 Glycolmethacrylate 
resin, embedding moulds (16 x 12 x 6mm, 19 x 13 x 5mm, 15 x 5 x 2mm, 
12 x 6 x 5mm), tissue stubs.
Pressure Seal Plastics, Chesterfield, S. Yorkshire, UK.: plastic foam, 
clear PVC plastic (0.2 mm thick), coloured PVC plastic (0.5 mm thick). 
Racal Safety Ltd, Wembley, London, UK. : Flow Helmet (Airstream
Dustmaster).
Sabre International Products Ltd, Reading, Berkshire, UK.: Gavage
Needles: Luer fitting, 15-16G intra-venous needles modified by cutting 
to appropriate length and rounding off tip, Syringes (Luer fitting, 1 
ml, 2 ml).
Sigma Chemical Company Ltd, Poole, Dorset, UK.: Gelatin mountant,
Monastoral blue B.
Sterilin Ltd, Middlesex, UK. : Sterilin tubes.
W.M. Supplies Ltd, Oldham, Lancashire, UK.: Tyvek "J-suit" coverall 
suits and boots.
Surgikos Ltd, Livingston, Scotland, UK. : Disposable surgical gloves 
(Microtouch):
TAAB Laboratory Equipment Ltd, Aldermaston, Berkshire, UK.: Dustoff
fluorocarbon gas, TAAB Superglass (for Ralph knives), scalpel blades
(N° 22), camel hair brush (N° 5), single edged razor blades, tissue 
stubs, embbedding moulds for EM, Spurr EM resin embedding kit.
3.1.3 Instruments.
Galaxy G400D0 balance:(OHAUS Scale Corp., Flerham Park, NJ. USA)
Fume hood: Astecair 3000, (Astec Environmental Sytems, Weston-Super- 
Mare, Avon, UK).
Microscope(s): Leitz Dialux, (E. Leitz (Instruments) Ltd, Luton,
Bedfordshire, UK), StereoNikon SMZ-10 stereoscope, Diaphot Nikon 
(type 102) Inverted microscope, Nikon TMS (type 104) Inverted 
microscope, (Nikon UK Ltd, Telford, Shropshire, UK).
Camera (s): Nikon UFX-II photographic systems and Nikon FE2 SLR,
(Nikon UK Ltd)
Flow cabinet: Pathfinder, (Havant, Hampshire, UK) with activated
charcoal filters suitable for formaldehyde fumes and autopsy odours.
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Microtome: Bright 5030/WD/MR-CV, (Bright Instruments Co, Huntingdon,
Cambridgeshire, UK).
Incubator: LEEC MKII Proportional Temperature Controller, (LEEC Ltd,
Nottingham, Nottinghamshire, UK).
Knifemaker: LKB 2078 histoknifemaker, (LKB, Bromma, Sweden)
Sledge (fixed frozen sectioning) microtome: Reichert with freezing
stage attached to Mectron thermocouple system (Frigistor Ltd, UK) .
Hot plate, Slide drying cabinet, Water bath: (Raymond A. Lamb Ltd,
Sunbeam Rd, London, UK) .
Osmometer: Wescor Inc. 5100 Vapour Pressure Osmometer, (Chemlab
Scientific Products Ltd, Hornchurch, Essex, UK).
Sterilising tower, (Sartorius, Gottingen, FDR).
Autoclave: Rodwell Series 32, (Rodwell Scientific Instruments, UK).
Thin plastic film Isolator: made "in-house" at the Robens Institute by 
Mr S. Tuttlebury (Trexler & Reynolds, 1957).
26-BTC air blower: (Air Flow Developments Ltd, supplied by P.J. 
Holloway & Sons Ltd, London, UK) .
Halidehound (halide sniffer): (Ricca-Reddington Industries, Florida,
USA) .
Ear punch pliers: Junior Punch plier (3/64" hole), (Maun Industries,
UK) .
Surgical instruments: scalpel blades N° 22, single edged razor blades, 
scissors, forceps, fine point forceps (N° 5), (TAAB Laboratory
Equipment Ltd, Aldermaston, Berkshire, UK) .
Animal balance: Torbal Torsion balance (0-2 Kg reading to lg), (K.T.
Forrest & Co., Streatham, London, UK).
Radio frequency sealing machine: (STANELCO Ltd, Borehamwood, Herts,
UK) . .
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Rotating mixer: (TAAB Laboratory Equipment Ltd.),
3.2 ANIMALS.
3.2.1 Licence Details.
All experimental procedures on rats and mice were performed under 
Licence (N° 61672, Certificate Al) issued by the Home Office under the 
Cruelty to Animals Act (1876) Licence to Experiment on Living Animals. 
This Act has now been replaced by the Animals (Scientific Procedures) 
Act (198 6), however licences issued under previous Act remain valid. 
Since July 1988 all carcinogenesis studies commenced have been 
designed and performed according to United Kingdom Committee on Cancer 
Research Guidelines for the Welfare of Animals in Experimental 
Neoplasia (1988).
All experimental procedures involving pigs were performed by Dr M.E.C. 
Robbins at the CRC Normal Tissue Radiobiology Research Group, The 
Churchill Hospital, Headington, Oxford, according to the procedures 
stipulated on his licence issued under Acts mentioned above.
Similarly all experimental procedures involving marmosets were 
performed according to guidelines in the Act for primate work under 
the supervision of Dr R.J. Tudor, D.H.S.S. Department of Toxicology, 
St. Bartholomew's Hospital Medical College, London, UK.
3.2.2 Rats
Male Wistar rats (Porton strain, random bred closed colony maintained 
by Experimental Biology Unit, University of Surrey) were used. Rats 
were regularly handled prior to dosing, to minimise stress-responses 
during experiments. The rats were given food (Spratts Laboratory 
Animal diet No. 1, Spratts Barking, UK) and tap water ad libitum.
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They were housed in translucent "shoe-box" type cages; dimensions 60 
x 35 x 18 cm (up to 9 rats per cage) on sterile soft wood shavings 
(Lee and Son, Chertsey, Surrey, UK) and acclimatized to a controlled 
environment (12 hours light : dark schedule with the light cycle
beginning at 0730 hr GMT), temperature of room maintained at 23+l°C 
and humidity at 40+10% and 15 air changes per hour.
3.2.3 Mice.
Several strains [Schnider (Sch) (University of Surrey strain), Obese 
(Ob/Ob) (University of Surrey strain), C57B1/6 and Balb/c (Bantam
and Kingman Ltd, Hull, N. Yorkshire), Nude mice (MFl-nu/nu/Ola/Hsd) 
(Harlan Olac Ltd, Shaw's Farm, Blackthorn, Bicester, Oxfordshire, 
UK.)] were used in a number of studies, investigating differences in 
reponse to nephrotoxins (see section 3.6.2). All strains were housed 
in translucent mouse box cages, dimensions 32 x 25 x 16 cm (with no 
more than 12 mice per cage) on sterile soft wood shavings (Lee and 
Son, Chertsey, Surrey, UK) and acclimatized to a contolled environment 
as outlined in section 3.2.2 above. Germ free Nude mice were 
maintained in an isolator system (see section 3.6.6.4.D).
3.2.4 Pigs
The animals were maintained at the CRC Normal Tissue Radiobiology 
Research Group, (University of Oxford) Research Institute,Churchill 
Hospital, Oxford, under the supervision of Dr. Mike Robbins. Female 
Large White pigs (from the Pig Improvement Company, Oxford, UK.) were 
used. These were kept in pens (indoors) in a controlled environment of 
(12 hours dark/light schedule), temperature maintained at 18+2°C, 
humidity - not controlled: atmospheric. Animals were housed for a two
week acclimatisation period prior to commencing any experimental
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procedure to minimise any stress induced due to their change in 
environment. The animals were fed on a proprietary pig diet (Speedi- 
pork, BBO Ltd, UK) and allowed water from a demand/access system. In 
the initial experiments the animals were 6-7 months old with a body 
weight of 60-70 kg. The later experiments were performed on younger 
pigs aged 14 weeks and with body weights 20-30 kg. The reasons for 
using younger animals were: economical (pigs cost £40 each, and £1.50 
a day to keep, therefore young pigs are more cost effective), and 
space (younger pigs are smaller and so it was possible to keep more in 
the limited amount of pen space that was available).
3.2.5 Marmosets.
Animals were housed in the Animal Unit of DHSS Department of 
Toxicology, St Bartholemew's Hospital, Medical College, London and 
maintained in a controlled environment with 12 hr light from 0700-1900 
hr, temperature 23+3°C, relative humidity 50+10%. The animals were 
housed individually in metabolic cages, and fed SDS Marmoset diet and 
fruit, and allowed tap water ad libitum.
3.2.6 Animal Identification.
Animals (rats and mice) were identified using a numbering system. 
Each animal either had one or both ears punched using punch pliers 
according to the system illustrated in Figure 3.1. Four punch 
positions on the left ear represented single figures; 1, 2, 4 or 5,
whereas equivalent positions on the right ear represented tens ; 10,
20, 40 or 50, complete holes on the right ear represented hundreds;
100, 200. Thus it was possible using this system to give all animals
individual identification numbers up to 299.
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a) 40
100
R
d)
48
C 3
179
Figure 3.1 Schematic diagram illustrating the ear punch 
identification system for rats and mice. a) illustrates punch 
positions and their allocated numerical values; b)-e) illustrate 
examples of identification numbers constructed with different punch 
positions: b) 3, c) 6, d) 48 and e) 179.
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In the carcinogenesis experiments each animal was given an individual 
number. In some of the short-term toxicity studies (especially with 
mice) all the animals in one experimental group were identified by 
the same number ie control = 1, low dose = 3, high dose = 4.
The pigs were given individual identification numbers were on plastic 
"punch" tags which were attached to the animal's ear.
3.3 DOSING PROTOCOLS.
3.3.1 Anaesthetics.
3.3.1.1 Rats and mice.
These were anaesthetised using sodium pentobarbitone (Sagatal) 60 
mg/kg intraperitoneally (ip). To allow an accurate injection volume 
to be administered to mice, the Sagatal was freshly diluted 1:10 with 
physiological saline (0.9% NaCl w/v) immediately prior to injecting. 
Ether (diethyl ether) anaesthesia was used on occassions where only a 
postmortem examination was to be performed and no actual surgical 
procedures. This was the preferred method of anaesthesia (or pre­
anaesthesia to reduce the stress for the large (600g plus, body 
weight) rats prior to administering the Sagatal), in the 
carcinogenesis experiments. A measured volume of ether (50 ml) was 
poured on to a cotton wool pad which was held in a wire holder within 
the bucket (with a secure lid) which was used as the anaesthetising 
chamber. Animals were then placed in this chamber for a suitable 
period until they were completely anaesthetised.
3.3.1.2 Pigs.
The pigs were anaesthetised with a gas mixture of 2-3% halothane, 30% 
nitrous oxide plus 70% oxygen as administered by means of a mask 
which covered the animals snout.
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3.3.2 2-Bromoethanamine hydrobromide (BEA) MW 204.9 C2 H7 N Br2
Animals were injected intraperitoneally (i.p.) with a single dose <50—
100 mg/kg body weight) BEA freshly prepared (Bach et al, 1983) in
physiological saline (100 mg BEA per ml of saline) at .0900 hours 
unless otherwise stated.
3.3.3 N-butyl-(4-hydroacybutyl)-nitrosamine (BBN).
BBN is a yellow-brown oil, chemical formula: Cg H^g N2 02 
MW 174.3, and is soluble in common organic solvents.
BBN is heat and light sensitive, therefore preweighed vials 
containing 2g BBN were wrapped in aluminium foil placed in outer
"carcinogen" containers and stored at -20°C. Immediately prior to 
use 12.5 ml of 20:80 ethanol:water, solution was added to 2g BBN to 
obtain a solution where 0.5 ml contained 80 mg BBN.
Animals were dosed twice weekly for 5 weeks to a total dose of 800 mg. 
Each dose of 80 mg was administered in a 0.5 ml volume of a
20:80 ethanol:water solution by oral intubation (Becci et al, 1979; 
McCormick et al, 1981a). Oral gavage dosing of this carcinogen was 
chosen because it has been shown by Becci et al (1979) and McCormick 
et al, (1981a) to be a more controlled method of quantitatively dosing 
animals, thus less animals are required overall. In addition there is 
a minimum risk of exposure to staff administering the BBN compared to 
dosing via dietary or drinking water methods and there is a very 
limited likelihood of control or other animals being affected.
Animals in experiment number 5 (section 3.6.5.5) recieved a total of 
400 mg of BBN; they were dosed twice weekly for 2.5 weeks. This was 
an attempt to reduce the bladder tumour incidence in the positive 
control groups (i.e. BBN only treated).
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3.3.3.1 Safety Procedures for working with BBN
BBN was weighed out according to GLP procedures for high risk 
chemicals instigated by Robens Institute (Protocol:GTX/METHODS/- 
CARCINOGENS).
1. Each worker involved in dosing BBN wore the following protective 
equipment to reduce the possible exposure risk:
a) full length total cover elasticated cuff lab coat
b) disposable face mask
c) disposable paper coverall "J-suit" including slipover boots
d) flow helmet
e) 2 pairs gloves (1 disposable surgical, 1 industrial rubber)
2. The mixing of solutions and filling of syringes, was performed in a 
plastic seed tray (40 x 25 x 3 cm) within a radioactive work tray (100 
x 5 0 x 6  cm), both coated with benchkote (absorbent side up) and all 
equipment was labelled with carcinogen tape.
3. All dosing was carried out by oral gavage over an empty cage, 
syringes were disposed in a labelled Cinbin receptical which was 
"double bagged" when full and disposed of by Hazardous Waste 
procedures implemented by the University.
4. After dosing any BBN residues remaining were diluted in a 5% Decon 
90 solution and the glass vial returned to carcinogen container. Both 
container and vial were be disposed of by approved Hazardous Waste 
procedures implemented by the University.
5. The cages were cleaned twice a week, sawdust etc placed directly 
into black bin bags. No more than three cage loads of waste per bag. 
This was placed inside a second bag and sealed with carcinogen tape 
for immediate incineration. (In BBN study number 5, the University
98
had changed it's policy on disposing of carcinogenic bedding and it 
had to be disposed of through the Hazardous Waste procedure).
6. The empty cages were decontaminated using 5% (v/v) Decon 90 sol­
ution for at least 48 hr. These cages were then thoroughly rinsed and 
placed in the normal cage washing procedure.
7. The benches were covered with black plastic and benchkote, 
decontaminated after each dosing/cleaning session by a fine spray of 
5% (v/v) Decon 90 and wiped with Kimwipes, all cleaning material was 
double bagged and incinerated.
8. The floor was cleaned after each session with 5% (v/v) Decon 90 
solution.
3.3.4 Aspirin (Acetylsalicylic acid) MW 180.15 Cg Hg 04
Animals were dosed twice weekly for 18 weeks by gavage with aspirin at
90 mg/kg. The aspirin was administered as a suspension (90 mg/ml
concentration) in 1.25% (w/v) carboxy-methylcellulose. Each animal 
recieved 0.1 ml/lOOg body weight.
3.3.5 Paracetamol (Acetaminophen) MW 151.16 Cg Hg N
3.3.5.1 Pilot study (see section 3.6.5.2)
Animals were dosed twice weekly for 18 weeks by gavage with 
paracetamol at 75 mg/kg. The paracetamol was administered as a 
suspension (75 mg/ml concentration) in 1.25% (w/v) carboxy-
methylcellulose. Each animal recieved 0.1 ml/lOOg body weight.
3.3.5.2 Main study - BBN study 5. (see section 3.6.5.5)
Animals were dosed twice weekly for 18 weeks by gavage with 
paracetamol at 100 mg/kg. The paracetamol was administered as a
suspension (100 mg/ml concentration) in 1.25% (w/v) carboxy-
methylcellulose. Each animal recieved 0.1 ml/lOOg body weight.
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3.3.6 N-Phenylanthranilic acid (NPAA) MW 213.23 C1g N O2 
Animals were dosed twice weekly for 18 weeks by gavage with NPAA at 
107 mg/kg. The NPAA was administered as a suspension (107 mg/ml 
concentration) in 1.25% (w/v) carboxy-methylcellulose. Each animal 
recieved 0.1 ml/lOOg body weight.
3.3.7 Sodium N-phenylanthranilate (NaNPAA) MW 235.23 H^g N C>2 Na
Animals (pigs) were dosed with a single intravenous infusion (given 
over a 30 min period) of NaNPAA (117.5 or 235 mg/kg bodyweight) 
freshly prepared in distilled water (235 mg/ml concentration).
3.4 TISSUE PREPARATION.
3.4.1 Fixation.
The purpose of fixation is to preserve the morphology of tissue as 
near as possible to that in life minimising shrinkage and distortion 
artefacts. The choice of fixative is critical when the detection of 
enzymes and antigens is attempted. The process of morphological 
preservation and retention of enzymic and antigenic activity to the 
same degree is difficult as each criteria compromises an adequate 
expression of the other criteria. Low concentrations of the commonly 
used aldehyde fixatives glutaraldehyde and formaldehyde, i.e. 3-4% 
coupled with low temperature 0-4°C for short periods of fixation 24 
hr as a maximum have been used to adequately preserve morphology 
together with enzyme activities (Burnett, 1982; Alpers & Beckstead, 
1984,1985) and antigen activity (Beckstead, 1985). For these reasons 
the standard fixation procedure for rat and mouse tissues was 
immersion for 24 hr in formal calcium fixative (4% v/v formaldehyde, 
1% w/v calcium chloride, based on the method from Bancroft & Stevens, 
1982) . The addition of extra cellular calcium enhances the retention
100
of enzyme activity. Pig tissues were fixed for longer periods between
48-72 hr because of the increased mass of pig kidneys. This did not
seem to have a detrimental effect on the retention of histochemically 
determined enzymic activity.
3.4.2 Postmortem and Tissue Processing.
1. Animals were sacrificed by: either cervical dislocation or 
anaesthetised using sodium pentabarbitone - Sagatal at 60 mg/kg body 
weight i.p., unless otherwise stated.
2. The abdominal cavity was opened via a midline incision from
pubic symphis to xyphoid process and the peritoneum incised carefully 
with scissors then retracted, together with the skin flaps to expose 
the intestines.
3. The intestinal tract was carefully moved to the left hand, side 
of the animal thus exposing the kidneys, ureter and bladder.
4. A loose ligature was placed around the 'neck' of the bladder. 
The bladder was then gently emptied of urine (if it was still 
full) by applying manual pressure using forefinger and thumb, or if a 
sample of urine was require then a 2ml syringe attached to a 23G 
needle was used to aspirate the bladder of urine.
5. A 2 ml plastic syringe containing cold 4°C formal fixative (see 
section 3.3.1 for details) was attached to a 23G needle. Introducing 
the needle close to the neck of the bladder, the fixative is injected 
thus inflating the bladder with 1.5 - 2 ml of fixative.
6. Once the bladder was inflated, the ligature was tied tightly, the 
needle and syringe removed and the bladder dissected free from the
animal using scissors and immersed immediately in cold 4°C 
formal:calcium for 24 hr.
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7. The kidney(s) and ureter were dissected intact after the
surrounding fat and fascia had first been removed by blunt dissection.
8. The kidney(s) were depoled using a single edged razor blade
to facilitate the diffusion of fixative to the inner medulla 
and papilla regions. The depoling cuts were made such that it is 
possible to distinguish easily between left and right kidneys.
9. After 24-48 hr fixation tissue specimens were obtained as 
follows
9a. The bladder was sectioned longitudinally in half. The internal 
surface was examined under a stereomicroscope.
9b. The kidney was sliced in a transverse place through the hilus
so as to obtain a 1 - 2 mm thick slice containing the papilla tip.
The upper 2 cm of the ureter was dissected free of the kidney.
3.4.3 Buffer Washing removes excess fixative solution from the 
tissue which could affect the infiltration and embedding of the 
tissue. Later, once sections have been prepared, excess fixative 
solution remaining in the tissue may alter the staining properties of 
the tissue. Buffer washing also maintains the osmolality of the 
tissues, reducing shrinkage and artefacts.
Buffer - 0.1M Phosphate buffer pH 7.2-7.4
1. Stock A - 0.2 M sodium dihydrogen orthophosphate (MW 156.01)
2. Stock B - 0.2 M disodium hydrogen orthophosphate (MW 141.96)
3. Solution for pH 7.2 14.0 ml - Stock A, 36.0 ml - Stock B and 
make up to 100 ml with 50.0 ml - Distilled water.
This solution should also be stored and used at 4°C.
Procedure was modified from traditional electron microscope 
procedures with tissue being rinsed and washed in four changes of 0.1
102
M. Phosphate buffer of 30 minutes each on a rotatory mixer maintained 
at 4°C.
3.4.4 Dehydration removes aqueous tissue fluids including buffer and 
replacing it with an organic solvent which is usually miscible with 
the embedding media. A graded series of alcohols (ethanol) was used 
(following the procedure below) to dehydrate the tissue and still 
maintain enzyme activity. All the dehydrating solutions are used at 
a temperature of 4°C.
1. Replace buffer, rinse with 50% v/v ethanol and allow tissue 
to 'rotate' in this solution for 20 - 30 min.
2. 70% v/v ethanol was substituted for 50% ethanol - 20-30 min.
3. 100% v/v ethanol was substituted for two changes of 60 min.
3.4.5 Infiltration.
The choice of glycolmethacrylate as the embedding media was made 
because of several factors:
1. Plastic embedding preserves tissue structure much more faithfully 
than does paraffin.
2. The hydrophilic nature of glycolmethacrylate allows convenience in 
dehydration and versatility in staining sections.
3. The ability to cut 1-2 um semithin sections offers unprecidented 
light microscope resolution.
4. Glycolmethacrylate resin allows the use of enzyme histochemistry 
and high resolution autoradiography on the same and and serially 
cut tissue sections.
5. En bloc macroscopic examination and photography is possible, as is 
low magnification electron microscopy (on formvar coated grids using 
carbon coated sections).
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6. Immunohistochemistry, including the use of colloidal gold labels 
is also possible.
Procedure
* ALL procedures involving glycolmethacrylate should be performed in 
a fume cupboard.*
A 100 ml volume of JB-4 solution A was catalysed by adding 0.90 g of 
catalyst (1 spoonful) while stirring until all the solid has
dissolved. Approximately 30-45 min at room temperature with a magnetic 
stirrer. Exclude air by the use of cling film over neck of flask. 
Catalysed Solution A is then used to infiltrate the alcohol dehydrated 
tissue. The final 100% ethanol solution was decanted off the tissue 
specimen and solution A is poured directly onto the specimen.
Sufficient solution A was added to allow the tissue specimen to float. 
Upon becoming properly inflated the tissue became translucent and sink 
to the bottom of the container. Overnight gentle rotation at 4°C is
recommended for most tissue specimens to become infiltrated.
3.4.6 Embedding.
1. 1 ml of JB-4 solution B was added to 25 ml of freshly 
catalysed solution A (which is over ice to slow down polymerisation), 
stirred well, and used as quickly as possible after mixing.
2. The moulds used for embedding were clean, dry and free of dust
(which would otherwise become embedded and scratch the knife-edge
during sectioning). Using a disposable pipette (and wearing
protective disposable surgical gloves), 2-3 ml of solution A+B was
placed into a mould cup. The tissue specimen was placed into the cup 
and orientated in the middle of the cup leaving some excess resin 
around the tissue.
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3. A prewritten label which has the tissue identification code 
written in pencil (many inks are soluble in JB-4 resin!) was placed 
on a nylon embedding stub. The block holder was then placed over the 
tissue in the mould and the remaining capacity filled with resin.
4. For best polymerisation results, the moulds were placed in a 
dessicator under vacuum or nitrogen atmosphere, because oxygen 
inhibits the polymerisation of JB-4 resin. However, as a very small 
surface area of the block is exposed to the air when a nylon holder is 
placed in the mould adequate polymerisation can be achieved in normal 
atmosphere. The polymerisation was allowed to proceed at room 
temperature for 2-3 hr or alternatively overnight at 4°C. Once 
polymerised the blocks were removed from the moulds. There was often 
a liquid film at the air/resin interface which was wiped off.
5. JB-4 resin blocks were found to be easier to section if allowed to 
stand open in the air for a few hours prior to sectioning. If the 
blocks soften due to absorption of atmospheric moisture in humid 
weather, they were dried over silica gel. Conversely if they become 
too brittle due to drying out they were restored by placing in 
controlled humidity. The blocks were placed in a dessicator 
containing a dish of saturated solution of potassium carbonate, allow 
2 hr to equilibrate then remove the potassium carbonate and the 
blocks were left to stand for 1-2 days.
3.4.7 Sectioning.
To obtain the 1-2 um thick semithin sections required to allow high 
resolution light microscopy it is necessary to cut the JB-4 resin 
using glass Ralph knives.
3.4.7.1 Making Ralph, type glass knives.
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1. The glass was cleaned with detergent (Decon 90) or a suitable sol­
vent (absolute alcohol or acetone) to remove all grease and dust. 
Rinsed thoroughly in water and dried.
2. Ralph knives can be made adequately using the "LKB 2078
Histoknife" maker following the manufacturers recommended procedure.
4. The knives are mounted onto aluminium strips (dimensions: 17 x 2.5 
x 0.6 cm) which fit into the knife holder of the Bright 5030/WD/MR-CV 
microtome.
5. The strips are warmed to 60°C on a hot plate. A single
large drop of dental wax is placed on the centre of the strip.
6. With the knife edge uppermost, place the knife onto the drop of
dental wax. Using firm downward pressure position the knife so that 
there is a thin layer of wax covering the underside of the glass knife 
and the knife edge is parallel to the edge of the aluminium strip.
7. Remove the assembled knife and strip from the hot plate and allow 
the wax to cool and harden. This method of attachment is quick, 
economical and quite satisfactory when sectioning .soft tissues such as 
kidney.
3.4.7.2 Cutting sections.
1. Use a dry glass knife with a Bright 5030/WD/MR-CV microtome, this 
is capable of advancing between cuts in increments to 1 um.
2. Blocks are mounted in the microtome so that its shortest edge is 
parallel to the knife edge and its block face is vertical relative to 
the knife edge.
3. Excess resin has to be trimmed off the block prior to sectioning 
the actual tissue. The microtome setting for this procedure can be 
at a thickness between 5 um and 12 um.
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4. Once tissue is visible in trimmed sections, reduce the advance 
setting to 2 um and continue trimming until the exact tissue area 
appears in the section. Orientation of the block may be necessary 
relative to the knife edge. Once the correct tissue area has been 
reached, 'lock' the knife holder and platform using the locking bar.
5. A slow cutting speed is used, as fast speeds produce vibration 
between block and knife edge resulting in 'chattering'.
6. As the section is cut it is often folded on itself. The operator 
can, with practice, tease and stretch the section to loosen the folds, 
using watch makers forceps and a small brush. As the section comes 
off the knife edge lightly breathing on it helps it to flatten out and 
reduces the folding because the section absorbs, some of the warm water 
vapour.
7. The section is then dropped onto a water bath containing clean 
distilled water at room temperature. The section will spread out and 
should be a clean scratch-free and fold-free surface with the tissue 
portion clearly visible.
8. To mount the section of a glass slide, insert the clean slide at 
an angle into the water on which the section is floating. The slide 
is then brought over the section so its edge is attracted to the slide 
by surface tension. By drawing the slide upwards and vertically out of 
the water the section will attach.
9. The slide is then placed on a hot plate at a temperature of 60°C 
and the section is allowed to dry onto the slide.
10. Prior to picking up the section, the glass slide was marked with 
the block identification number using a diamond pencil, or an ordinary 
lead pencil when frosted end glass slides were used.
11. The sections were now ready for staining and required no
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dehydration or clearing procedures.
3.4.8 Preparation of Tissue for Transmission Electron Microscopy 
(TEM) .
The preparation of tissues for TEM is basically the same as for JB-4
glycolmethacrylate preparation; with stages of fixation, dehydration,
infiltration and embedding. The main difference being that the tissue
3blocks are much smaller (ideally about 1 mm ) which means more care in 
the initial selection of tissue samples. This procedure has been 
designed to fit in around our fixation method for light microscopy to 
maximise the use of time etc.
3.4.8.1 Fixation.
1. Immersion of tissues in 2% (v/v) glutaraldehyde (TAAB) in 0.1 M 
phosphate buffer pH 7.4 at 4°C for 12-18 hr.
Our routine fixation method is immersion in formal calcium at 4°C 
(see section 5.4.1) and frequently TEM is decided as a necessary 
technique only after examining the histological slides at the light 
microscope level. Thus if the tissue has been processed through the 
formaldehyde fixation instead of the usual glutaraldehyde fixation it 
will still be suitable for ultrastructural morphology, even if not 
"ideal".
2. Wash tissue in four changes of 0.1 M phosphate buffer pH 7.4, at 
least 30 min per wash.
3. Post fix tissue in 1% (v/v) osmium tetroxide in 0.1 M phosphate 
buffer pH 7.4 for 1 hr. Use minimal volume of solution, ie sufficient 
to cover the tissue blocks, osmium is very toxic and expensive using a 
minimal volume reduces exposure risk and maximises the use of the 
osmium.
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4. Wash the tissue in distilled water prior to dehydrating the 
tissue.
3.4.8.2 Dehydration.
A graded series of alcohols (50% (v/v), 75% (v/v), 95% (v/v) and 100%
ethanol) is used to dehydrate the tissues, change the solutions every 
30 min except for the 100% alcohol step when the time is extended to 
2 changes of 60 min. An additional dehydration step with propylene 
oxide may be necessary (if the resin is not miscible with alcohol e.g. 
Epon) the final alcohol solution is replaced with a 1:1 propylene 
oxide:alcohol solution left for 20 min and then this solution is 
replaced with propylene oxide only, again for 20 min.
3.4.8.3 Infiltration.
3.4.8.3.A Spurr Resin (TAAB)
1. Use a rotating mixer. An equal volume of resin is added to the last 
dehydration solution to obtain a solution of 50:50 concentration 
Spurr:alcohol, leave for 30 min.
2. A second equal volume of Spurr (Spurr, 1969) is added to the above 
solution to now give a solution of 75:25 concentration Spurr:alcohol, 
leave for 30 min.
3. The 75:25 solution is decanted off and 100% Spurr added, leave for 
8 hr, the solution is changed for a fresh volume of 100% Spurr and 
left overnight.
3.4.8.3.B Epon Resin (TAAB).
The final propylene oxide solution is decanted off and replaced with 
a 1:1 propylene oxide:Epon solution, leave for a minimum of 30 min 
preferably longer 1-2 hr.
3.4.8.4 Embedding.
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3.4.8.4.A Spurr resin: the tissue blocks were placed in in fresh 
Spurr resin within suitable moulds and polymerised at 70°C for 8 hr.
3.4.8.4.B Epon resin: the tissue blocks were placed in moulds 
containing fresh resin and polymerised at 60°C for 48 hr.
3.4.9 Preparation of Fixed Frozen Sections.
3.4.9.1 Principle of fixed frozen sectioning is that tissue is placed 
on freezing stage which is connected to continuously running cold 
water supply and a thermocouple to control the temperature of the 
stage. The electrical setup cools the block by the cold water 
extracting the heat away from the stage and tissue block, thus 
gradually freezing the tissue such that it becomes hard enough to 
section.
3.4.9.2 Procedure.
1. Tissue was placed on the stage with a small piece of damp tissue 
paper between the stage and tissue to act as an adherent surface. The 
tissue was allowed to freeze, bathing the tissue in with fixative 
applied with a small brush helps the tissue to freeze rapidly.
2. The position, angle and height of stage was adjusted with respect 
to the microtome blade so that the upper most surface of the tissue is 
horizontal.
3. The tissue block was trimmed down with the knife to give the 
largest area possible of the tissue. Narrow blocks cut easier than 
wide blocks so it was necessary on occassions to trim the sides of the 
tissue away with a razor blade.
4. Sections were cut at 15 um although with practice and slight 
adjustments and a well frozen block it was possible to section at 10 
um.
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5. Sections were picked up by rolling a wet small brush along the 
section which adheres to the brush and then placing the section in a 
container of fixative eg a sterilin.
6. To manouvere the sections on to a slide; the sections plus 
fixative were placed into a beaker or petri dish, then with a glass 
rod manipulator (glass pipette with rounded end), a section was moved 
on to a slide. Holding the section in position with the glass rod the 
slide was removed from the fixative solution and the section adhered 
to the slide and was allowed to dry for staining.
3.5 STAINING. 
3.5.1 Routine Histological Stains.
All of the staining procedures used with JB-4 resin are modifications 
of procedures already well described for paraffin wax sections 
(Bancroft & Stevens, 1982; Pearse, 1972).
3.5.1.1 Toluidine Blue.
Solutions
1% (w/v) Toluidine Blue in a 1% (w/v) Borax solution pH 9-11.0. 
Procedure
1. Place sections in 1% (w/v) Toluidine Blue solution for 1 min.
2. Rinse sections in running tap water to differentiate for 5 
min.
3. Dry sections in slide dryer at temperature of 40°C.
4. Mount coverclips on section using single drop of D.P.X.
Results
Tissue is blue, but surprisingly good differentiation is possible 
between nuclei, cytoplasm, intracellular granules. In kidney 
proximal tubule lysosomal granules are particularly well stained.
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Metachromasia occurs in interstitial matrix of papilla and medulla 
where tissue components cause pinkish staining to occur.
This stain is rapid, simple and.easily modified by altering pH, time 
of staining and differentiation to achieve ideal staining for 
particular tissue being examined. It allows the quality of fixation 
and embedding to be assessed, and a general idea of the tissue
orientation in the block.
3.5.1.2 Haemotoxylin and Eosin (Modified from standard paraffin proce­
dure, times extended slightly).
Solutions
1. Harris Haematoxylin (freshly filtered).
2. 1% (w/v) Eosin Solution
3. 1% (v/v) acid alcohol (1% (v/v) 1 M HC1 in 70% (v/v) alcohol).
Procedure
1. Stain sections in Haematoxylin for 15 - 20 min.
2. Wash well in running tap water (for 5 min) until sections 'blue.'
3. Differentiate sections in 1% (v/v) acid alcohol, dip once or
twice for 1-2 seconds.
4. Wash in running tap water for 2-3 min until sections 'blue' 
again.
5. Stain in 1% (w/v) Eosin for 10 min.
6. Wash in running tap water for 5 min.
7. The dehydration and cleaning stage is usually performed here 
prior to mounting the sections. This is essential in paraffin 
sections, but can be omitted at this stage for semithin sections. 
Directly mounting the sections in D.P.X. after air drying at 40°C in 
a slide dryer.
Results
This stain differentiates a wide range of tissue structures. When 
coupled with high resolution microscopy on resin embedded semithin 
sections many intracellular organelles such as mitochondria ' and 
lysosomes are also visible.
Typical results are:
Nuclei - (blue black), Cytoplasm - (varying shades of pink), Muscle 
fibres - (deep pinky red), collagen - (pale pinky red), red blood 
cells - (orange/red), Fibrin - (deep pink), Mitochondria - (varying 
shades of pink/red), Lysosomes - (contrasting against cytoplasm).
Steps 1 - 4 are followed as a counterstain to Periodic Acid Schiff
(PAS) stain.
3.5.1.3 Giemsa.
Solutions
1. 10% (v/v) of stock Giemsa and water
2. 95% alcohol 
Procedure
1. Stain sections in solution of 10% (v/v) Giemsa to distilled water
2. Sections can be stained at room temperature overnight, or 
for 1 hr, 30 min at 45°C
3. Rinse briefly in distilled water
4.* Differentiate for 1-2 min in 95% (v/v) alcohol
5. Allow to air dry and mount in D.P.X.
* Omit this step if sections stained at 45°C.
Results
This stain gives superb results with respect to interstitial matrix 
differentiation and is preferred to the more traditional PAS method to 
stain the mucopolysaccharides. Basement membrane and interstitium
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deep pink, Nuclei - blue/black, Cytoplasm - pale blue.
5.3.1.4 Periodic Acid Schiff (PAS) stain for carbohydrates.
Modified from (Bancroft & Stevens, 1982)
Procedure
1. Immerse sections in a 1% (w/v) periodic acid solution for 15-20 
min.
2. Rinse sections in distilled water for 2-3 min.
3. Immerse sections in Schiffs Reagent for 60 min.
4. Rinse sections in running tap water for 5 min.
5. Counter stain with Haematoxylin (follow steps 1-4 in Haematoxylin 
and Eosin procedure, section 3.5.1.2).
Results
Tissue areas having carbohydrate containing moieties within them stain 
pink, e.g. proximal tubule brush borders, basement membranes, lamina 
propria of urothelium and interstitial cell matrix.
3.5.1.5 Oil red O stain for lipids.
Performed on fixed frozen or frozen sections only.
Solutions
Stock solution: Oil red 0 saturated in 95% (v/v) isopropanol.
Working solution (prepare 1 hr in advance), 3 volumes of Oil red 0
stock solution with 2 volumes of distilled water and filter prior to 
use.
Procedure.
1. Dry sections onto the slides.
2. Rinse sections in 60% (v/v) isopropanol.
3. Stain in Oil red O working solution for 15 min.
4. Differentiate in 60% (v/v) isopropanol until a delipidised
control section becomes colourless.
5. Wash in water.
6. Counterstain in Mayer's haemalum.
7. Wash in tap water.
8. Rinse in distilled water, mount in glycerin jelly.
Result
Unsaturated hydrophobic lipids and mineral oils stain red, some 
phospholipids stain pink.
Lipid extraction for delipidised control sections.
Chloroform-methanol solution (2:1 v/v) for lhr at room temperature.
3.5.2 Enzyme Histochemical Stains.
The following methods are modified from the methods of Burnett 
(1982) used in a study of enzyme histochemistry in JB-4 methacrylate 
sections.
3.5.2.1 Gamma-glutamyl-transpeptidase (GGT) (Modified by Pearse, 1972 
from the method of Glenser & Folk, 1961)
Solutions Medium
1. N-(gamma-L-glutamyl-beta-napthylamide) 4 mg/ml acetone. 0.5 ml
2. Aqueous glycglycine 20 mg/ml 0.5 ml
3. TRIS buffer 0.1M pH 7.2 10.0 ml
4. Fast Garnet Red (G.B.C.) 15 mg/10 ml incubating media.
These volumes were adjusted to fill a coplin jar for routine staining 
of 10 slides, i.e. 50 ml.
Procedure
1. Incubate sections in medium for 4-6 hr at 37°C, checking sections 
macroscopically periodically for adequate staining.
2. Rinse throughout with distilled water.
115
3. Counterstain with Harris Haematoxylin (follow steps 1-4 in 
Haematoxylin and Eosin method, see section 3.5.1.2)
4. Air dry and mount in glycerin-gelatin mountant, as D.P.X. will 
'lift' stain from sections!
Results
A reddish-brown final reaction product indicates positive activity.
3.5.2.2 Alkaline phosphatase (alk. phos.). (After Burnett, 1982) 
Gomori calcium method
Solutions Media
1. 2% (w/v) sodium glycerophosphate 5.0 ml
2. 2% (w/v) sodium barbitone 5.0 ml
3. 2% (w/v) calcium nitrate 10.0 ml
4. 1% (w/v) magnesium chloride 2.5 ml
5. Distilled water 2.5 ml
The of the incubation medium should be between pH 9-9.4, the
volumes adjusted to fill a 50 ml coplin jar.
Procedure
1. Preheat the incubation medium to 37°C
2. Incubate the sections for 21 hr at 37°C
3. Rinse sections in distilled water, at least 3 changes
4. Immerse sections in 2% (w/v) cobalt nitrate for 5 min.
5. Rinse repeatedly in distilled water
6. Immerse in 1% (v/v) ammonium sulphide for 2 min.
* Perform this procedure in a fume cupboard as hydrogen sulphide gas 
generated is poisonous and smells of rotten eggs!
7. Rinse repeatedly in distilled water.
8. Counterstain in 2% (w/v) methyl green for 5-10 min., or Harris 
Haematoxylin for 5 min.
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9. Rinse in running tap water
10. Air dry and mount in D.P.X.
Results
A black final reaction product indicates positive acitivity.
3.5.2.3 Adenosine Triphosphatase (ATPase) (Calcium method of Padykula 
& Herman, modified by Bancroft & Stevens, 1982)
Solutions
1. Veronal buffer pH 4.6: sodium acetate (trihydrate) (1.94 g in 100
ml distilled water) - 5 ml, sodium barbitone (2.94 g in 100 ml
distilled water) - 5 ml, 0.1M Hydrochloric acid - 10 ml, distilled 
water 8 ml.
Incubating Medium
2. 0.1M sodium barbitone 2.94 g in
100 ml distilled water 6 ml
3. 0.18M calcium chloride 2.34 g in
100 ml distilled water 3 ml
4. Distilled water 21 ml
5. Adenosine Triphosphate 75 mg
Adjust incubating medium to pH 9.4
Procedure
1. Pre-incubate the sections in the veronal buffer pH 4.6 for
15 min. at 37°C
2. Incubate sections in incubating medium at 37°C for 21 hr.
3. Rinse in 3 changes of 0.18M calcium chloride solution
4. Immerse sections in 2% (w/v) cobalt chloride for 5 min.
5. Rinse in 4 changes of a 1:10 dilution of 0.1M sodium barbitone 
solution
6. Rinse in tap water
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7. Transfer to 1% v/v ammonium sulphide for 2 min.
8. Wash in running tap water
9. Counterstain in 2% (w/v) methyl green for 5-10 min.
10. Wash in running tap water for 5 min.
11. Air dry, and mount in D.P.X.
Results
A black final reaction product indicates positive activity.
3.5.2.4 Acid Phosphatase (Acid Phos.) (Modified from Burnstone, 1958) 
Solutions Media
1. Napthol As-Bl phosphate 5.0 mg in 0.5 ml DMSO
2. 0.2M acetate buffer pH 5.2 25 ml
3. Distilled water 24 ml
4. Red violet LB 30 mg
5. 10% (w/v) manganese chloride 2 drops per coplin jar
Procedure
1. Incubate sections in medium for 21 hr at 37°C
2. Rinse thoroughly in distilled water
3. Counterstain in Haematoxylin for 10 min.
4. Wash in running tap water for 5 min.
5. Air dry, and mount in glycerin-gelatin mountant 
Results
Red final reaction product indicates positive activity.
3 . 6 EXPERIMENTS .
3.6.1 Short-term Acutely Induced RPN in Wistar Rat.
This study was performed to identify the earliest morphological change 
occurring during the onset of acute RPN induced with BEA. Enzyme
histochemical staining was performed to try and elucidate if subtle
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cellular changes occurred which could not be detected by routine 
histological staining and may give an insight into the mechanism of 
pathogenesis.
Thirty animals were dosed with BEA at 100 mg/kg as described in 
section 3.2.2. Groups of 3 rats were sacrificed at 2, 4, 6, 8, 12, 18, 
24, 48, 72 and 144 hr, and groups of 2 control animals were sacrificed 
at 12, 48 and 144 hr. Kidney, ureter and bladder tissues were
processed for glycolmethacrylate resin embedding (described in section
3.4.2). Semithin sections were stained with routine histological 
stains (section 3.5.1) and by enzyme histochemistry (section 3.5.2).
3.6.1.1 Monastoral blue B Vascular labelling Study.
This investigation was performed to determine whether leaky 
vasculature was involved in the initiation of RPN.
Monastoral blue B is a copper phthalocyanine used for as a 
intravascular marker. This colloidal substance has certain advantages 
over collidal carbon; water-insolubility, non-toxicity, uniform 
particle distribution, commercially available and has high contrast in 
both thick and thin sections (Joris et al, 1982).
Two animals from each group was anaesthetised using Sagatal (see 
section 3.3.1.1) and the abdominal cavity opened as described earlier 
(see section 3.4.2). Monastoral blue B (3% (w/v) suspension) was 
administered (0.1 ml/50g body weight) by introducing a 23G needle 
(attached to a 1 ml syringe) through the diaphragm directly into the 
left ventricle of the heart. The Monastoral blue B label was injected 
slowly, after 1 min. the kidneys were removed, fixed in formal calcium 
and processed for high resolution light microscopy as described in 
sections 3.4.3-3.4.6.
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3.6.2 Chemically Induced RPN in Mice.
3.6.2.1 Study of different doses of BEA in the Schnider mouse.
Twelve male Schnider mice (University of Surrey strain) were housed as 
outlined in section 3.2.3. Five groups of 2 mice were treated with 
different doses of BEA (section 3.3.2) at concentrations ranging from 
25-200 mg/kg. Control animals (2) were dosed with vehicle only. 
Each dose volume was calculated for a mouse of average weight of 25g, 
this injection volume was adjusted +0.1 ml/5g body weight depending 
on the body weight.
Animals were ear clipped for identification (see section 3.2.6) and 
allowed free access to food and water for a period of 60 hr when all 
animals were sacrificed by cervical dislocation.
Tissues were prepared as outlined in section 3.4 and sections stained 
for Giemsa, H&E, Toluidine blue and PAS stains (section 3.5.1).
3.6.2.2 Time course study of different doses of BEA in Nude (MF1- 
nu/nu/Ola/Hsd) mice.
In the nude mouse xenograft studies (see section 3.6.6) animals were 
sacrificed because no tumour had taken based on the lack of any 
visible growth in the region of transplantation after 9 weeks. 
Immunological changes have been implicated as both the primary event 
and secondary consequence of a variety of renal lesions (Druet et al, 
1987), but there is no published data on the use of Nude mice in 
nephrotoxicity studies. There has been some suggestion that 
immunological changes may have an important role in the development of 
analgesic nephropathy (Hook et al, 1979) based on the arguement that 
metabolites of phenacetin (eg p-phenetidine) and salicylate were 
strongly immunogenic. Gault et al, (1971) found no immune deposits in
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patients with early analgesic nephropathy, but there is little 
information on such changes in experimental models. These animals 
were used for additional studies in BEA-induced RPN to increase the 
species/strain data; to determine whether immunologically deprived 
strains responded differently to mouse strains that are 
immunologically complete.
Twenty two male MFl-nu/nu/Ola/Hsd mice (Harlan Olac) were dosed ip 
with either 50, 100 or 200 mg/Kg bodyweight dose of BEA, injection
volume 0.1 ml per 10 g body weight of a 10 mg/ml (w/v) solution of BEA 
in physiological saline. Control animals recieved physiological 
saline ip at 0.1 ml per 10 g body weight. Animals were observed after 
treatment for any gross behavioural changes. Periodic sacrifices of 
animals from each dose group were performed at 24, 48 and 72 hr post
BEA treatment. Animals were sacrificed by diethyl ether anaesthesia 
and then cervical dislocation. Table 3.1 summarises the dosing and 
sacrifice protocol. Animals were postmortemed and the tissues 
processed as described in section 3.4.
Table 3.1 showing dose and sacrifice time points for nude mice 
acute BEA studies.
Dose BEA (mg/kg bw)
Time (hr) 0 50 100 200
24 2 2 4 2
48 1 1 2 2
72 1 1 2 2
Totals 4 4 8 6
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3.6.2.3 Time course study of BEA in 3 different mouse strains.
The part of this study reporting data from 3-48 hr was performed as 
part of an M.Sc Toxicology student project with Ms. J. Scarlett 
(Scarlett, 1988; Scarlett et al, 1990). This investigation was 
extended to include additional time points (7, 14 and 21 days) by the
author, and is presented with the histopathology of the earlier time 
points as an intergral part of this thesis.
3.6.2.3.A Experimental protocol.
Male Obese mice (University of Surrey strain) body weight: 30+8g; male 
Balb/c mice (Bantam and Kingman Ltd, Hull, E. Yorkshire, U.K.) body 
weight 20+1.25g and male C567B1/6 mice (Bantam and Kingman Ltd.): body 
weight 22+2g were used in this study. The Obese mice had a greater 
body weight range as a consequence of the supplier (University of 
Surrey Animal Unit) breeding up a small colony to provide sufficient 
numbers of mice, so supplying mice of a greater age/weight range than 
the commercial suppliers. The Obese mice used in this experiment were 
not old enough for those destined to develop gross obesity to be 
identified.
The animals were housed (10-12 animals per cage) in translucent shoe 
box type cages of dimensions 32 x 25 x 16 cm on sterile soft wood 
shavings in a controlled environment. Food and water was available ad 
libitum. One group was dosed with BEA 100 mg/kg i.p., (0.1 ml per
10 g body of a 10 mg/ml (w/v) solution in physiological saline (0.9% 
(w/v) sodium chloride) and the controls received physiological saline 
only.
Urine collection: animals (n = 3) were housed in metal metabolism
cages (aluminium with a wire mesh floor) immediately after dosing for 
the 3, 6 and 12 hr groups, and 12 hr prior to sacrifice for the 24 and
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48 hr groups. Water was available ad libitum, but no food was present. 
In individual animals any urine present in the bladder was aspirated 
using a 23G needle and placed in a microcentrifugation tube.
Groups of animals (n=3) from treated and control groups were 
sacrificed periodically at 3, 6, 12, 24, 48 hr and 7, 14 and 21 day
after BEA administration by anaesthesia in diethyl ether, then 
cervical dislocation. Animals were weighed at sacrifice, kidney weight 
was recorded. Tissues were fixed in formal calcium at 4°C and embedded 
in glycolmethacrylate resin. Semithin (2 um) sections were stained 
with H&E, Giemsa, PAS and enzyme histochemistry performed for acid 
phosphatase and alkaline phosphatase and gamma-glutamyltranspeptidase 
(see sections -3.5.1 and 3.5.2) .
Urine samples: Individual urine samples obtained from post mortem
at were immediately analysed for osmolality. Any urine remaining was 
placed in a microcentrifuge tube and stored at 4°C for urinary urea 
nitrogen determination at a later time. Pooled urine samples were 
stored at 4° C for the later determination of osmolality and urea 
nitrogen.
Blood samples: These were centrifuged at 5,000 rpm for 3-4 minutes
and serum stored at 4°C until analysed for osmolality and urea 
nitrogen content.
Osmolality: the osmolality of both urine and serum samples was deter­
mined in mmol/kg using a Wescor Inc. 5100C Vapour Pressure osmometer 
using standards from 290-1000 mmol/kg.
Urea nitrogen: the urea nitrogen in urine (diluted 100 fold) and serum 
was determined using a blood urea nitrogen kit No. 535 (Sigma 
Diagnostics, Poole, Dorset, U.K.).
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Calculations: all data are presented as mean + standard deviation.
3.5.3 BEA induced RPN in Marmosets.
Two animals were used in this experiment and housed as outlined in 
section 3.2.5. One animal was dosed with BEA at 50 mg/kg, the other 
received a dose of BEA at 100 mg/kg, prepared as detailed in section
3.3.2. Both animals were then allowed food and water ad libitum for 
48 hr after which they were sacrificed by staff at D.H.S.S., Dept of 
Toxicology, St. Bartholomew's Hospital Medical College, London. 
Kidney, bladder and ureter tissues were immersion fixed and processed 
for glycolmethacrylate resin and embedded (section 3.4) routine 
histological stains of Giemsa, H&E, Toluidine Blue and PAS (section
3.5.1) and alkaline phosphatase (section 3.5.2) were performed.
3.6.4 Chemically Induced RPN in the Pig.
3.6.4.1 Introduction.
The primary choice of rodents for nephrotoxicity studies reflects 
their low cost, ready availability, ease of handling and the 
considerable base-line data on renal function and toxicity. However, 
the extrapolation of nephrotoxicity data from rodents to man is 
complicated by the marked renal anatomical and functional differences 
between the two species. In contrast the human and pig kidney are 
remarkably similar in terms of physiological and anatomical 
characteristics (Table 3.2). Both are multipapillate, produce urine 
of similar osmolality, and have GFR values, numbers of glomeruli per 
kidney and nephron dimensions that are comparable. The pig kidney is 
thus an attractive model with which to study clinically important 
nephrotoxicities, particularly RPN. A series of studies were
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undertaken to determine whether BEA would induce an acute RPN lesion 
in the pig in a similar manner to that developed in the rat.
3.6.4.2 Study 1
Four female Large White pigs, 6-7 months old (weight 61+9 kg), were 
given freshly prepared 2-bromoethanamine (BEA) hydrobromide (section
3.3.2) by a slow i.v. infusion (over 2-3 minutes) while
anaesthetised with a mixture of 2-3% halothane, ~30% nitrous oxide 
plus ~70% oxygen. BEA was given at dose levels of 50 or 100 mg/kg 
(n=2). The animals were allowed access to food and water and
monitored daily for any signs of distress.
After 7 days the animals were killed with an overdose of halothane 
anaesthetisia and postmortemed. The kidneys, ureters and bladder were 
removed intact. The kidneys were then bisected longitudinally along 
the lateral border through the hilus. All tissues were fixed in 
calcium:formaldehyde (4°C) for 72 hr. Control kidneys and bladder 
were obtained from abbatoir material. The cut interior surfaces of 
the kidneys were examined macroscopically and tissue blocks of renal 
pyramids were prepared (Figure 3.2) to include the papilla tip as 
described by Lomax-Smith & Seymour (1980a). Together with pieces of 
ureter and bladder, the blocks were processed and embedded in
glycolmethacrylate resin. Semithin sections (lum) were routinely 
stained with Haematoxylin and Eosin, Giemsa and Toluidine Blue, 
(section 3.4.1). Fixed frozen sections (section 3.4.9) were cut from 
control and treated papillae and stained with Oil red O for the 
presence of lipids (see section 3.5.1.5).
3.6.4.3 Study 2.
Two female Large White pigs of body weight 70 kg were given BEA at a 
dose of 100 mg/kg iv. together with an anti-emetic (Maxalon: high dose,
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Beecham Research Ltd, Essex, UK).
Figure 3.2 Schematic diagram illustrating how tissue blocks 
containing a single papilla were obtained from the bisected kidney A) 
by cutting in a transverse plane B) to allow all the papillae to be 
seen and dissected C). From Lomax-Smith & Seymour, (1980a).
One animal died 24 hr later, the remaining animal survived with no
further distress until sacrifice at 14 days. Kidneys, ureter and
bladder were taken for histological examination as described above
(see section 3.6.3.1).
3.6.4.4 Study 3.
Four female pigs, 12 weeks (body weight 25-30 kg) were purchased and 
maintained at the Churchill Hospital Research Institute for a 2 week 
acclimatisation period prior to commencing the study. This study was 
performed to determine whether the degree of RPN could be increased 
with 2 x 50 mg/kg doses of BEA rather than a single dose of 100 mg/kg 
BEA (which killed the pigs).
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Two groups of 2 animals were treated as follows:
Group 1; animals given a single iv infusion of BEA at a dose of 50
mg/kg. These animals were then given a second dose of BEA (50 mg/kg)
7 days after the first dose, then allowed to survive for a further 7 
days before sacrifice.
Group 2; animals were dosed with the sodium salt of N-
phenylanthranilic acid (NaNPAA), see section 3.1.1.1. This compound 
has been found to induce RPN acutely in the Wistar rat (Gregg & Bach, 
unpublished observation) in a similar manner to that after BEA
administration. It is a water soluble compound (unlike NPAA) and as 
such could be administered by a single ip injection (in the rat) up to 
dose levels of 1 mmol/kg.
One animal was infused iv (as for BEA) with a 0.5 mmol/kg solution of 
NaNPAA (118 mg/kg). The animal was to have been left 7 days and then 
sacrificed, however, this compound was extremely toxic and the pig
died within 3 min of recieving the dose. The breathing rate dropped
dramatically and the animal died whilst still under anaesthetisia. 
The second animal recieved a reduced dose of 0.25 mmol/kg infused over 
a 30 min period. This animal survived until it was sacrificed 7 days
later. Kidneys ureters and bladder were taken for histological
examination.
3.6.4.5 Study 4.
Four young female pigs (12 weeks old) were purchased and housed for a 
2 week acclimatisation period prior to study commencing, a fifth pig 
was donated by another group at the hospital for use as a control 
animal (this animal had. been a control animal in their study on 
effects of low dose radiation on skin).
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Group A: 2 animals to recieve 2 x lOOmg/kg dose of BEA via an iv
infusion over 30 min. Second dose given 7 days after first, animals to 
be sacrificed on day 14 of the study.
First animal died 14 hrs after being dosed. It was decided to not 
dose the second animal in this group with the second dose as it was 
apparent that 100 mg/kg dose of BEA was a toxic dose in pigs (3/6 
pigs dosed died within 24 hrs of dosing with BEA 100 mg/kg). Second 
animal was sacrificed after 14 days together with control animal and 
animals from group B.
Group B: animals recieved NaNPAA at dose levels of 0.5 and 1.0 mmol/kg 
via iv infusion over 30 min. Animals survived until sacrifice 14 days 
later.
3.6.4.6 Study 5: Effect of paracetamol on the pathogene­
sis of BEA induced RPN in the pig.
Increasingly there has been a focus of interest in the possible role 
of acetaminophen (paracetamol) in contributing to end stage renal 
disease (Sandler et al, 1989; Bennett & DeBroe, 1989) . While 
paracetamol has been implicated in causing renal papillary necrosis 
(Krikler, 1967; Masters & Krikler, 1976; Dubach, 1983), this drug 
appears to be one of the least papillotoxic analgesics for 
experimental animals (Molland, 1978; Nanra et al, 1978; Eknoyan, 1982; 
Prescott, 1982; Henry & Tange, 1987). Much of the epidemiological 
information on its use has been confounded by its coformulation with 
aspirin and/or caffeine and/or polypharmacy with other analgesics and 
nonsteroidal anti-inflammatory drugs. The use and sale of
paracetamol in mixed analgesic powders and as the single compound has, 
certainly in Europe, increased dramatically over the last decade or so 
(Pommer et al, 1986;, Wing et al, 1989) .
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There is a need to establish the sub-acute toxicity of paracetamol on 
a multipapillate kidney with a pre-existing RPN.
3.6.4.6.A Animals and dosing procedures.
Eight young (12 weeks old) Large white female pigs were housed for a 
two week acclimatisation period prior to commencing the study and 
animals had access to water on a demand/feed system throughout this 
investigation. Four study groups were set up: Group 1 - 2  animals
were given an iv infusion of BEA (50 mg/kg dose) as described above 
(section 3.6.3.1), Group 2 - 2  animals were given paracetamol in their 
diet so that each animal recieved a daily dose of 100 mg/kg body 
weight. This dose was calculated on the assumption that a typical 
analgesic abuser of bodyweight 60 kg consumes annually 2 kg of 
analgesics. The appropriate quantity of paracetamol powder was added 
to water-moistened normal pig diet pellets (Speedipork, BBO Ltd, 
Oxford, UK) and throughly mixed by hand. This mixture was then 
given to the pigs twice daily and was consumed immediately within 10- 
20 min. Group 3 - 2  animals were treated with a combination of the 
treatment regimes for Groups 1 and 2; animals were given BEA (50 
mg/kg), then fed on a diet containing paracetamol (100 mg/kg/day). 
Group 4 - two animals were controls and received only the normal diet.
3. 6.4. 6. B Non-invasive monitoring of renal function.
In an attempt to monitor any changes non-invasively we measured the 
kidney length, diameter and parenchymal thickness of both kidneys for 
each animal by ultrasound scan (using a Roche Abdoscan instrument). 
Renal functional parameters were determined by radioisotopic 
renography (Robbins, 1985): glomerular filtration rate (GFR) using
99mrc-DTPA and effective renal plasma flow rate (ERPF) using ^31j_
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hippuran. These parameters were determined prior to commencing 
treatment and on day 26 of the study. Values were expressed as mean + 
standard error, the 95% confidence limit values were calculated 
according to Bailey, (1981). .
3.6.4.6.C Gross and microscopic pathology.
At postmortem kidney length, weight and body weight were noted. 
Tissues (kidney, ureter and bladder) were then fixed in formal calcium 
and subsequently processed for embedding in glycolmethacrylate resin 
(see section 3.4). Semithin (2 um) sections were stained with H&E, 
Giemsa and Periodic-acid-Schiff (PAS) (see section 3.5.1) and 
examined for any histopathological changes at the light microscopical 
level.
3.6.5 Experimental Carcinogenesis Studies
3.6.5.1 Study 1: N-butyl-(4-hydroxybutyl)-nitrosamine (BBN)
initiation and BEA induced RPN in rat.
3.6.5.1.A Study 1, aims:.
To study the effect on urothelial carcinogenesis of N-butyl-N(4- 
hydroxybutyl)nitrosamine (BBN) initiation and 2-bromoethanamine (BEA) 
induced renal papillary necrosis as a promotion step.
The reasons for separate smaller studies (in terms of animal numbers) 
initially were three fold; 1) we had no previous experience of 
carcinogenesis studies, 2) the capacity of room available where a 
maximum number of 180-200 animals could be accommodated, 3) not 
wanting to commit too many resources.
3.6.5.B Study 1, experimental protocol:
Seventy-five male Wistar rats with an average weight of 110+10g were 
housed in a room with controlled access and environmental conditions
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maintained as described in section 3.2.2. Groups (each of 25 animals) 
were treated as follows:
Group A: animals were dosed with BBN according to procedure detailed 
in section 3.3.3, then after one weeks respite each was given a single 
dose of BEA (100 mg/kg) prepared as detailed in section 3.3.2.
Group B: animals were dosed with BBN as described in section 3.3.3. 
Group C: animals were dosed with vehicle alone (20:80, ethanol:water). 
After one weeks respite the animals were dosed with a single dose of 
freshly prepared BEA (100 mg/kg) as described in section 3.2.2.
All animals were allowed food and water ad libitum and the bedding was 
changed twice weekly. Animals were monitored twice daily during the 
BBN dosing period and daily afterwards. Animals that were moribund 
were removed, humanely sacrificed and postmortemed to determine the 
cause of death. Any animals which died during the dosing periods were 
discounted from the study. Frequently the animals were found 
cannibalised and it was not possible to retrieve any tissues for 
histopathological assessment.
Groups of animals (n=3) were periodically sacrificed at 1, 2, 3, 4, 7
days and 3, 6, weeks post BEA injection. The animals were sacrificed
by terminal sodium pentabarbitone anaesthetisia. The animals were 
postmortemed as described in section 3.4.2 with the following 
modification:
The left ureter and kidney pelvis was retrogradely perfused by 
glutaraldehyde via a ureteral cannulation (Ijomah, unpublished data). 
The right kidney, ureter and bladder tissues were processed (section
3.4.2) and routine and enzyme histochemical staining was performed 
(sections 3.5.1 and 3.5.2).
The very early time points (1-7 day) were performed to determine
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whether BBN pretreatment had any effect on the usual pathological 
response of the animals to BEA ie did BBN alter the induction of acute 
RPN by BEA.
3.6.5.2 Study 2: Effect of superimposing additional carcinogen 
dosing after BBN/BEA initiation/promotion treatment
3.6.5.2.A Study 2, aims:
A small pilot group was set up to determine whether further admi­
nistration of the carcinogen during a period of intensive prolife­
ration of the target cells; (pelvic and ureteric urothelium as a 
consequence of BEA-induced RPN), resulted in an increased tumour yield 
or increased targetting for the urothelial cells of the upper urinary 
tract.
3.6.5.2.B Study 2: protocol.
Ninety male Wistar rats with an average weight of 110+10g were housed 
and maintained as described in section 3.2.2. Four groups of animals 
were treated as described above in section 3.6.5.1.B, with 37 animals 
in Group Af 20 animals in Group B and 25 animals in Group C.
Group D: 8 animals were treated as group A (section 3.6.5.1.B above),
then further dosed with BBN recieving a single dose (80 mg/kg in a 0.5 
ml volume) on three consecutive days after the BEA dose.
Groups of animals (n=3) from Groups A-C were sacrificed at 3 day and 
3, 6, 13, 21, 30 and 40 weeks post BEA injection and groups of animals 
(n=2) from pilot study (Group 4) were sacrificed at 13, 21, 30 and 40 
weeks. Tissues were taken for histological examination as described in 
section 3.6.5.I.B.
3.6.5.3 Study 3: Effect of superimposing analgesic dosing after 
BBN/BEA initiation/promotion treatment.
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3.6.5.3.A Study 3, aims:
To determine if superimposing analgesic dosing after an 
initiation/promotion treatment would affect either the target region 
of tumour induction, reduce the latent period of tumour induction and 
increase the number or degree of severity of the tumours induced.
3.6.5.3.B Study 3: protocol.
One hundred and thirty five male Wistar rats weight 100+15g were
divided into five groups:
Groups A-C were treated as described in section 3.6.5.1.B with Group A
(n=28), Group B (n=30) and Group C (n=35).
Group D - consisted of 21 animals which were dosed with BBN as 
previously described (see section 3.3.3) and after one weeks respite 
recieved a single ip dose of BEA (see section 3.3.2) at a modified 
dose concentration of 75 mg/kg. The 21 animals were then subdivided 
into three groups of 7 animals. These subgroups then recived either 
aspirin (as described in section 3.3.4), paracetamol (as described in 
section 3.3.5.1) or NPAA (as described in section 3.3.6).
Group E - these 21 animals were dosed with vehicle alone (20:80 
ethanol:water solution) and then BEA only (at the same time as 
previous group), given at the modified dosage of 75 mg/kg. These 21 
animals were subdivided into three groups of 7 animals which were then 
treated with either aspirin, paracetamol or NPAA as described for 
Group D animals.
Groups of animals from groups A-C (n=3) were sacrificed at 7, 14, 18,
28, 40 and 48 weeks post BEA injection. Groups of animals from Groups
D and E were sacrificed by sodium pentabarbitone anaesthesia (section 
3.3.1) at 7 (n=2), 14 (n=2) and 18 (n=3) weeks post BEA injection.
Tissues were taken for histology as described in section 3.4.
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3.6.5.4 Study 4: BBN initiation and RPN promotion and subsequent BBN
dosing.
3.6.5.4.A Study 4: aims:
To determine whether results from pilot study from study 2 (section
3.6.5.2) could be reproduced with larger numbers of animals. To 
investigate if giving the "promotor" (BEA) prior to the initiator 
(BBN) affected the incidence of tumours and urothelial hyperplasia.
3.6.5.4.B Study 4: protocol.
Male Wistar rats (n=180) average weight 100+15g were divided into six 
groups (each of 30 animals), housed in cages in a separate room 
maintained as for previous experiments. The animals were dosed as 
follows:
Group A - animals dosed with BBN (section 3.3.3) and BEA after one 
weeks respite (section 3.3.2) at a reduced dosage of 75 mg/Kg. The 
reduced dosage was an attempt to reduce the number of deaths that had 
occurred in the earlier studies (studies 1 & 2, sections 3.6.5.1 and
3.6.5.2).
Group B - animals were dosed with BBN only (see section 3.3.2) .
Group C - animals were dosed with vehicle alone (20:80 ethanol: water
solution) and then BEA as described in section 3.3.2 at the reduced 
dosage of 75 mg/kg.
Group D - animals were dosed exactly as the Group A animals but in 
addition recieved a further four doses of BBN on consecutive days 
after recieving the dose of BEA.
Group E - animals were dosed as for Group B animals but in addition 
recieved four further doses of BBN on the same days as the animals in 
Group D.
135
Group F - animals were dosed with BEA and then recieved four doses of
BBN as for Groups D and E.
Note: it has only come to my attention as I wrote this up that Group F 
does not fulfill the control group role it was intended to. For a 
true control for promoter before initiator the animals should have 
recieved BEA, then BBN (as described in section 3.3.3), ie 10 doses 
over 5 weeks to get a total dose of 800mg. In fact they only recieved 
4 doses, a total of 320 mg!!
Groups of animals (n=3 or 4) were sacrificed by sodium pentabarbitone 
anaesthesia (section 3.3.1) at 12, 18, 30, 35, 40, 46-47*, 51-52* and
58 weeks. Weeks denoted with * indicate sacrifice time points when 
donor animals were used in tumour xenograft studies (see section
3.6.6).
3.6.5.5 Study 5; chronic dosing with paracetamol after BBN/BEA
treatment.
3.6.5.5.A Study 5, aims:
To study the effect on urothelial carcinogenesis of chronic dosing
with analgesics (paracetamol) after BBN initiation and BEA-induced 
renal papillary necrosis as a promotion step. The study is to
investigate whether pre-neoplastic changes can be induced earlier with 
paracetamol dosing.
3.6.5.5.B Study 5: protocol.
Male Wistar rats (n=200) weight 106+17g (*) were divided into eight 
groups and housed in cages (6 animals to a cage) in a separate room; 
environment maintained (as described in section 3.2.2). (*) - because
of a delay in commencing this study due to the shipping delay of BBN
from the USA, the animals weighed 148+30 g when dosing began.
Group A - animals (n=20) were untreated controls, recieved only normal
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diet and water.
Group B - animals (n=30) recieved BEA only as described in section
3.3.2 at the reduced dose of 75 mg/Kg.
Group C - animals (n=15) were dosed with BBN only as described in
section 3.3.3. The total dose was reduced to 400 mg. The animals 
were given 5 doses of BBN over a 2.5 week period.
Group D - animals (n=30) were dosed with paracetamol as described in 
section 3.3.5.2. The dosing commenced on same day as for groups F and 
G.
Group E - animals (n=30) were dosed with BBN (as for Group C) and BEA 
(as for Group B)
Group F - animals (n=30) were dosed with BBN and BEA (as for Group E) 
in addition these animals recieved paracetamol after the BEA dose (as 
for Group D).
Group G - animals (n=30) were dosed with BEA (as for Group B) and then 
paracetamol (as for Group D).
Group H - animals (n=15) were dosed with BBN (as for Group C). and
then paracetamol (as for Group D).
Animals were sacrificed at intervals of 3, 6, 9, 12, 18, 24 and 30
weeks, by ether pre-anaesthesia and sagatal anaesthesia. Kidney, 
ureter and bladder tissues were taken for pathological examination at 
the light and electron microscopic level (as described section 3.4 and 
3.4.8). Other tissues (liver, lung, stomach, intestine, spleen, heart) 
were initially taken for gross examination with histology performed if 
deemed necessary.
3.6.6 Tumour Xenograft Studies in Nude Mice.
These studies were concerned with the transplantation of tumour tissue
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derived from donor rats (from BBN study 4 (section 3.6.5.4) which had 
been treated by the BBN/BEA initiation/promotion protocol), described 
above in section 3.6.5.
3.6.6.1 Gnotobiotics.
As mentioned in Section 2.4, the Nude mouse has an incomplete immune 
system (Hansen, 1978) and is hence susceptible to bacterial and viral 
pathogens. It is necessary to maintain and breed these animals in a 
pathogen-free, controlled environment to ensure their good health and 
longevity (Ediger & Giovanella, 1978) .
Gnotobiotics has been defined as the science involved with maintaining 
a microbiologically controlled environment and the biological 
knowledge necessary to obtain and use living specimens in this 
environment (Trexler, 1987) .
All aspects of gnotobiotic research, the appropriate techniques and 
related problems have been reviewed (Coates, 1968; Coates & 
Gustaffson, 1984; Trexler, 1987).
3.6.6.2 Isolator Design.
The work space in which a microbiologically controlled environment is 
maintained is termed an isolator. Isolators may take on several forms 
such as the; rigid 'stainless steel' isolators (Gustaffson, 1948, 
1959), flexible plastic films eg polyvinylchloride (PVC) (Trexler & 
Reynolds, 1957), or laminar air flow cabinets are all suitable for 
keeping gnotobiotic animals (see Trexler, (1984) for review on 
isolators and equipment).
Flexible PVC isolators are by far the most commonly used because of 
their ease of manufacture, and their relative low cost compared to 
rigid and laminar air flow cabinets. They also offer five main
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advantages which outweigh their main disadvantages, see Table 3.3).
The basic design of an isolator of this type is a plastic bubble into 
which access is via an entry port and flexible plastic sleeves 
attached to arm-length rubber gloves provide manipulation access for 
the experimenter. The entry port is sealed at both ends with a PVC cap 
which provides an air-lock system into which cages, equipment, diet 
and water can be passed from the external environment and then into 
the controlled environment without contamination (Figure 3.3).
Table 3.3
Advantages Disadvantages
1. Great flexibility allows 1. Readily damaged-by sharp
greater 'in-isolator' edges, but easily repaired,
manipulation.
2. Cannot be steam sterilised
2. Transparency of PVC allows but can be sterilised chemi-
good observation. cally and by radiation.
3. PVC films can be cut and 
joined easily which permits 
design modification and 
running repairs.
4. Cost of materials are low 
and in-house design and 
construction possible.
5. Flexible walls act as 
reservoir assisting in 
keeping air pressure 
differential which allows 
low air pressure operation
Sterilisation is required for the whole isolator prior to commencement 
of the experiment and any equipment subsequently introduced must be 
sterilised too. Design and planning of experimental procedure in 
advance is vital. This allows all the necessary cages, surgical 
instruments to be placed within the isolator prior to sterilistion. 
The working space is very restricted in the isolator and the
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conditions in the isolator (maintaining a germ-free environment) 
prevents any instant access to non-sterile equipment from outside if 
it is required.
external entry port cap
entry port
air outlet trap
flexible film envelope
internal entry port cap
support frame
gloved sleeve
air supply (blower fan)
iinimTimiiHi-uiirinri l i l l l l i i l l
glass wool air filter flexible hosing
Figure 3.3 Diagram of a typical flexible film isolator.
3.6.6.3 Sterilisation procedures.
Sterilisation can be achieved 3 ways:
1. Autoclaving at 121°C for 20 min or 180°C for 30 min 
(dry heat).
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2. Gamma irridiation which requires special equipment.
3. Chemical - simple, effective, requires no special equipment. A 2% 
peracetic acid solution is the most commonly used method of chemically 
sterilising isolators and items which must be placed in the isolator.
Vapour from 2% v/v peracetic acid solution kills spores etc in 20
minutes by its potent oxidative action. However, peracetic acid cannot
penetrate hydrophobic materials such as grease etc, so the 2% 
peracetic acid solution has a small quantity of a detergent solution 
(Triton X-100) added as a wetting agent to allow the sterilising 
solution to reach all bacteria. It is for this reason that rubber 
gloves should be worn when handling any items to be placed in the 
isolator should be handled. Vapour is much more effective because it 
disperses to all areas of isolator, so use a household spray to 
administer the peracetic acid. Personal protection is required when 
using peracetic acid; a flow helmet (which provides a filtered air 
supply) should be used (see Methods section 3.1.3) gloves and safety 
glasses in a well ventilated environment.
3.6.6.4 Experimental procedures.
3.6.€.4.A Isolator.
The isolator was a flexible plastic variety (Figures 3.3, 3.4 and
3.5), constructed "in-house" by Mr S. Tuttlebury, and consisted of a 
clear flexible polyvinyl chloride (PVC) envelope (dimensions of 
approximately 125 x 90 x 60 cm) resting on a rigid chipboard base 
covered by a pad of plastic foam. A supporting frame over the cage 
area prevented the envelope from collapsing in the event of a decrease 
in the pressure of the air supply. The envelope walls and sleeves
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Figure 3.4: isolator in working situation, showing entry port
cap and securing rubber band and tapes, thermometer, humidity 
gauge, flexible envelope and gloved sleeves.
Figure 3.5: shows the internal environment of isolation with
cages in position, glass wool (4 um pore) air filter, water 
bottles and limited available working space.
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consisted of clear PVC, thickness 0.2 mm and the floor of coloured 
PVC plastic , thickness 0.5 mm. Wrist length household gloves were 
attached securely to the sleeves by being fitted over rigid plastic 
rings using rubber bands, rubber "O" rings followed by 2.54 cm white 
PVC pressure sensitive tape. A sheet of stiff PVC plastic lined the 
floor of the envelope to prevent the puncturing of the PVC envelope 
from the inside by for instance dried faeces, diet pellets, surgical 
instruments. The frame also supported a double capped entry port made 
of rigid PVC, the inner cap was secured by means of a 2.54 cm rubber 
band and the outer cap was secured with a 2.54 cm wide rubber band and 
2.54 cm white PVC pressure sensitive tape. The frame also supported a 
small blower fan type 26-BTC blower, mains generated as the air supply 
and a liquid paraffin outlet trap. Air exits through a paraffin oil 
trap which prevents backflow of external air when sleeves are used, 
the trap also had a lid to prevent the entry of flying insects (Ward, 
1986) . The air supply flow rate was such to maintain a positive 
pressure on the isolator walls between 2-5 mm water via flexible 
hosing through a glass wool filter. The filter consisted of a 
stainless steel wire cylindrical support around which 3 layers of 12 
mm thick, 4 um pore diameter glass fibre wool were wrapped. The
filter was sited within the isolator near the top of one corner where 
it was least likely to be damaged when cages or other equipment was 
moved. Prior to introducing equipment, cages, etc the isolator
envelope had to be checked for leaks and holes, by inflating the
isolator, sealing the isolator outlet vent and the air input port 
using rubber bungs. Then.a fluorocarbon containing gas mix (Dustoff) 
was sprayed into the isolator ensuring that the sleeves contained some 
of the mixture. A "sniffer" device (Halidehound) which detects halide
gases eg fluorocarbons is carefully scanned over all isolator surfaces 
concentrating particularly on sleeves and any join welds. An alarm 
indicates a hole where halogen containing gas is escaping. This is 
marked with a wax pencil, and then may be temporarily repaired with 
white adhesive tape or a more permanent repair is performed using a 
radio frequency sealing machine.
Once the isolator is leak-free it can be sterilised. Autoclaved cages 
and ear punch pliers together with sealed packets of gamma irridiated 
(50 Gy from a ^Co source at Isotron, Wiltshire, UK) tissues, plastic 
bags, syringes, needles, plastic ruler, were all placed inside prior 
to sterilising the whole isolator. A 2% (v/v) peracetic acid:l% (v/v) 
Triton X-100 detergent solution was liberally sprayed on all inside 
surfaces of the isolator concentrating on the arm sleeves and port. 
The isolator was left inflated for 48 hr, which also served to finally 
check no leaks were present and then the air input supply was attached 
and the sterilising atmosphere vented outside the lab for 48 hours to 
remove all traces of peracetic acid.
3.€.6.4.B Animals.
Thirty male isolator-reared MFl-nu/nu/Ola/Hsd mice, age 5 weeks, were 
obtained from Harlan Olac Ltd, Shaw's Farm, Blackthorn, Bicester, 
Oxfordshire, UK.
Animals were housed in three groups of 10 in autoclaved sterile mouse 
boxes 48 x 16 x 15 cm on irradiated-sterile bedding (Irradiated at 2.5 
Gy, Harlan Olac Ltd).
The temperature of laboratory (and inside the isolator), was 
maintained at 21+2°C and humidity was nominally 40+15%. A 10 hr 
light:14 dark lighting schedule commencing at 0800GMT was maintained.
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(However, the isolator was housed in a general laboratory so the light 
period sometimes extended to 12 hr).
Animals were allowed to acclimatise to the isolator and laboratory 
environment for 10 days prior to experimentation. They were allowed* 
food and autoclave sterilised tap water ad libitum. Food was an 
irridiated pellet diet (2.5 Gy) CD2 mouse diet (Harlan Olac Ltd). Tap 
water was sterilised tap water (autoclaved at 121°C for 50 minutes). 
Vitamin supplements were added to the water, after sterilisation in
the stock bottles within isolator. Vitamin K supplement (Konatin 10) 
are supplied sterile in vials diluted in 20ml sterile distilled water 
to give stock to vitamin K solution, 1 ml of this stock vitamin K 
solution was added to 1 L of drinking water to give a concentration of 
800 ug/L. Vitamin had to be made up and sterilised by autocla- 
ving prior to adding to drinking water. Cyancobalamin 0.0200g, 
NaH2P0^:2H20 1.2g, and sodium chloride 53.Og were added to 400 ml
distilled water, 2 ml of this autoclaved solution was added to 1L of 
drinking water to give a concentration of 100 ug/L.
Animals were checked daily and handled regularly to minimise the 
stress of handling during experimentation. To avoid them biting
through the gloves animals were picked up by the base of the tail 
using rubber tipped forceps.
Cages were cleaned thrice weekly on Monday, Wednesday and Fridays
(am). Animals were transferred to a spare sterile cage while 
cleaning was in progress.
3.6.6.4.C Transplantation protocol.
The transplantation procedure was performed in a sterile working 
environment within a., horizontal flow cabinet.
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1. Donor animal [W/A rat (University of Surrey strain) weight 
approx 600g previously treated with BBN/BEA (see section 3.6.5.4.B)- 
45 weeks earlier] was killed by ether anaesthetisia followed by 
cervical dislocation.
2. Animal was then placed abdomen downwards onto double sided tape
(which had been attached prior, to a plastic bag 30cm x 40cm) . The
bag was reversed such that the rat was contained within it with the
abdomen sealed to the plastic wall via the double sided tape.
3. Commencing at pubis the skin layer of abdomen was opened using
scissors to xiphoid process, and laterally on both sides at the level 
of iliac crests and lower ribcage to give two skin flaps through the 
plastic bag to provide a sterile environment. These flaps were
retracted by means of surgical clamps.
4. The muscular layer of the peritoneum was swabbed down with 100% 
ethanol, prior to peritoneum being opened and retracted as in 3.
5. Using a fresh pair of sterile scissors and forceps the bladder,
kidneys and ureter were dissected free, whole and placed immediately 
into a sterile petri dish containing cold (4°C) sterile RPMI-1640 (pH
7.0-7.2) medium, containing sodium hydrogen-carbonate, glutamine 200mM 
lOx and Antibiotic-antimycotic solution. Media was sterilised by
filtering the solution through a Tower filter system.
6. Excess fat and connective tissue were blunt dissected free 
of kidney and ureter. Viewing through a stereomicroscope (Stereo 
Nikon SMZ-10), within the flow cabinet the ureters were examined 
closely for any abnormalities in appearance and then cut away from 
kidney and replaced into sterile cold RPMI-1640 medium. [Dissection 
and examination procedures were performed on tissue placed, on sheet of 
sterile filter paper, Whatman No 1 and continually bathed in sterile
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cold RPMI-1640 media].
7. The bladder was bisected longitudinally and examined for any 
tumours or nodular areas on its interior surface. Such areas were 
then isolated and dissected using fine forceps and microscissors; any 
tissue pieces being placed into separate multiwell compartments in 
cold RPMI-1640 medium.
8. Kidneys were bisected and depoled, the cut surfaces were examined 
using a stereomicroscope. Any tumours or highly irregular tissue 
areas were carefully dissected and placed in 24-well multiwell 
chambers containing cold RPMI-1640 media.
9. The multiwell chamber was closed, then placed inside a sterile 
specimen bag. This was placed inside the isolator port to sit on a 
cold aluminium block (also inside a sterile specimen bag). The port 
was sprayed with 2% peracetic acid vapour. In order to maintain the 
sterile environment within the isolator there is a minium transfer 
time of 15 min (to allow the peracetic acid to sterilise contents in 
the port). The cold aluminium block serves to keep the tissues at a 
temperature of 4°C during this transfer time.
10. After 15 min the interior side of port was opened and multiwell
plus block washed down with sterile water before being moved into
isolator. Using a sterile scalpel blade, tissue pieces were minced up
in a few drops of cold media to a fine mince, tissue pieces being 
3approximately 1mm or less in volume.
11. Using a 1ml sterile syringe and a 16G cannula tube this minced 
tissue was picked up to that the minced tissue was enclosed inside the 
cannula tube. The syringe contained sufficient media to expel the 
tissue into the aninial.
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12. Each nude mouse was scruffed by the loose skin at the base
of the neck and restrained by holding the base of the tail down with 
the little finger of left hand whilst the second and third fingers 
supported the body of the animal from beneath.
13. A small nick was placed in flank of the animal using small
scalpel blade no 22. Through this incision, the cannula tube was 
introduced. The tube was manoeuvred subcutaneously such that the 
bolus of media (containing the tissue mince) was inserted on the
right anterior lateral flank just posterior of right foreleg.
14. This procedure was repeated on several animals, each receiving 
one or more pieces of tissue either from bladder tumour, ureter or 
pelvic wall.
15. Animals were earmarked according to our usual system (see
Methods, section 3.2.6), and then allowed food and water ad libitum.
16. Any remaining tissue which was not utilised in transplantation 
procedures was further minced and subdivided among a 24-well multiwell 
chamber containing complete RPMI-1640 media (containing 10% Foetal 
calf serum) for cell culture (see Section 3.6.7).
16. Mice were monitored daily and measurements and observations of 
tumour growth taken weekly. Tumour diameter measured 2 directions 
placed into following formula:
L x (B)^  x 0.4 = Volume mm^ (Kyriazis et al, 1985) .
17. When tumour volume according to formula had reached between
3 3 . .800mm - 1000mm (1 cubic cm) the tissue was harvested.
18. The tumour tissue was then processed according to the diagram
below allowing maximal use of tissue for examination procedures 
(Figure 3.6).
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and enzyme staining. in 1% 0^0^
for EM.
Figure 3.6 Schematic diagram showing different endpoints for 
tumour tissue harvested from nude mice.
3.6.6.4.D Harvesting tumours in nude mice.
1. Animals were sacrificed by cervical dislocation in the isolator.
Using sterile forceps and scissors the tumour was dissected out of the 
animal. The tumour consisted of 2 cystic portions containing pale 
yellow straw coloured fluid and a larger nodular solid portion, tissue 
was placed in sterile cold RPMI-1640 media.
1. Approximately one quarter was placed in sterile cold RPMI-1640
media and minced with a scalpel blade, then passaged subcutaneously
into another mouse (as described above in section 3.6.6.3).
2. Approximately one quarter (consisting of 2 x 1/8 portions) were
snap-frozen by the method of Chayen et al, (1976). Chips of dry ice
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were added to methanol until the vigorous bubbling stopped, then a 
smaller beaker containing n-hexane was placed in this methanol-dry ice 
slurry and allowed to equilibriate to -70°C.
3. Tissue portions were dropped directly into the hexane and allowed 
to freeze for approximately one minute. Tissue was removed with cold 
forceps (having equilibriated on dry ice to -7 0°C temperature 
beforehand), and placed in a cryogenic storage tube (NUNC) which was 
then immediately placed into a insulated box containing dry ice.
4. These tubes were then stored in a - 80°C freezer for future micro 
enzyme- and immuno-cytochemistry.
5. The remaining tissues were fixed for either light microscopy in 
formal calcium fixative (section 3.4.1), or electron microscopy in 
2.5% (v/v) glutaraldehyde fixative in phosphate buffer.
3.6.6.5 Assessing the growth of transplanted tissues.
In practice the index of tumour growth was expressed as a linear
dimension; calculated as the mean of the product of two dimensions
measured at 90° to each other ie A x B / 2 = I, and not calculated as 
2L x (B) x 0.4 for a number of reasons.
For ease, speed and convenience a short plastic ruler was used to 
measure the linear dimensions. Although one person had there was 
some difficulty in measuring the tumour dimensions with this method 
it was superior to using calipers. It was virtually impossible to 
measure the tumour dimensions using the calipers as they were not 
"user friendly" and had no easily readable scale etc. The ruler was 
easily sterilised with the peracetic acid method, had an "easy to 
read" scale and was less likely to cause injury to the mouse should he 
struggle, which they were quite apt to do.
The actual act of handling the mice served to make the measuring
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difficult as the skin on the flank was often obscured under a 
restraining finger, or the skin "bunched up" producing false lumps. 
As the animals got older the flank skin often became scarred due to 
the numerous fights which occurred regularly also the presence of
lymphatic nodes gave false positive results.
Raw data was recorded and later calculated according to the formula L
2 . x (B) x 0.4 , where L was assumed to be the largest dimension.
e.g. 7 x 10 was calculated as 10 x (7)^  x 0.4 = 196 mm^
and not calculated as 7 x (10)^  x 0.4 = 280 mm^.
3.6.7 In vitro Cell Culture of Urothelial Cells From Ureter, Bladder 
and Pelvic Epithelia of Wistar Rat.
3.6.7.1 Introduction.
This experiment was performed as part of the nude mice tumour
xenograft study (section 3.6.6 described above). The aim was to 
culture urothelial cells from the ureter, pelvic and bladder 
epithelial regions and any tumours present. Then to establish cell 
lines, and characterise these cell lines in terms of morphology, 
biochemistry and metabolism.
3.6.7.2 Experimental procedures.
1. Kidney, ureters and bladders were removed from BBN/BEA treated 
animals as described in section 3.6.6.4.B.
2. The methods were a modification of culture procedures described by 
Masters et al, (1986) and Lawson et al, (1986) where cold (0-4°C)
incomplete RPMI-1640 media was. used as a maintaining medium until
microsdissection could be performed (see section 3.6.6.4.B).
3. Tissues were placed in cold RPMI-1640 media in a .24-multiwell 
plate which stood on a aluminium block placed on ice to maintain the
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tissues at 0-4°C.
Tissues were taken for nude mouse xenografting, the remainder of the 
tissue was divided and seeded out into a second plate containing 
complete RPMI-1640 medium (with 10% fetal calf serum) added. The 
holding medium in the first plate was replaced with complete medium.
5. These plates were then placed within an incubator maintained at 
37°C in a 5% carbon dioxide:95% oxygen atmosphere. These were left 
undisturbed for 48 hr to allow cells to attach.
6. The cultures were examined evey 24 hr after the initial 48 hr 
period using Nikon Labphase microscope. The cultures were scored 
according to a simple scheme which recorded a) any adherence and b) if 
any growth had occurred.
7. The media was changed every 48 hr by aseptic transfer techniques 
perfomed within a flow cabinet.
Cell cultures showing significant growth were photographed using 
Ilford FP4 film on a Nikon FE2 SLR camera, and Nikon phase microscope 
with objective lens magnifications of xlO, x20 , x40 and x90.
3.7 ASSESSMENT.
3.7.1 Macroscopic Assessment
During postmortems all major tissues (organs within abdominal and 
thoracic cavities) were examined for any gross pathological changes. 
After the tissues had fixed for 24-48 hr a more thorough examination 
was performed during the tissue slicing stage of tissue processing 
(see section 3.4.2, part 9), using a stereomicroscope. This was 
particularly important in the carcinogenesis experiments where the 
bisected bladder and kidney pelvic cavity were closely examined for 
the presence of tumours. The macroscopic assessment enabled particular
regions of tissues could be taken for subsequent histological 
examination. Photographs of tumours and kidney lesions from all 
experiments (rat and pig) were taken using the stereoscope and Nikon 
UFX-II camera system.
3.7.2 Microcopic Assessment.
All histological sections were assessed using Leitz Dialux light 
microscope and any photographs taken using a Nikon UFX-II camera 
system attached to the microscope.
The RPN lesions were graded using the criteria of Burry (1977), and 
Henry & Tange (1982) as a basis for my grading system which was 
modified and upgraded throughout the period of these investigations as 
I became more familiar with the lesion and the pathological changes 
present. The assessment of pathological changes was done on an 
anatomical region basis, with the basic regions examined as shown in 
Table 3.4. The pelvic, ureteric and bladder urothelia (in an arbitrary 
order of priority) were assessed for hyperplastic and neoplastic 
changes according to Kunze (1987), Mostofi et al, (1973) and Helpap et 
al, (1985).
3.8 TISSUES FROM PATIENTS WITH ANALGESIC NEPHROPATHY.
3.8.1 Introduction.
One of the frequent criticisms of the use of animal models of human 
disease is the difficulty in extrapolating data from these 
experimental models to the clinical situation. It was therefore of 
great interest to obtain some tissue samples from analgesic abusing 
patients so that a comparison of the pathological changes between the 
clinical and the experimental specimens could be performed.
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Table 3.4: Pathological changes assessed in grading of RPN.
Change assessedAnatomical 
Region.
Nephron segment/ 
region.
Papilla
Medulla
Cortex
interstitial cell
interstitial cell 
matrix
capillaries 
loops Henle 
collecting duct
covering epithelium
collecting ducts 
loops Henle
interstitial cells
vasa rectae
general
proximal tubule
Pelvis & Ureter urothelium
capillaries 
PMN: Polymorphonuclear leukocytes.
nuclei changes:pyknosis 
basophilia, enlargement
increase/decrease stain 
-ing, granularity, PMN 
influx, fibrosis.
adherence of platelets, 
erythrocytes.
nuclei enlargement, 
mitoses, necrosis, casts.
cytoplasmic swelling,
PAS positive cytoplas­
mic granules, lipidosis 
mitoses, necrosis, casts
hyperplasia,lipidosis, 
necrosis, denudation.
as for papilla, also PAS 
casts early in loops.
as for papilla.
endothelial nuclei baso­
philic, PAS casts, cell­
ular debris.
dilatation of tubular 
elements, sclerosis & 
fibrosis (late stages 
only), inflammatory cell 
influx.
disruption of brush bor­
der, loss of associated 
enzymes, atrophy in late 
stages.
hyperplasia, mitoses, 
loss of glycocalyx, 
increase in cytoplasmic 
PAS granules.
histochemical, micro- 
angiopathy.
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A collaborative study with Dr Anke Schwarz (Freie Universitat, Berlin) 
was initiated because of her mutual interest in the pathogenesis of 
analgesic nephropathy. Dr Schwarz works as the consultant 
nephrologist in a urology department which has a large number of 
dialysis patients who are known to abuse analgesics, she therefore 
kindly agreed to send tissue specimens when they were available.
The tissue specimens had been fixed in routine 10% (v/v) neutral
buffered formalin for unspecified time periods (a minimum of one 
week), this compromised the enzyme histochemistry staining because of 
the extended periods in high concentrations of fixative.
This did have the benefit of ensuring that all the specimens were 
adequately fixed including any potential biohazardous pathogens that 
were in the specimen.
3.8.2 Experimental Procedure.
The specimens were examined macroscopically, renal pyramids (if 
identifiable as such) or a representative slice through cortex and 
medulla together with any pelvic or ureteric urothelia were taken 
(according to the method of Lomax-Smith & Seymour, 1980a, see Figure
3.2) and processed for embedding in glycolmethacrylate resin as 
described in section 3.4.
3.8.3 Clinical Histories.
Specimen 1: a shrunken kidney (80 x 40 x 30 mm, 60g weight) was
obtained from a 68 year old woman who had undergone a nephrectomy 
because of a small uroepithelial carcinoma (15 x 3 x 5 mm) at the 
uretero-pelvic junction. The patient had consumed several kinds of 
compund analgesics for a number of years, at least 1 tablet for at 
least 8 years (probably more and for longer - the patient gave several
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contradictory statements regarding her analgesic intake). Ultrasound 
scan showed shrunken kidneys with calcification (papillary necrosis) 
and a renal insufficiency with a serum creatinine of 500 umol/1 before 
nephretomy. The patient was now on hemodialysis.
Specimen 2: shrunken kidneys (Left weight 70g, Right weight 80g) from
a 58 year old woman who had died (1988) from pulmonary metastasis of 
breast carcinoma (mastectomy performed in 1982). .The patient had 
consumed compound analgesics containing phenacetin for at least 10 
years, about 10 tablets daily (cumulative amount of phenacetin 5kg). 
Renal insufficiency was detected in 1969, patient presumed to have 
continued to abuse analgesics, had complicating urinary tract
infections, urinary obstructions by calcified papillae and 
haemodialysis was commenced in 1978. Prolonged hemodialysis treatment 
has resulted in secondary polycystic degeneration in both kidneys. 
Also secondary arteriosclerotic stenosis of kidney arteries is 
present, which is present in 60% of analgesic kidneys. Renal
tuberculosis (which patient had in one kidney) is commonly associated 
with renal interstitial disease, mostly analgesic nephropathy (Dr A. 
Schwarz, personnel communication).
Specimen 3: kidney was obtained from a 60 year old woman who.had died
of acute cardiac failure (induced by coronary heart disease, heart
insufficiency, hypokalaemia by tubular loss of potassium resulted in 
ventricular fibrillation). The patient had completely denied any form 
of analgesic intake, however clinical and pathological symptoms 
suggested she had analgesic nephropathy; shrunken irregular kidneys 
with papillary cavities, a history of recurrent renal concrements and 
had already undergone unilateral nephrectomy some years previously 
because of pyelonephritis. Hemodialysis had been commenced just 4
156
weeks prior to death.
Specimen 4: one kidney from a 63 year old woman who had undergone a
nephrectomy because of renal pelvis carcinoma. Patient had consumed 
analgesic compounds 3-4 tablets daily for 30 years (because of 
headaches!). Compounds consumed were Togal (which contains 
acetylsalicylic acid) and Spalt (which contained phenacetin up to 1965 
and since then has contained salicylamide and phenazonsalicylate). 
The patient had advanced renal insuffienciency with a serum creatinine 
of 350 umol/1 (upper normal limit of 110 umol/1), and now is receiving 
haemodialysis.
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CHAPTER 4
CHEMICALLY INDUCED RENAL PAPILLARY NECROSIS: RESULTS AND DISCUSSION. 
RESULTS.
4.1 2-Bromoethanamine (BEA) Induced RPN in Rats.
4.1.1 Short-term Time Course Study.
The reasons and methods for this investigation are described in Chapter 
2, section 2.5, Methods section 3.6.1 respectively.
Tables 4.1A and 4.IB summarise the morphological and histochemical 
changes that occurred over 144 hours after a single ip dose of BEA 
(100 mg/kg) see Figures 4.1-4.15.
4.1.1.1 Monastoral blue B assessment of microvascular filling and 
integrity.
See Methods section 3.6.1.1 for reasons for and methods used in this 
investigation. The macroscopic distribution of Monastral blue B in the 
control kidneys showed marked labelling of glomeruli in the cortex, 
medullary rays and to a lesser extent the papilla. In treated kidneys 
there was a progressive increase in medullary rays and papillary 
labelling in the viable zone, but not in the necrotic tip. The 
labelling of glomeruli remained virtually constant, with a slight 
decrease during the 24-48 hr period, coinciding with more Monastral 
blue B in the medullary rays and papilla. At 144 hr the cortico- 
medullary labelling had reverted to that observed in control kidneys. 
Neutral red counter-stained 1 um sections showed capillary labelling 
in the capillaries within the papilla, glomeruli and pelvic 
urothelium. No label was, however, seen to have extravasated into 
the interstitial matrix prior to the initial frank necrotic changes 
observed at 8-12 hr.
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Table 4.1A: Early (0-144 hrs) morphological changes in BEA-
induced RPN in male Wistar rats.
Time Point Morphological Changes
Control Normal with papilla interstitial matrix increasing in 
volume towards tip (Figure 4.1). Urothelium 2-4 cells thick, paler 
superficial layer which is PAS positive (Figure 4.2).
2 hours No changes discernible
4 hours Medullary interstitial cell nuclei becoming acutely
irregular and pyknotic (Figure 4.3).
6 hours Mild hyperplasia of papilla covering epithelium to 2-3 
ce'Tis thick
8 hours Marked pyknosis of interstitial cell nuclei, sloughing 
of hyperplastic covering epithelium. Platelets adhering to 
endothelium dilated distal tubular profiles.
12 hours Leading edge of sloughing covering epithelium showing
mild 2-3 cell thick hyperplasia. Degenerative changes in tubular
elements in papilla. Hyperplasia in upper ureteric urothelium.
18 hours 50% of papilla affected by RPN. Cytoplasmic granules
in necrotic collecting duct cells (Figure 4.4), mitotic figures 
present. Hyperplasia of pelvic urothelium opposite leading edge of 
covering epithelium (Figure 4.5).
24 hours Medulla affected by necrosis, loss of tissue integrity 
with cellular debris and proteinaceous casts in papilla. Casts in 
dilated distal tubules in cortex. Fornix area of urothelium, 
hyperplastic, mitotic figures present
48 hours Covering epithelium leading edge 5 cells thick, cells very 
irregular nuclei, cytoplasmic granules present (Figure 4.6) General 
hyperplasia of pelvic and ureteric urothelium.
72 hours 75% denudation of papilla covering epithelium. Tubular 
necrosis extending to outer medulla. Marked dilatation of
proximal and distal tubules (Figure 4.7).
144 hours 75-100% loss of covering epithelium, papilla is a mass of 
necrotic tubules, (Figures 4.8) extensive adhesion of platelets in 
capillares and total loss of tissue integrity (Figure 4.9) 
lymphocytic infiltration. hyperplasia of pelvic and uretic 
urothelium (Figure 4.10), bladder urothelial superficial layer 
becoming increasingly basophilic. Numerous granules in proximal 
tubule segments.
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Table 4.IB: Early (0-144 hrs) histochemical changes in BEA-
induced RPN in male Wistar rats.
Time point Histochemical changes
Control Occasion PAS positive granules in urothelium Aik Phos and 
ATPase enzyme staining in proximal tubule brush borders (also GGT), 
intermediate and basal layer of urothelium with superficial layer 
devoid of stain (Figure 4.11).
2 hours No changes discernible
4 hours Increase in interstitial matrix staining with 
Giemsa. Slight increase in ATPase staining around pyknotic nuclei
6 hours Slight decrease in Aik Phos and GGT proximal tubule brush 
border staining
8 hours Increase in Aik Phos staining in pelvic urothelium
opposite denuded covering epithelium (Figure 4.12).
12 hours Increase interstitial matrix staining at papilla 
tip. Hyperplastic urothelium has increased apical Aik Phos staining 
and increased ATPase staining of endothium sub-urothelial 
capillaries
18 hours Mosaic pattern of Aik Phos and ATPase staining in
hyperplastic urothelium (Figure 4.13). ATPase endothelial staining 
increase, moderate Acid Phos staining of interstitial cells in
medulla
24 hours Decreased interstitial matrix staining, loss of proximal
tubular brush border enzymes Aik Phos, ATPase and GGT coincide with 
an increase of these enzymes in proteinaceous casts in the necrotic 
papilla (Figure 4.14). Loss of Acid Phos staining from S2 proximal 
tubule segment
48 hours PAS positive staining material in proteinaceous casts. 
Continued loss of Aik Phos, ATPase and GGT from proximal tubule 
brush borders, also loss of Aik Phos and ATPase to slight degree 
from pelvic and ureteric urothelium
72 hours Variable enzyme staining in proteinaceous casts, GGT most 
pronounced. Urothelial staining in ureter reduced to few Aik Phos 
positive cells, no bladder staining at all. Sub urothelial 
capillary ATPase staining increased (Figure 4.15).
144 hours Granular Aik Phos and GGT staining in interstitium 
adjacent to hyperplastic fornix urothelium. Increased Acid Phos 
lysosomal staining in proximal tubule segments. Sub-urothelial 
capillary ATPase endothelial staining increase in quantity to 
occlude lumen.
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Figure 4.1. Papilla tip from kidney of control animal showing 
characteristic pink (Giemsa) staining of interstitial matrix and 
single cuboidal covering epithelium (arrowhead). Giemsa x 89.
Figure 4.2 Control urothelium from Wistar rat showing three 
distinct layers; a) epithelium, b) lamina propria, c) lamina 
muscularis. Giemsa x 357.
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Figure 4.3. Pyknotic interstitial cell nuclei in the papilla tip, 4 
hr after BEA (100 mg/Kg), Giemsa x 178.
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Figure 4.4. Collecting duct (CD) epithelial cells undergoing 
simultaneous repair and necrosis with basophilic staining cytoplasm 
granules and sloughing cells, 48 hr after BEA (100 mg/Kg), 
Toluidine blue x 223.
Figure 4.5. Hyperplastic pelvic urothelium (PE) opposite denuded 
papilla covering epithelium (CE) 72 hr after BEA (100 mg/Kg), 
Toluidine blue x 17 8.
Figure 4.6. Hyperplasia of leading edge of remaining covering 
epithelium (CE), blebbing, sloughing cells have atypical nuclei and 
numerous eosinophilic cytoplasmic granule, 72 hr after BEA (100 
mg/kg) , H&E x 8 93.
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Figure 4.7. Dilatation of distal and proximal tubular lumen in 
cortex, 72 hr after BEA (100 mg/Kg), Toluidine blue x 89.
Figure 4.8 Low magnification micrograph showing typical RPN lesion 
72 hr after BEA, note denudation of covering epithelium 
(arrowheads). Giemsa x 36.
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Figure 4.9 Loss of tissue integrity at papilla tip with extensive 
platelet adherence in capillaries (arrowheads), 72 after BEA. Giemsa 
x 893.
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Figure 4.10. Hyperplastic ureteric urothelium, 72 hours after BEA 
(100 mg/kg), Giemsa x 223.
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Figure 4.11. Alkaline phosphatase (Aik. Phos.) staining in
control bladder urothelium (arrowheads). Superficial "umbrella" cell 
layer devoid of stain. Alkaline phosphatase x 357.
Figure 4.12. Increased Aik. Phos. staining in pelvic urothelium 
(PE) opposite denuded covering epithelium (arrowheads) 8 hr after 
BEA, Alkaline phosphatase x 178.
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Figure 4.13. Mosaic pattern of Aik. Phos. staining in hyperplastic 
urothelium, 18 hr after BEA, Alkaline phosphatase x 357.
Figure 4.14 Heterogenous ATPase staining in proteinaceous casts 
in necrotic tubules in papilla, 72 hr after BEA, ATPase x 36.
IFigure 4.15 Sub-urothelial capillary endothelium stained with 
ATPase, thickness increasing to occlude lumen (arrowheads), ATPase x
4.1.2 Intermediate and Long-term Time Course Study.
4.1.2.1 Three weeks time point.
The result presented here are from animals used in these studies were 
actually the BEA only treated control group of the series of
carcinogenesis studies (see section 3.6.5). It was felt that to 
present them separately from the results of those studies (see chapter 
5) was justified in establishing the time course description of the
pathological changes occurring at extended time points after BEA-
induced RPN was important for comparison with the carcinogenesis
results and with the human tissue from analgesic abusers.
All animals displayed morphological changes associated with total RPN. 
There was complete denudation of the covering epithelium, with the 
totally necrotic papilla beginning to slough off from the medulla 
along a line joining the two fornices of pelvis (Figure 4.16) .
893.
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Figure 4.16. Necrotic "ghost" papilla (Gh) sloughing of medulla, 
along crescentic line denoting extent of lesion (arrowheads), 3
weeks after a single ip dose of BEA (100 mg/kg), Toluidine blue x 
43.
Figure 4.17 Increased deposition of mucopolysaccharides in the 
interstitial matrix and basement membranes (arrow) of juxtamedullary 
glomeruli and adjacent distal tubules, Giemsa x 357.
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This "ghost" papilla had proteinaceous casts (which stained faintly 
for alk. phos. and GGT and more intensely for PAS) in the degenerative 
loops of Henle and collecting ducts. Numerous platelets were 
adherent to the capillary endothelium together with erythrocytes. 
There was papillary hyperplasia of the pelvic and ureteric urothelium. 
The bladder urothelium showed no morphological changes, however, the 
sub-urothelial capillaries continued to stain intensely for ATPase, 
whereas the urothelium had variable staining for alk. phos. and 
ATPase.
There were areas of marked necrosis radiating out from the medulla to 
the cortex along the vasa rectae affecting both the proximal and
distal tubules. In these areas of necrosis there was an increase in 
and mucopolysaccharide deposition in the interstitial matrix and in
the basement membranes around distal tubules and juxtamedullary 
glomeruli (Figure 4.17). The necrotic proximal tubules had variable 
brush border staining for ATPase, alk. phos. and GGT with the most 
intense staining in the Pg proximal tubule segment. Interstitial 
cell nuclei adjacent to the vasa recta (medullary rays) were enlarged 
and basophilic. At the junction between 'ghost' papilla and medulla 
there were aggregates of polymorphonuclear leucocytes.
4.1.2.2. Six weeks time point.
The major morphological change at this time point was the re-
epithelisation of the covering epithelium of the papilla/urothelium, 
where the 'ghost' papilla had sloughed off completely (Figure 4.18). 
This new epithelium was mildly hyperplastic with the occasional cell 
blebbing into pelvic space, nuclei were of variable shape and there 
was an occasional mitotic figure present. The restoration of the
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Figure 4.18. Papilla stump showing re-epithelialisation of the 
covering epithelium where the "ghost" papilla sloughed off, 6 weeks 
after a single ip dose of BEA (100 mg/kg), Giemsa x 177.
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Figure 4.19 Sclerosis and basement membrane thickening of glomeruli 
(G) and distal tubules together with monocytic leukocyte infiltra­
tion (arrowhead), 6 weeks after BEA (100 mg/kg), Giemsa x 223.
covering epithelium increased the deposition of interstitial matrix 
components whereas at earlier time points the pink (Giemsa) staining 
had decreased. This interstitial matrix staining was not as intense 
as control medullary interstitial matrix and there was no increase in 
the number of interstitial cell nuclei either. There was some granular 
alk. phos. and ATPase staining in this restored matrix areas, basal to 
the re-epithelised covering urothelium.
The pelvic urothelium was mildly hyperplastic with cell being of 
variable size, shape and basophilic staining. Severe hyperplasia of 
the ureteric urothelium occurred which was papillary in some regions 
with a few areas of enlarged nuclei and increased dysplasia together 
with sloughing of the superficial cells into the ureteric lumen. The 
bladder urothelium was either normal or very mildly hyperplastic. The 
urothelial changes usually consisting of a ruffled superficial cell 
surface with an occasional basophilic staining nuclei. Within the 
urothelium of all areas the following distribution of enzyme staining 
was noted: pelvic urothelium had reduced alk. phos. and ATPase
staining with only trace to faintly positive staining in a mosaic 
pattern, this pattern was also found in the bladder urothelium.
The ureteric urothelium was severely hyperplastic which was 
nodular/papillary in some areas. Variable alk. phos. and ATPase 
staining was observed throughout the ureteric urothelium. This 
staining was negative in some areas, whereas other regions had a 
mosaic pattern with an apical distribution in those areas of positive 
staining. Sub-urothelial capillaries in all areas stained positively 
and intensely for alk. phos. and ATPase with some occlusion of the 
lumen in some vessels. PAS staining of pelvic and bladder urothelia 
was usually confined to the glycocalyx on the superficial cell layer
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with occasional intensely staining granules present.
The necrotic changes in cortex described in section 4.2.1 were more 
pronounced after 6 weeks. The radiating pattern of atrophying 
tubules and increasingly sclerotic distal tubules and glomeruli 
(which were intensely PAS-positive stained), was accentuated by 
interstitial cell necrosis together with monocytic inflammatory cell 
infiltrates. These changes are indicative of a progressive 
interstitial nephritis. Enzyme staining for alk. phos. and GGT was 
variable and evident only in the proximal tubule brush borders where 
no necrosis had occrred. PAS staining of brush borders followed a 
similar pattern with the Pg segment being stained most intensely. 
Some sclerotic glomeruli had increased ATPase staining within the 
glomerular tuft.
4.1.2.3 Thirteen weeks time point.
The morphological changes at 13 weeks were a continuation and 
development of the degenerative cascade described at 6 weeks (see 
section 4.1.2.2). The papilla, if present, remained as a stump less 
than a quarter of its original length. Often it was just a re- 
epithelialised ridge from which the necrotic "ghost" papilla had 
broken away. The covering epithelium was mildly hyperplastic, with 
condensed basophilic nuclei and the occasional blebbing superficial 
cells. An increased interstitial matrix deposition occurred in the 
medulla/papilla stump. This was often devoid of tubular elements and 
any nuclei present were usually basophilic and pyknotic. The matrix 
appeared fibrous in nature, often bright pink and extended throughout 
medulla and cortex into areas undergoing atrophy. Granular intensely 
positive staining areas of interstitial matrix for alk. phos.
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continued to stain in areas adjacent to the re-epithelialised covering 
epithelium.
In general the pelvic urothelium was mildly hyperplastic, but had 
disorganised cellular layers with large basophilic nuclei, together 
with large cells with eosinophilic granular staining cytoplasm 
(macrophages) scattered throughout. In the ureteric urothelium the 
lamina propria was very prominently stained for mucopolysaccharides 
with Giemsa, in some areas this extended up into the hyperplastic 
urothelium where it was papillary in nature. Throughout the ureteric 
and bladder urothelium there were patches of sloughing cells which 
were often very basophilic and vacuolated. The bladder urothelium 
was very ruffled on the luminal surface of the superficial layer. 
In the ureteric urothelium there was an extremely intense mosaic 
pattern of cytoplasmic staining for alk. phos., whereas the pelvic and 
bladder urothelia were devoid of such staining.
The cortical interstitial nephritis and necrotic tubules was more 
advanced with prominent sclerotic and thickened basement membranes 
especially of the glomerulus (Figure 4.19), Bowman's capsule and 
distal tubules. Any enzyme staining was restricted to viable 
proximal tubule brush borders which were often extremely disrupted, 
extruding into the lumen.
4.1.2.4 Twenty-one weeks tine point.
An exacerbation of the morphological changes already described at 13 
weeks was apparent at this time point. In particular the re- 
epithelised covering epithelium was hyperplastic up to 4 cell layers 
thick in one area. The central portion of the cortex opposite the 
papilla/hilum had total interstitial nephritis with very few tubules 
present, many were sclerotic, also there was marked numbers of
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inflammatory cell infiltrates (Figure 4.20), cortical scarring and 
collapse of the underlying parenchyma. Only proximal tubules which 
were intact gave positive brush border staining with PAS and the alk. 
phos.
The pelvic urothelium was generally of normal appearance, but some 
areas had basophilic nuclei in basally located cells and the 
occassional vacuolated, sloughing cell with pyknotic nuclei in the 
superficial layer. There were intensely PAS staining granules present 
in the superficial layer of the pelvic urothelium. The bladder 
urothelium was normal with a few hyperplastic areas up to 5 cells 
thick, whose superficial layers were extremely ruffled, occassional 
PAS positive inclusion bodies were present in this urothelium too. 
Variable hyperplasia (from simple to papillary) occurred in the ureter 
with many basophilic enlarged nuclei in the superficial layer 
together with numerous intensely PAS positive staining inclusion 
bodies which were more obvious in hyperplastic and dysplastic regions 
(Figure 4.21).
4.1.2.5 Thirty weeks time point.
The following changes were apparent at this time point (being a 
progression of the RPN and chronic severe interstitial nephritis. 
Opposite the papilla stump, complete collapse of cortical parenchymal 
tissue had occurred with no identifiable tubular elements present only 
very sclerotic and fibrotic glomeruli (Figures 4.22a,b). Medullary 
collecting ducts and distal tubules were extremely dilated had 
basophilic casts together with mineralised deposits in the necrotic 
loops of Henle. The hyperplastic covering epithelium was 4-5 cells 
thick with extreme basophilic nuclei and positive cytoplasmic alk.
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Figure 4.20 Interstitial nephritis with tubular atrophy and 
sclerosis inflammatory cell infiltrations (arrow) in the cortex of 
kidney, 21 weeks after BEA (100 mg/kg). Giemsa x 108.
Figure 4.21 Numerous PAS positive staining granules and inclusion 
bodies in superficial layer of hyperplastic ureteric urothelium, 21 
weeks after BEA (100 mg/kg). PAS x 893.
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Figure 4.22a. Collapse of cortex (Cx) due to interstitial nephritis 
and atrophy of tubules producing surface scarring and decrease in 
thickness of cortex relative to medulla (M), 30 weeks after BEA.
Giemsa x 43.
Figure 4.22b Higher magnification of above figure showing extensive 
tubular atrophy, inflammatory cell infiltrates and pronounced 
sclerosis of glomeruli (arrow). Giemsa x 434.
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phos. staining. There was severe hyperplasia, dysplasia and loss of 
polarity in the ureteric urothelium with papillary hyperplastic areas 
which had intensely PAS-positive inclusion bodies within the 
superficial layer, but no alk. phos. staining.
The bladder urothelium was 2-3 cells thick and extremely ruffled in 
the superficial layer. It had a few PAS-positive inclusion bodies 
(less than ureter) and some areas of urothelium alk. phos. positive 
staining was present.
Figure 4.23 Papillary and nodular hyperplasia of ureter urothelium 
showing faint mosaic pattern of alkaline phosphatase staining, 40 
weeks after a single ip dose of BEA (100 mg/kg). Alkaline 
phosphatase x 270.
4.1.2.4 Forty weeks time point.
The main changes were an increase in mineralised deposits within and 
adjacent to the lumen and basement membrane of the loops of Henle in 
the papilla stump. Distal tubules and collecting duct casts were more
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extensive and contained PAS-positive material and exfoliated cells. 
Solid nodular hyperplasia occurred in one animal in the pelvic 
urothelium at the mouth of the ureter. The ureteric urothelium had 
variety of hyperplastic changes (papillary and nodular) (Figure 4.23) 
with dysplasia throughout and variable basophilia of nuclei.
Cells with eosinophilic granular cytoplasm (macrophages) were 
prominent throughout all urothelia; pelvic, ureteric and bladder.
At a gross level calcified "ghost" papillae were often present, in 
pelvic space producing caliculi. This occurred in a few animals 
through the study, but increasingly from 13 weeks onwards.
4.2 BROMOETHANAMINE INDUCED RPN IN MICE.
4.2.1 Results From Schnider Mouse Strain Treated With a Range of 
BEA Doses (25-200 mg/kg).
Methods for this study are described in section 3.6.2.1.
Total necrosis of the papilla similar to that observed in Wistar rat 
(section 4.1) extending into the medulla was only evident in mice 
dosed with 200 mg/kg BEA.
The necrosis evident in the 100 mg/kg and 150 mg/kg dosed animals had 
morphological changes concomittant with intermediate RPN in Wistar 
rats dosed with 50 mg/kg BEA. The loss of covering epithelium does 
not appear to be a primary morphological change in Schnider mice, but 
changes in the interstitial matrix staining are the major necrotic 
change together with vascular wall damages in the capillaries.
The dose levels of 25 mg/kg and 50 mg/kg produce early RPN with 
swollen collecting duct cells, casts in the loops of Henle and 
platelets adhering to the endothelium. This vascular wall damage 
precedes the interstitial changes that are concommitant with early RPN
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in the Wistar rat. Interstitial cell nuclei and matrix changes are 
initiated in the mid-papilla region and not at the tip as in the rat. 
No hyperplasia of pelvic urothelium occurred, but sloughing appeared 
to happen and detachment of the covering epithelium from papilla 
occurred.
The morphological changes described above are after 60 hr, whereas 
similar changes have been described in the rat much earlier in the 
time course see Table 4.1A.
4.2.2 Time Course Study of BEA in Three Different Mouse Strains.
4.2.2.1 Functional results.
The pooled urine results did not produce consistent results for 
osmolality, the Balb/c strain did not produce sufficient urine to 
collect and analyse at any time point. It was for these reasons that 
the individual samples collected direct from the bladder were used to 
produce mean values for each time point.
Mean control values for urine and serum osmolality, urea nitrogen and 
urine serum ratios are shown in Table 4.2.
4.2.2.2 Gross pathological results.
Table 4.3 shows the mean control kidney weight/body weight ratio 
values for each strain.
Balb/c mice had a higher mean control kidney/body weight ratio value 
(0.0177+0.0004), than either Obese (0.0158+0.0008) or C57B1/6 
(0.0148+0.0004), n = 15 for all strains.
4.2.2.3 Histopathological results.
4.2.2.3.A Controls.
There were no differences in morphology or histochemistry in any of 
the strains.
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Table 4.2: Mean Urine and Serum Control values for Urea Nitrogen
and Osmolality.
Strain Urea Nitrogen Osmolality
Urine (U) Serum (S) U/S ratio Urine Serum U/S ratio
(mmol/kg) (mg/dl) (mmol/kg) (mg/dl)
Obese
M 1496 18.28 81.84 1234 317.29 3.89
SD 675 6.39 397 87.0
n 5 14 10 14
Balb/c
M 1304 295 4.42
SD ND ND ND 387 82
n 3 14
C57B1/6
M 1069 16.92 63.18 991 292 3.39
SD 491 5.98 249 82
n 9 15 8 15
M = mean value, SD = standard deviation, n = number samples, ND = no
data.
Table 4.3: Mean Control values of Kidney/Body Weight ratio.
Strain KW/BW ratio
(g/kg)
SD SE
(xlO-4)
95% cf 
(xlO-4)
range
Balb/c 0.0177 0.0004 1.03 ±2.018 0.0175-0.0179
Obese 0.0158 0.0008 2.065 +4.047 0.0154-0.0162
C57B1/6 0.0148 0.0004 1.03 ±2.018 0.0146-0.0150
KW/BW ratio - kidney weight/body weight ratio, SD - standard deviation 
SE - standard error, 95% cf - 95 % confidence limits, n = 15 for all 
groups.
In all the strains the proximal tubule segments in the outer cortex 
(predominantly and stained preferentially for alk. phos. where 
as the Pg segment stained most intensely for GGT.
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4.2.2.3.B Three hr time point
The initial changes in all strains were pyknotic interstitial cell 
nuclei (Figure 4.24) in the upper papilla region and areas of 
intensely staining interstitial cell matrix in the papilla with PAS 
and Giemsa. The C57B1/6 mice also had hydropic cytoplasmic changes in 
the Pg segment with some brush border disruption.
4.2.2.3.C Six hr time point
All strains had adherent platelets and erythrocytes in the capillaries 
in the papilla. There was an increase in the number of pyknotic
interstitial cell nuclei in Obese mice (upper papilla region) and
C57BL/4 mice (papilla tip). Obese and C57B1/6 mice had collecting duct 
cells which contained PAS positive staining granules within the 
cytoplasm. C57B1/6 mice also had casts in the loop of Henle and 
intensely eosinophilic staining granules/droplets in the cytoplasm of 
loop of Henle, collecting duct and proximal tubules. Some Pg segments 
had lost alk. phos. brush border staining.
4.2.2.3.D Twelve hr time point
Obese mice had enlarged vacuolated covering epithelium and pelvic 
epithelium cells in the fornices. All tubular lumen in the papilla
were dilated with occassional alk. phos. staining casts in the loop 
of Henle. Cortical changes were evident as PAS positive staining casts 
in the collecting duct. Balb/c mice had an increasing number of 
enlarged collecting duct cells with decreased interstitial cell matrix 
staining in the mid-papilla region. C57B1/6 mice had enlarged 
collecting duct cells in papilla with more PAS positive, basophilic 
cytoplasmic granules (Figure 4.25), and cortical collecting duct 
cells exfoliating into the lumen. Proximal tubule brush border
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Figure 4.24. Pyknotic interstitial cell nuclei (arrow) in papilla of 
C57B1/6 mouse 3 hr after 100 mg/kg BEA, Giemsa x 543.
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Figure 4.25. Enlarged collecting duct (CD) epithelial cells 
containing basophilic cytoplasmic granules (arrow), C57B1/6 mouse 12 
hr after 100 mg/kg BEA, Giemsa x 868.
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disruption and blebbing into the lumen was observed together with loss 
of alk. phos. staining in both Obese and C57B1/6 mice (P2 segment).
4.2.2.3.E Twenty-four hr time point.
Obese and C57B1/6 mice showed the following changes; prominent inter­
stitial cell matrix staining in at the papilla tip, an influx of 
polymorphonuclear leucocytes in capillaries and interstitial cell 
matrix of papilla, covering epithelium cells in fornices were swollen 
and blebbing containing basophilic cytoplasmic granules (Figure 4.26) 
which were also PAS positive (C57B1/6 > Obese). Basophilic staining 
casts with exfoliated cells were present in loops of Henle, collecting 
duct, in all regions of the kidney. Balb/c mice had a total loss of 
interstitial cell matrix staining in the upper papilla, but the 
collecting duct and loop of Henle were still intact with no necrosis 
evident. A few basophilic casts present in the cortical collecting 
duct and occassional alk. phos. staining casts in the papilla.
Figure 4.26. Hyperplastic, blebbing covering epithelial (CE) cells 
with vacuoles and basophilic cytoplasmic granules, C57B1/6 mouse 24 
hr after 100 mg/kg BEA, Giemsa x 868.
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4.2.2.3.F Forty-eight hr time point
C57B1/6 mice had dilated tubular lumen in the papilla with many 
collecting duct cells containing PAS positive staining cytoplasmic 
granules, increased interstitial cell matrix staining at papilla tip, 
mild hyperplasia (2-3 cells thick) of the pelvic epithelium in the 
fornices with lobulated basophilic staining nuclei. Balb/c mice had 
pyknotic nuclei in loop of Henle and collecting duct in upper papilla, 
enlarged basophilic interstitial cell nuclei adjacent to the vasa 
rectae, PAS positive staining casts in the cortical collecting duct. 
There was no noticeable progression in intensity of lesion at 48 hr 
in the Obese mice.
4.2.2.3.G Seven day time point
Obese mice had necrotic collecting duct and loop of Henle with 
exfoliating cells, some proximal tubules which had basophilic staining 
nuclei and cytoplasm in a radiating pattern. Some glomeruli and 
Bowman's capsule had thickened basement membranes and sclerosis 
particularly the juxtamedullary glomeruli. C57B1/6 mice had intact 
collecting duct and loop of Henle in the papilla the overall 
appearance of the lesion was worse with the changes described 
previously being more intense. Many casts throughout the kidney and 
more adherent platelets, variable alk. phos. and PAS staining of the 
proximal tubule brush border and displacement of collecting duct 
nuclei to luminal surface of cells.
4.2.2 .3. H Fourteen day time point
C57B1/6 mice had alk. phos. staining casts in the papilla, in the 
cortex there were some proximal tubule segments which had flattened 
epithelial cells with basophilic staining cytoplasm. In Obese mice 
there was no noticeable difference in the appearance of kidneys from
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BEA treated animals from the kidneys from control animals. Balb/c did 
not show any differences from control kidneys.
4.2.2.3.1 Twenty-four day time point
The C57B1/6 mice had casts within the papilla (Figure 4.27) but no 
gross total necrosis of the loop of Henle, collecting duct or 
covering epithelium usually found in the Wistar rat. There was focal 
interstitial nephritis with aggregates of monocytic leucocytes and 
basophilic staining atrophying tubules adjacent to juxtamedullary 
glomeruli (Figure 4.28), very prominent basement membrane staining 
(with PAS). Balb/c mice showed no gross necrosis in the papilla but 
prominent PAS staining casts were present in the vasa rectae vessels 
which also had thickened basement membranesr and some focal 
interstitial nephritis in the cortex but not to the same degree as 
C57B1/6 mice. No slides from Obese animals were available for 
examination at the 21 day timepoint.
4.2.3 Results From Dose and Time Course Studies in Nude 
Mice.
The reasons for having Nude mice available and the basis for using 
them in acute RPN studies have been presented in Methods section
3.6.2.2.
4.2.3.1 Controls.
No abnormal morphology was observed in any of the control kidneys
examined (n=4) and structural and histochemical features were the same
as seen in other mouse strains. The brush border of all proximal 
tubular segments stained for PAS positive material. The P^ and P2
segments stain positively for alk. phos. while the P^ segment showed
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Figure 4.27. Casts and numerous platelets in capillaries and intact 
covering (CE) and collecting duct (CD) epithelia, C57B1/6 mouse 21 
days after 100 mg/kg BEA, Giemsa x 543.
Figure 4.28. Thickened basement membranes and atrophying tubules in 
focal interstitial nephritis, C57B1/6 mouse 21 days after 100 mg/kg, 
Giemsa x 543.
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the preferential localisation of GGT.
Whereas rat papilla stains prominently for the interstitial cell 
matrix Nude mice (in common with other mouse strains, section 4.2.2) 
did not. The interstitial mucopolysaccharide matrix in the mouse 
stained much more uniformly and did not increase in intensity towards 
the papilla tip as it does in the rat (Gregg et al, 1990a,b).
4.2.3.2 Twenty-four hour time point.
4.2.3.2.A 50 mg dose.
The interstitial matrix showed no changes in PAS, but intense pink 
Giemsa staining was observed throughout the papilla. In the papilla 
tip the collecting duct epithelial cells had slightly swollen 
cytoplasm which contained small PAS positive granules. The Pg 
proximal tubule brush border had a decreased staining intensity for 
PAS. There were no changes in the other histochemical stains.
4.2.3.2.B 100 mg dose.
The interstitial matrix was disrupted at the papilla tip as shown by 
decreased staining with both PAS and Giemsa. Interstitial cell nuclei 
were pyknotic and associated with polymorphonuclear leukocyte 
infiltration (Figure 4.29). Capillaries in the papilla tip had 
adherent platelet and numerous erythrocyte thrombi. Swollen 
collecting duct cells contained basophilic and eosinophilic staining 
granules which were PAS positive (Figure 4.30). Loops of Henle in the 
mid-papilla region contained proteinaceous casts which were also PAS 
positive. The P2 brush border was necrotic with variable alk. phos. 
staining.
4.2.3.2.C 200 mg dose.
All of the changes described for the 100 mg dose were observed with
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Figure 4.29. Pyknotic interstitial cell nuclei and polymorphonuclear 
leukocytes in interstitial matrix (arrow), 24 hr after 100 mg/kg
BEA. Giemsa x 543.
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Figure 4.30. swollen collecting duct epithelial cells contain PAS 
positive staining granules in cytoplasm (arrow), 24 hr after 100 
mg/kg BEA. PAS x 868.
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the following additions. The luminal membrane of collecting duct 
epithelial cells was irregular and blebbing into the lumen, there was 
also adherent cellular debris within the lumen. There was vacuolation 
of the Pg cytoplasm and a decrease in alk. phos. brush border staining 
in all segments of the proximal tubule.
4.2.3.3 Forty-eight hour time point.
4.2.3.3.A 100 mg dose.
There was a loss of interstitial matrix staining at the papilla tip 
together with an increase in pyknotic interstitial cell nuclei 
throughout the papilla and the medulla. Numerous adherent platelets 
and erythrocytes were present in the capillaries (Figure 4.31). The 
collecting duct (medullary and cortical) contained numerous 
proteinaceous casts in the lumen, which stained positively for PAS, 
and similar casts were observed in the loops of Henle. The P2 
proximal tubule segment showed a loss of alk. phos and GGT staining 
from the brush border. Necrosis of the Pg proximal tubule segment was 
evident with cytoplasmic vacuolation, detachment of the brush border 
and extrusion of nuclei into the lumen (Figure 4.32).
4.2.3.3.B 200 mg dose.
There was progressive necrosis of many nephrons with extensive cast 
formation (Figure 4.33) in the papilla, medulla and cortex. Many of 
the changes for the 100 mg dose at 48 hr were also observed. 
Additional changes included dilatation of the collecting ducts in the 
mid-papilla region, which contained alk. phos. positive casts, as did 
the loops of Henle. The epithelium covering the papilla, together with 
the upper pelvic urothelium, was hyperplastic in the fornix region. 
Proximal tubular necrosis was more marked than at the 100 mg dose,
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Figure 4.31 Adherent platelets and erythrocytes in capillaries 
(arrow), 48 hr after 100 mg/kg BEA. Giemsa x 868.
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Figure 4.32 proximal tubular segment cytoplasmic vacuolation
and disrupted brush border (arrow), 48 hr after 100 mg/kg BEA.
Giemsa x 543.
Figure 4.33. Extensive cast formation in papilla and medulla, 
48 hr after 200 mg/kg BEA. Giemsa x 89.
Figure 4.34. Necrotic P^ with PAS positive cytoplasmic droplets and 
large basophilic droplets in lumen (arrow) , 48 hr after 200 mg/kg
BEA. PAS x 8 68.
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particularly in the Pg segment where PAS positive staining cytoplasmic 
granules were numerous (Figure 4.34). There was a loss of GGT brush 
border staining and large basophilic droplets within the lumen of Pg, 
collecting duct and loops of Henle in the medulla. The Pg segment 
showed extensive necrosis, but some evidence of re-epithelialisation 
was also present with flattened basophilic cells.
These cells exhibited increased alk. phos. staining intensity along 
the apical (brush border) membrane (Figure 4.35). In addition focal 
severe interstitial nephritis with thickened glomerular membrane and 
capsular membrane was observed. Adjacent tubules were atrophyic and 
surrounded by invasive monocytic cells.
4.2.3.4 Seventy-two hour time point
4.2.3.4.A 50 mg dose.
The interstitial cell matrix was granular where loss had occurred.
There were numerous polymorphonuclear leukocytes within the matrix 
space. Interstitial cell nuclei were pyknotic at the papilla tip. 
There was hyperplasia (up to 3 cells thick) of the epithelium 
covering the papilla tip, many of these cells contained PAS positive 
staining granules. The changes in the proximal tubule were restricted 
to variable alk. phos. and GGT staining along the brush border of the 
Pg and Pg segments.
4.2.3.4.B 100 mg dose.
The changes at this dose are almost identical to those described for
200 mg at 48 hr, this description will suffice.
4.2.3.4.C 200 mg dose.
Evidence of frank RPN was observed with the total loss of the
interstitial cell nuclei and matrix (Figure 4.36), denudation of the
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Figure 4.35. Re-epithelialisation of P2 segment with intense 
alkaline phosphatase staining of apical membrane (arrow), 48 hr
after 200 mg/kg BEA. Alkaline phosphastase x 543.
Figure 4.36. denudation of covering epithelium (arrow), total 
necrosis of tubular and interstitial elements of papilla, collecting 
duct and loop of Henle "ghosts" contain exfoliated cellular debris 
(arrowheads), 72 hr after 200 mg/kg BEA. Giemsa x 217.
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covering epithelium at the papilla tip (Figure 4.36), hyperplasia of 
the leading edge and numerous PAS positive granules in the cytoplasm. 
There was hyperplasia of the pelvic urothelium in the fornices with 
mitotic figures present in the pelvic urothelium opposite the papilla 
tip. All tubular elements of the cortex were necrotic with extensive 
cast formation (Figure 4.37) which stained positively for alk. phos., 
GGT and PAS. Some proximal tubular segments were re-epithelialising 
having a flattened epithelial cell (with intensely luminal staining 
for alk. phos. see Figure 4.38) the majority of proximal tubular 
segments were, however, necrotic with extensive cast formation 
exhibiting positive staining for alk. phos. and GGT. The cortical 
collecting duct cells had swollen pale staining cytoplasm, these 
tubules were extremely dilated with cellular debris, and PAS staining 
casts within their lumen (Figure 4.39).
Figure 4.37. Extensive necrosis and cast formation of cortical 
tubules, 72 hr after 200 mg/kg BEA. Giemsa x 543.
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Figure 4.38 Re-epithelialised proximal tubule segment has flattened 
cells with intense alkaline phosphatase staining on luminal 
membrane, 72 hr after 200 mg/kg BEA. Alkaline phosphatase stain x 
868 .
Figure 4.39 Hyperplasia of collecting duct (CD) in cortex, lumen 
contains intensely PAS positive staining casts. PAS x 217.
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4.3 MORPHOLOGICAL CHANGES IN MARMOSET KIDNEYS TREATED WITH BEA.
The reasons for using marmosets are briefly discussed in section 1.4.4 
and the methods in section 3.6.3.
4.3.1 Animal Dosed with BEA 50 mg/kg.
Marmosets do not have a true papilla as found in the rat but have a 
rounded papilla ridge. In this kidney after BEA (50 mg/kg) the papilla 
was intact with no gross morphological changes. The morphology of 
cortex and medulla was "normal" with no gross necrotic changes.
In the papilla a few interstitial cell nuclei were pyknotic in the 
papilla tip. The intensity of the interstitial cell matrix staining 
intensity was darker in the mid-medulla area, but was a paler, pink 
towards the papilla tip (as the volume of this matrix increased 
relative to the volume of tubular elements). The collecting duct 
cells were cuboidal in medulla becoming columnar in papilla tip, a few 
cells had swollen nuclei and cell cytoplasm. A few loops of Henle 
had basophilic casts which had some mineralised deposits, together 
with crystalline deposits (shown by darkfield microscopy) in the 
lumen. The covering epithelium of the papilla was betwen 1-3 cells 
thick with variable cytoplasmic and nuclear staining, the occasional 
cytoplasmic vacuolation and sloughing cell. Superficial cells were 
covered with a prominent pink glycocalyx layer in several areas which 
was blebbing into the pelvic space.
The morphology of pelvic urothelium was very similar to the papilla 
covering epithelium increasing to 4 cells thick with variable 
basophilic and eosinophilic cellular staining with Giemsa stain.
4.3.2 Animal Dosed with 100 mg/kg.
As with results described in section 4.3.2 the morphology of cortex 
was "normal" with no gross necrotic change. The papilla ridge was
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intact with areas of interstitial cell matrix disruption and nuclei 
pyknosis. The most prominent change was a hyperplasia of the covering 
epithelium of the papilla (to 7 cells thick, see Figure 4.40) some 
cells were vacuolated with extremely basophilic nuclei and others 
had eosinophilic cytoplasmic staining with a loss of glycocalyx from 
cell surface (Figure 4.41) . The pelvic urothelium was also
hyperplastic with eosinophilic staining granules in large vacuolated 
cells. Basophilic casts were present in the loop of Henle (Figure 
4.41), together with large numbers of erythrocytes and platelets in 
capillaries. All these changes suggest the presence of an early RPN 
due to BEA similar to that in the rat, but far less severe 
considering the duration of the experiment was 48 hr.
Figure 4.40. Papilla of Marmoset 48 hr after a single ip dose of BEA 
(100 mg/kg), note hyperplastic covering epithelium (CE). Giemsa x 43.
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Figure 4.41. Hyperplastic covering epithelium (CE) shown above, 
note pale basophilic staining casts (arrow) in loop of Henle (LH) . 
Giemsa x 27 0.
4.4 CHEMICALLY INDUCED RPN IN THE PIG.
A number of the investigations (section 3.6.4) were performed on pigs 
were repeated due to the limitation of only being able to 4 animals in 
any single experiment because of a lack of pen space. It thus made 
sense to combine results from studies where the experimental protocol 
was similar.
4.4.1 Results from Studies 1 and 2: BEA-induced RPN in Pigs (6-7 
Months Old.
4.4.1.1 General observations
In study 1 neither animal given 50 mg/kg BEA showed any signs of dis­
tress, but those receiving 100 mg/kg had an emetic response 15 min 
after recovering from the anaesthetic. This lasted for several hours,
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and 1 animal died (from unknown causes) approximately 24 hr later. In 
study 2 despite the administration of an anti-emetic both animals 
still vomited a considerable number of times on recovering from the 
anaesthetisia. One animal died within 24 hr (from unknown causes) in 
the early hours of the morning and thus was not found until the next 
morning and the tissues had undergone too much autolytic changes for 
useful assessment of histopathological changes. The remaining animal 
survived up to sacrifice (14 days later) with no apparent clinical 
effects as a consequence of the BEA.
4.4.1.2. Macroscopic changes
There were prominent casts in the medullary rays, and dark areas at 
the papilla tips from which the epithelium covering had exfoliated in 
pigs given the high dose (Figure 4.42). There were no apparent 
pronounced changes in the pigs given 50 mg/kg BEA. In study 2 there 
was, however, no gross exfoliation of the covering epithelium.
4.4.1.3 Microscopic changes
In both studies morphological changes that were associated with the 
onset of early RPN were present after dosing with 50 and 100 mg/kg 
BEA. These included disruption of interstitial matrix (Figure 4.43), 
focal interstitial cell necrosis (Figure 4.44) exfoliation of the 
papilla covering epithelium and necrosis of collecting duct epithelial 
cells (Figure 4.45). These changes were more pronounced in the 
animals given 100 mg/kg BEA. In the single animal which was 
sacrificed at 14 days after dosing with 100 mg/kg BEA had some changes 
which were not apparent in the animal killed at 7 days. There was 
hyperplasia of the pelvic/calyceal urothelium which had a vacuolated 
superficial layer with amorphous material erupting from the distended
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Figure 4.42. Papilla tip, 7 days after single iv dose BEA 100 mg/kg 
showing exfoliated covering epithelium exposing underlying capillary 
bed and interstitium. x 5 approximately.
Figure 4.43. Papilla tip from pig kidney 7 days after single iv 
dose BEA (100 mg/kg) showing disruption of interstitial matrix 
(arrow) with a decrease in 'pink' Giemsa staining. Giemsa x 223.
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Figure 4.44. Focal interstitial cell necrosis (arrowheads) 
together with disrupted interstitial matrix (*), 7 days after
single iv dose of BEA (100 mg/kg), Giemsa x 714.
Figure 4.45 Focal interstitial cell necrosis (arrow) and necrotic 
collecting duct epithelial cells (CD) in papilla, 7 days after 
single iv dose BEA (100 mg/kg), Giemsa x 714.
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cells. Many collecting duct profiles were hyperplastic with basophilic 
cells having nuclei of variable shape and size together with mitotic 
figures present. There were also areas of microhaemorhaging within 
the interstitial matrix. Fixed frozen sections showed an intense 
deposit of lipid material in the papilla covering epithelium in
control tissues, but lipid droplets were absent in the renal medullary 
interstitial cells with Oil red 0. The early RPN diagnosis was
confirmed by Oil red 0 staining showing the presence of lipid droplets
in the collecting duct epithelium in the 100 mg/kg treated group
(Figure 4.46) .
Figure 4.46 Fixed frozen section of papilla 7 days after single iv 
dose of BEA 100 mg/kg showing Oil red O stained lipid in collecting 
duct (arrow) and covering epithelium cells. Oil red 0 x 223.
4.4.2. Results from studies 3 and 4: BEA and NaNPAA-induced RPN in
young pigs.
The justification in not combining the results with those of studies 1 
and 2 is that the animals used in this study were younger (14 weeks 
old compared to 28-32 weeks) for the animals reported above.
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4.4.2.1 General observations.
Four of the animals in the studies were dosed with BEA; two received 
two doses of 50 mg/kg and two received a single dose of 100 mg/kg. 
Again one of the high dose BEA animals died within 24 hrs of receiving 
the dose from unknown causes after a period of sustained vomiting. 
Four animals were dosed with NaNPAA; two received 1.0 mmol/kg dose and 
two received 0.5 mmol/kg dose. One of the animals which received the 
high dose of NaNPAA died almost immediately. The animals which died 
had too much autolytic changes to consider worthwhile assessing 
because they died during the night and were not found until morning. 
The animals which were given NaNPAA over an extended infusion period 
of 30 min survived with no observable ill effects for the duration of 
the experiment.
4.4.2.2 Microscopic changes.
4.4.2.2.A Control results
In the single control animal available in these studies there were no 
obvious abnormalities with regard to tissue and cellular morphology. 
Giemsa staining of the interstitial matrix was uniform and not 
disrupted although there was the occassional aggregation of 
interstitial nuclei (Figure 4.47).
Collecting duct cells were usually columnar with basally located 
rounded nuclei and at the papilla tip contained apical and basally 
located PAS positive staining granules. These granules were also 
present in pelvic calyceal and ureteric urothelia and in the covering 
epithelium. Occassionally vacuoles were observed within the apical 
region of the superficial layer of pelvic calyceal cells. These 
vacuoles contained PAS positive staining material.
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Figure 4.47. Control papilla showing uniform staining interstitial
matrix and occasional aggregate of interstitial cell nuclei 
(arrowhead), Giemsa x 89.
4.4.2.2.B Treated group results.
Overall changes supported a RPN lesion or interstitial cell nephritis, 
particularly because of interstitial cell proliferation, collecting 
duct epithelial cell hyperplasia, thick ascending limb necrosis and 
hyerplasia of the pelvic/calyceal and ureteric urothelium with 
vacuolation and mitotic figures present throughout many of the tubular 
cells in the papilla and medulla. Changes observed were very similar 
to previous experiments using BEA reported above section 4.4.1.3.
There appears to be little difference between the morphological 
changes in the lesions produced by the BEA or NaNPAA compounds. Any 
inter-section differences were not due to the different populations of 
papillae in kidney ie polar or mid zonal.
The most prominent changes occurred in collecting duct epithelial
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cells usually in region midway down length of the papilla where 
hyperplasia and dysplasia of these cells was often evident. The 
nuclei exhibited variable shapes and frequently intense basophilic 
staining and shrunken or undergoing mitosis (Figure 4.48). The 
hyperplasia was of a low papilloma type pattern with small clumps 
cells protruding into the lumen which was often entirely occluded 
(Figure 4.49). Frequently there were aggregates of proliferating 
interstitial cells (or monocytic leukocytes) adjacent to the 
hyperplastic collecting ducts cells, often to the extent that it was 
difficult to differentiate between these aggregates and the collecting 
duct epithelial cells.
In addition to these prominent changes Other morphological 
abnormalities included enlarged, lobulated nuclei with basophilic 
cytoplasmic staining in urothelia covering papilla and calyceal which 
also frequently had blebbing or vacuolated superficial cells which 
were PAS positive staining (Figure 4.50).
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Figure 4.48. Hyperplasia and dysplasia of collecting duct (CD) 
epithelial cells with mitotic figures present (arrowheads) 7 days after 
BEA or NaNPAA. H&E x 446.
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Figure 4.49. Hyperplasia in collecting ducts (CD) cells form a low 
papilloma clump pattern (arrowheads), H&E x 89.
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Figure 4.50. Pelvic calyceal epithelium (PE) with vacuolated 
blebbing, superficial layer cells which are also PAS positive 
(arrowheads). PAS x 357.
PAS positive granules evident in distal papilla collecting duct 
epithelial cells. In the loops of Henle (thick ascending portion) the
basophilic staining, condensed cell nuclei were frequently displaced 
to the luminal apical region of the cell and/or exfoliating into the 
lumen.
4.4.3 Study 5: Effects of Superimposed Paracetamol Dosing on an
Already Existing RPN.
Since renal size, weight and function increase with age in the pig up
to approximately 1 year of age, the experimental results were also
compared with those obtained for age-matched historical controls.
4.4.3.1 Renal function.
4.4.3.1.A Glomerular filtration rate (GFR).
The percentage changes in GFR for each experimental group, compared 
with the pooled mean pretreatment value, as shown in Figure 4.51. All
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groups showed an increase in GFR after 24 days, the largest increase 
occurring in the control pigs.
4.4.3.1.B Effective renal plasma flow (ERPF).
These data were plotted for trend with individual values at day 0 
(prior to treatment) and at day 26 of the study (Figure 4.52) . In both 
the BEA/paracetamol and BEA only treated groups there is a trend for 
an increase in ERPF value with the final values falling outside the 
95% confidence limits for historical control data.
4.4.3.1.C Ultrasound assessment.
There was no obvious significant differences in any of the data (not 
shown) obtained from the ultrasound scan measurements in any of the 
groups.
4.4.3.2 Gross pathology: kidney weight and body weight data.
Figure 4.53a illustrates the mean body weight values for all groups. 
Although the mean values for treated groups were significantly greater 
than that observed in controls, all values were within the 95% 
confidence limits obtained from historical control data. Thus there 
was no significant difference in the extent of the increase in body 
weight between the groups.
The mean kidney weight values are shown in Figure 4.53b. Only the 
paracetamol treated group was significantly different from the 
experimental control value; it also lay outside the 95% confidence 
limits for historical control data. When expressed as a fraction of 
the body weight (Figure 4.53c) this value fell within the 95% 
confidence limits for historical control data and thus there was no 
significant difference between any of the mean group values.
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Figure 4.51. Mean GFR values at day 26 expressed as a percentage 
compared to the pooled mean GFR pretreatment values at day 0.
BEA = 2-bromoethanamine, APAP = paracetamol.
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Figure 4.52. Individual ERPF values plotted for trend at day 0 and 
day 26. BEA = 2-bromoethanamine, APAP = paracetamol.
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Figures 4.53a-c. illustrate: a) the mean body weight values, b) the 
mean kidney weight values and c) the mean kidney weight/ body weight 
values. BEA *= 2-bromoethanamine, PARA = paracetamol.
212
4.4.3.3 Histopathological results.
The papillae from the kidneys of BEA and BEA/paracetamol treated 
animals showed similar changes: hyperplasia with blebbing of covering
epithelium, some pyknotic interstitial cell nuclei and slightly 
disrupted interstitial cell matrix (Figure 4.54) compared to control 
papillae (Figure 4.55). There were also pyknotic, exfoliating nuclei 
within the thick ascending loop of Henle (Figure 4.56). The most 
obvious morphological change in the papillae from BEA and 
BEA/paracetamol treated animals was an extensive hyperplasia of the 
pelvic calyceal and ureteric urothelium with vacuolation and blebbing 
of the superficial cells (Figure 4.57), compare with control pelvic 
calyceal urothelium (Figure 4.58). Both Giemsa and PAS stains 
highlight the carbohydrate nature of the substance within these 
vacuoles and cells. Similar but less severe changes were also observed 
in the bladder urothelium. There were no necrotic changes in the 
paracetamol only treated animals, but some dilatation of the kidney 
tubules were seen (Figure 4.59), the urothelia was no different from 
that in controls.
4.5 HUMAN ANALGESIC ABUSERS.
4.5.1 General Commenta.
The information obtained from the clinical histories told us that the 
few human tissue samples provided by Dr Anke Schwarz came from 
typical analgesic abusers. All the patients were women aged between 
50 and 63 yr (mean 62.25 yr) who had each had a history of analgesic 
abuse with the period of consumption (of mixed analgesic compounds) 
ranging from 8-30 yr. Typically patients denied abuse and continued 
even when previous medical treatment had been necessary (unilateral
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Figure 4.54. Papilla tip from BEA only treated animal with
hyperplastic, blebbing, covering epithelium (arrow), pyknotic
interstitial cell nuclei and disrupted interstitial matrix. Giemsa 
x 178.
Figure 4.55. Papilla tip from control animal shows normal appearance 
of covering epithelium (CE) and interstitial matrix (*), Giemsa x 
178 .
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Figure 4.56. Pyknotic, exfoliating nuclei (arrow) in thick 
ascending limb of Henle from BEA treated animal. Giemsa x 446.
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Figure 4.57. Extensive hyperplasia of pelvic calyceal urothelium 
with vacuoles containing granular or amorphous mucopolysaccharide 
material, from a BEA/paracetamol treated animal. Giemsa x 357.
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Figure 4.58 Pelvic calyceal urothelium from control animal, Giemsa 
x 357.
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Figure 4.59 Dilated juxtamedullary glomeruli and adjacent tubules 
from paracetamol only treated animal. Giemsa x 446.
nephrectomy) because of the condition. All patients displayed typical 
syptoms of analgesic nephropathy: shrunken kidneys, calcified
papillae, recurrent urinary tract infection, and clinical evidence of 
progressive renal insufficiency. Hemodialysis had been required by 
all the patients (one for a period of 10 yr) , 2 patients were still
receiving hemodialysis, illustrating the long-term economic cost to 
health services of analgesic nephropathy. 2 patients had urothelial 
carcinoma of the renal pelvis and ureter.
4.5.2 Histopathological Changes.
Histologically the tissues showed many changes associated with 
advanced analgesic nephropathy as described by Burry et al, (1977) . 
Tissues were often so shrunken and covered in fat that it was hard to 
believe that the tissue did actually represent a kidney. Papillary 
necrosis was evident with total loss of tissue integrity in the 
papilla (when present) with many casts, adherent platelets in the
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capillaries (Figure 4.60). There was a lot of fibrosis and sclerosis 
of the medullary and cortical tissue and atropy which is associated 
with a chronic interstitial nephritis. There were thickened basement 
membranes around the distal tubules and collecting ducts in medulla, 
and atypical basophilic nuclei in these nephron segments too (Figure 
4.61). In the cortex there were numerous sclerotic glomeruli and 
aggregates of monocytic leukocytes (Figure 4.62). Although no 
urothelial carcinoma of the pelvis or ureter was observed in these 
samples this may have been because the pathologists in Germany removed 
most of these lesions for their own histopathological samples (Dr Anke 
Schwarz, personal communication). However, hyperplastic blebbing 
covering epithelium of the papilla was observed (Figure 4.63) which 
was atypical, frequently sloughing, though this may have been an 
autolytic artefact.
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Figure 4.60 showing adherent platelets in capillaries within papilla 
from the kidney of an analgesic abuser, Giemsa x 357.
Figure 4.61 Thickened basement membrane (arrowhead) around distal 
tubule and atypical basophilic nuclei in collecting duct (CD) in 
medulla from kidney of an analgesic abuser. Giemsa x 357.
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Figure 4.62. Interstitial nephritis in the cortex of kidney from an 
analgesic abuser. Note sclerotic glomeruli (arrowheads), tubular 
atrophy and aggregates of monocytic leukocytes (arrow), Giemsa x 
357.
Figure 4.63. hyperplastic, blebbing, covering epithelium of papilla 
from kidney of an analgesic abuser, Giemsa x 357.
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4.6 DISCUSSION OF CHEMICALLY INDUCED RPN INVESTIGATIONS.
4.6.1 Rat: Morphology and Enzyme Histochemistry.
In this study, the detailed sequence of morphological changes 
associated with a BEA-induced RPN in male Wistar rats has been 
assessed. High resolution microscopy using lum glycolmethacrylate 
embedded tissue (sections 4.1.1-4.1.1.6) identified the earliest cells 
to show degenerative changes, the cascade of injury during the 
development of RPN, the role of microvascular integrity, and changes 
in the carbohydrate containing components in different parts of the 
kidney.
Histochemistry provides a sensitive means of detecting subtle changes 
in cells following chemical insult. It is therefore a powerful tool 
to study the progression of a model lesion in the kidney and to 
develop a more rational understanding of the sequence of 
pathophysiological changes that lead from a primary (and often focal) 
injury to the final advanced (and possibly end stage) nephropathy. 
Relatively little is known about the histochemical changes that are 
associated with the genesis of analgesic-related renal papillary 
necrosis in man (Bach & Bridges, 1985)
The data reported in this study (section 4.1.1) clearly illustrate 
that the renal medullary interstitial cells undergo the earliest 
degenerative changes in rats. They are also the first cell type in 
which necrosis was clearly established. This confirms earlier 
studies using BEA (Hill et al, 1972; Bach et al, 1983), and supports 
similar changes for RPN induced by aspirin (Molland, 1976, 1978), and 
N-phenylanthranilic acid (Hardy & Bach, 1984). This suggests that the 
basis of papillotoxicity caused by three different classes of 
chemicals resides in the biochemical characteristics of the medullary
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interstitial cells. It does not, however, explain the failure of 
Hill et al, (1972) and Murray et al, (1972) to observe similar 
changes. Other differences in morphological changes following BEA
have been reported between female Hooded rats (Hill et al, 1972; 
Murray et al, 1972) and male Wistar rats (Bach et al, 1983; Gregg et 
al, 1990a,b). Renal medullary interstitial cell necrosis and 
medullary matrix changes were early targets in the development of the 
lesion in male Wistar rats (Bach et al, 1983; Gregg et al, 1990a). 
Most of the changes in female Hooded rats were reported in terms of 
simultaneous tubule and blood vessel degeneration at the light (Murray 
et al, 1972) and ultrastructural levels (Hill et al, 1972) . These 
authors did not report matrix changes.
The data reported in this thesis (section 4.1.1) confirm earlier
investigations (Bach et al, 1983; Mattingley et al, 1985) in which the 
mucopolysaccharide matrix first showed an increased, followed by a 
loss of, staining intensity in those areas where necrosis had 
occurred. Similar matrix changes have been reported in animals
following aspirin-induced RPN (Molland, 1976, 1978) and treatment with 
BEA (Bach et al, 1983; Gregg et al, 1989a). The present study made use 
of a calcium containing fixative, which helps to prevent the leaching 
of extracellular mucopolysaccharide matrix (Horobin, 1982), and used 
both Giemsa and PAS staining, each of which interact with
carbohydrate moieties, rather than binding or interacting with highly 
charged groups (-SO  ^ or -COO-) previously shown by colloidal iron and 
Toluidine blue (Bach et al, 1983) . Thus the medullary
mucopolysaccharide undergoes an early perturbation, although the 
exact chemical changes (loss of matrix or binding sites), conformation
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or structural changes of the proteoglycan/glycosaminoglycan material 
still require full evaluation. Recent studies (Bach & Lu,
unpublished observation) have suggested that the matrix undergoes 
desulphation and depolymerisation following BEA administration. 
Uronic acid-containing substances are excreted in the urine of rats 
treated with BEA (Ding et al, 1989) . The time course of this 
excretion parallels the histochemical changes observed in this study 
(section 4.1.1). These substances could represent degradation 
products derived from the glycosaminoglycan; hylauronic acid. This 
has been reported to be the dominant glycosaminglycans present in the 
interstitial matrix of the rat (Pitcock et al, 1988), with an 
important physiological roles in the maintanence of the anatomical 
integrity of the tubular elements in the papilla and water 
reabsorption (Pitcock et al, 1988). Such changes in the hylauronic 
acid component of the interstitial matrix could drastically alter the 
micro-environment of the medullary nephron and lead to changes in 
renal function, with cell degeneration and/or death. It was not 
possible, from light microscopic data, to be certain if the matrix 
changes are a consequence or the cause of interstitial cell 
degeneration, or if a chemical effect on the collecting duct cells 
plays a role in these mucopolysaccharide changes. Some studies have 
shown an increase (Burry, 1978; Burry et al, 1977) or a decrease 
(Gloor, 1978) in the medullary mucopolysaccharide matrix staining in 
analgesic abusers. But it is not possible to say this represents 
early and late changes as is the case in animals.
It has been suggested that RPN might be a consequence of ischaemic 
infarction or that microvascular degeneration could be integral 
component in the pathogenesis of the lesion (Rosner, 197 6; Shelley,
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1978). High resolution microscopy (section 4.1.1) in this study 
showed that platelet adhesion did not occur before 12 hr, at which
time the medullary interstitial cell necrosis was advanced. Hill et 
al (1972) also reported that microvascular occlusion developed late in 
the genesis of RPN. Previous studies in the acutely induced lesion 
(Bach et al, 1983) showed that colloidal carbon filled the medullary 
microvascular regions in which necrosis had already occurred. 
Colloidal carbon only demonstrates the pattern of vascular filling and 
cannot provide data on endothelial changes that would result in the 
leakage of material into the matrix. Monastral blue B has been used 
by Joris et al, (1982) to show leaky capillaries that were associated 
with inflammatory changes. Monastral blue filled medullary
capillaries in all areas where BEA-induced necrosis had occurred and 
it was also compartmentalised to the medullary microvasculature with 
no evidence of extravasation before necrosis was extensive. This 
established the absence of early microvascular occlusion and/or 
leakage of plasma material during the development of the papillary
lesion. Taken together these data serve to confirm that the 
endothelial changes in an acutely induced RPN represent a consequence 
of papillary necrosis, and do not play a preliminary role in the 
development of the lesion.
The use of fixed, glycolmethacrylate embedded sections to study a 
series of renal enzyme markers allowed a comparison of the results 
from the investigations reported here (section 4.1.1) with those of
Hill et al, (1972) and obtain other information on the development of
the lesion, and changes in the proximal tubule.
Hill et al, (1972) studied both lactate dehydrogenase and ATPase in
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frozen, freeze-dried 4um section from rats treated with BEA. They 
reported a transient loss of ATPase from the vasa recta and the loss 
of lactate dehydrogenase from the papilla tip. Whereas an increase in 
ATPase staining in the interstitial cells at the papilla tip was 
observed. These apparent differences in observations may be due to 
the different methodologies used. However none of these changes could 
be related to the pathogenesis of the primary lesion or ,to its 
secondary consequences because there were too few time points. There 
are differences in the morphological course of the BEA-induced lesion 
described by in this thesis compared to that reported by Heptinstall 
and co-workers (Hill et al, 1972; Murray et al, 1972; Wyllie et al, 
1972). Early cortical proximal tubular hydropic changes are
transient (Bach et al, 1983; Gregg et al, 1990a), but the deposition 
of tubular casts, first in the ducts of Bellini and later in the 
medullary collecting ducts, appears to play a prominent role in the 
development of distal tubule dilatation and, later, the dilatation of 
the proximal tubule (Gregg et al, 1990a). Repair between the 
junction of the necrosed and still viable tissue was very active at 18 
hr, and the presence of substantial macrophage invasion was expected 
on the basis of their participation in both the inflammatory response 
and repair processes initiated by cellular damage (Vernon-Booth, 
1972) .
The loss of proximal tubular brush border marker enzymes at 12 hr 
(section 4.1.1) shows that these changes occur relatively late in the 
development of the lesion, considering that the matrix changes 
occurred as early as 2-4 hr after BEA (Bach et al, 1983; Gregg et al, 
1990a,b) and the interstitial cells showed frank degeneration at 8 hr 
(Gregg et al, 1990a). Thus it is unlikely that proximal tubular
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changes play any role in the primary development of RPN. More 
importantly, routine morphology (eg. H&E staining) of the proximal 
tubule using 5 urn wax embedded sections only shows mild and transient 
hydropic changes (Bach et al, 1983). The data from this study 
described above do not make it possible to be certain if the loss of 
proximal tubular marker enzymes represents subtle BEA-associated 
cellular injury to this part of the nephron, damage to the glomeruli 
leading to a protein overloading of the proximal tubular cells, or if 
the brush border changes resulted from the diuresis that follows early 
papillary injury (Fuwa & Waugh, 1968; Sabatini et al, 1984; Wilks et 
al, 1986). It does, however, establish that the presence of enzyme 
activity in casts from 12 hr represents a consequence of the loss of 
the brush border from the proximal tubule. An enzymuria has been 
shown to be sustained for up to 7 days after an acute BEA-induced RPN 
(Saw, 1988; Delacruz et al, 1989), but the loss of brush border 
enzymes (alkaline phosphatase and GGT, see section 4.1.1) seemed occur 
as a consequence of RPN. The casts also contain cellular debris. 
The sequential dilatation of the distal and then proximal tubules 
suggests that material in the collecting ducts did, in fact, 
contribute to the cystic changes that occurred in the nephron, but 
other factors may be involved. A transient albinuria has been 
reported after BEA-induced RPN (Moret et al, 1989), it has been 
suggested that this represents an effect on the glomerular 
permselectivity by BEA (possibly by the cationic BEA neutralising 
polyanions), which could exacerbate the loss of brush border enzymes 
and cast formation.
The development of upper urothelial hyperplasia shortly after the
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first definite signs of papillary necrosis suggested that these 
proliferative changes occurred subsequent to the development of the 
medullary lesion. Repair of the damaged papillary urothelium appears 
to be a marked and prolonged process. More importantly, there is 
also an increase in urothelial proliferation in the pelvis opposite 
the region of necrosis and also in the ureter, as assessed by the 
increase in cell layer thickness. There was a distinct pattern of 
proliferative change in the upper urothelium following BEA 
administration. The epithelium covering the papilla tip showed a 
mild proliferation before it was lost. Subsequently, there were 
marked ■ epithelial cell hyperplasias in the pelvis, the fornix and 
especially the ureter. It was only at 144 hr that mild
proliferative changes were first seen in the bladder.
3 . .Using continuous infusion of H-thymidine and autoradiography, 
Mattingley and co-workers have investigate the proliferative response 
in the different regions of the pelvis and ureter after a BEA-induced 
RPN (Mattingley et al, 1990). Compared to the baseline cell turnover 
rate there was a 2-3 fold increase in all the areas of the urothelium 
144 hr after BEA, except for the collecting duct (8-fold) and the 
pelvic fornix (16-fold). The most active regions of cell 
proliferation after BEA were the collecing duct, pelvic fornix, pelvic 
urothelia (opposite the papilla tip and margin of the papillary 
injury) and the origin of the ureter. These data show that the 
urothelia of the upper urinary tract is very responsive to an acutely 
induced RPN, particularly as assessed by this autoradiographic 
technique. The delayed development of urothelial changes for the 
first 24 hr after the necrosis of the papilla suggests that this 
urothelial hyperplasia may be a consequence of RPN. Bach (1981)
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reported a transient excretion of crystals (magnesium ammonium 
phospate) in the urine early after administration of BEA to male 
Wistar rats. These crystals could cause a mechanical injury to the 
urothelium resulting the hyperplastic response. It is known that 
mechanical injury by foreign bodies including crystals can stimulate 
hyperplasia in the urothelium (Mobley et al, 1966).
It is generally agreed that there is a progressive inter-relationship 
between hyperplasia, dysplasia and malignancy (Farber & Sporn, 1976; 
Cohen, 1983) . The study reported in this thesis appears to be the 
first that has examined the changes in the renal pelvis and upper 
ureter following an acutely induced RPN. The very marked pelvic and 
upper ureteric response to an acute RPN in the absence of a major 
bladder change highlights the focal nature of the injury and the 
urothelial response.
More importantly, the hyperplastic cells show marked changes in enzyme 
histochemistry, with increased alkaline phosphatase staining (section
4.1.1). These changes were maintained, especially in those areas 
where the hyperplasia was most marked. There is a very high 
incidence of UUC in human analgesic abusers (Bach & Bridges, 1985) and 
hyperplasia is also common in the upper urothelial tract (Lomax-Smith 
& Seymour, 1980a,b; Blohme & Johansson, 1981) . Although there is no 
proven "cause-and-effeet" between RPN and upper urothelial carcinoma, 
the development of bladder carcinoma has been well described in the 
experimental situation, where hyperplasia may be a prelude to 
malignancy (Hicks & Choweniac, 1978; Cohen, 1985; Ito & Fukushima,
1986). Hyperplastic bladder cells also show changes in histochemical 
profiles which include an increased loss of alkaline phosphatase and
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an increased staining for GGT (Kunze, 1979; Ozono et al, 1985). The 
absence of these two features from the hyperplastic urothelia
reported in these investigations suggests that the proliferative
changes that follow the BEA-induced lesion probably represents a 
repair of injured tissue (Shimamura & Bonk, 197 6; Bach et al, 1983)
rather than a pre-malignant change per se. This difference could
also be due to differences in methodology used to determine 
histochemical staining. j
It is difficult to explain the difference between the renal ATPase
changes recorded by Hill et al, (1972), and those reported in this
investigation, but the time-course differences in the morphological 
changes between the two studies have already been highlighted (Gregg
et al, 1990b) and may be due to strain differences in the rodents
used. The changes in the staining of ATPase and alkaline
phosphatase in the pelvic, ureter and bladder sub-urothelial 
capillaries in the present investigation were most marked. Similar 
changes in glomerular or proximal tubular injuries caused by other 
chemicals have not been observed (Kirby, Gregg and Bach, unpublished 
observation). The thickening of the ATPase stained areas, to the 
point where the lumen of the vessel was occluded, suggests that a 
capillary sclerosis had occurred. A microangiopathy with a
progressive narrowing of the capillaries due to basement membrane 
thickening and the deposit of lipid material, has been described in 
humans with RPN (Gloor, 1978; Mihatsch et al, 1979, 1984; Palvio et 
al, 1985). These changes are thought to be pathognomonic.in human 
analgesic abusers,, but have not been reported previously in animal 
models of RPN and therefore warrant further investigation.
In conclusion, the sequence of enzyme histochemical changes reported
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above supports the suggestion that the renal medullary interstitial 
cells and the mucopolysaccharide matrix are the earliest anatomical 
regions of the kidney to be affected by BEA. The fine elements of 
the medulla such as the loops of Henle and the endothelia also 
eventually undergo necrosis. Subsequently, the covering epithelium 
of the papilla and the collecting ducts are damaged. Once necrosis 
has developed there is a progressive accumulation of proteinaceous 
casts (that contain enzyme markers from the proximal tubule) within 
the loops of Henle and collecting ducts, that may lead to distal and 
then proximal tubular dilatation. The upper urothelium adjacent to 
the necrosed papilla undergoes changes from 24 hr. These include
hyperplasia and an increased alkaline phosphatase staining, which was 
maintained for 144 hr. From 18 hr the sub-urothelial microvasculature 
of the pelvis, ureter and bladder show increased final reaction 
products for ATPase and alkaline phosphatase changes that may be
indicative of a microangiopathy.
In view of the high incidence of upper urothelial carcinoma in human 
analgesic abusers (Bach & Bridges, 1985), the finding of hyperplasia 
following an acute lesion suggests that the upper urothelial tract has 
a high proliferative activity. This needs to be more fully
evaluated, but suggests that papillary necrosis may, in itself, be a 
process that could promote an already initiated urothelium. This 
concept has been addressed by a series of studies reported below - see 
chapter 5.
The intermediate and long-term changes reported (sections 4.1.2.1-
4.1.2.6) are similar to those reported by Axelsen (1978b) with re-
epithelialisation of, the papilla stump at 14-21 days. The time course
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of the re-epthelialisation and restoration of the interstitial matrix 
in the papilla stump parallels a functional return of concentrating 
ability (Saw, 1988). The progressive changes resulting in the 
development of a severe chronic interstitial nephritis with scarring 
of the cortical surface, infiltration of monocytic leukocytes, 
collapse of renal parenchymal tissue, atrophy of tubules, fibrosis, 
sclerosis and mineralisation of basement membranes (see sections 
4.1.2.1-4.1.2.6) mimics closely the long-term changes reported to 
occur in the clinical situation as a consequence of analgesic- 
associated RPN (Burry, 1968; Burry et al, 1977; Gloor, 1978) see 
section 2.1.2.3. These changes were also observed in the human renal 
tissue specimens obtained from analgesic abusers, provided by Dr A. 
Schwarz, see section 4.5.2. This provides further evidence for the 
suggestion that the BEA-induced acute RPN is a valid model for the 
chronic analgesic-associated RPN in that not only are the early 
pathological changes similar, but the long-term changes are almost 
identical.
4.6.2 Mouse: Different Strains.
A pilot study was performed prior to the main study to determine a 
suitable dose of BEA which caused a renal lesion at 24 hr. Four 
strains of mice were used; Schnider, Balb/c, C57B1/6 and CD1. Each 
group of mice (n=2) recieved either a 50 or 100 mg/Kg ip dose of BEA. 
The animals were sacrificed after 24 hr and the kidneys processed for 
histopathology (see section 3.4). The kidney sections were then 
graded for pathological changes indicative of RPN (see section 3.7, 
Table 3.4).
The order of sensitivity to BEA was Schnider > Balb/c > C57B1/6 with
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the CD1 mice having no RPN. Since Schnider mice had been used in 
previous studies with BEA (see section 3.6.2.1) it was decided to use 
the Balb/c and C57B1/6 strains in order to expand the data base on 
mouse strain response to BEA-induced nephrotoxicity. The absence of 
RPN in CD1 mice, is very interesting but has not been considered 
further and could form the basis of future studies. The Balb/c and 
C57B1/6 mice are both inbred strains which originated from stock 
established at the Jackson Laboratory (Bar Harbor, USA.) around 1947. 
The choice of Obese mice as the third strain was really due to their 
availability within the University and their susceptibility to obesity 
and diabetes. The Obese mice are a random bred strain originating 
from C57B1/6 mice found to carry a gene for obesity, ob/ob. In 1957 
some of these ob/ob or ob/+ C57B1/6 mice were imported to Edinburgh 
where they were crossed with 2 non-inbred strains maintained as closed 
colonies; JH and CRL, to obtain faster growth and larger litters 
(Flatt & Bailey, 1981). As this strain was random-bred not all 
individuals will carry the gene for obesity (eg ob/+ or ob/ob). This 
can only be determined when the animals are mature and grossly obese 
individuals can be differentiated from their litter mates.
Diabetics are prone to a number of nephropathies in the clinical 
situation including RPN. Therefore it was of interest to see whether 
this strain of mice with a genetic susceptibility for developing 
diabetes was more sensitive to the nephrotoxic effects of BEA. Also 
as the Obese mice are derived from a C57B1/6 strain originally, but 
have since been crossed with two other strains it was also 
interesting to determine if hybrid vigour made the Obese mouse less 
susceptible than the in-bred C57B1/6 mouse.
It is difficult to identify one strain which is more sensitive on the
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criteria of responding first as the earliest histological changes
occuring in all strains were very subtle and difficult to quantify.
However, in terms of continuing lesion development, cortical 
interaction and actual severity of the appearance of lesion then the 
C57B1/6 strain are the most sensitive (sections 4.2.2.4.B-4.2.2.4.1) . 
This strain showed greater intensity of necrotic changes than the 
Obese strain which showed a very similar pattern of lesion development 
up to the 24 hr timepoint. C57B1/6 mice showed the earliest cortical 
changes with hydropic Pg segment and disruption of the brush border. 
The time point when earliest definite morphological changes occurred
was 6 hr (section 4.2.2.4.C) with adherent platelets in the papilla,
PAS positive staining casts in the loop of Henle (possibly leakage of 
mucopolysaccharides from disrupted Pg segment brush border), pyknotic 
nuclei and increased interstitial cell matrix staining. The lesion in 
the Obese mice seemed to reach a plateau at 24/48 hr (section 
4.2.2.4.E) whereas the C57B1/6 mice continued to progress to give 
focal interstitial nephritis in the region of the juxtamedullary 
glomeruli and tubules (section 4.2.2.4.1) similar to those observed in 
the rat (see section 4.1.2.3-4.1.2.5). By 14 days (section 4.2.2.4.I) 
both Obese mice and Balb/c mice showed little difference from the 
control sections except the latter had focal interstitial nephritis 
which was not as pronounced as in the C57B1/6 strain.
Mice do not appear to be affected to the same degree as rats by BEA. 
Schnider mice showed changes associated with an intermediate RPN 
following doses of 150-200 mg/kg, but only 60 hr after the 
administration of BEA. The Wistar rat, in comparison, shows changes 
associated with intermediate RPN (see section 2.1.2.3) 8-18 hr after
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BEA at 100 mg/kg. Mice also have a definite cortical necrosis which 
is more pronounced than the rat and occurs prior to any gross necrosis 
of collecting duct, loops of Henle, covering epithelium etc which is 
the opposite of what is observed in the rat. The earliest changes are 
an increase in interstitial cell matrix staining and interstitial cell 
nuclei necrosis but usually in the upper papilla region rather than 
the papilla tip (C57B1/6 mice were an exception). Adherent platelets 
and erythrocytes to capillary endothelium appear before necrosis of 
other tubular elements in papilla which is different to the sequence 
of events in the rat. The BEA induced lesion progresses more 
generally in the mouse with no total necrosis of the collecting duct 
or denudation of the covering epithelium. There was no evidence of 
hyperplasia of the urothelium of the pelvis or ureter based on the 
criteria (Table 3.4) used for rats.
The most prominent early changes occurred at 24-48 hr with PAS 
positive granules present in collecting duct cells. These cells did 
not become necrotic which suggests the mouse has a better capacity to 
respond to metabolic changes than the rat, if indeed that is what 
these histological changes represent. There was a pronounced drop in 
urine osmolality within the first 6 hr after BEA, similar functional 
changes have been described in the rat as an early consequence of BEA 
(Wilks et al, 1986) .
Mice seem to be able to recover from doses of BEA up to 200 mg/kg 
perhaps because there does not seem to be the same degree of targeting 
for the papilla as in the rat. If BEA has a general nephrotoxic 
effect in the mouse kidney including the proximal tubule, then because 
of the greater concentration of xenobiotic metabolising enzymes (eg 
P-450) in the cortex the mouse is able to inactivate these toxins.
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Mice may have differing extrarenal or renal metabolism to the rat 
which could affect the response of the mouse to BEA. The favoured 
hypothesis of BEA-induced RPN is via a prostaglandin hydroperoxidase 
mediated peroxidation within the interstitial cells (Bach & Bridges, 
1984, 1985 and see Chapter 6-General Discussion). It could be that
differences in the medullary interstitial cells and the prostaglandin 
metabolism system between the mouse and rat may explain the 
differences observed.
Functional differences may also explain why the lack of a frank RPN 
lesion in mice. The C57B1/6 mice had the lowest mean control urine
osmolality value of all the mouse strains (see Table 4.2). Their
increased sensitivity to BEA would seem to provide evidence that the
concentration of toxins in the papilla is not the primary mechanism
for the initiation of RPN pathogenesis. This is in contrast to the 
findings of Sabatini et al, (1981) who found that concentrating 
capacity was essential to produce BEA toxicity. The low osmolality 
may represent a diuresis which has been reported to be a factor which 
can provide some protection against BEA toxicity (Sabatini, 1984). If 
concentrating capacity was an initiating factor for BEA toxicity in 
mice, one would have expected the Balb/c mice to be more sensitive to 
BEA since this strain had the highest osmolality and produced very 
little urine. This provides additional evidence that differences in 
the metabolism of rats and mice is a likely explanation for the 
observed differences or other factors may be involved.
C57B1/6 mice had the lowest kidney weight/body weight ratio value in 
control animals (Table 4.3). As dose is administered based on body 
weight, then C57B1/6 received a larger renal dose relative to their
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body weight than did the Balb/c or Obese mice (see Table 4.4).
Table 4.4: Renal dose for each strain calculated for 100 mg/kg BW in
a mouse of body weight 20 g.
Strain KW/BW ratio 
dose
(g/kg)
KW
(g)
Renal dose
(mg/g)
Adjusted
(mg/kg)
Balb/c 0.0177 0.354 282.48 100
Obese 0.0158 0.316 316.45 89
C57B1/6 0.0148 0.296 337.83 83
Renal dose* - dose of compound affecting kidney assuming 100% dose 
reaches kidney, KW/BW - kidney weight/body weight ratio.
Adjusted dose - dose required administered as a mg/kg BW dose to give 
equal renal dose.
Table 4.4, shows the order of renal dose received is C57B1/6 > Obese > 
Balb/c, which is also the order of sensitivity to BEA. Thus, 
effective renal dose may be a critical factor in strain sensitivity 
coupled with metabolic differences which account for the strain 
sensitivity order observed.
In future strain comparison experiments it may be appropriate to use 
historical control data for organ/body weight ratios to ensure that 
each strain receives the same effective organ dose (mg/g). This 
effective organ dose parameter assumes that 100% of administered dose 
reaches the target organ.
4.6.3 Nude Mouse.
The morphological changes in the medulla of the nude mouse closely 
parallel the development of RPN observed in the rat (Gregg et al, 
1990a) at 24 hr after 100 and 200 mg/kg doses of BEA. These included
236
the earliest changes in the interstitial matrix, as shown by slight 
increase in staining and the presence of PAS-positive inclusion bodies 
in the collecting duct epithelial cell cytoplasm. During the 48-72 hr 
period a spectrum of necrotic changes were observed in the tubular 
elements of the nude mouse papilla similar to these seen in rats dosed 
with BEA. The nude mouse is more sensitive to the toxicity of BEA 
than other murine strains (Scarlett et al, 1990). The necrotic 
changes in the medulla occur earlier and are more prominent than in 
the Obese, Balb/c or C57B1/6 mice. The nude mice develop frank 
necrosis within 48-72 hr, whereas the other strains we have studied do 
not develop a frank RPN and recover most signs of injury within 7-14 
days after BEA (Scarlett et al, 1990). Although there was no kidney 
weight/body weight data generated from this study, the effective 
renal dose argument discussed above (section 4.6.2) could be relevant 
to the greater sensitivity of the nude mouse to BEA than other mouse 
strains. If the kidney weight/body weight ratio for nude mice is less 
than those reported in other strains in this thesis (see Table 4.3) 
(implying that the nude mouse kidneys are small relative to body 
weight), then since dose is administered according to body weight 
these mice may have actually received a larger effective renal dose 
that the other strains.
The hyperplasia of the covering epithelium of the papilla and pelvic 
urothelium which developed was similar to that observed in rats 
treated with BEA (Gregg et al, 1990a) and N-phenylanthranilic acid 
(Hardy & Bach, 1984). No such hyperplasia has been observed in other 
mouse strains after BEA (Scarlett et al, 1990).
Gross necrosis similar to that reported in the rat, occurred primarily 
in the medulla/papilla followed by the cortex with the extreme papilla
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tip affected at a much later stage. Changes in the cortex included 
total segment necrosis followed by re-epithelialisation. The
proximal tubular necrosis and re-epithelialisation are similar to the 
pattern of necrosis observed after p-aminophenol (Davis et al, 1983) 
and hexachloro-1,3-butadiene administration to rats and mice (Ishmael 
et al, 1982; Lock et al, 1984). The cortical necrosis preceded the 
loss of covering epithelium and collecting duct epithelial cells in 
the papilla. All previous studies using several strains of rat (Bach 
& Bridges, 1985), conventional mouse strains (Bach, P H & Gregg, N J, 
unpublished data; Scarlett et al, 1990), the Hamster (Carlton & 
Englehardt, 1989) and pig (Gregg et al, 1989a) BEA caused a highly 
selective RPN and minimal early, transient cortical changes (Bach et 
al, 1983; Gregg et al, 1990a,b). However, high doses of BEA may cause 
secondary cortical degeneration which develop as an interstitial 
nephritis affecting the cortex 21 days or more after the initial 
insult (Axelsen, 1978b; Bach & Bridges, 1985; see section 4.1.2.3-
4.1.2.6). By far the most interesting aspect of this investigation 
was the novel observation that BEA causes cortical necrosis in nude 
mice. BEA has previously been considered to be totally target
selective for the medulla. Cortical changes in the rat (Bach et al,
1983; Gregg et al, 1990a) now appear to be a transient hydropic
degeneration associated with a proteinuria (largely albumin) (Moret et 
al, 1989) that could be due to BEA affecting the glomerular
permselectivity (discussed above, section 4.6.1).
The cortical necrosis in the nude mouse were evident prior to the 
onset of frank RPN (when loss of covering epithelium and collecting 
duct epithelial cell.necrosis occurs). This alteration of a generally
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accepted cascade of degenerative changes from papilla tip > medulla > 
cortex in the rat given BEA may be related to a unique characteristic 
of this mutant strain. The response of germ-free animals to chemicals 
is known to vary from conventional animals (Love et al, 1977; Sumi & 
Miyakawa, 1983). This raises the possibility that gut-flora pay a 
role in the target selectivity of BEA. This does not appear to be the 
case in rats where BEA causes a target selective medullary injury in 
both germ-free and conventional animals (Gregg, .NJ, Ward, FW, Coates, 
ME and Bach, PH, unpublished observation). There is no rational basis 
to suggest that the athymic nature and therefore incomplete immune 
system of the nude mouse is implicated in the development of this 
BEA-induced P2 and Pg proximal tubular necrosis. At present there is 
no data on the sensitivity of the parent MF1 mouse (from which this 
nude mouse strain was derived) to BEA. At present the atypical 
response of the nude mouse to BEA cannot be explained. It may, 
however, be due to differences in proximal tubule cell biochemistry, 
an understanding of which could help elucidate the mechanism of BEA 
toxicity and therefore the understanding the pathogenesis of RPN in 
general.
In conclusion, this is believed to be the first nephrotoxicity study 
in the nude mouse, where the need to keep them germ-free has 
probably precluded their widespread use. The data shows that BEA is 
not the specific papillotoxin reported in other species and strains 
investigated so far. This remarkable difference in the response of 
the nude mouse to BEA warrants further investigation to assess the 
mechanistic basis of the change, and the role of the incomplete or 
depressed immune system. Alternatively the germ-free nature of these 
mice may be central to the atypical lesion. The nude mouse may prove
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to be a novel species for investigating nephrotoxicity in those 
circumstances where the immune system is depressed or has been 
suppressed in the clinical situation by the use of immunosuppressant 
drugs such as Cyclosporin A.
4.6.4 Marmoset Results.
The small number of animals used in this study meant there was no 
control tissue available with which to compare the morphological 
changes observed. However the initial results would seem to suggest 
that (if these changes are real and reproducible) BEA does not induce 
a frank RPN in the marmoset as is the case in the rat at these doses. 
The pronounced hyperplasia of the covering epithelium of the papilla 
that was induced may be due to a direct toxic effect of BEA on the 
covering epithelial cells. The limited number of animals used does, 
however, make it presumptious to extrapolate this data. In a review 
on naturally occurring renal disease in non-human primates, Skelton- 
Stroud & Glaister, (1987) do not report any spontaneous hyperplasia of 
the covering epithelium or pelvic urothelium. Hyperplasia of these 
epithelia have been reported to occur in baboons with NSAID-induced 
RPN (Skelton-Stroud, 1987). In baboons the urothelium has been 
reported to have a pronounced capacity for proliferation which occurs 
in response to focal or widespread damage (Skelton-Stroud & Glaister,
1987) . If marmosets have a similar capacity and the hyperplasia 
which was observed after BEA treatment (section 4.3.2) is real then 
perhaps this is relevant to man. If a nephrotoxin which can induce an 
acute renal lesion can also induce a pronounced hyperplasia (as 
reported here in marmoset, rat and pig (sections 4.4.1.-4.4.3) in the 
urothelium lining the upper urinary tract, then this may provide the
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basis for subsequent carcinogenesis. This concept is discussed in 
detail below - see Chapters 5 and 6.
4.6.5 RPN Induced in the Pig.
4.6.5.1 BEA-induced RPN.
These studies showed that BEA is also papillotoxic in the pig, but it 
has less effect at low doses and is more systemically toxic than in 
the rat. The lesion in the pig is hot as pronounced as a comparable 
lesion in Wistar rat 7 days after treatment with 100 mg/kg BEA. 
However, the changes which were most pronounced in both groups were 
foci of necrotic interstitial cells together with disruption of the 
interstitial matrix (section 4.4.1.3). Similar.changes were found 
with NaNPAA (section 4.4.2.2.B) in the pig, this compound has also 
been observed to induce an acute RPN in the Wistar rat within 24 hr 
the morphology (or pathology) of which is essentially identical to 
that induced by BEA (Gregg N.J., 1987 unpublished observation). In
the rat the 'fine' anatomical elements are the earliest to show 
changes, which are apparent within 4-6 hr (section 4.1.1), and 
precede a cascade of necrotic changes which result in an acute RPN 
lesion. Since the same anatomical elements are primarily affected in 
the pig papilla after BEA, this suggests a similar cascade of necrosis 
occurs.
There were differences in the response of the pigs to BEA when 
comparing the older animals used in studies 1 & 2 (section 4.4.1) to 
the younger animals used in studies 3 & 4 (4.4.2). The older animals 
had more pronounced changes than the younger animals. The renal 
function of Large White pigs is not fully mature until approximately 
12 months of age (Robbins, 1984). If the renal function is still
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developing then one can also presume that the renal functional reserve 
is also developing. The young pigs may be able to adjust better to a 
toxic insult because the development of new functioning nephrons, and 
is therefore able to compensate for any nephrons which are affected 
functionally by nephrotoxins. Since age is known to be a risk factor 
in developing nephropathies (Porter, 1989) then future studies should 
use older functionally mature animals in order to extrapolate better 
the results to the clinical situation.
In the normal rat kidney the medullary interstitial cells stain for 
lipid (Bojesen, 1974), but once RPN has been induced there are marked 
lipid staining of endothelia, collecting duct and covering epithelial 
cells of the papilla (Bach & Gregg, 1988). By contrast the medullary 
interstitial cells of the control pig did not stain for lipid, but the 
covering epithelium did. Following BEA there was a substantially 
increased deposition of lipid material in the collecting duct 
epithelium (section 4.4.1.3). Since other nephrotoxins that do not 
affect the medulla (eg hexachlorobutadiene, aminoglycosides, 
cisplatin, Bach et al, 1987) do not produce this lipidosis in the 
collecting duct epithelium it has been suggested that this lipid 
deposition could be pathognomonic for RPN (Bach & Gregg, 1988) . The 
decreased effects of BEA on the pig medulla may be due to a number of 
causes. The multipapillate anatomy of the pig kidney may be less 
prone to the papillotoxic effects because BEA is not "concentrated" in 
a single papillae as it is in the rat, or because the urine 
concentrating capacity of the pig is less than that of the rat (Stolte 
& Alt, 1982). Alternatively, both the hepatic and renal metabolism of 
several chemicals differs in rats and pigs (Litterst et al, 1975;
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Shimada et al, 1986; Fujimori et al, 1986) . Thus more hepatic 
metabolism or biliary excretion of BEA by pigs could reduce its 
papillotoxicity. Interestingly, whereas lipid droplets predominate in 
the rat medullary interstitial cells they were not apparent in the 
pigs. Pigs are reported to have less long-chain poly-unsaturated 
fatty acids (to act as substrates for lipid peroxidation) within the 
interstitial cell lipid droplets (Bojesen, 1980). Thus if 
peroxidative metabolism and lipid peroxidation of poly-unsaturated 
lipid droplets is important in the pathogenesis of RPN (Bach & 
Bridges, 1984; Bach & Gregg, 1988), pigs would be less sensitive. 
These factors may account for the reduced severity of the renal lesion 
in the pig and serves to illustrate marked species differences in the 
renal handling of nephrotoxic compounds in the multipapillate kidney.
4.6.5.2 Paracetamol Study.
The results presented here indicate that treatment with BEA, 
paracetamol or BEA followed by paracetamol had no marked effect on the 
maturational increase in body weight, renal weight and size seen in 
immature pigs (section 4.4.3.3). These animals exhibit marked 
increases in renal size and function in their first year of life, by 
which time stable adult levels are reached (Robbins, 1984). Similarly 
drug treatment did not prevent the increase in glomerular filtration 
rate seen in age-matched controls (section 4.4.3.1.A). However, in 
those pigs treated with BEA or BEA followed by paracetamol, a 
significantly greater increase in effective renal plasma flow compared 
with that noted in age-matched controls was found (section 4.4.3.1.B). 
The addition of paracetamol to the BEA treatment did not increase the 
effective renal plasma flow over BEA alone (Figure 4.52). 
Prostaglandins are believed to be important vasoactive compounds in
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the control of renal haemodynamics, particularly when the kidney is 
traumatised (Clive & Stoff, 1984; Schlondorff, 198 6). The increase in 
effective renal plasma flow in the BEA and BEA/paracetamol treated 
animals may represent a response to a persisting injury of the kidney. 
Previous studies in the rat have shown an increased medullary blood 
flow early after BEA (Solez et al, 1974) , if a similar early change 
occurs in the pig, then this study shows that these haemodynamic 
changes are sustained. The major source of renal prostaglandin 
synthesis are the interstitial cells (Schlondorff, 1986), which have 
indeed been postulated to be the target cells for BEA-induced 
nephrotoxicity (Bach & Bridges, 1984, 1985). A subtle injury to the
interstitial cells by BEA (since no widespread frank necrosis was 
observed in this study, section 4.4.3.3), may produce a perturbation 
of prostaglandin metabolism. This could be an increased synthesis of 
prostaglandins or synthesis of a vasodilatory prostaglandin reflecting 
the sustained effective renal plasma flow observed.
The lack of any significant changes with the ultrasound technique 
could suggest the absence of pathological changes, but also 
illustrates the inherent weakness in this non-invasive technique. It 
is difficult to identify focal changes in renal morphology at an early 
stage in the development of a lesion by most non-invasive techniques. 
Hence, the need for histopathological examination which allows one to 
identify such focal changes and determine whether the changes are 
significant in terms of renal function and/or a potential indicator of 
progressive changes which may result in a severe lesion developing.
The most obvious histopathological changes occurred in the BEA and 
BEA/paracetamol treated groups: urothelial hyperplasia of the pelvis
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and ureter interstitial matrix changes, pyknotic interstitial cell 
nuclei and necrosis of the thick ascending limb.
It is clear that these, albeit preliminary, observations that the 
functional and histological changes were only present in the BEA and 
BEA/paracetamol treated groups. No such changes were observed with 
paracetamol alone, indicating that the above changes were solely due 
to BEA. Paracetamol, at this dose and duration of exposure does not 
enhance BEA-induced RPN in the pig. This is certainly at odds with 
what is seen in the rat; where treatment with paracetamol prior to and 
after BEA exacerbates the morphological changes within the RPN lesion 
(Bach & Gregg, 1988).
The prospective epidemiological study of Sandler et al, (198 9) 
indicates an increased risk of developing chronic renal disease with 
long-term daily use of paracetamol. These findings contrast the 
recent retrospective study of McCredie & Stewart (1988) who were 
unable to show an increased risk for developing analgesic nephropathy 
due to paracetamol consumption.
There has, however, been an impressive decline in end-stage-renal 
disease associated with analgesic abuse in Denmark, Finland, Sweden 
and Australia since legislation restricted access to phenacetin and 
paracetamol, see Table 4.5 (Schwarz, 1987; Kincaid-Smith, 1988). This 
decline probably provides the best indirect evidence for the 
implication of paracetamol in exacerbating role in the development of 
chronic renal disease. These data cannot differentiate between 
paracetamol and its consumption co-formulated with other analgesics 
and/or caffeine.
The results reported in this thesis show that the multipapillate pig 
kidney is not affected by paracetamol in the dose regimen used.
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Country Legislation and sign of decline of analgesic-associated 
nephropathy.
Denmark Prescription required for phenacetin and acetaminophen 
in 1961
9% decline in deaths due to chronic non-obstructive 
pyelonephritis at autopsy (1956-60 to 1961-65)
50% decline in RPN at autopsy (1959-1967)
2 6% decline in diagnosis of pyelonephritis in women at 
autopsy; men unchanged (1961-1967)
61% decline in RPN at autopsy (1961-65 to 1971-75)
71% decline (women) and 60% (men) in diagnosis of 
chronic interstitial nephritis (1961-1975)
Sweden Warning on drug packages with phenacetin and acetylsali- 
cyclic acid in 1957
Prescription required for phenacetin and acetaminophen 
in 1961
75% decline in uremia as cause of death among analgesic 
users (1962-1970)
75% decline of analgesic-associated nephropathy in 
renal transplant series (1965-69 to 1976-1979)
Finland Prescription required for phenacetin in 1962 
Phenacetin prohibited in 1965
94% decline of RPN and 54% decline of death due to 
kidney disease at autopsy (1962-1977)
Australia Gradual removal of phenacetin in pain medication 
between 1967 and 1975
33% decline of death due to kidney disease and 50% 
decline of death due to analgesic-associated 
nephropathy at autopsy (1964-1971)
Prescription required for mixtures of analgesics and 
for large packets of analgesics in 197 9
Canada Phenacetin combined with acetylsalicylic acid and its 
derivates prohibited in 1973
50% decline of analgesic-associated nephropathy in 
surveys of nephrologists (1971-1980)
Great Britain Phenacetin prohibited in 1980
Switzerland Prescription required for phenacetin and for acetamino­
phen in large packages in 1981
FR Germany^ Warning on packages of phenacetin in 1981 
Phenacetin prohibited in 1986
Netherlands Phenacetin prohibited in 1984
Table 4.5 Decline of kidney disease and signs of analgesic-associated 
nephropathy after phenacetin (and acetaminophen) restriction in 
several countries. From Schwarz, (1987) .
246
The pig kidney appears less sensitive to papillotoxic chemicals than 
the rat based on this and earlier studies (Gregg et al, 1989a). It 
has been suggested that paracetamol toxicity occurs via a mechanism 
which involves increased biotransformation via cytochrome-P450 oxida­
tion; together with a glutathione depletion this produces toxic 
metabolites which bind to cellular macromolecules (Siper & Gandolfi, 
1986). Pigs are, however, known to have a deficiency in the 
sulphation pathway (Jackoby, 1980) thus acetaminophen should be more 
toxic in this species. One possible explanation is that there is more 
extra-renal metabolism of the paracetamol in the pig which reduces the 
effect of paracetamol in the kidney. Although there is no information 
with regard to metabolism of paracetamol in the Large White pig/ 
Peggins et al, (1987) showed that the minipig kidney has large levels 
of glutathione and glutathione-S-transferase activity in the kidney 
compared with the liver. The medulla possesses 60-70% of the 
glutathione compared to the cortex. The apparent lack of paracetamol 
nephrotoxicity suggested in this study could reflect a protective 
effect of glutathione conjugation of all potential toxic metabolites 
thus preventing any toxic effects (Peggins et al, 1987). It is likely 
that the renal metabolism of paracetamol is similar in the Large White ' 
pig.
The similarity of the pig in terms of renal function and structure 
with that of man raises the important question of how relevant is the 
data obtained from those rodent studies when applied to papillary 
nephropathies. These findings highlight the need for further studies 
to ascertain the applicability of the pig as a suitable experimental 
model in which to study the pathogenesis of acutely and chronically 
induced RPN and extrapolate the data to the clinical situation.
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CHAPTER 5
RESULTS FROM CARCINOGENESIS STUDIES USING BBN INITIATION FOLLOWED BY 
BEA-INDUCED RPN
In studies 1-4 where the basic experimental protocol was the same (BBN 
initiation followed by BEA induction of an acute RPN), the results 
from the main experimental groups have been combined to produce a more 
detailed time course of pathological changes with larger numbers of 
animals. The justification for combining the results was judged on 
inter-study variation of results that were no greater than expected 
from studies on RPN and necessitated by the low numbers of animals 
used at the different time points in each of the four studies. The 
results for the BEA only control groups for the relevant time points 
have already been described above - see section 4.2.
The results for various pilot studies performed to try and enhance the 
severity and frequency of urothelial changes are presented separately 
(sections 5.3, 5.4.1).
5.1 UROTHELIAL MORPHOLOGY CHANGES UP TO SIX WEEKS
5.1.1 Up to One Week Time Point.
In the first study (see section 3.5.5) animals were sacrificed at 1, 
2, 3 and 4 days post-BEA dosing to determine the effects, if any, of
BBN on the known urothelial hyperplastic and degenerative changes due 
to RPN (see section 4.1). The pathology changes in the kidney, 
bladder and ureter tissues was assessed and it was concluded that no 
changes other than an acute RPN had occurred in the BBN initiated/BEA 
treated animals. These were the same as in BEA only treated animals 
(section 4.1.1). The appearance of kidneys from BBN only treated 
animals did not differ significantly from the kidneys of control
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animals.
After 1 week (5 days) there was little difference in the morphological 
changes in BBN/BEA treated animals other than the RPN lesion described 
in section 4.1. As before the kidneys from animals treated with BBN 
alone were similar in appearance to normal control kidneys.
5.1.2 Three Weeks Time Point.
The BEA treated group had foci marked hyperplasia in the ureteric 
urothelium some of which was papillary in pattern (see secton 4f2). 
The BBN only treated animals had normal morphology with no hyperplasia 
present in any of the urothelia.
Animals in the BBN/BEA treated group had (in addition to the 
morphological changes associated with the RPN lesion, (see section
4.1.2.1) mild hyperplasia of the pelvic and ureteric urothelium, but 
no urothelial hyperplasia in the bladder which was the same as in the 
BEA only treated animals (section 4.1.2.1). Aik. phos. staining was
positive in bladder urothelium and concentrated towards the apex of 
intermediate and superficial cell layers. Little or no staining was
observed in the pelvic and ureteric urothelium with alk. phos., 
however dispersed foci of ATP positive staining occurred in both 
regions.
5.1.3 Six Weeks Time Point.
In the BBN only treated group a number of interstitial cell changes 
were noted in papilla, but not in significant quantities. Glomeruli 
were seen to be enlarged having a reduced Bowman's space with a slight 
degree of basement membrane sclerosis occurring around the Bowman's 
capsule. Animals in the BBN/BEA treated group had totai RPN as in the 
BEA only treated (see 4.1.2.2) with the papilla having sloughed with a
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re-epithelialisation of the covering epithelium. Epithelial cells 
had nuclei of variable size and shape, with mitotic figures present in 
the fornix together with a slightly reduced alk. phos. staining 
compared to the remaining pelvic urothelium. Restoration of the 
interstitial matrix occurred with extremely intense staining granules 
around the loops of Henle basement membrane. There was focal severe 
papillary/nodular hyperplasia in the ureteric urothelium (Figure 5.1), 
with sloughing, dysplastic, basophilic cells in the superficial 
layer. Mast cells (with intensely basophilic granular cytoplasm) were 
aggregated below and adjacent to this nodular "invasive" urothelium 
(Figure 5.2) There was no hyperplasia of the bladder urothelium only 
a severe "ruffling" of the glycocalyx of the superfical cells. The 
basal sub-urothelial capillaries showed a progressive microangiopathy 
similar to that seen in BEA only treated rats (section 4.1.2.2) .
5.2 UROTHELIAL MORPHOLOGICAL CHANGES AND TUMOUR INCIDENCE UP TO 
FORTY MEEKS TIME POINT.
5.2.1 Thirteen Weeks Time Point.
The BBN only treated group had similar changes to those described at 
the 6 week time point. The urothelium of pelvis and ureter tended to 
have a more intensely staining lamina propria for mucopolysaccharides 
with the Giemsa stain, with a "ruffled" superficial cell layer.
The animals in the BBN/BEA treated group had total RPN as described at 
6 weeks and in BEA only treated group (see section 4.1.2.3) with re- 
epithelised stump with a deposition of interstitial matrix together 
with calcified deposits around the tubular basement membrane. The 
papilla covering epithelium was mildly hyperplastic, blebbing and had 
an occasional mitotic figure present. There was a general
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Figure 5.1 Nodular and papillary hyperplasia in the ureter, 6 weeks 
after BBN initiation and BEA promotion (BBN/BEA). Many areas are 
dysplastic nuclei (arrowhead) and are sloughing into lumen. Giemsa 
x 177.
Figure 5.2 Higher magnification of above figure showing cellular 
detail of nodular hyperplasia, note aggregates of mast cells in 
lamina propria (arrow). Giemsa x 357.
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hyperplasia throughout the urothelium including the bladder varying 
from mild simple hyperplasia to severe focal papillary and nodular 
hyperplasia with potentially 'invasive' areas (Figure 5.3) One animal 
in particular had basophilic/eosinophilic staining superficial 
'umbrella' cells whose nuclei were enlarged, variable shaped and 
multi-nucleated (Figure 5.4) Focal papillary hyperplasia with
"invasive" nodular hyperplasia (Figure 5.5), of grade P1/P2, (Helpap 
et al, 1985), penetrating through the lamina propria (Figure 5.6) and 
aggregates of mast cells with basophilic granular cytoplasm adjacent 
to the invasive area (Figure 5.7). These "invasive" regions of 
urothelium were stained negatively for alk. phos. whereas the 
papillary hyperplastic regions of urothelium had a positive staining 
mosaic pattern for alk. phos. (Figure 5.8).
5.2.2 Twenty-one Weeks Time Point.
At this time point there were no noteworthy or additional 
morphological changes compared to those described above (section
5.2.1) at 13 weeks in the BBN only treated group.
The BBN/BEA treated group of animals all showed the greatest numbers 
of abnormalities within the urothelium particularly in the ureter, 
with two thirds of the ureters examined having papillary hyperplasia 
together with foci of nodular hyperplasia or invasive areas. One 
animal had a large papillary hyperplasia/papilloma located at the 
mouth of the ureter which completely filled the lumen of the ureter. 
A papilloma (4.0 mm in diameter) was observed in the bladder (Figure 
5.9). It was well differentiated with a well developed interstitial 
fibrous core and vasculature, together with irregularly staining 
"nests" of cells and many mitotic figures throughout. Mast cells
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Figure 5.3 Dysplastic, hyperplastic urothelium in ureter, 13 weeks 
after BBN/BEA treatment. Giemsa x 36.
Figure 5.4 Higher magnification of above figure showing nodular 
"invasive" area and large multinucleated cell in superficial layer. 
Giemsa x 434.
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Figure 5.5 Papillary and nodular hyperplasia in ureter 13 weeks 
after BBN/BEA treatment. Toluidine blue x 223.
Figure 5.6 Higher magnification of an "invasive" area shown above 
(arrow) projecting down through lamina propria (LP) and beginning to 
invade lamina muscularis (Mu). Toluidine blue x 1085.
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Figure 5.7 A second "invasive" nodular hyperplastic area (arrow) in 
ureter 13 weeks after BBN/BEA, invading through lamina muscularis, 
mast cells are aggregated adjacent to "invasive" area (arrowheads). 
Toluidine blue x 223.
Figure 5.8 Alkaline phosphatase stained section of ureter 
shown above. Mosaic distribution of this enzyme occurs throughout 
hyperplastic urothelium but nodular "invasive" area show a decrease 
or total lack of staining (arrow). Alkaline Phosphatase x 270.
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Figure 5.9 Bladder papilloma from animal 21 weeks after BBN/BEA 
treatment. Giemsa x 36.
similar to those observed at earlier time points (section 5.1.3) were 
seen throughout the epithelial layers of the papilloma and in the 
interstitial lamina propria core of the tumour adjacent to 
capillaries. The papilloma showed little staining for alk. phos. 
except in occasional superficial cells and in the endothelium lining 
the capillaries of the interstitial core. ATPase staining of 
capillary endothelial cells in the sub-basal and urothelial coated 
capillaries showed that the intensity and area of staining for the 
microangiopathic endothelial cell layer increased towards the lumen of 
ureter. The cortical changes present were those of the BEA only 
treated group, due to the progressive RPN and interstitial nephritis 
(see section 4.1.2.4).
5.2.3 Thirty Weeks Time Point.
Macroscopically all the animals treated with BEA, including the 
BBN/BEA group had severe cortical scarring indicative of the
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Animal N° Group Comments
69 BEA both kidneys scarred (Right »  Left), 
upper ureter 4 mm in width, no 
abnormalities inside, papilla stump, no 
tumours in bladder.
78 BEA both kidneys scarred and cystic, papilla 
ghost in pelvis, no tumours in bladder.
23 BBN kidneys normal appearance, papilla 
intact, pelvic space full of blood!, no 
tumours in pelvis or bladder.
22 BBN kidneys normal appearance, papilla 
intact, pelvis and bladder full of 
blood, several small microtumours in 
bladder, 1 tumour papilloma 3 mm diam.
23 BBN kidneys normal appearance, dark colour 
to papilla, 2 papilloma tumours in 
bladder 3-4 mm diam;
11 BBN/BEA both kidneys scarred, focal RPN lesion 
at papilla tip, blood in bladder, 2 
microtumours in bladder < 1-2 mm diam.
8 BBN/BEA both kidneys scarred, papilla stump 
mineralized, blood in pelvic space and 
in bladder, 1 papilloma in bladder 3 mm 
diam.
9 BBN/BEA both kidneys scarred, papilla stump 
mineralized, blood in pelvic space, no 
tumours in bladder.
53 BBN/BEA/BBN both kidneys pronounced scarring, right 
kidney atrophied, papilla stump, blood 
in bladder, 2-3 papilloma tumours 2-4 mm 
diam.
Table 5.1 Macroscopic assessment results from BBN study 2, at thirty 
weeks time point.
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underlying interstitial nephritis, a secondary change in the 
degenerative pathogenesis of RPN.
Table 5.1 shows a representative example of macroscopic results 
observed at this time point.
In the BBN/BEA group the animals in general had a greater proportion 
of the papilla remaining intact after necrosis due to the RPN compared 
to the BEA only treated animals. Microscopic examination revealed that 
no tumours were observed in the BEA treated group. One BEA only 
treated animal did have a severe nodular hyperplastic pelvic/ureteric 
urothelium with some irregular atypia in the pelvis.
All the BBN only treated animals exhibited visible haematuria in the 
bladder at post mortem. For the first time bladder papillomas were 
observed in the bladders of the BBN only treated animals, being of a 
typical "cauliflower" appearance. The histological appearance of these 
BBN induced papillomas were similar to those of the BBN/BEA papillomas 
described above found at 21 weeks (Figure 5.9). One animal had 3 
papillomas (2-3 mm in diameter) which had severe cellular atypia and 
there was also papillary and nodular hyperplasia in the ureteric 
urothelium (Figure 5.10).
The BBN/BEA treated animals had hyperplasia and dysplastic urothelium 
in the pelvis and ureter together with some areas of flat nodular 
"invasive" hyperplasia and small papillomas in the bladder. Cellular 
atypia in these hyperplastic urothelia comprised of enlarged lobed 
nuclei and occassional mitotic figures plus multinucleated cells. 
"Umbrella" cells in the superficial layer of bladder were often 
basophilic with prominent aggregations of eosinophilic staining 
macrophage cells throughout the superficial and intermediate layers
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Figure 5.10 Nodular and papillary hyperplasia of ureteric 
urothelium from BBN only treated animal, 30 weeks after dosing. 
Giemsa x 434.
with acid phos. staining in and around these cells. Mast cells were 
also prominent in and around invasive and severely hyperplastic areas 
of the urothelium at 21 weeks. There was also some evidence of 
microangiopathy in the sub-urothelial capillaries where there was 
occlusion of the lumen and thickening of the endothelial basement 
membrane.
In the ureteric urothelium there was nodular and papillary hyperplasia 
with loss of polarity and atypical nuclei, mitotic figures and also 
possibly areas of carcinoma i n  s i t u  where the urothelium is of normal 
thickness or exhibits some mild hyperplasia but the nuclei show severe 
atypia: enlargement, basophilia, loss of polarity etc. A considerable 
number of animals had a papilla stump with a severely hyperplastic 
covering epithelium (Figure 5.11). There was frequently an associated 
nodular "invasive" hyperplasia of the urothelium in the pelvic 
fornices (Figure 5.12). In 25-30% of the animals transitional cell
259
Figure 5.11 Papilla stump (Pap) with severe hyperplastic covering 
epithelium and nodular hyperplasia of adjacent pelvic urothelium 
(arrow), 30 weeks after BBN/BEA treatment. Giemsa x 89.
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H - ir rh o r-  m s r r n i f  i  r a l - l  n n  n-f n n H n l  s r  h v n p r n l3 < ? 't " i r '  1Figure 5.12 ig e agn c tio of odu a ype plastic pelvic 
urothelium (from above figure) invading renal parenchymal tissue 
(arrow), note collecting duct (CD) with mitotic figure present. 
Giemsa x 357.
tumours were found in the pelvic/ureter junction, these tumours were 
typically nodular/papillary (Figure 5.13) with mitotic figures
present, did not stain for alk. phos. and also had mast cells present 
in the lamina propria adjacent to the nodular regions of the tumour 
(Figure 5.14) .
5.2.4 Forty Weeks Time Point.
Table 5.2 shows a representative example of macroscopic results
observed at this time point.
The BBN only treated group had normal kidney morphology, no RPN, 
tubular atrophy or necrosis. Approximately 80% of the BBN only 
treated animals had bladder tumours. Typically these tumours were 2-6 
mm in diameter, well differentiated, with a papillary or papilloma 
structure with occasional areas of superficial necrosis and
haemorrhaging. Many areas of bladder urothelium were devoid of any 
epithelial cells The denuded basement membrane was stained prominently 
for mucopolysaccharides with PAS and Giemsa. The pelvic urothelium 
was of normal thickness (2-4 cells). There were, however, many 
variable shaped lobular nuclei present. There was also papillary 
hyperplasia in some ureters similar to that observed at 30 weeks 
(Figure 5.10).
Occasionally BBN/BEA treated animal did not exhibit RPN and had an 
intact papilla (in approximately 2-3 animals, > 2% of total number of 
animals dosed with this protocol). Morphological changes occurred 
similar to those described in BEA only animals (see section 4.2.6) due 
to the underlying RPN and cortical interstitial nephritis lesions. 
These changes varied among individual animals but generally followed a 
similar pattern. The papilla remained as a re-epithelialised stump
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Figure 5.13 Typical solid nodular "invasive tumour found at
pelvic/ureter junction, 30 weeks after BBN/BEA treatment. Giemsa x
,;l •. V ‘ >
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Figure 5.14 Higher magnification of invasive region of tumour in 
above figure showing atypical cell nuclei and aggregates of mast 
cells adjacent to invading tumour cells (arrowheads). Giemsa x 434.
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Animal N°. Group Comments
83 BEA both kidneys enlarged, scarred, ghost 
papillae in pelvis, enlarged ureters, 
small bladder, no tumours.
80 BEA left kidney hypertrophic, scarred, 
cystic, ureter enlarged, right kidney 
atrophied, no tumours.
27 BBN kidneys normal appearance, bladder 
enlarged, papilloma tumour 3-4 mm diam.
26 BBN kidneys normal appearance, bladder 
contains 3 tumours (papillomas), 3-5 mm
diam.
37 BBN kidneys normal appearance, no tumours in 
bladder.
45 BBN/BEA kidneys cystic and scarred surface, 
bladder full of blood stained urine, 
large papilloma tumour 5-6 mm diam., 
necrotic and haemorhagging on surface.
7 BBN/BEA kidneys scarred and cystic, papilla 
stump, bladder contains 2 tumours 2-3 mm 
diam.
21 BBN/BEA kidneys cystic and scarred surface, 
papilla stump, bladder contains tumour 
broken from urothelium 4-5 mm diam.
58 BBN/BEA/BBN kidneys slightly scarred and cystic, 
papilla intact!, bladder contains 1 
tumour broken from urothelium 2-3 mm 
diam.
57 BBN/BEA/BBN kidneys scarred, pelvis and upper ureter 
full of papilloma tumour 8-10 mm diam., 
bladder, contains 1 papilloma tumour 5-6 
mm diam.
Table 5.2 Macroscopic assessment results from BBN study 2, at forty 
weeks time point.
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with intact (if somewhat abnormal) tubular elements within a pink 
staining interstitial matrix. This was covered by an extremely hyper­
plastic epithelium which was blebbing and papillary in areas The 
interstitial matrix of the papilla was fibrotic in nature and also 
granular in some areas, it did not extend all the way to the tip of 
the papilla. At this time point all the BBN/BEA treated animals had 
bladder tumours which were visible macroscopically. They were tran­
sitional cell papillomas varying in in size from small papilloma (2 
mm diameter) to large well differentiated tumours filling the entire 
bladder. One such tumour (Figure 5*15) exhibited numerous tumour 
types: nodular invasive (Figure 5.16), keratinisation of papilloma
(Figure 5.17), and papillary transitional cell carcinoma. Within 
this tumour there was variable staining for both PAS and alk. phos., 
with the keratinised regions being particularly prominently stained 
for PAS (Figure 5.18).
Urothelial changes were very variable, the most prominent changes 
occurring in the pelvic/ureter mouth junction where nodular, solid, 
severe hyperplastic lesions were located (possibly carcinoma) which 
had cellular atypia, loss of polarity and capillaries within the 
epithelial cell layers. The pelvic urothelium often had vacuolated, 
disrupted, superficial layers with numerous macrophages (cells with 
eosinophilic staining granular cytoplasm) present. The ureteric 
urothelium was hyperplastic; papillary in areas, nodular "invasive" 
at the mouth of the ureter and pelvic junction with aggregates of mast 
cells located in basal region.
The kidneys from one animal at 40 weeks had a tumourous mass filling 
the entire upper ureter (Figure 5.19) and extending into the pelvis.
264
Figure 5.15 Large well differentiated tumour filling entire 
bladder, 40 weeks after BBN/BEA treatment. Giemsa, x 89.
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Figure 5.16 Solid nodular transitional cell tumour found in part of 
large bladder tumour in figure 5.14, 40 weeks after BBN/BEA
treatment. Giemsa x 108.
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Figure 5.17 Keratinisation and mineralisation in papillary 
transitional cell carcinoma found in part of large bladder tumour in 
figure 5.14, 40 weeks after BBN/BEA. Giemsa x 434.
Figure 5.18 Prominent PAS staining (arrowhead) of keratinised areas 
in tumour shown above. PAS x 27 0.
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Figure 5.19 Macroscopic photograph of enlarged upper ureter portion 
(arrowheads) containing tumour (shown below) found 40 weeks after 
BBN/BEA treatment, x 3 approximately.
Figure 5.20 Papillary transitional cell tumour found in upper 
ureter, with nodular basal region,40 weeks after BBN/BEA treatment. 
Giemsa x 36.
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The tumour microscopically was a transitional cell tumour, papillary 
in nature (Figure 5.20). The basal layers were extremely nodular, 
with loss of polarity and much cellular atypia (enlarged, variable 
shaped nuclei), basophilic deposits within the tumour tissue (Figure 
5.21). It was difficult to differentiate between the lamina propria 
and lamina muscularis and the epithelial cells suggesting an invasive 
stage in tumour development (Figure 5.21). The nodular and possibly 
"invasive" regions of this tumour did not stain for alk. phos. but the 
superficial papillary regions of this tumour did stain positively for 
this enzyme (Figure 5.22).
There was no positive staining observed for the marker enzyme GGT in 
any urothelial tissues at any time point during all of these studies.
5.3 BBN STUDY 3: SUPERIMPOSTION OF SINGLE ANALGESICS.
In general many of the histological changes observed in all groups 
were similar and due to the BEA insult progressing from an RPN into 
severe interstitial nephritis affecting many of the nephrons within 
the cortex (see sections 4.1.2.2-4.1.2.4). These changes were 
variable between individual animals and between experimental groups.
5.3.1 Morphological Changes at Seven Weeks Time Point.
Superimposing aspirin and NPAA on the BEA-induced RPN did not produce 
any significant changes from the general changes described above. 
However, the superimposing of paracetamol did produce two interesting 
results:
1) One animal in the BEA/PARA group had a severe hyperplastic covering 
urothelium on the papilla stump which was 7-9 cells thick with a well
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Figure 5.21 Higher magnification of nodular region of tumour in 
upper ureter, showing nuclear pleomorphism, mineralisation (arrow) 
highlights difficulty in differentiating urothelial cells from 
basement membrane (*)/ lamina propria and lamina muscularis
suggesting an invasive stage of development. Giemsa x 434.
Figure 5.22 Nodular regions of tumour shown above do not stain for 
alkaline phosphatase (arrowheads) whereas papillary regions of the 
tumour stain positively (arrow). Alkaline phosphatase x 223.
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developed vascular supply via a stalk of interstitium from the papilla 
stump (Figure 5.23) . The urothelium had a mosaic pattern of cells 
with basophilic staining nuclei. The superficial cells had 
eosinophilic granular staining cytoplasm, these cells appeared to be 
undergoing necrotic changes. A mosaic pattern of alk. phos. staining 
was evident within 2/3 of the hyperplastic cells the remainder were 
not stained. The interstitial cells and matrix adjacent and basal to 
the hyperplastic urothelium also stained positively for alk. phos.
2) One animal in the BBN/BEA/PARA group had a well defined 
transitional cell carcinoma in the ureter (Figure 5.24) with extremely 
variable cell size, loss of polarity, good vascular development within 
the tumour mass (Figure 5.25). There was diverse cytoplasmic staining 
with PAS and alk. phos. (Figure 5.26) and the PAS granules were 
particularly pronounced throughout the urothelium of this tumour.
5.3.2 Morphological Changes at the Fourteen Week Time Point.
The BEA/PARA control group had a bladder papilloma which had many 
areas of dysplasia, mitotic figures present throughout and necrotic 
areas within the tumour mass (Figure 5.27). Within the ureter there 
were some extended areas of diffuse nodular hyperplasia, with 
cellular atypia and necrotic superficial cell layers.
5.3.3 Morphological Changes at the Eighteen Week Time Point.
Mosaic alk. phos. staining was present throughout the hyperplastic 
urothelium of all groups.
5.3.3.1 In the BBN/BEA/ASP treated group there was nodular 
hyperplasia at the pelvis/ureter junction with mitotic figures 
present. There were nests of hyperplastic urothelium in the bladder 
together with one transitional cell papilloma (Figure 5.28).
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Figure 5.23 Severe hyperplastic covering epithelium on papilla 
stump, 7 weeks after BEA/PARA treatment. Giemsa x 177.
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Figure 5.24 Well differentiated transitional cell carcinoma in 
ureter, 7 weeks after BBN/BEA/PARA treatment. Giemsa x 177.
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Figure 5.25 Higher magnification of above figure showing nuclear
pleomorphism, loss of cellular polarity and well developed
microvasculature within tumour mass (arrowhead). Giemsa x 357.
Figure 5.26 Mosaic staining of alkaline phosphatase within ureter 
tumour shown in Figures 5.2 4 and 5.25. Alkaline phosphatase x 177.
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Figure 5.27 Papilloma in bladder of animal 14 weeks after BEA/PARA 
treatment with much vacuolation and necrosis of superficial tumour 
tissue evident. Giemsa x 36.
•VC ‘ i ■. ,
Figure 5.28 Bladder papilloma found 18 weeks after BBN/BEA/ASP 
treatment. Giemsa x 89.
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5.3.3.2 There was marked increase in the number of macrophages 
present in the superficial layers of hyperplastic urothelium in the 
BEA/PARA group.
5.3.3.3 The BBN/BEA/PARA treated group had papillomas in 2/3 
animals, one was extremely large (9 mm) in diameter with with well 
developed interstitial cords throughout the tumour mass (Figure 5.29). 
There was also severe focal and simple hyperplasia in the bladder and 
ureter with numerous atypical nuclei and mitotic figures present. Both 
the papillomas were negatively staining with respect to alk. phos. 
enzyme, no GGT staining of any hyperplastic or carcinoma areas was 
observed.
Figure 5.29 Extremely large bladder papilloma (9mm diameter) found 
18 weeks after BBN/BEA/PARA treatment. Giemsa x 36.
5.4 SUBSEQUENT BBN DOSING FOLLOWING BBN INITIATION AND BEA INDUCED
RPN.
The rational for this exerimental procedure is described in
Methods sections 3. 6.5.2 and 3.6.5.4.
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5.4.1 Pilot Study
This pilot study (section 3.6.5.2) group showed little difference 
between BBN/BEA results at the earlier time points.
At 30 weeks, however, the BBN/BEA/BBN treated group had a greater 
number of urothelial abnormalities with a greater degree of severity 
than BBN/BEA group. Foci of papillary hyperplasia were present in 
the ureter with cellular atypia, nodular "invasive" hyperplasia 
(possible P1/P2 grading) and/or in situ carcinoma was present. 
Bladder papillomas were very disorganised in structure away from 
central stalk and fibrous interstitial core with numerous mitotic 
figures present in cell layers adjacent to fibrous core.
At 40 weeks at the macroscopic level one BBN/BEA/BBN treated animal 
had a large tumour in the pelvis of the kidney which it completely 
filled (Fig. 5.30) and extended into the upper ureter, which was 
enlarged and distended.
At the microscopic level this tumour developed out of the pelvic wall 
with mitotic figures evident in this area (Figure 5.31). It was a 
typical well differentiated transitional cell carcinoma with numerous 
macrophages throughout. Superficial areas of the tumour were
undergoing necrosis, with many leucocytes present together with 
necrotic epithelia cells. One extremity either arose from the side 
of the ureter or was a downgrowth of the pelvic tumour into the mouth 
of the ureter. The ureter was extremely dilated with nodular and 
papillary hyperplasia present. The bladder urothelium was very 
dysplastic having extremely variable cell nuclei shape and size. One 
large bladder papilloma was present, which was well differentiated. 
Prior to the stalk of papilloma the bladder urothelium became severely
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Figure 5.30 Macroscopic photograph of tumour found in pelvis 40 
weeks after BBN/BEA treatment, followed by subsequent further dosing 
with BBN. x 5 approximately.
Figure 5.31 Origin of pelvic tumour shown above, tumour arises from 
pelvic urothelium (arrow), note mitotic figures (arrowheads). H&E x 
357.
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hyperplastic becoming 8-10 cells thick. Throughout the pelvic and 
ureteric urothelium there was a noticeable increase in PAS-positive 
granular inclusion bodies in the superficial layer of hyperplastic 
areas.
5.4.2 Main Study:
The only differences between the results observed in BBN/BEA and 
BBN/BEA/BBN treated groups occurred at 18 weeks when keratinization of 
some bladder tumours was observed in the BBN/BEA/BBN group. This 
pathological change had only been observed at much later time points 
in previous studies (40 weeks after BBN/BEA treatment).
At 30 weeks time point the tumour incidence observed macroscopically 
in all groups was as follows:- BEA (0/5), BEA/BBN (0/5), BBN (1/5), 
BBN/BBN (2/5), BBN/BEA (5/5) and BBN/BEA/BBN (5/5) . Overall the 
tumours in the BBN/BEA/BBN group were larger in size than those found 
in the BBN/BEA group. The histological changes in the tumours were, 
however, no different to those already described above in section
5.2.3. for bladder tumours. There were, however, no pelvic or 
ureteric tumours.
The changes for the tumours found in the animals from this study which 
acted as donor animals in the Nude mouse tumour xenograft study are 
described in section 5.6.2.1.
Animals sacrificed at 58 weeks in this study were a terminal sacrifice 
ending the experiment. Only 5 animals in total (2 BBN, 3 BBN/BEA) 
were sacrificed and 1 of these was moribund. No tumours were found in 
the pelvis, ureter or bladder of these animals. One of the BBN/BEA 
animals did not appear to have any indication of having had a RPN 
lesion; the papilla was intact and the kidney cortex surface was
277
smooth and normal in appearance. Due to a lack of time these 
specimens have not been examined histologically, specimens from the 
fifth BBN study took priority over these late time points.
5.5 STUDY 5: SUPERIMPOSITION OF PARACETAMOL AFTER BBN/BEA TREATMENT.
The rational for this study is described in Methods section 3.6.5.5.
At the first sacrifice point (6 weeks) there was only a 20% gross 
incidence of RPN (necrosis of papilla tip, leaving a residual stump) 
in BEA-dosed animals. By the third sacrifice point (18 weeks) the 
gross incidence of RPN was still only 25% in the animals dosed with 
BEA. In some of the treated animals with an intact papilla there were 
histological changes which are indicative of an early RPN - loss of 
interstitial matrix staining, adherent platelets in capillaries, casts 
in the loops of Henle. This was surprising as this compound has been 
used in our laboratory for at least 10 years and has always produced a 
RPN lesion in 100% of the animals treated at doses greater than the 
threshold dose of 25-35 mg/kg. One would therefore have expected all 
the animals to have RPN lesions following the dose of 75 mg/kg used in 
this study and the histological changes would have been more 
pronounced than those exhibited by 50% of the animals in this study. 
These changes were similar to changes expected to occur over the 12-24 
hr time point, see section 4.1.
5.6 NUDE MOUSE XENOGRAFT TUMOUR RESULTS.
5.6.1 Transplanted Tumour Growth.
Twenty-one mice were used in xenograft procedures, 19 received 
xenografted rat tissues, the remaining 2 received passaged tumour 
tissues from 2 of the original 19 mice. Nineteen mice were originally 
xenografted with rat tissue: 7 mice received donor tissue from the
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renal pelvis region, 7 mice received donor tissue from the bladder, 3 
mice received donor tissue from the ureter and 2 mice received donor 
tissue from the papilla tip. Fifteen of the donor animals had been 
treated with the BBN/BEA regimen and the remaining 4 animals had been 
treated with the BBN/BEA/BBN regimen.
Only the xenografted bladder tissues consistently "took" in the nude
mice hosts: 5/7 grew to a measurable size by 4-5 weeks after
xenografting. Only 2 tumours (from mice numbers 7 and 13) grew to a
size such that they were visible macroscopically as gross distended
lumps on the flank and had an average size indices of 36 and 35
respectively (LI x L2 /2) see Methods section 3.6.6.5. However, when
2these values are converted by the formula (L x (B) ) x 0.4 to give
3
calculated tumour volumes, then the volumes became 230 and 216 mm by 
week 11 and 13 post transplantation respectively (Table 5.3).
Figure 5.32 shows the growth curve of tumour growth (plotted as 
calculated volume against time). In both these animals tumour growth 
was initially slow, then at week 8/9 there was a sudden increase in 
the growth rate of both tumours with the tumour volume approximately 
trebling in the subsequent 3/4 weeks. These tumours were passaged 
into two more mice (numbers 20 and 21), however only one of these 
tumours "took" but failed to grow well and after 5 weeks it began to 
diminish in size so the mouse was sacrificed. Also during the moving 
of the isolator to a different room one of the plastic sleeves became 
holed, this was quickly repaired. A microbiological analysis of mice 
faeces was performed (by Mrs T. Amor, Microbiology Dept, University of 
Surrey) several days later to determine if any contamination had 
occurred. Several of the remaining mice were becoming thin and losing
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Table 5.3: Volumes (mm ) of xenografted tumours
Time (weeks)
12 13M. T. 1 2 3 4 5 6 7 8 9 10 11
1 P nr .8 .8 - - - - nr X
2 P nr - 6.4 6.4 - - - nr X
3 P nr .8 -
oOO 3.2 - OO nr X
4 P nr 1.2 .8 - - - OO nr X
5 B nr .8 OO .8 - 6.4 4.8 nr X
6# B nr - - - X
7 * * B nr .8 6 18 18 22 25 nr 80 230 230X
8 B nr 1 8 13 13 13 11 nr 11 14 18 X
9 B nr 1 14 14 32 32 50 nr 26 50 32
10 Pt nr .8 .8 .8 3 6 8 nr 11 10 X
11 Pt nr .8 3 3 5 3 3 nr 3 - X
12 U nr 1 .8 14 6 8 8 nr 22 22 X
13* B nr 1. .1 3 14 26 32 nr 60 86 70
14 P 32 nr 18 11 - X
15 U 3 nr .8 - - X
16 U 11 nr - - 3 X
17 P 3 nr - 8 6 X
18 P - nr 8 - - X
19 B 14 nr - 25 32 14 X
20 Bpl 6 26 26 14 14 14 X
21 Bpl - - - - - X
8 X
M. - mouse number; T. - donor tissue type (P:pelvis, B:bladder, 
Urureter, Pt:papilla tip, Bpl: first bladder tumour passage);
6# - animal terminated early because injured in fight; 7*
xenograft tumour passaged into mouse 20; 13** - xenograft tumour
passaged into mouse 21; X - terminal sacrifice; nr - not recor­
ded; - - no presence of tumour.
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Figure 5.32 shows the growth curve of xenografted tumour growth 
(plotted as calculated volume against time).
281
weight including one of the subpassaged mice. The test proved 
positive with Proteus sp., Sporing Baccilus sp. and Coccus sp. being 
identified. Although Proteus species of bacteria are normal gut flora 
in this strain of nude mice the presence of Baccilus sp. is often 
indicative of environmental contamination and the Coccus sp. could be 
any strain of a frequently pathogenic bacteria species (Dr M. Coates, 
personnel communication). The loss of weight may be attributable to a 
bacterial infection by any of the above species or one which was not 
identified (analysis for viral infection was not possible). This loss 
of weight together with the lack of successful growth of the passaged 
tumours were the main reasons for terminating this experiment.
5.6.2 Histological results.
5.6.2.1 Donor tissue.
The original bladder tumour from a donor BBN/BEA/BBN animal was a 
transitional cell carcinoma (Figure 5.33) with well developed 
interstitial connective tissue cords containing many mast cells. Many 
of the transitional cells showed pleomorphism (nuclei of variable 
shape and size see Figure 5.34), together with numerous mitotic 
figures. There was no alk. phos. staining in any of the tumour cells 
only in the endothelium of the capillaries in the connective cords. 
Many cells had PAS positive staining cytoplasmic granules.
The kidneys of all donor animals had frank RPN with a re- 
epithelialised papilla stump, severe interstitial nephritis throughout 
the medulla and cortex. The pelvic and ureteric urothelium had 
hyperplastic lesions varying from mild to severe nodular hyperplasia 
(in some areas possibly invasive).
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Figure 5.33 Transitional cell tumour from bladder of BBN/BEA/BBN 
treated animal which was one of donor tumours used for xenograft 
experiments. Giemsa x 216.
Figure 5.34 Higher magnification of tumour shown above illustrating 
well differentiated pleomorphic cells. Giemsa x 434.
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5.6.2.2 Xenografted tissue.
Macroscopically the tumours were of variable shape, encapsulated in a 
fibrous connective tissue presumably sub-dermal tissue of nude mouse 
origin (Figure 5.35). One of the tumours had macroscopically had some 
cystic regions which were hollow containing a colourless fluid. 
Histologically the tumours comprised of a transitional cell tumour 
with a solid, nodular, disorganised structure. The cells showed 
pleomorphism and were well differentiated (Figure 5.36). Interstitial 
connective tissue cords formed a radiating pattern within the solid 
tumour, a very similar appearance to the bladder tumour from the donor 
animal. Similarly to the donor tissues there was no alkaline 
phosphatase enzyme staining in the xenografted tumour tissue. In 
contrast there was no positive PAS staining cytoplasmic granules in 
the xenografted tumour cells. The tumour which was a hollow cyst 
structure had walls which were an epithelium 2-5 cells thick arranged 
as in the classical structure of urothelium lining the pelvis, ureter 
or bladder in control animals. Some regions of the tumour resemble 
carcinoma in situ with a very disorganised basophilic nuclei within an 
epithelium of normal thickness. Other areas were loosely arranged 
with extremely variable staining cytoplasm and nuclei
5.6.3. In vitro Results and Discussion.
5.6.3.1 Results.
The earliest stage of growth was an outgrowth of cells from the donor 
tissue, see Figure 5.37. These outgrowths consisted of a flattened 
plaque of epithelial-like cells. The cells were of varying shape and 
size with numerous cytoplasmic droplets (whose nature was not 
determined), the cell nuclei were also of varying size and shape with
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Figure 5.35 Solid, nodular transitional cell tumour encapsulated 
in fibrous connective tissue (*) harvested from a Nude mouse. Giemsa 
x 216 .
Figure 5.36 Higher magnification of harvested xenografted tumour
shown above, note well differentiated cells compare with donor 
tumour shown in Figure 5.34. Giemsa x 434.
Figure 5.37 Outgrowth from original piece of bladder tumour (arrow) 
of urothelial cells grown after 4 days in culture. Phase 
microscopy x 108.
prominent rounded nucleoli see Figure 5.38. A few of these plaques 
grew to an appreciable size (visible without a microscope), all 
consistently were composed of epithelial-like cells. Attempts to sub­
culture these colonies failed either because of an excessive 
trypsinisation period (during sub-culturing process) or that bacterial 
contamination occurred. Bacterial contamination was a frequent reason 
for discarding cultures.
5. 6.3.2 Discussion.
The reasons for failing to culture a cell line successfully due to the 
problems created by bacterial contamination may be an inadequate 
aseptic technique for transfering the media to multiwell plates, or 
due to endogenous urinary tract bacteria from the donor tissues. 
Control wells with only media present (no cells) only rarely had 
contaminating bacteria present.
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Figure 5.38 Higher magnification of urothelial cells in culture 
(after 7 days) showing plaque of flattened cells with large nuclei 
and numerous cytoplasmic droplets. Phase microscopy x 434.
5.7 DISCUSSION OF RESULTS FROM EXPERIMENTALLY INDUCED CARCINOGENESIS 
STUDIES.
These investigations were undertaken to test the hypothesis that 
analgesic associated RPN and UUC are linked by a common pathological 
sequence of events. Long-term studies with BEA (Bach, 1981) showed 
that an acute RPN resolved and raised the question that UUC 
represented a classical initiation-promotion type as a consequence of 
RPN. The possible "cause-and-effeet" relationship was investigated in 
these studies. Previous research using a 2-stage initiation-promo­
tion model has established that urothelial hyperplasia may develop 
into tumours (see section 2.3.5.2). The urothelial specific carcinogen 
N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) was used in the following 
series of studies to initiate the urothelium at sub-carcinogenic doses 
followed by an acutely (BEA) induced RPN in Wistar rats. BBN was
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chosen as the carcinogen to facilitate controlled oral dosing (see 
section 2.3.5.2.B) to reduce the exposure risk to personnel and 
because of its greater specificity than FANFT with no benign 'extra- 
urothelial tumours' induced (see section 2.3.5.2.A). The second 
series of experiments in this study (Methods section 3.6.5; Results- 
section 5.1-5.5 above) where BBN was used to initiate the urothelium 
followed by a BEA induced RPN.
5.7.1 Short-term Changes in BBN/BEA Studies:0-6 Weeks.
BBN was chosen as the initiating agent (as explained in section
2.3.5.2.A) and the first priority was to ensure that the response of 
the rat kidney to BEA was not altered by such treatment. The result 
from the early time points in this study did not show any differences 
in the development of the acute RPN as was seen in control animals 
treated with BEA alone (section 4.1.1 and 4.1.2). The conclusion was 
that there were no obvious pathological differences and BBN initiation 
did not alter in any way the response of the rat kidney to BEA.
5.7.2 Intermediate and Long-term Changes in BBN/BEA Studies:6-40 
Weeks.
Compared to the BEA only and BBN only treated control groups, animals 
from the BBN/BEA treated group had more severe urothelial abnormali­
ties (sections 4.1.2.3-4.1.2.6). Tumours in the renal pelvis and 
upper ureter were only found in the BBN/BEA treated animals 
(sections 4.1.2.5 and 4.1.2.6), and bladder tumours appeared earlier 
(at 21 weeks compared to 30 weeks, sections 4.1.2.4 and 4.1.2.5) and 
were usually larger with more dysplasia and cellular atypia compared 
to those observed in the BBN only treated animals. The loss of
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alkaline phosphatase staining in urothelium has been reported to be a 
marker histochemical change in chemically induced urothelial 
malignancies (Kunze, 1979). The finding in this study that 'nodular' 
invasive hyperplasia and nodular tumour tissue lacks any positive 
staining for this enzyme suggests the existence of premalignant and 
malignant cell populations, based on the experience of Kunze & 
Schauer, (1977) and Kunze, (1979). Thus the urothelium of animals 
treated with BBN that had been initiated before an acute RPN was 
induced. These data suggest that a BBN initiated urothelium can be 
promoted to pre-neoplastic and neoplastic cells in the upper ureter 
and renal pelvis by an acute RPN.
Studies by Mattingley and co-workers (Mattingley et al, 1990) using
3 . . . . . . .continuous H-thymidme administration to animals with a BEA-mduced
RPN (see section 4.6.1 for more detailed discussion) have shown that 
the urothelial cells lining the renal pelvis (particularly the 
fornices region) and ureter were particularly sensitive to 
proliferative response. This region of urothelia also showed a 
pronounced hyperplastic response in the marmoset (section 4.3.1) and 
in the pig (section 4.4.2.3.B and 4.4.3.4) after BEA. These 
hyperplastic changes may be due to a direct toxic effect of the BEA on 
the urothelial cells in this region. The hyperplasia may also be due 
to a number of consequences of the RPN lesion; the excretion of 
magnesium ammonium phosphate crystals may cause mechanical injury and 
irritation, the excretion of cell debris including brush border 
enzymes may also act as an irritant on the urothelial cells, or may 
result in a loss of protective glycocalx from the urothelium. All 
these possible factors will be discussed in more detail below and in 
Chapter 6.
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Compared to the BBN only treated group, animals from the BBN/BEA group 
had more severe urothelial abnormalities earlier, and any tumours were 
usually larger and with more dysplasia and cellular atypia.
Changes which were common between the BEA only group and BBN/BEA group 
were; hyperplasia of the urothelium (especially pelvis and ureter) 
with loss of alk. phos. staining in the urothelium and increased PAS 
positive glycocalyx staining which progressed with time. The
glycocalyx normally provides a protective barrier against bacterial 
and chemical attack, thus if the urine becomes more chemically 
hostile, a natural response of the urothelium may be an increase in 
the thickness or chemical nature of this barrier. The prominent 
glycocalyx staining with PAS-positive inclusion bodies accummulating 
too, could represent a long-term aberration of cellular function 
especially because they were most marked in those regions where the 
urothelial dysplasia was greatest. It is also possible that the 
increased glycocalyx staining is a response to changed renal function 
due to a loss of concentrating ability as a consequence of the RPN. 
PAS-positive staining inclusion bodies have been reported to be 
present in malignant bladder carcinomas by Hukill & Vidone (1965). 
The presence of the granules (inclusion bodies) could be related to 
the glycocalyx, particularly because changes in these complex 
carbohydrates have been linked to tumourigenesis and cell surface 
recognition (Iozzo, 1985; Smets & Van Beek, 1985).
These changes in carbohydrate staining may therefore represent early 
or subtle changes in the urothelial cells that predispose them to, or 
are directly responsible for, abnormal growth patterns. Similarly, 
increased glycosaminoglycans may be an expression of metabolic changes
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within the urothelial cells due to direct or indirect biochemical 
alterations as a result of a circulating (nephro) toxin. Makhailidis 
et al, (1987) in a review of prostanoids and their role in function, 
pathogenesis and treatment of disease in the urinary bladder report 
that "the link between prostanoids and glycosaminoglycans may be of 
great relevance, since glycosaminoglycans appear to inhibit the direct 
contact and adherence of chemicals and bacteria to the bladder mucosal 
surface". Certain prostanoids raise intracellular cyclic AMP levels 
which in turn increases local glycosaminoglycan production. The 
inclusion bodies may represent a response to increased prostanoid 
levels within the urothelial cells. However, analgesics and NSAID 
impair prostaglandin synthesis by inhibiting cycloxygenase enzyme in 
the arachidonic acid cascade and glycosaminoglycan synthesis is 
reduced, thus allowing bacterial and chemical attack directly on 
urothelial cells.
The loss of alkaline phosphatase staining in the hyperplastic 
urothelium which occurred gradually after about 6 weeks post BEA 
dosing in BEA only treated group, in nodular 'invasive' hyperplastic 
areas in BBN/BEA treated group is a histochemical change which has 
been reported frequently in chemical induced urothelial malignancies. 
(Kunze 1979; Kunze & Schauer, 1971, Stiller & Rauscher, 1971). The 
focal loss of alkaline phosphatase from otherwise apparently 
histologically normal rat bladder urothelial cells follows 
carcinogenic doses of BBN or FANFT (Kunze & Schauer, 1971) . The loss 
of alkaline phosphatase in the research reported in the published data 
(Kunze, 1979) was irreversible and occurred after the discontinuation 
of carcinogen, and could not therefore be a direct toxic effect. 
These alkaline phosphatase-free cells are considered to be pre-
neoplastic cells that develop into papillomas and carcinomas (Kunze, 
1979,1986). Gamma-glutamyl transpeptidase (GGT) positive cells are
already well established as markers for the pre-malignant changes in 
other organs (De Young et al, 1978; Bannasch, 1986a,b; Hannigan & 
Pitot, 1985; Moriyama et al, 1983). It has therefore been generally 
assummed that the presence of foci of GGT in the urothelia is a 
sensitive and specific marker of malignancy, especially because these 
changes are present in nodular hyperplasia and carcinoma that develops 
after BBN (Ozono et al, 1985). GGT foci were not demonstrated in 
this study which may be due to differing methodologies from previous 
reported studies, Ozono et al (1985) used wax sections whereas in this 
thesis glycolmethacrylate sections were used. Alternatively
Vanderlaan et al, (1982) has suggested that GGT identifies only 
advanced carcinomas and large papillomas, and may not be a 
pathognomonic indicator of premalignant changes under all 
circumstances.
From the results of the BBN/BEA study (section 5.2) it does appear 
that an initiated urothelium can be promoted by RPN to develop 
hyperplasia, dysplasia and finally tumours. This suggests that it is 
possible for RPN in the clinical situation to progress to UUC assuming 
the pathogenesis of BEA-induced RPN is the same as that for analgesic 
induced RPN: which on a morphological basis appears to be true.
The pilot study (see section 3.6.5.2 and 5.4.1) where further doses of 
BBN were administered to a BBN/BEA treated animal to hopefully mimic 
continued initiation of urothelium with carcinogens in human clinical 
situation. It is postulated that many chemicals are carcinogenic
when given to embryonic or newborn animals, but not when given to
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adults (Warwick, 1971) because the former have populations of rapidly 
dividing cells within their tissues. The rationale for this study was 
based to some degree on the results of Mattingley et al, (1990) (who 
found that the cells of the upper ureter and pelvis were capable of 
rapid proliferation), and on results from studies in this thesis 
(section 4.1.1) that have shown a marked hyperplasia of the cells in 
this region. It was of interest to determine whether administering 
the carcinogen during the period of intense proliferative activity 
increased the targeting of the carcinogen to these cells, and/or 
resulted in an increased tumour yield.
The results from this study (section 5.4.1) show that dosing with the 
carcinogen during the 3 days after a single dose of BEA causes a 
propencity to develop pelvic tumours similar to those reported in 
FANFT studies (Erturk et al, 1969). Hyperplasia of the pelvic 
urothelium occurs after BEA-induced RPN, it is possible that rapidly 
regenerating cells are sensitive to chemical attack. However, the 
main study performed later to confirm these results (sections 3.6.5.4 
and 5.4.2) where larger numbers of animals were used, did not show any 
differences between the BBN/BEA treatment and the BBN/BEA/BBN 
treatment. No pelvic or ureter tumours were induced and the only 
observed difference was that bladder tumours from the BBN/BEA/BBN 
treated group showed keratinisation earlier that the BBN/BEA-induced 
tumours (section 5.4.2).
5.7.3 Paracetamol Studies.
It appears from this pilot study (section 5.3) that paracetamol on its 
own could play a significant role in the initiation/promotion of the 
urothelium to produce severe hyperplasia, dysplasia and tumours
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following an acutely induced RPN.
The very rapid development of dysplasias and tumours (within 7 to 14 
weeks) in uninitiated animals given an acute RPN and then exposed to 
paracetamol raises a number of very important health care questions. 
Vast amounts of paracetamol are consumed (Wing et al, 1989), and it 
has generally been assumed that it is the most innocuous of the "over 
the counter" analgesics (except when taken in overdose) and should be 
taken as a single compound, rather than mixed analgesics. If the data 
in the rat are real and the same mechanisms apply to man (ie 
paracetamol can cause tumours where there is pre-existing renal 
papillary necrosis), then the health consequences of continued 
paracetamol exposure may have a very significant detrimental effect. 
However, studies performed in the pig to investigate this concept 
(that paracetamol can promote a urothelial carcinogenesis following an 
acute RPN in the multipapillate kidney) have been detailed earlier in 
this thesis (section 3.6.4.6). The results from this study (section 
4.4.3.3) suggest that subsequent dosing with paracetamol does not 
exacerbate the acute RPN (discussed in detail above, section 4.6.5.2). 
However, a pronounced pelvic urothelial hyperplasia with abnormal PAS- 
positive intracellular staining was observed (section 4.4.3.4) which 
may represent a pre-neoplastic change which if allowed to develop over 
a longer time period could have developed into tumours. To confirm 
this hypothesis it would be necessary to treat a group of pigs as 
described (section 3.6.4.6) and monitor the animals for a longer 
period of time. It may be possible to monitor the tumour development 
using clinical techniques such as urinary cytology (Eriksson & 
Johansson, 1976), retrograde ureterpyelography (Oschner et al, 1974) 
and computerised tomography (Gatewood et al, 1982; Nielsen & Ostri>
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1988) .
5.7.4 BBN Study 5 - An Irreproducible Experiment
The finding (section 5.5) that at every sacrifice time point so far 
examined only 20-25% of the BEA-dosed animals exhibited gross RPN 
(loss of papilla tip with stump remaining) and mild RPN changes in 50% 
of those animals that had intact papillae is puzzling. As stated 
above previous studies performed in this laboratory over the last 
decade and all reports from many other studies (see Table 2.6 for 
references) have shown that BEA > 25-35 mg/kg (Bach et al, 1983) 
induces a RPN lesion in 100% of the animals dosed. All of the 
materials used, weighings, injection times etc have been throughly 
checked and no errors or discrepencies (which could explain the 
anomalous results in this study) have been found. The study was 
allowed to continue until the 30th week to ensure that the protocol 
did not induce tumours despite the lack of an obvious RPN. It was 
felt that the cost of extending the study to 30 weeks in terms of time 
was justified, relative to the time, effort and expense of the study 
so far. This was also deemed necessary to obtain results from a time 
point (30 weeks) to compare to early studies, when tumours had been 
induced (section 5.2). Similar negative results were, however, found 
at 30 weeks; there was only a 20% incidence of gross RPN and no 
tumours were present. The experiment was terminated with no 
worthwhile results forthcoming.
A possible explanation for the anomalous results is as follows:- The 
Wistar rat strain at the University of Surrey had been recently 
"cleaned up" by having new breeding stock barrier-bred from Caesarean- 
born animals at a commercial animal suppliers. This was performed to
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remove a minor, but endemic respiratory infection, while the animal 
unit was rebuilt, fumigated and re-decorated as part of an improvement 
and up-grading of the facilities. The BBN study N° 5: Chronic dosing 
with paracetamol after BBN/BEA treatment (section 3.6.5.4) was 
performed using these "clean" rats 2-3 months after breeding stock 
had been re-housed. The most probable explanation for the anomalous
reponse is a reduced sensitivity to bromoethanamine, but the cause
cannot be explained.
The dose response curve to BEA of these "new" animals has been checked 
several times (including at the 30 week time point of this study) and
these studies have shown that (within the limits of biological
variability) has returned to that has always been previously 
experienced.
This normal dose-response to BEA was not, however, in itself adequate 
to re-investigate the problem. A number of urinary markers are being 
currently developed to allow us to assess non-invasively that 
papillary necrosis has occurred. The monitoring of urine for 
assessing magnesium levels, triglygerides, uronic acid and sustained 
lactate dehydrogenase release (Delacruz et al, 1989; Ding et al, 1989; 
Moret et al, 1989) provides an unambiguous indication of papillary 
injury. The increase in urinary triglycerides is related to the 
accumulation of renal lipid material and the increase in uronic acid 
relates to the loss of the medullary mucopoysacharide.
5.7.5 Relevance of the BBN/BEA Model of UUC.
Considering the results obtained from this study (section 5.1-5.5) in 
terms of the criteria necessary to designate a chemical or agent 
carcinogenic (section 2.3.2) then the RPN lesion within the BBN/BEA
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regimen can be considered a carcinogenic process. The BBN/BEA regimen 
which induces pelvic and ureter tumours can be considered a model of 
UUC, since tumours are induced in greater numbers than in control 
animals of this strain (with reference to historical control data 
Table 2.14). Tumours are also induced earlier than control animals 
(refering to BBN only treated animals). The fact that the BBN only 
animals develop tumours means that strictly according to the criteria 
of Berenblum (1974) for initiation-promotion then this study does not 
conform exactly to the classical initiation-promotion studies. 
However, administering the BEA step before the BBN step (as described 
in section 3.6.5.4) did not induce any urothelial tumours even in the 
bladder, whereas BBN only treated and BBN/BEA treated animals both 
developed bladder tumours as described above in results section 5.2-
5.4.
Compared to earlier studies used to induce UUC (see section 2.2.5) 
with analgesics (Johansson et al, 1976; Isaka et al, 1979; Nakanishi 
et al, 1982) this model system has a number of advantages over the 
dietary administration of carcinogen and promotor compound.
1. The dose of initiating carcinogen is known and can be controlled 
and manipulated (Becci et al, 1979; McCormick et al, 1981a), if 
required, whereas in the dietary fed methods there is little control 
over the exact dose of the carcinogen each animal is consuming.
2. It is also possible to control the promotion stage (by reducing 
the dose of BEA to induce a less severe RPN lesion), also when 
administering additional compounds such as analgesics the oral gavage 
technique allows a quantitative dose to be given which is similar to 
a typical daily dose consumed by an analgesic abuser.
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These factors make this model system much more adaptable than previous 
investigations. Compared to the spontaneous tumour models in the
DA/Han rat and BN/BiRij rat strains (see section 2.3.5.1) this 
chemically induced procedure produces tumours earlier although it must 
be said that the 25-30% incidence of identifiable macroscopic tumours 
is probably considered low and not very cost-effective.
The weaknesses of this model are:
1. It still requires a considerable period of time to induce tumours 
for harvesting to use in in vitro studies etc which is costly, both 
from an economic point of view and one of man hours involved in the 
maintenance of the animals.
2. The quantitative dosing technique when used in long-term dosing 
procedures, ie subsequent dosing with analgesics, was laborious, time 
consuming especially when all the animal maintenance procedures have 
to performed by the researcher.
3. The final incidence rate of UUC is low (30% maximum), this might 
not be considered cost-effective. There is a need for further 
research as to how one may increase the numbers of tumours induced. 
The pilot study with single analgesics would seem to suggest that this 
at least reduces the latent period of tumours and also increases the 
severity of the urothelial pre-neoplastic changes. Other studies have 
used experimentally induced urinary tract infection together with 
FANFT initiation to obtain an increased incidence of pelvic tumours 
(Johansson et al, 1987). Urinary tract infection is associated with 
RPN and BBN (discussed in detail below, section 6.2.1) it may be 
possible to increase the incidence of tumours in the pelvis and upper 
ureter by superimposing a urinary tract infection on the BBN/BEA 
treatment.
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4. There is a high incidence of tumours in the control carcinogen 
only treated group. One answer here is to reduce the dose of 
carcinogen, but increase the frequency of dosing. The problem here is 
that there is no longer a comparison with earlier studies and.a new 
learning curve must be begun.
5.7.6 Nude Mouse Xenograft Studies.
The overall "take" rate of the donor tumours of 10.5% (2/19) is low 
(section 5.6.1) compared to the generally acceptable "take" rate of 
50% for a variety of human tumours xenografted into nude mice (Polvsen 
et al, 1982). Considering the donor bladder tumours alone then the 
"take" rate of 29% (2/7) is an improvement, but still low when
compared to the "take rate" of 60% in other studies using xenografting 
chemically-induced (FANFT) bladder tumours into NMRI-nu/nu mice 
(Weldon & Solway, 1975). There a number of possible reasons why the 
pelvis and ureter donor tissues failed to take:- there was 
insufficient tumour tissue present in the original transplanted 
tissue. This may stem from the technical difficulties of surgically 
dissecting the very small tumour areas from the pelvis and ureter. If 
the transplanted tissue was non-malignant or in a regressive state 
then this may account for the fact that these tissues did not develop 
in the host. The donor tumour tissues appeared to be well 
differentiated with well developed connective tissues within the 
tumour tissue. "Take" rates have been reported to be the highest in 
tumour tissues which have the least histological differentiation ie 
invasive metastases (Sharkey & Fogh, 1984). The ability of a tissue to 
be accepted as a xenograft depends on the how well the tumour cell can 
adhere/attach/invade the host tissues and a number of other factors
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including angiogenesis; encouraging capillary growth into the tumour 
tissue to sustain its growth and development (Gabbert, 1985). 
Typically the "tumour" tissue from BBN/BEA treated rats is papillary 
in nature and not invasive, this may be a factor in whether the tissue 
"takes" in the host tissue.
The slow initial growth rate of the successful xenografted tumours is 
not unusual. Other studies have shown that the primary transplant time 
is significantly longer than that of subsequent passages and that the 
chance of non-takes is increased during the primary transplant period 
(Polvsen et al, 1982). If tumour cells can be transplanted to a third 
passage then there is a 90% chance of the tumour being established as 
a cell line. Growth rates have been shown to vary considerably in 
studies of different human tumours transplanted in nude mice. Polvsen 
et al, (1982) report that the average passage time to reach a 
measurable mean diameter of 10 mm was for kidney tumours 5.8 weeks, 
urinary tract tumours 2.3 weeks and colon tumours 7.8 weeks, although 
a considerable range can be experienced e.g. kidney tumours: 1.2
20.8 weeks. Rapid growth rate has, however, been correlated with an 
increased success in the "take" of the transplanted tumour (Mattern et 
al, 1981; Sharkey & Fogh, 1984). The growth rate of the successful
tumours was slow (11/12 weeks to reach a mean calculated volume of 200
3 .mm ) compared to studies with transplanted human urothelial cancers
3
(4/5 weeks to reach a mean calculated volume of 500 mm ) as reported 
by several workers (Huland et al, 1985; Kyriazis et al, 1984,1985), or
with pituitary adenocarcinoma tumours which only took 20 days to grow
3 . .to a mean volume of 200 mm (Kyriazis & Kyriazis, 1980). Differences
in the "host" nude mice strain have been suggested as one possible
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reason for the differences in "take" rates and growth rates of tumours 
in nude mice.
Many investigators have observed that the health of the nude mouse is 
of major importance for the successful maintenance of tumour lines. 
Stress has been shown to affect the health of laboratory animals and 
the experimental results that are obtained from such stressed animals 
(Fortmeyer, 1982). Every precaution was taken to minimise the 
potential environmental and experimental stress that may have been 
experienced by the nude mice. However, the mice may have induced a 
type of stress by their own natural territorial behaviour.
As mentioned earlier (section 3.6.6.5) these nude mice were prone to 
fighting between themselves, particularly immediately after the cages 
had been cleaned. It is presumed that each male mouse considered the 
clean fresh unmarked bedding as "his territory" and proceeded to 
defend it against all intruders (the other 9 mice in the cage). The 
animals are therefore stressed from fighting and/or injuries. In an 
attempt to reduce such stress injured mice were separated on their 
own facilitate healing, but isolation can stress rodents (Fortmeyer, 
1982) . It is perhaps for this reason that it is recommended that one 
uses female mice for experimental investigations (Sharkey & Fogh, 
1984) .
The morphological results and the histochemical results (the lack of 
alkaline phophatase staining in both the donor and xenografted 
tumours, see section 5.6.2), indicate that the tumours harvested from 
the nude mice were identical to the donor tumours. Limitations in 
time have meant that micro-cytochemical investigations on the very 
small tissue samples stored at -70°C have not yet been performed. 
These investigations together with karyological studies on the cells
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grown in vitro may have provided some more evidence for better 
defining the similarities or differences between the donor tumour and 
the xenografted tumour.
The mice used to subpassage the successfully grown bladder tumours 
were old, the same stock group as the original host mice. Older nude 
mice have a better developed killer cell immunity system (Sharkey & 
Fogh, 1984) with which to illicit an immunological response and thus 
prevent the tumour tissue establishing.
The choice of the subcutaneous transplantation site (section
3.6.6.4.B) may not have been the best site for growing these 
chemically induced tumours. It may have been better to transplant the 
tumour cells intraperitoneally where the rich, easily accessible, 
peritoneal blood supply provides a good site for tumour cells to 
"embed” and grow. This site has the major disadvantage in that it is 
not possible to monitor the growth of the tumour non-invasively which 
means it is a single end-point study method. Given that one of our 
main objectives was to obtain a quickly growing tumour with which to 
establish an in vitro cell line it may have been prudent (with 
hindsight) to take a small number of animals and subject them to this 
type of experimental procedure. Another alternative would have been 
to transplant the tumour cells directly into the bladder of nude mice, 
thus providing an environment almost exactly the same as the growth 
site of the donor tumour with regard to basement membrane, 
extracellular matrix etc. This technique has been used with moderate 
success by Huland et al, (1986) who obtained a 33% take rate of a cell 
suspension of human transitional cell carcinoma injected 
intravesicularly into the NMRI-nu/nu mouse bladder which had
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previously been instilled with N-methyl-N-nitrosurea to induce 
inflamination of the bladder urothelium. The accepted transplanted 
bladder tumours showed multifocal tumour growth with 4/5 tumours also 
showing muscle invasion. Similarly Naito et al, (1987) has shown that 
transplanting renal cell carcinomas into the renal subcapsule of nude 
mice produces tumours which grow faster, were larger, had more 
systemic metastases, had a better vascular system and were more 
invasive than than those transplanted subcutaneously. Naito et al, 
(1987) suggest that the tissue organ of tumour origin is the best site 
for implantation and growth of tumours in nude mice. The initial slow 
growth period in our successful tumours (Figure 5.32) may correspond 
to a period where the tumour cells are adapting to living in a 
"foreign" environment with different osmolality, extracellular matrix 
composition, growth factors, etc. and basement membrane to that of its 
original tissue site. Another critical factor involved in the success 
of the growth rate of the transplanted tumour is how quickly the 
tumour becomes vascularized and thus is provided with the means to 
sustain rapid and uncontrolled growth. The step of tumour 
vascularization is essential for the success for spontaneous tumours 
(Folkman, 1985) so it is likely to be just as important in nude mice 
xenografts. The delay in rapid tumour growth may correspond to the 
period where the transplanted tumour is having to "embed" into a 
different extracellular matrix and establish a blood supply by
releasing tumour angiogenesis factor (Folkman, 1985). It can be
envisaged how much easier this would be for a tumour cell which had 
been transplanted into a tissue type which for all instances is
identical to it's site of origin, resulting in a better chance of
acceptance, rate of growth, sustained growth and invasion. Future
studies of this nature should consider these facts. Although these 
alternative organ transplantation site methods may initially involve 
greater technical difficulties they will probably result in an 
improved experimental system in the long-term.
5.7.7. Discussion of In Vitro Studies.
It was important to attempt to develop in vitro cell cultures of the 
chemically induced tumours for several reasons:
1. Having such a malignant urothelial cell line would have helped 
reduce the need for large numbers of animals required presently to 
investigate the mechanism and factors controlling cell growth in the 
upper urothelial tumours.
2. The use of in vitro cell lines allows a greater flexibility in 
experimental design and procedures which is more economical than using 
animals in long term in vivo experiments. It is possible to change 
factors which may affect the tumour development; vitamin addition or 
mineral insufficiency, addition of chemotherapeutic agents to the
growth media, alteration of pH, change in oxygen tension. All of
these changes could be performed in the in vitro situation prior to
repeating any "interesting" results in the in vivo situation.
3. It be desirable to undertake chromosomal analysis, including 
assessment of oncogene activation products, to determine whether the 
induction of tumours was due to the activation of these genes.
4. The ability to culture large numbers of tumour cells economically 
could allow metabolic and biochemical analyses of tumour cells to be 
performed more cost effectively than in in vivo studies.
5. Such a cell line could be compared with material derived, from 
human tumours to characterise any similarities which may be
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diagnostically useful in human analgesic abusers.
5.7.8 Role of Mast Cells and Macrophages in the Development of UUC.
Throughout this study it was noticed that mast cells were frequently 
associated with the nodular pre-neoplastic hyperplasias (section 5.1 
and 5.2, Figures 5.2 and 5.7) in the lamina propria. Also they were 
frequently observed in the intersitial cords which are a feature of 
this type of tumour (section 5.2.2). In the late time points 
macrophages were observed within the superficial layer of urothelium 
(section 5.23, 5.3, 5.32).
Mast cells play an essential role in tumour invasion as they are able 
to increase the permeability of local blood vessels by the release of 
histamine (Gabbert, 1985). Thus the presence of mast cells in the 
lamina propria close to the nodular hyperplasias may aid the 
chemotaxic growth of these cells towards blood vessels (Nicolson,
1988). Histamine also promotes non-specific inflammatory reactions 
including oedema which may help the downgrowth and invasion of nodular 
hyperplasia by disrupting the lamina propria and distorting the 
extracellular matrix filaments (Parawaresch et al, 1985). The tumour 
cells may release an "attractant" to encourage the aggregation of 
macrophages into the area and then enroll these cells into the tumour 
progression process (Normann, 1985).
Similarly macrophages may play a role in the tumour progression by 
stimulating angiogenesis and producing growth factors (De Baetselier 
et al, 1985) . Macrophages when "activated" kill cells by generating 
reactive species such as hydrogen peroxide, superoxide anion (O2 ) via 
a number of oxidative pathways. It may be possible for macrophages to 
metabolically activate substances such as paracetamol, since they have
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a considerable potential for oxidation.
Recent studies by Marietta (1988) have elucidated a possible role for 
macrophages in the early stages of carcinogenesis through the 
endogenous production of nitrosamines from nitrate. Activated 
macrophages can perform n-nitrosation reaction and immunostimulation 
leads to an increased production of urinary nitrate (Marietta, 1988). 
Since RPN and UUC have both been associated with urinary tract 
infections (Eknoyan et al, 1982; Johansson & Wahlquvist, 1977) a 
situation can be envisaged where an increase in macrophages occurs to 
combat the urinary tract infection, and because of their subsequent 
"activation" these macrophages are able to produce N-nitrosamines 
locally to affect the urothelial cells. If these N-nitrosamines have 
a 4-hydroxybutyl structure then they may specifically initiate 
urothelial tumours (Okada, 1984) . The possibility that bacterial 
infection per se could have a role to play in the pathogenesis of UUC 
is discussed in detail below - section 6.2.1.
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CHAPTER 6.
GENERAL DISCUSSION INTER-RELATING MECHANISMS OF PATHOGENESIS OF RPN 
AND UUC, CONCLUSIONS AND POSSIBLE FUTURE RESEARCH DIRECTIONS.
6.1 MECHANISTIC BASIS OF RPN.
6.1.1 Mechanisms Postulated to Have a Role in the Pathogenesis of RPN
and Brief Summary of Chemically Induced RPN Studies.
Several hypotheses (see Table 6.1) have been put forward to explain 
analgesic nephropathy (Rosner, 1976; Shelley, 1978; Duggin, 1980;
Prescott, 1982), but it is only recently that the concept of a
progression of the condition from an early, silent lesion to end stage 
renal disease has been given some experimental credence (Bach & 
Bridges, 1985; Bach & Gregg, 1988; Gregg et al, 1989b; Bach et al,
1989) .
Table 6.1; some of the hypotheses which have been implicated in the 
pathogenesis of RPN and UUC.
1. The counter-current concentration mechanism.
2. Microvascular degeneration and medullary ischaemia.
3. Perturbation of arachidonic acid metabolism.
4. Alterations in intermediary metabolism.
5. Immunological changes.
6. Metabolic activation of biologically reactive intermediates.
7. Xenobiotic metabolism.(Peroxidase-mediated)
8. Cytotoxicity.
It has often been difficult to induce a model papillary necrosis in 
rodents using mixed analgesics (Bach & Bridges, 1985; Bach & Hardy, 
1985, and see section 2.1.3.2.D). 2-Bromoethanamine hydrobromide has, 
however, been regarded as an ideal chemical with which to induce a
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model RPN (see section 2.1.3.2.F). With the exception of the 
anomalous response of the nude mouse reported above (section 4.2.3). 
It targets selectively for the renal medulla in both sexes and all 
strains and species investigated so far. This includes Wistar, Fischer 
344, Sprague-Dawley, Holtzman, Donrju, Munich Wistar, Gunn and 
Battleboro rats (see Table 2.6) in CD-I, Schnider (Bach, P.H. & Gregg, 
N.J., unpublished observation), Obese, Balb/c and C57B1/6 mice 
(Scarlett et al, 1990), Syrian Hamster (Carlton & Englehardt, 1989) 
and the pig (Gregg et al, 1989a). Both the functional and the 
pathological changes caused by BEA are virtually identical to those 
associated with analgesic nephropathy in man and the lesion induced in 
animals using analgesics or NSAID (Bach & Bridges, 1985) . Another 
advantage of BEA is that it causes a dose related RPN (at doses > 50 
mg/kg ip) in 24-48 hr in all rats as opposed to the uncertainty of 3- 
12 months dosing rodents with mixed analgesics (Bach & Hardy, 1985) . 
It also causes no extra-renal lesions, unlike the NSAID which target 
for the gastro-intestinal tract (Kaump, 1966).
Light microscopy is the major investigative technique used to identify 
nephropathic lesions in toxicological studies and in the clinical 
situation but it has almost exclusively performed on 5 urn wax 
sections. The use of semithin (1-2 urn) glycolmethacrylate resin 
sections within this research project has allowed high resolution 
microscopy, coupled with selective enzyme histochemistry, to provide 
unprecedented morphological detail and the identification of the 
earliest cellular changes that initiate the pathogenesis of such 
nephropathies (Bach et al, 1987; Gregg et al, 1990a,b).
The results from investigations using BEA-induced RPN suggest
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(sections 4.1-4.4) that this "model” system mimics closely the 
morphological changes occurring during the pathogenesis of RPN in the 
clinical situation due to analgesic abuse (Burry et al, 1977; Gloor, 
1978; Bach & Bridges, 1985). The earliest degenerative change is 
located in the renal medullary interstitial cells which undergo 
necrosis first in the rat (section 4.1.1), and similar changes also 
occur in the mouse (section 4.2). While there are no time course data 
on the marmoset and pig these cells are also show the most prominent 
morphological changes.
The necrosis of the medullary interstitial cells is followed by, or 
closely associated with, alterations in the alterations in the 
mucopolysaccharide matrix and followed by degeneration of the 
endothelium, distal tubules, collecting ducts and loops of Henle, with 
changes in the enzyme histochemical staining profiles of the proximal 
tubules and microvasculature. The subtle degenerative changes in the 
proximal tubule do not appear to be central to the development of the 
papillary lesion. Exfoliated brush border enzymes and cells are 
important components of the proteinaceous casts in the distal nephron. 
Hyperplasia, the formation of distal tubular casts and then the 
proximal and distal tubular dilatation all appear to be secondary 
consequences of papillary necrosis, and the delayed increase in 
alkaline phosphatase staining in the urothelium supports this. The 
increased ATPase staining of sub-urothelial capillary endothelium 
suggests that there is a progressive microangiopathy similar to that 
described in human analgesic abusers with RPN (Mihatsch et al, 1979) . 
The time course of the complex cascade of morphological and 
histochemical changes occurring in the pathogenesis of BEA-induced RPN 
induced in the Wistar rat is schematically represented in Figure 6.1.
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The data presented in chapter 4 are the first to document such a 
cascade for BEA-induced RPN.
Similarly analgesic nephropathy is not a single event/ but a dynamic 
process of renal degeneration and repair in man, as the consequence of 
multiple exposure renal injury, and the reponse of the kidney under a 
continued barrage of insult. It is best considered in terms of the 
primary injury; RPN, and its secondary consequences. It is likely 
that the damage to the fine elements of the medulla such as the 
intersitial cells, loops of Henle, collecting duct, etc; (all of which 
have been described above in the acute or sub-acute experimental 
models, see section 2.1.2.3) each contribute to their own series of 
degeneration-repair consequences as the heterogenous population of the 
renal cells normally work in concert to maintain function even after 
injury (Bach, 1989).
The mechanistic basis of the primary RPN caused by any of the possible 
experimental manipulations is far from clearly understood. In common 
with most other toxic lesions a variety of mechanisms have been 
proposed at one time or another and some of these can be largely 
disregarded out of hand. For example, there is no link between 
immunological injury and RPN in human analgesic abusers (Gault et al, 
1971) or in animals with a model lesion (Murray & Von Stowasser, 
1976), nor with changes in intermediary metabolism (see Shelley, 
1978). However, the data from the nude mouse study (section 4.2.3), 
suggest that the immune system could have some role in the 
pathogenesis of toxic nephropathies.
6.1.2. Role of Haemodynamic and Vasculature Changes in RPN.
Over the last 20 years there has been a persistent suggestion that the
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medulla is close to anoxia (it is argued that only 10% of the renal 
blood supply reaches this part of the kidney) and it is therefore 
prone to ischaemic, injury. The potential for analgesic and NSAIDs
to reduce haemoperfusion (see Shelley, 1978, Bach and Bridges, 1985) 
together with microvascular degeneration at the late stages of all RPN 
has been envisaged as support of this hypothesis. This argument is
not supported by a critical assessment of the facts as the medulla is 
well oxygenated on the basis that the kidneys recieve 20-25% of the 
resting cardiac output. Most of the experimental evidence for the 
acute models does not support vascular occlusion or degeneration (Ham 
& Tange, 1969; Sherwood et al, 1971; Bach et al, 1983; Gregg et al, 
1990a) [see section 2.1.3.2.D.i], but cannot identify stasis, flow 
changes or increases in oxygen requirements. Data from Solez et al., 
(1974) showed increased radiolabelled albumin clearance following BEA, 
which appears to exclude homeostasis. The data from these studies 
(section 4.1.1.1) supports the argument that microvasculature changes 
are not an initiating factor in the pathogenesis of acutely induced 
RPN, but more likely play a role in the exacerbation of the lesion. 
There was no extravasation of Monastoral blue B and platelet adherence 
only occurred at late time points and in areas of the papilla where 
necrosis of the interstitial matrix and interstitial cells was 
pronounced (section 4.1.1). Comparing these results with the data of 
Solez et al, (1974) who reported an early increase in medullary blood 
flow 6 hr after BEA it seems unlikely that ischaemia and 
microvasculature changes have an initiating role to play in the early 
pathogenesis of acute RPN though it seems probably that these changes 
will help exacerbate the lesion.
Data from the pig study (section 4.4.3.1.B) show that the effective
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renal plasma flow to the kidney increases as a consequence of the 
administration of BEA. However, the determination of the effective 
renal plasma flow was performed 26 days after the administration of 
BEA and there is no data to show how these haemodynamic parameters are 
affected immediately after dosing with BEA. Effective renal plasma 
flow determination does, however, only provide an average assessment 
for the whole kidney and not a focal assessment for the medulla.
It would be attractive to do effective renal plasma flow assessment in 
rats over early time points after BEA and to repeat the assessment of 
effective renal plasm flow in the pig at earlier time points. The pig 
has been suggested to be a more relevant species in which to 
investigate RPN (see section 4.6.5.2 above), however, to perform a 
time course study on the pig similar to performed in rats (section
3.6.1 and 4.1.1) would be difficult and expensive but the 
investigation of the morphological and functional changes at an 
earlier time point could be useful.
6.1.3 Role of Metabolic Activation in Pathogenesis of RPN.
Metabolic activation by the mixed functional oxidase systems has been 
recognised as a key factor in a number of toxic lesions, including the 
kidney (Rush et al, 1984), but the absence of cytochrome P-450 from 
the medulla has suggested that such a process is unlikely. Many of 
the peroxidative enzymes such as the hydroperoxidase activity 
associated with cyclo-oxygenase (in prostaglandin synthase) are 
capable of a similar series of metabolic activations to P-450 (see 
Bach and Bridges, 1984, 1985). Several peroxidases convert the two 
major metabolites of phenacetin, p-phenetidine (Anderssen et al, 1983) 
and acetaminophen (Joshi et al, 1978; Zenser et al, 1979a,b; Nelson et
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al, 1981; Mohandas et al, 1981a,b) to reactive intermediates. Despite 
the fact that this hypothesis is attractive neither acetaminophen nor 
p-phenetidine cause RPN in the experimental situation.
All of the enzymes involved in prostaglandin synthesis are localised 
to the medullary interstitial cells, endothelial cells of all arteries 
and arterioles, the collecting ducts (Smith, 1981; Smith & Wilkin, 
1977; Smith & Bell 1978). This almost ubiquious distribution of 
prostaglandin synthetase and other peroxidase activities in the 
medulla make it most difficult to to explain why papillotoxins affect 
predominently one cell type as the earliest manifestation of target 
selectivity. The medulla has very low levels of glutathione and 
therefore once generated any reactive intermediate would not be 
readily inactivated (Bach & Bridges, 1985). The medullary 
interstitial cells, are rich in prostaglandin hyperoxidase and other 
peroxidases which have the potential to produce biologically reactive 
intermediates (Bach & Bridges, 1984,1985; Bach & Gregg, 1988). These 
cells also, however, contain high levels of poly-unsaturated fatty 
acids (Bojesen, 1974) that would predispose to lipid peroxidation if 
such reactive intermediates were generated locally (Bach & Bridges,
1984) . The interstitial cell does seem to be the target both in BEA- 
induced RPN and aspirin-induced RPN in Hooded rats (Molland, 1976, 
1978), and the reason for this target cell cytotoxicity probably 
resides in the biochemical characteristics of these cells. These 
facts, considered together with the fact that interstitial cells do 
not undergo proliferative changes when damaged, nor is there a stem 
cell population from which to replace 'lost or damaged', cells (Bach & 
Bridges, 1985, Mattingley et al, 1990), could lead to the continuous
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and insidious loss of these cells with the concomitant cascade of 
pathological changes (Figure 6.1). The predisposition of
interstitial cells to lipid peroxidation is supported by work done by 
Benns et al (1985) who reported that interstitial cells in culture are 
sensitive to the toxic effects of BEA and paracetamol. Studies using 
3T3, MDCK and HaK cells in culture provide additional evidence that 
lipid peroxidation could be the initiating mechanism in RPN (Bach et 
al, 1986). 3T3 and MDCK cells have a high prostaglandin synthetase
enzyme activity whereas HaK cells do not, in addition 3T3 cells also 
contain high numbers of lipid droplets but MDCK and HaK cells are 
essentially free of lipid droplets. The 3T3 cells which contain both 
high concentrations of prostaglandin synthetase enzymes and lipid 
droplets were the most sensitive to the toxic effects of BEA. BEA at 
a concentration of 0.2mM was cytotoxic to 3T3 cells in 2-4 hr, whereas 
the MDCK and HaK cells were resistant to BEA at concentrations up to 
2.0mM over 24 hr (Bach et al, 1986).
The interstitial cells synthetise the mucopolysaccharide ground 
substance that serves to support the delicate anatomical elements in 
the medulla, and also acts as a matrix that controls the availability 
and movement of liquid, ions and other molecules between different 
renal compartments. The early loss of this matrix will drastically 
affect renal function and morphology and play an important role in the 
cascade of degenerative changes. The loss of matrix could well be a 
key factor in the loss of concentrating ability. This could increase 
the urinary excretion of xenobiotic metabolites which affect more 
interstitial cells (thus perpetuating the lesion) and also the urinary 
tract urothelium. However it is still not certain from this light 
microscopy study whether the matrix changes are a consequence, or a
cause of the interstitial cell degeneration, or if a chemical effect 
on the collecting duct.cell plays a role in these matrix changes. 
Species differences in the glycosominoglycans/proteoglycans
constituents (see Table 6.2) of the interstitial matrix may offer some 
explanation for the differing susceptibility of different 
species/strains to BEA-induced necrosis in this region (Pitcock et al, 
1988) .
Species Type and distribution (%) of glycosaminoglycans in kidney
HA ChS HS DS Hep
RAT 13-17% 15% 56-70% 4-13% trace
PIG 30% 5-30% 73% 22% <0.05%
MAN 10-38% 15-17% 45-67% 15-26% 0.5%
HA, hylauronic acid; ChS, chondroitin sulphate; HS, heparan sulphate; 
DS, dermatan sulphate; Hep, heparin.
Table 6.2 Species variation in the type and distribution of 
glycosaminoglycans in kidney. Modified from Bach & Bridges, (1985) .
Future studies utilising immunohistochemistry including lectin markers 
for the matrix and ultrastructural studies with transmission electron 
microscopy should hopefuly provide some answers to this problem. The 
focus of such ultrastural and immunohistochemical studies should be on 
the very early time points (with small time intervals), in the cascade 
of necrosis (0-4 hr). The aim being to observe a more subtle cascade 
of necrotic changes and thus be able to identify which is the primary 
change ie interstitial cell necrosis or interstitial matrix 
alteration.
316
Interstitial cells also play a prominent role in prostaglandin 
synthesis, which are substances acting as modulation of local, rather 
than systemic, homeostasis. Thus prostaglandins can be envisioned as 
serving a cytoprotective role which is an important factor when the 
kidney is 'stressed' (either by disease, electrolyte depletion or 
fluid overload) in protecting the respective renal compartment from 
injury (Schlondorff, 1986) .
Perturbation of the arachidonic acid cascade could: by decreasing
prostaglandin synthesis (Bach & Bridges, 1984) result in an ischaemic 
response thus exacerbating the RPN lesion. The prominent necrosis of 
the thick ascending limb of Henle in the pig paracetamol study may 
provide some evidence for a possible mechanism linking the initial 
necrosis of interstitial cells, functional changes and the 
exacerbation of the RPN lesion. The thick ascending limb of the 
nephron is concerned with the absorption of salt (primarily sodium 
chloride) from the lumen as an intergral part of the countercurrent 
concentrating mechanism. To effect this absorption of sodium chloride 
a co-transport carrier protein present in the luminal membrane 
transports one Na+, two Cl”, and one K+ ions into the cells of the 
thick ascending limb (Greven, 1987). There is some evidence that this 
carrier protein may be intimately associated with the Tamm-Horsfall 
glycoprotein (Greven, 1987). The link with the necrosis of the 
interstitial cells is through prostaglandins particularly PGE2 which 
is synthesised mainly by the medullary interstitial cells 
(Schlondorff, 1986) . PGE2 has a number of potent effects on control
of renal haemodynamics, salt and water excretion (Clive & Stoff, 1984) 
presumably acting via the Na+-2C1~-K+ co-transport system, since 
prostaglandins act • at the thick ascending limb (Greven & Farjam,
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1988) . Clive & Stoff, (1984) have suggested the existence of a 
prostaglandin-mediated counter regulatory mechanism that could be 
suppressed by drugs with a resultant impairment of renal haemodynamics
i > . +  — +producing ischaemia, loss of ions (Na , Cl , K ), loss of Tamm- 
Horsfall glycoprotein and pronounced diuresis resulting in a cascade 
of necrotic changes similar to those described in BEA-induced and 
analgesic induced RPN (Bach & Bridges, 1985; Bach & Hardy, 1985). 
Greven (1987), in a review of loop diuretics (drugs which affect the 
thick ascending limb) suggests that adenylate cyclase (through cAMP) 
may have a role to play in regulating the Na+-2C1--K+ co-transporter 
system. Thus necrosis of the thick ascending limb could occur as a 
consequence of the interstitial cell necrosis because of the loss of 
regulatory prostaglandins.
The increased mucopolysaccharide staining observed (described in 
section 4.1.1) could represent the consequences of an increase in 
prostaglandin synthesis due to the renal stress and toxic injury 
following BEA-induced RPN. An association between prostaglandin 
synthesis, an increase in intracellular cAMP and an elevated 
localised glycosaminoglycan production has been reported (De Asua et 
al, 1975; Green et al, 1982).
The long-term progression of BEA-induced RPN affects the anatomical 
elements in the cortex producing an interstitial nephritis including 
cortical scarring, (a feature which is common in kidneys of human 
analgesic abusers), general atrophy and sclerosis of glomeruli, 
proximal and distal tubules, thus severely compromising the 
functioning capability of the kidney. This sclerosis and thickened 
basement membrane is first apparent in juxtamedullary nephrons where
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their loops of Henle descend deep to the papilla tip. They are thus 
the first nephrons affected by the cast formation and dilatation 
following the necrosis (section 4.1.2). Cast formation may occur as 
a consequence of a transient albuminuria due to a transient change in 
glomerlular permselectivity after BEA (Moret et al, 1989) . These 
intraluminal casts probably cause a blockage and produce a back 
pressure. With a build up of luminal pressure and unphysiological 
conditions (including potential toxins) within luminal fluid, thus the 
sclerosis and basement membrane thickening which is observed as a 
long-term consequence of a BEA-induced RPN could be a cellular 
response to these changes.
Hyperplasia of the pelvic urothelium may be a secondary consequence of 
RPN, a response to a direct cytotoxic injury by BEA, or as a result of 
mechanical injury from the marked transient excretion of magnesium 
ammononium phosphate crystals (Bach & Gregg, 1990) and is most 
evident in areas adjacent and opposite denuded covering papilla 
epithelium (Gregg et al, 1990a; Mattingley et al, 1985; and section 
4.1.1). This rapid proliferative response could be a protective 
adaptation to mechanical injury (discussed above section 4.6.1 and 
below section 6.2.5), increased output of cytotoxic urinary 
metabolites or a response to "growth factors" produced by residual 
covering epithelium in an attempt to re-epithelialise denuded areas. 
The increased alkaline phophastase staining which occurs initially 
(section 4.1.1) is probably a cytoprotective response since this
enzyme is found in increased quantity at the apex of viable cell
layers in control urothelia below the "umbrella" cell layer.
This hyperplasia of pelvic and ureteric urothelium is continued for
many weeks after the onset of RPN, eventually foci of papillary and
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nodular hyperplasia develop which are postulated pre-neoplastic stages 
in bladder carcinogenesis (Cohen, 1983). This suggests that RPN may 
in itself be a process that could promote an already initiated
urothelium.
6.2 MECHANISM OF BBN/BEA INDUCED UUC.
The data reported above (section 5.1-5.6) is one of the first studies
to show that a localised injury to the papilla can "promote" the
adjacent urothelia to a neoplastic state after initiation. This 
suggests a classical two stage process of initiation with BBN followed 
by an acute BEA-induced RPN resulting in the development of upper 
urothelial tumours. Promotion is, however, considered to be a 
multiexposure situation and therefore a single dose of BEA does not 
fit into this strict definition (see section 2.3.4.1). It is, however, 
likely that the changes associated with the BEA-induced degenerative 
cascade produces a sequence of multiple insults, which in concert
promote the urothelium. This suggest that analgesic-associated RPN 
per se may be a key factor in producing a proliferative response in a 
pelvic or ureteric epithelial cells, especially those that had already 
been initiated. These proliferating cells could then progress to 
localised upper urothelial carcinoma. It is uncertain how valid a 2- 
stage model is for human analgesic abusers, since carcinogenesis is a 
complex and dynamic process which is dependant on a great variety of 
interactions between the cells and carcinogenic agents. Since RPN in 
man is a pathological condition in which the pathogenetic mechanism 
which initiates the condition probably has a multifactoral basis (see 
section 6.1.1 above). Then a pathological condition which develops as 
a consequence of RPN will probably have a more complex mechanism of
pathogenesis. However, there are a number of factors (eg hyperplasia 
and bacterial infection section 2.2.6) which are common to RPN and UUC 
in the clinical situation and have also been reported (see below) for 
experimental studies where animals were fed analgesics.
6.2.1 Role of Urinary Tract Infection in the Development of UUC.
Urinary tract infection (UTI) had been associated with RPN and UUC in 
man (Eknoyan et al, 1982; Johansson & Wahlqvist, 1977) . 
Experimentlally UTI induced by the intravesical innoculation of 
Proteus mirabilis in the Gunn rat has been reported to induce RPN and 
hyperplasia of the renal pelvis urothelium (Thomas & Tange, 1985). 
Johansson et al, (1987) also found an increased incidence of upper 
urothelial tumours in female Sptague-Dawley rats initiated with FANFT 
and then intravesically innoculated with E. coli (06K13H1).
The mechanistic basis for these changes are unclear. They could 
include bacterial toxins or metabolic products, mechanical effects, 
enzymic effects of the urothelia, etc. More importantly, bacteria 
have been reported to be able to produce N-nitrosamines by 
nitrosylating secondary amines in the bladder or urinary tract (Claude 
et al, 1988). Secondary amines can result from N-glucoronidated 
metablites (such as BBN-Gluc, see section 2.3.5.2.B.i), being excreted, 
undergoing subsequent hydrolysis to N-hydroxylamines (Kadlubar et al, 
1977). These N-hydroxylamines may be metabolised by the bacteria to 
the N-nitrosamines producing localised initiation in the urothelial 
cells.
The plasma membranes of urothelial cells from BBN-induced pre­
neoplastic hyperplasia have been found to contain more unsaturated 
fatty acids than normal urothelial cells (Mimata et al, 1987). Thus
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precancerous urothelia may be more permeable and allow easier invasion 
by bacteria. Thus, bacterial infection may set up its own cascade of 
effects in the urinary tract.
The mucoid glycocalyx of the urothelial cells is a protective layer 
against bacterial attack. E. coli bind to urinary tract cells because 
their fimbrae have a number of different adhesin molecules which bind 
to carbohydrate groups in the mucoid glycocalyx thus enhancing the 
chance of colonising the urothelial cells (Parkkinen et al, 1988) . S- 
type fimbrae are in particular associated with E. coli that produce 
pyelonephritis and UTI. A major inhibitor of S-fimbrae adhesins is 
Tamm-Horsfall glycoprotein (THG) (Parkkinen et al, 1988) . The 
mechanism of this protection relates to the normal turnover of THG as 
soluble carbohydrates in the urine which block the receptors of the 
fimbrae adhesins thus inhibiting the binding of the bacteria to the 
urothelial glycocalyx (Parkikinen et al, 1988). It has been reported 
that the addition of THG at urinary concentrations (1-10 ug/ml) will 
interfere with 50 ug/ml of E. coli S-fimbrae colonisation (Parkkinen 
et al, 1988) .
THG is completely lost from the distal nephron in BEA-induced RPN 
(Bach & Bridges, 1984), thus there is an oppurtunity for bacteria to 
attach, colonise and induce UTI as the inhibitory mechanism has been 
disrupted. This UTI can possibly exacerbate RPN and UUC as described 
in detail above illustrating a possible link between RPN and UUC and 
the complexity of the whole pathogenic mechanism.
It is also probable that UTI increases the influx of macrophages into 
the urothelium to combat the infection. It has been suggested that 
macrophages have the potential to metabolise endogenous nitroamines
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which could initiate urothelial cells, and thus add to the complex
cascade resulting from UTI, this concept has been discussed in detail 
above (see section 5.7.8).
6.2.2 Role for Metabolic Activation via Prostaglandin Hydroperoxidase 
Synthase Enzymes.
Zenser et al (1985) proposed a mechanism by which the prostaglandin 
hydroperoxidase (PGH) component of the prostaglandin synthetase 
enzyme system is important in the mechanism of UUC. The papilla is a
region of high PGH activity and several renal toxins (eg
acetaminophen, p-phenetidine, NPAA) could serve as substrates to 
peroxidative metabolism to produce reactive intermediates (Anderssen 
et al, 1983; Zenser et al, 1983a,b; Mohandas et al, 1981a,b, Feldman & 
Bach, 1985 unpublished data) via a free radical mechanism (Boyd & 
Elling, 1984). In vitro studies on human urothelial cells have shown 
that PGH activity is present (Danon et al, 1986) thus the PGH 
activation of substances may occur within the cells. This may explain 
how activation of urothelial cells could occur in the experimental 
situation when there is frank interstitial cell necrosis due to BEA 
(presumably with a loss of PGH activity). A study by Mimata et al
(1987) found that precancerous urothelial cells (initiated with BBN)
had a higher arachidonic acid concentration that normal urothelial 
cells. This increased presence of arachidonic acid may stimulte PGH 
synthetase enzymes system to induce prostaglandin synthesis. The PGH 
can also metabolise other substrates to further initiate or promote 
the precancerous cells to progress to cancer. Additional synthesis of 
prostaglandins may have a positive feedback effect since PGF2 has been 
shown to initiate DNA synthesis, proliferation and an early elevation
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in cGMP in fibroblasts (De Asua et al, 1975).
6.2.3 Role of Oncogenes in UUC.
Weinberg (1988), states that the application of chemical carcinogens 
induces cancer Creating mutant alleles (oncogenes) of pre-existing 
cellular genes (proto-oncogenes). The most simple scenario is that in 
which a urothelial cell undergoes point mutation which after clonal 
proliferation results in a tumour, this occurs in bladder cancer with 
the Ha-ras oncogene (Reddy et al, 1982). In reality the process is 
much more complex, generally requiring tyo or more oncogenes to be 
activated to achieve full transformation at different steps in the. 
carcinogenic process (Figure 6.2).
THE DEVELOPMENT OF MALIGNANCY 
"A MULTI-STAGE PROCESS"
INITIATION PROMOTION PROGRESSION
I (MUTAGENS) (PROMOTERS) (PROGRESSORS)
NORMAL
CELL
INITIATED
CELL
TUMOR
CELL
MALIGNANT
CELL
ONCOGENE
ACTIVATION
Figure 6.2 The multistage nature of cancer. Substances involved in 
the activation of oncogenes in the initiation, promotion, and 
progression stages are called mutagens, promoters and progressors 
respectively. From Spandidos, (1985).
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This requirement may provide some explanation as to why carcinogenesis 
is a multistep process occurring over a long time period in vivo 
(Weinberg, 1988).
The Ha-ras oncogene is the result of a point mutation where guanine is 
replaced by thymine. This leads to a single amino acid change where 
valine is encoded (instead of glycine) and this changes the whole 
function of the Ha-ras product (Spandidos, 1985). Proto-oncogene 
products are postulated to play a vital role in critical cellular 
functions (such as regulation of gene expression, control of cellular 
differentiation by encoding for protein kinases which affect the 
growth factor receptors), and because of this have remained unchanges 
for millions of years. The Ha-ras proto-oncogene that is found in 
mammalian cells is essentially the same gene as that found in yeast 
and drosophila (Weinberg, 1988). The p21 protein encoded by the 
proto-oncogene is a guanosine triphosphatase (GTP-binding) membrane 
associated protein (Willman & Fenoglio-Preiser, 1987) . The activated 
ras p21 protein product (see Figure 6.3) has an impaired GTPase 
activity (Spandidos, 1985), the proto-oncogene induces
differentiation whereas the Ha-ras oncogene induces dedifferentiation 
(Peehl & Staney, 1986). The N-nitrosamine induction of tumours 
support the concept that rapid DNA alkylation and DNA repair are 
essential for possible early activation of the Ha-ras oncogene, since 
N-nitrosamines are rapidly metabolised (Montesano et al, 1985) . BBN 
is rapidly metabolised to BCPN and BBN-Gluc within 2 min (Bonfanti et 
al, 1988) (see section 2.3.5.2.B.i) and BBN also induces Ha-ras 
oncogenes in the NIH3T3 transfection assay (Fujita et al, 1988) . Pre­
neoplastic nodular and papillary hyperplasia induced by BBN have been 
reported to express Ha-ras p21 product (Ward et al, 1988) .
RECEPTOR CELL MEMBRANE
o
GDP
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Figure 6.3 Hypothetical signal transmission from growth factor to 
adenylate cyclase through p21 and growth factor receptor. From
Spandidos, (1985).
One possible mechanism for the UUC in BBN/BEA model is that the BBN 
activates the Ha-ras oncogene and the proliferation following BEA-
induced RPN results in a clonal expansion of those initiated cells to 
produce tumours.
6.2.4 Role for Stagnation and Pooling of Urine in Renal Pelvis, 
Ureter and Bladder
A common feature of BEA-induced RPN is a diuresis (section 
2.1.3.2.D.i) and a flaccid bladder and evidence of pooling in the 
ureters. Even when the the concentrating ability has been partly
regained such changes persist.
A mechanism for the metabolic activation of bladder carcingens via the 
prostaglandin synthetase system (Kadlubar et al, 1977) has been 
proposed and Antrup et al, (1981) also reported that the urinary human
bladder urothelial cells in culture can metabolize several different 
classes of chemical carcinogens into their ultimate proximate form. 
Any urinary tract carcinogens are transported to the urothelium via 
the urine (Cohen et al, 1983). Urine borne chemicals excreted by 
kidney could reach toxic levels because of the concentrating mechanism 
involved in the production of urine. The role of urine in altering 
urothelial carcinoma has been determined by diverting urine away from 
the bladder (to the lower intestinal tract, via a uretersigmoidostomy) 
drastically reduced the frequency of bladder tumours which followed 
FANFT feeding (Rowland et al, 1980). Studies using a heterotopic 
bladder (where a donor rat provides the bladder which is transplanted 
into the gluteal muscle of a recipient) have shown that an induced 
urothelia does not progress to a malignant lesion if it is filled with 
saline, but does develop tumours when filled with normal urine (Oyasu 
et al, 1981). It is then feasible to contemplate a situation where 
potential carcinogenic metabolites are excreted. Such factors 
occurring after RPN would increase the probability of metabolic 
activation by urothelial cells. Potential carcinogenic metabolites of 
analgesics (eg N-hydroxyphenacetin from phenacetin, Veronese et al, 
1985) could be present in sufficient quantities to both initiate and 
promote the urothelium. However, Figure 6.4 shows how 60-80% of 
phenacetin is metabolised to paracetamol which in turn is excreted in 
the urine as glucuronides (55%) and sulphate conjugates (30%) 
(Clissold, 1986). O-Glucoronides may react directly with the bladder 
epithelium whereas N-Glucoronides can be hydrolyzed to free N-hydroxy- 
aromatic amines, which can be activated to DNA damaging products 
(McQueen et al, 1987; Kadlubar et al, 1977). This may have occurred
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Figure 6.4 Schematic representation of the metabolic pathways 
postulated to account for the elimination of therapeutic doses of 
acetanilide, paracetamol and phenacetin. From Clissold, (1986).
in the BBN/BEA experiments where single analgesics were administered 
after RPN had been induced and more severe tumours developed early 
than with BBN/BEA treatment alone (section 5.4.1). The "ghost" 
papilla can detach and form caliculi within the pelvic space or block 
the ureter thus causing a stagnation of urine in upper urinary tract. 
The stagnation of urine in the renal pelvis has been shown to be an 
important factor in the induction of hyperplasias in the pelvis and 
ureter using experimental unilateral ureter ligation (Ito et al, 
1971). Urine stagnation could occur in RPN due to loss of normal 
pelvic and ureter peristasis (that normally occurs), sloughing 
papillae or other cellular debris blocking the ureter etc. Each of
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these would produce conditions to enhance UUC induction and several 
may occur simultaneously* Such pooling of urine may have occurred in 
the animals with pre-neoplastic papillary hyperplasias such as those 
observed 13 weeks after BBN/BEA treatment (section 5.2.1), since the 
papillary hyperplasias may also reduce ureteric urine flow. Greatly 
enlarged bladders were observed in many of the BBN/BEA animals and 
some had dilated upper ureters giving some credence to the hypothesis 
and paralleling the ureter ligation experiments described by Ito et 
al, (1971) . Prostaglandins (which are known to be inhibited by aspirin 
and NSAID) also have effects on the smooth muscle of gut and bladder 
(Borda et al, 1983). It is possible they also play a part in the 
modulating pelvic and ureteral peristalsis. A decrease in synthesis 
of prostaglandins could stop peristalsis with a resultant stagnation 
of urine in the upper urinary tract thus increasing exposure time to 
any urinary carcinogens.
6.2.5 Summary of Possible Mechanistic Basis Linking RPN and UUC.
The most attractive hypothesis to explain the selective targeting of 
malignant change to upper ureter and pelvis resides in the metabolic 
activation of endogenous or exogenous compounds which have a short 
half life in the medulla, but still may activate oncogenes to 
"initiate" the urothelial cells. Other factors such as loss of 
mucoid covering, delayed passage of urine would exacerbate any 
pathophysiological changes initiated by the locally generated 
reactive metabolites. Many patients with UUC have, however, been 
exposed to potential urothelial initiating agents by a high incidence 
of cigarette smoking which has been associated with an increased 
incidence of urothelial malignancies and carcinomas (McCredie et al,
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1983b). Diet, alcohol, caffeine consumptions have also been 
associated with an increased risk of developing urothelial carcinomas 
(Koch et al, 1986; Kunze et al, 1986; Ross et al, 1989) .
The data from these investigations suggests a number of 
possibilities:
1) RPN (or chemicals that cause it) may initiate upper urothelial 
cells and paracetamol (and presumably other chemicals) may act as 
promoters.
2) Biochemical changes in the kidney or urothelia after an acutely
induced RPN predispose to paracetamol (and/or other factors) acting as 
total carcinogens.
3) BBN initiation prior to RPN induction may target the toxic effects 
of paracetamol and other analgesics/NSAID to specific areas of the
urothelium which are more susceptible to proliferative changes
This warrants further investigation considering the high levels of 
consumption in single and mixed analgesic compounds by human analgesic 
abusers (Pommer et al, 1986; Sandler et al, 1989) who develop RPN and 
subsequently upper urothelial carcinoma.
The disease condition of RPN and the associated condition of UUC pose
a large burden both economic and personnel care on the medical
services of the world. Thus the determination of the molecular
pathogenesis of RPN and UUC is an important goal.
6.2.6 Possible Relevance of the BBN/BEA Model of UUC to Investigating 
the Pathogenesis of the Relationship Between UUC and Balkan Endemic 
Nephopathy.
Balkan endemic nephropathy (BEN) is thought to be caused by fungal
toxins, more specifically Ochratoxin A (see section 2.2.2). Patients
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with BEN are exposed to mixed mycotoxins. Ochratoxin A which has been 
reported to cause renal cancer in mice (Kaniwasa & Suzuki, 1978) but 
not urothelial cancer, but ochratoxin A has been found to be very 
nephrotoxic in rats (Berndt, 1987). UUC is associated with BEN, but 
as with UUC and RPN there is as yet no clear evidence for a causal 
relationship. Patients with BEN also have a very high intake of
nitrate- and smoke-cured foods and a high fat diet (personal
experience, Rumania 1989!), together with a high alcohol intake. Is 
the UUC associated with BEN due to urothelial initiation from a 
variety of environmental sources being "promoted" by an acute
nephropathy which targets for the proximal tubule and glomerulus
(Delacruz, 1988) The concept of an experimentally induced upper 
urothelial carcinoma (using the classical two stage initiation- 
promotion process) now has a valid scientific basis from the studies 
reported above. This concept lends itself to the investigation of the 
role that Ochratoxin A plays in a similar malignant condition, using,
perhaps, BBN as the initiating agent and assessing the response to an
acute or subchronic ochratoxin A-induced lesion. The question does
ochratoxin A have the potential to initiate the upper urothelial tract
and/or to promote an already intiated urothelium needs to be 
addressed.
6.3 CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS.
Despite the vast amount of clinical and experimental research over the 
past 40 years, the mechanism of pathogenesis of analgesic nephropathy 
is still not fully understood. This lack of knowledge has resulted in 
an inability to diagnose the condition non-invasively at an early 
stage in the development in order to effect some therapeutic control.
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Currently it appears that legislative measures are the only proven 
successful means of reducing the numbers of analgesic preparations 
that are abused and altering their formulations. In those countries 
where legislation has restricted access of mixed analgesic compounds 
(Australia, Finland, Sweden, Denmark) there appears to have been a 
marked decline in the number of patients requiring long-term dialysis 
as a consequence of analgesic nephropathy (Schwarz, 1987, Kincaid- 
Smith, 1988). This may not, however, reflect the relatively long 
latent period before the condition becomes clinically apparent, but 
merely the failure of the early renal lesion to develop to end stage 
renal disease. It could also, by the absence of renal failure, be 
allowing sufficient time for upper urothelial carcinoma to develop.
The International Workshop on the Health Significance and Early 
Detection of Nephrotoxicity made a consensus recommendation that 
"responsible authorities and private bodies take the appropriate steps 
to educate the public with regard to the hazards of the use of 
analgesics and to reduce access to certain analgesics and prohibit 
inappropriate combinations" (CEC-IPCS, 1989).
While such a recommendation is sound its implementation is greatly 
hampered by the failure to identify which analgesic(s) or NSAID(s) 
has/have the greatest papillotoxic potential, what are the risk 
factors and what combination of analgesics and NSAID (and/or other 
therapeutic or non-therapeutic agents) may be inappropriate. Taken in 
combination with the recently postulated role of caffeine (one of the 
most widely consumed biologically active compounds) in the 
pathogenesis of analgesic associated nephropathy, there are still many 
questions which need to be answered.
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In the absence of sensitive and selective non-invasive tests to 
identify early changes that precede clinically identifiable RPN, 
little progress can be made in future epidemiological studies. This 
highlights the future value of animal models until such diagnostic 
criteria are available. Despite some limitations for the acute and 
sub-chronic model lesions highlighted in this thesis, they are the 
most cost-effective way for investigation this complex clinical 
condition. Once the mechanism of the primary papillary lesion and its 
secondary consequences are fully understood for these models, it 
should be relative straightforward to extrapolate many of these 
findings to the human condition. These animal models should also 
provide the optimal system in which to compare the papillotoxicity of 
therapeutic agents and chemicals and identify high risk factors. The 
use of an animal species such as the pig (which is more closely 
related to man in terms of renal function and anatomy) may provide the 
model system of choice for extrapolating experimental research 
findings in order to compliment clinical and epidemiological studies. 
In view of the fact that the majority of all past and current 
toxicological investigations on drugs by the pharmaceutical industries 
and government agencies were/are performed on rodent species (mainly 
the rat), the findings of this preliminary investigation in the pig 
raises the question of how relevant is the data obtained from these 
rodent studies when applied to nephropathies which affect the 
papilla. The development of purpose-bred miniature pigs which are of 
more manageable size for laboratory studies and are commercially 
available, means that one of the major constraints (one of size and 
' pen space required) limiting the use of pigs in toxicological 
investigations has been reduced. The recently developed micro-pig,
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which grows to a maximum size of 25kg and has a life span of 10-15 
years, has been suggested as being ideal for long-term studies because 
of its size and ease in handling (Panepinto, 1986). However, a micro­
pig costs approximately ten times more than a Large White pig and 
the current lack of a data base on their response to nephrotoxins 
probably means that the conventional and miniature strains of pig 
will continue to be the prefered choice of porcine strains to use in 
nephrotoxicity studies. Such effort will help make worthwhile 
advances in the understanding of the pathogenesis of RPN in analgesic 
abusers.
Priorities for future investigations with a high clinical relevance 
include development of a diagnostic technique to identify the earliest 
changes involved in the onset of RPN, establishing the role of 
caffeine in pathogenesis of the primary lesion or its secondary 
consequences (since caffeine is common to the majority of proprietary 
most mixed analgesics, added to most without a proven therapeutic 
basis) and investigating how new technology, such as magnetic 
resonance spectroscopy and imaging, and molecular biology can help 
elucidate the pathogenesis of the initiation of RPN.
6.4 FUTURE RESEARCH BASED ON PROGRESS MADE IN THIS INVESTIGATION.
The focus of drug development and chemical safety on the problem of 
analgesic/NSAID-induced RPN has resulted in a complacency with regard 
to the increasing evidence that other chemicals can also cause RPN. 
While some of these compounds could be amenable to peroxidative 
activation, others (such as L-triiodothyronine, Kennedy and Jones,
1989) do not fit into this hypothesis easily. The mechanistic basis 
of such a lesion a^ waits further investigations, but highlights the
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need to be aware that a far broader spectrum of chemicals can cause 
RPN than are currently accepted or than have previously been 
documented.
These data suggest that the upper urothelial hyperplasia is an acute 
response to either the renal papillary necrosis, or its secondary 
consequences the release of cellular debris into the pelvis or a 
combination of related factors. This localised proliferative change 
in the upper urothelia could, therefore, represent an injury that pro­
moted uncontrolled cell proliferation in any cell population that had 
already been subjected to a genotoxic initiation. These findings may 
help explain the aetiology of analgesic associated of upper urothelial 
carcinoma.
Results from studies in BEA-induced RPN in the mouse, marmoset and pig 
suggest that the lesion is initiated in a similar manner to the rat 
i.e the medullary interstitial cells are affected first. This finding 
raises further questions:
i) by what mechanism are the degenerative changes in the medullary 
interstitial cell caused?
ii) are the changes in other cell types eg loops of Henle, collecting 
duct and urothelium a consequence of chemical injury, or a result of 
the medullary interstitial cell degeneration?
iii) if peroxidative metabolism of papillotoxic chemicals is a key 
factor in the generation of reactive metabolites (Bach & Bridges,
1985) , what is the role of lipid droplets found in medullary 
interstitial cells?
iv) do the carbohydrate containing (PAS-positive) granules/droplets 
observed in the collecting ducts prior to necrosis have a role in the
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degenerative changes?, what is the relevance of the presence of 
increasing numbers of such PAS-positive granules in hyperplastic? and 
neoplastic urothelial cells?
v) are the interstitial matrix alterations an initiating factor or a 
consequence of interstitial cell necrosis?, do they relate to the PAS- 
postive granules?
vi) is the differing species response to BEA a result of differences 
in renal function/metabolism?, or differences in the type of 
interstitial cells found in the papilla?, and the composition of the 
lipids within the lipid droplets in those cells? Thus is the apparent 
resistance of the pig to papillotoxins due to the reported lower 
concentrations of polyunsaturated fatty acids in these cells which 
makes them less susceptible to lipid peroxidation?, or is the 
difference due to other renal/extra-renal factors?
vii) are the differences in interstitial matrix constituents (shown in 
Table 6.2) of the papilla critical to the ability of each species to 
cope with an acute RPN lesion?
viii) is it possible to determine a "marker change" in the urine of 
animals with RPN which could be used clinically to detect patients at 
risk?
ix) with regard to chronic analgesic dosing after an initiated 
urothelium, RPN promotion protocol, is it possible to isolate 
and identify any metabolites which could be the proximate 
carcinogen(s)?
x) would it be possible to culture tumour cell populations derived 
from BBN/BEA-induced tumours? and use in vitro techniques to determine 
some of these questions and reduce the need for continued in vivo
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experimentation.
xi) would using a strain of rat such as the DA/Han rat which is 
genetically disposed to urothelial malignancies produce a higher 
incidence of tumours?, perhaps just using the BEA-induced lesion!
xii) is there a common biochemical pathway that link, the seemingly
disparate changes of necrosis (RPN) occurring simultaneously with
24-repair (hyperplasia)?, could mediators such as cAMP, cGMP or Ca hold 
the key? These questions need molecular biology techniques to 
provide the answers.
xiii) the finding that the immune system (or lack of a complete 
immune system to be correct) can influence the targetting of toxins so 
radically that it would be interesting to assess the effects of other 
papillotoxins and nephrotoxins in general on the Nude mouse kidney. In 
particular the how does the Nude mouse proximal tubule responds to 
classical nephrotoxins that target for this region of the nephron eg 
HgC^/ p-aminophenol, hexachlorobutadiene? Also do all papillotoxins 
cause such a proximal tubular injury?
The elucidation of each of these questions is the next step in this 
continuing programme. The use of immunohistochemistry (lectins 
and/or gold-labelled probes), should provide some answers to these and 
other important questions.
Immunohistochemistry holds the key to several questions arising from 
the BBN/BEA model of RPN/UUC. This includes
xiv) is it possible to identify preneoplastic changes earlier in 
the pathogenic sequence?
xv) is it possible to relate these changes to structural or 
functional (eg oncogene activation) alterations in the cell?, 
utilising monoclonal antibodies to surface antigens, cyto-keratins, or
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lectins to glycoproteins.
xvi) does the identification of why early preneoplastic changes 
occur, provide a basis for establishing preventative and therapeutic 
measures?
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I. Introduction
The etiology o f  renal papillary necrosis (RPN) in humans has been 
associated with the long-term abuse o f analgesics and therapeutic doses o f  
nonsteroidal antiinflammatory drugs (NSAID). However, the lesion has not 
been clearly defined in terms o f  the exact causative agent(s), how much (of 
each) was taken to cause a lesion, and over what period. The primary 
pathogenesis and the role o f other complicating factors are also not clearly 
understood, nor have the secondary pathophysiological consequences of  
R PN  been adequately interrelated, despite the fact that chronic renal 
failure and upper urothelial carcinoma are frequently associated with 
analgesic abuse (Bach and Bridges, 1985).
The understanding o f  the pathophysiology o f a chronically developing 
renal lesion in humans is a major problem in those conditions where the 
etiology has been clearly defined, because o f  the strong likelihood o f  
concurrent and complicating secondary (and unrelated disease) factors. 
There are important anatomical and functional differences between the 
kidneys o f  most animals and humans (Mudge, 1982; Stolte and Alt, 1980). 
The use o f experimental models has generally shown a number o f very 
important clinical and morphological differences; therefore, the use o f  
these models has often limited the understanding o f  similar conditions in 
humans.
Although R PN  (and upper urothelial carcinoma) are examples o f renal 
disease developing chronically in humans, it has been possible to study a 
number o f  chemicals that induce these lesions rapidly in experimental 
animals. These models (Bach and Hardy, 1985; Bach and Bridges, 1985) all 
have the important pathophysiological hallmarks o f the lesion that has been
1
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described in humans (Burry, 1968; Burry et al., 1977; Rosner, 1976; Bach 
and Bridges, 1985). The use o f these experimental models has therefore 
fortuitously provided a way to study the development o f papillary necrosis 
and the progression to a series o f renal changes similar to those seen in 
human analgesic abusers. These models are also allowing the interre­
lationship between the primary lesion and its secondary consequences to be 
defined in terms o f biochemical mechanisms. An understanding o f the 
molecular genesis o f  this syndrome may be highly relevant to improved 
clinical management o f R PN  and upper urothelial carcinoma in humans.
II. Renal Papillary N ecrosis and Upper Urothelial 
Carcinoma in Humans
RPN was first described over 100 years ago (Turner, 1885). It is a lesion 
that may have a number o f different causes (Table I), but most often when 
encountered in the clinical environment before the 1950s, was due to 
diabetes mellitus or sickle cell disease (Mandel, 1952). The most frequent 
cause o f R PN  since then (and in current clinical experience) is chronic, 
inappropriate, high-dose analgesic intake, especially the addiction to mixed
TABLE I
Ca u s e s  o f  R e n a l  Pa p il l a r y  N e c r o s is  
i n  H u m a n s
Frequently reported causes 
Diabetes mellitus 
Analgesic abuse
High-dose nonsteroidal antiinflammatory drug 
therapy
U pper urinary tract obstructive uropathy 
Recurrent urinary tract infection 
Sickle cell hemoglobinopathy 
Acute pyelonephritis 
Less frequently reported causes
Dehydrated newborn infants (frequently 
jaundiced)
Renal vein thromboses 
Chronic alcoholism 
Severe jaundice 
Calyceal arthritis 
Renal transplant 
Systemic candidosis 
Trauma
Prolonged hypotension
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analgesics over a number o f years. Therapeutic doses o f N SA ID  may also 
induce RPN (Nanra and Kincaid-Smith, 1972; Burry et al., 1977; Prescott, 
1979, 1982; Bach and Bridges, 1985).
Initially, all o f the mixed analgesics that were associated with the 
pyelonephritis seen in urology clinics contained phenacetin, and the 
condition was dubbed “phenacetin kidney” (Spuhler and Zollinger, 1953). 
Subsequently, however, it become apparent that other analgesics had the 
potential to cause R PN  (Gilman, 1964). The early confusion over the cause 
o f RPN, and the fact that most patients abused, or were prescribed, mixed 
analgesics and/or a number o f different N SA ID , also served to obscure case 
history data that might have provided vital information for the more 
accurate identification o f  which analgesics and/or N SA ID  had the greatest 
potential to cause the lesion (Cove-Smith and Knapp, 1978; Nanra and 
Kincaid-Smith, 1975; Nanra et al., 1980). The early failure to realize that 
phenacetin was not the sole cause o f  R PN  shaped the dogma that resulted in 
the withdrawal o f this drug from the market (Shelley, 1967, 1978). This, it 
was assumed, would remove the major etiological factor in the genesis o f  
the lesion. When acetaminophen (paracetamol) replaced phenacetin in 
mixed analgesic preparations the incidence o f RPN was expected to drop 
(Gaulte ta l.,  1968; Duggin, 1977; Kincaid-Smith, 1979). The occurrence o f  
the lesion did not, however, decrease in those circumstances where the. 
abuse o f mixed analgesics continued (Prescott, 1979, 1982), although some 
decreases have been attributed to the withdrawal o f phenacetin and 
extensive educational programs to discourage the abuse o f mixed analgesics 
(Wilson and Gault, 1982). A variety o f indirect evidence (Table II) has now  
branded acetaminophen as a very important cause o f the lesion, but it is still 
not clear if there is any scientific foundation for this conclusion. By the time 
it was realized that most (if not all) mixed analgesics (and many on their 
own) had the potential to cause RPN (Table III), a great deal o f  the 
“phenacetin-containing mixed analgesic” dogma had been established in the 
medical literature. There is, however, strong evidence from several differ­
ent sources to suggest that therapeutic doses o f N SA ID  may also cause 
RPN (Prescott, 1979, 1982; Robertson et al;, 1980; Shohetal., 1981; Erwin 
and Boulton-Jones, 1982; Mitchell et al., 1982; Bach and Bridges, 1985). 
Based on toxicity data, it is obvious that there are other chemical substances 
(Table III) that have the potential to cause RPN in animals. Many o f  these 
chemicals have industrial uses, and some are persistent environmental 
contaminants. Clinical situations rarely (if ever) focus on these possible 
environmental causes, or on the potential for substances other than 
analgesics and N SA ID  to contribute to R PN  in humans.
There is good clinical evidence to show that patients who continue to 
abuse analgesics (after the condition is diagnosed), have a very poor
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TA BLE II
C i r c u m s t a n t i a l  E v i d e n c e  Li n k i n g  
A c e t a m i n o p h e n  t o  t h e  E t i o l o g y  o f  
R e n a l  Pa p il l a r y  N e c r o s is
Phenacetin dogma— the belief that phenacetin was 
the only etiological factor in the genesis of 
papillary necrosis 
Phenacetin is metabolized to acetaminophen 
Acetaminophen replaced phenacetin in mixed 
analgesics, and the incidence o f pyelonephritis 
did not decrease 
Urinary acetaminophen was used as a measure of 
phenacetin abuse in patients known to be taking 
mixed analgesics 
Acetaminophen and aspirin are concentrated in the 
medulla, but phenacetin is not 
The genesis o f acute hepatic and proximal tubular 
necrosis following large doses o f acetaminophen 
has been widely studied, and the conclusions 
extrapolated to a chronic lesion in the medulla
prognosis and rapidly develop end-stage renal disease (Nanra and Kincaid- 
Smith, 1972; Kingsley et al., 1972; Murray and Goldberg, 1975; Burry et 
al., 1977; Cove-Smith and Knapp, 1978), while patients who discontinue 
the abuse o f  the offending drugs tend to stabilize, or show improved renal 
function (Bell et al., 1969; Dubach et al., 1978, 1983). It is these patients, 
however, who may be at risk o f  developing upper urothelial carcinoma. 
There is a very high incidence o f  epidemiologically associated upper 
urothelial carcinoma in those countries such as Scandinavia, Switzerland, 
and Australia where R PN  has a high clinical prevalence (Bengtsson et al., 
1968, 1978; Dubach et al., 1971; Johansson et al., 1974, 1976; Mihatsch et 
al., 1979, 1980a—c, 1982a-c; Mahony et al., 1977; McCredie et al., 
1982a,b, 1983). There is, however, no proved cause—effect relationship 
between R PN  and upper urothelial carcinoma (Bach and Bridges, 1985).
The diagnosis o f  R PN  (Gault et al., 1968; Duggin, 1977, 1980; Kincaid- 
Smith, 1979; Bach and Bridges, 1985) and o f upper urothelial carcinoma 
(Bengtsson et al., 1968, 1978; Dubach et al., 1971; Johansson et al., 1974, 
1976; Mihatsch et al., 1979, 1980a— c, 1982a-c; Mahony et al., 1977; 
McCredie et al., 1982a,b, 1983; Bach and Bridges, 1985) is most difficult in 
the clinical situation, and both progress silently. One early clinical sign 
o f  analgesic nephropathy is the loss o f  urine-concentrating capacity 
(Bengtsson, 1962; Dubach et al., 1975; Nanra et al., 1978; Nanra, 1980). 
Polyuria may, however, be a consequence o f several nephropathies, and
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TABLE III
A n a l g e s i c s , N S A ID , a n d  O t h e r  D r u g s  a n d  C h e m ic a l s
W ITH  PAPILLOTOXIC EFFECTS'*
Acetaminophen Ibuprofen
Aclofenac Indomethacin
Aminopyrine 4-Isopropylbiphenyl
5-Aminosalicylic acid Ketophenbutazone
Antipyrine Ketoprofen
Aspirin Meclofenamic acid
Aspirin, phenacetin, and codeine Mefanamic acid
Aspirin, phenacetin, and caffeine Mono-N-methylaniline
2-Bromoethanamine hydrobromide Naproxen
3-Bromopropanamine hydrobromide Niflumic acid
Bucloxic acid Oxyphenbutazone
2-ChIoroethanamine hydrochloride Phenacetin
2-Chloro-N,N-dimethylethanamine Phenothiazine
Cyclophosphamide Phenylalkanoic acid
Dapsone N-Phenylanthranilic acid
Diphenyl Phenylbutazone
Diphenylamine Propyleneimine
Diphenylmethyl alcohol Sudoxicam
Ethyleneimine Sulfinpyrazone
Fenoprofen Tetrahydroxyquinoline
Flufenamic acid Tolfenamic acid
Glaphenine Tolmetin
“Full references in Bach and Bridges (1985).
loss o f  the concentrating mechanism may have a number o f renal and 
extrarenal causes. R PN  is also associated with electrolyte disturbances. 
Cove-Smith and Knapp (1978) reported a high incidence o f sodium  
wastage, and Jaeger et al., (1982) showed that patients were hypocalcemic as 
a result o f  a urinary Ca2+ loss. Patients with analgesic nephropathy have a 
pronounced defect in the urinary acidification mechanism following N H 4CI 
administration (Bengtsson, 1962; Steele et al., 1969; Krishnaswamy et al., 
1976; Nanra et al., 1978; Nanra, 1980), suggesting that damage to the 
medulla might be synonymous with loss o f effective urinary acidification 
and altered electrolyte balance. Other classical clinical biochemical param­
eters used to diagnose renal disease only identify incipient renal failure, by 
which time papillary necrosis has long since occurred and the secondary 
degenerative changes that follow this lesion have progressed toward 
end-stage renal disease. There are few telltale clinical symptoms (Table IV), 
none o f  which are pathognomonic o f the condition. Degenerative renal 
changes may be identified by radiology (Lindvall, 1978), but these are 
essentially indicative o f  an advanced lesion, and they may miss early, but
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TABLE IV
C l i n ic a l  F e a t u r e s  A s s o c ia t e d  w i t h  R e n a l  
Pa p il l a r y  N e c r o s is
Early  sym ptom s 
Female predominance 3 :1  to 8 :1 
Psychiatric dependence, emotional instability, 
and anxiety 
U pper gastrointestinal disease 
Anemia 
In te rm ed ia te  sym ptom s 
Bacteriuria, sterile pyuria, nocturia, dysuria, 
microscopic hematuria, ureteral colic, and 
lower back pains 
Defective concentration and acidification of 
urine, proteinuria, nocturia, and azotemia 
Late sym ptom s 
Hypertension, ischemic heart disease, and 
peripheral vascular disease 
Calculi and bladder stones 
Decreased glomerular filtration rate, increased 
blood urea nitrogen, renal tubular acidosis, 
and end-stage renal disease 
U pper urothelial carcinoma
frank RPN. The most dependable method o f assessing analgesic-related 
disease is by detailed patient histories, but the stigma o f analgesic abuse 
normally leads to patients giving unreliable or misleading data on their drug 
usage (Murray, 1974, 1978). Similarly, it is difficult to diagnose upper 
urothelial carcinoma unless cytology and other diagnostic procedures such 
as computerized tomography (Gatewood et al., 1982) are applied. The 
knowledge that a patient has been an analgesic abuser can provide a basis 
for routine cytological monitoring, but this is rarely carried out even in 
situations where the incidence o f the disease is high (Jackson et al., 1978). 
The prognosis for the patients with upper urothelial carcinoma is poor, due 
to the advanced stage o f renal parenchymal disease and widespread 
metastases (Hultengren et al., 1965; Mihatsch and Knusli, 1982) when the 
condition is first diagnosed.
III. Experim entally Induced Renal Papillary Necrosis
Early attempts to study RPN experimentally using analgesics and N SA ID  
have been plagued with irreproducible experiments and conflicting data, so 
much so that Rosner (1976) was o f the opinion that analgesic-associated
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R PN was a lesion peculiar to humans and that animals were remarkably 
resistant to this type o f pathology. Analgesics, N SA ID , and a variety of 
other drugs and chemicals can, in fact, be used to induce RPN experimen­
tally. The objectives o f  this article are to review briefly the different animal 
models o f R PN  that may be useful for the experimental pathologists, and 
highlight their advantages and limitations. The focus o f this article will be 
on the use o f  chemicals that induce RPN acutely or subacutely, because 
these compounds (particularly if  they affect the kidney only) provide a most 
useful way o f  studying the pathogenesis o f RPN. Many o f the histological 
changes that we have studied have been based on the use o f high-resolution 
light microscopy, where semithin sections o f glycolmethacrylate-embedded 
tissue has been assessed by a number o f conventional histochemical 
methods. In addition, several enzyme histochemical methods have also 
been used to study changes that originate in the proximal tubule, the 
urothelial cells, and the endothelial cells. Our own interest has been in the 
application o f  a multidisciplinary approach to elucidating the biochemical 
mechanisms o f  R PN  and its related changes such as chronic renal failure 
and upper urothelial carcinoma.
A. S p o n t a n e o u s  a n d  E x p e r i m e n t a l l y  M a n i p u l a t e d  M o d e l s  
o f  R e n a l  P a p i l l a r y  N e c r o s i s
R PN  occurs in animals as a result o f a variety o f other conditions. These 
include age (Gorer, 1940) and amyloid-related (Dunn, 1944; Cornelius, 
1970) changes in mice, and changes that are a consequence o f medullary 
bilirubin deposition (and perhaps other biochemical effects) in the Gunn rat 
(Gomba et al., 1973; Call and Tisher, 1975; Henry and Tange, 1982; 
Axelsen and Burry, 1972; Axelsen, 1973). In addition, systemic candidosis 
also causes necrosis o f the medulla (Adriano and Schwarz, 1955; Hurley 
and Winner, 1963; Knepshield et al., 1968; Tomashefski and Abromowsky, 
1981). It has previously been reported that vascular occlusion (Muirhead et 
al., 1950; Sheehan and Davis, 1959a,b; Baum et al., 1969; Beswick and 
Schatzki, I960  ), ureteral obstruction (Sheehan and Davis, 1959b; Dziukas 
et al., 1982), and the injection o f heterologous serum into rats (Patrick et al., 
1964; Kroe and Klavins, 1965; Wizgird et al., 1965; Ljungqvist and 
Richardson, 1966; Ljungqvist et al., 1967; Gullbrin g e t al., 1966) also cause 
RPN. Critical analysis o f these data (Bach and Bridges, 1985), however, 
suggests that the medullary infarct associated with all o f these methods 
differs from the chemically induced RPN, and is more comparable to the 
“warm ischemic” renal lesion (Mason and Thiel, 1982; Wolgast et al., 1982). 
It would still be valuable for these lesions to be more fully studied by
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histochemical methods, at both the light and ultrastructural levels, to 
establish the nature o f  the changes, and where they may be similar to the 
chemically induced lesion. The long-term feeding o f  rats with a diet 
deficient in essential fatty acids (Burr and Burr, 1929, 1930; Borland and 
Jackson, 1931; Molland, 1982) also causes RPN, but the widespread 
degenerative changes in many o f the major organs makes this a most 
complex experimental model.
B . A n a l g e s i c  a n d  N o n s t e r o i d a l
A n t i i n f l a m m a t o r y - I n d u c e d  R e n a l  P a p i l l a r y  N e c r o s i s
Attempts to induce the R PN  using analgesics or N SA ID  have proved to 
be difficult (Rosner, 1976). A number o f researchers have produced the 
lesion with mixed analgesics (see Rosner, 1976; Macklin and Szot, 1980), 
single constituents such as amidopyrine (Brown and Hardy, 1968), aceta­
minophen (Macklin and Szot, 1980; Furman et al., 1976, 1981), and aspirin 
(Molland, 1976), and a variety o f N SA ID , including phenylbutazone and 
indomethacin (Arnold et al., 1974; Burnett, 1982; Bokelman et al., 1971). 
Many “second-generation” N SA ID  also have the potential to cause RPN  
(Table III).
R PN  has been most difficult to study because the renal medulla is 
inaccessible to investigation, is not well defined biochemically, and consists 
o f a heterogeneous array o f  cell types. Several problems associated with 
studying this lesion have been reviewed in detail (Bach and Bridges, 1985; 
Bach and Hardy, 1985). Three experimental considerations are most 
essential to the design and interpretation o f  all investigations into the 
mechanism o f  renal papillary necrosis and upper urothelial carcinoma and 
therefore warrant repeating.
1. There have been no definitive noninvasive criteria by which to 
diagnose experimentally induced RPN. Polyuria represents one o f the early 
renal functional changes which precede R PN  in experimental animals given 
repeated doses o f  analgesics (Angervall and Bengtsson, 1968; Brown and 
Hardy, 1968; Nanra, 1980), N SA ID  (Booth et a l ,  1961), and N SA ID  
analogs (Hardy, 1970a,b, 1974), and those chemical probes that cause RPN  
acutely (see below). Loss o f  urinary concentrating ability is not, however, a 
specific functional change peculiar to RPN, but it also accompanies many 
other renal and extrarenal changes (Berndt, 1975; Piperno, 1981). Simi­
larly, enzymuria (Ellis and Price, 1975; Halman et al., 1986) has been 
studied in the acutely induced RPN, but this fails to define the location and 
extent o f  a renal lesion. It is only once the renal cortex shows degenerative 
changes that changes are observed in the usual clinical parameters o f renal 
function, such as blood urea nitrogen and serum creatinine. There are 
therefore no routine clinical biochemical parameters that are pathogno­
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monic o f the lesion even under the most stringently controlled experimen­
tal conditions in laboratory animals, and the identification o f this silent 
lesion is dependent on recourse to histopathology.
2. Several analgesics and N SA ID  (and other chemicals) cause an apex- 
limited R PN  that can be easily missed if  painstaking sectioning is not 
undertaken through this region to ensure that a focal lesion is not missed 
(Fig. 1). All histology should therefore include the papilla tip or the ducts o f  
Bellini to ensure that this important technical prerequisite has been met.
3. The appropriate choice o f  species can profoundly affect the course o f  
a chemically induced lesion. It has been suggested that the rat is particularly 
susceptible to papillotoxic chemicals, because o f the highly concentrated 
urine that they produce (Consensus Conference, 1984). This is, however, 
unproven (Bach and Hardy, 1985), and there is a paucity o f published 
comparative data to establish if  any species or strain is most appropriate; 
however, there are well-defined but subtle differences between rat strains 
(Bach and Hardy, 1985; Bach and Bridges, 1985). More importantly, the 
rat is very sensitive to the ulcerogenic effects o f analgesics and especially 
the N SA ID . Thus, it is not uncommon for rats to die from gastric 
perforation before frank renal lesions are apparent (Kaump, 1966). In 
addition, several o f  the chemicals with papillotoxic potential also cause 
discrete cortical lesions when given to rats at the dose regimens commonly 
used. There are, however, also instances where rats have proved to be 
particularly resistant to the papillotoxic effect o f analgesics and N SA ID  
(Rosner, 1976) for reasons that are still not understood (Bach and Bridges, 
1985). W hen R PN  has been successfully induced, the intensity o f the lesion 
at each different time point varies from gross (with marked advanced 
cortical degeneration), to mild and focal, and often there are also animals in 
which no lesion has been found at the end o f a long-term study. Based on 
this variability, it has been difficult to assign either time courses or 
dose-response relationships to pathological. change when the lesion is 
induced chronically.
In summary, most analgesics and N SA ID  have been implicated as causing 
RPN in the animals, but many o f the chemicals have not proved to be useful 
for inducing the lesion experimentally.
The use o f  those therapeutic compounds that have been implicated in the 
induction o f  R PN  in humans (Table III) has not, in general, proved to be 
useful in inducing papillary damage in animal models. Most o f the analgesics 
and N SA ID  have at one time or another been reported to cause R PN  in 
several different species, but these have not provided robust systems for 
studying the time course o f R PN  and interrelating the different morpholog­
ical changes that take place. Many o f these compounds cause marked 
extrarenal toxicity and have an ulcerogenic potential far greater than the
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Fig . 1. Transverse semithin kidney section including papilla tip and mouth of ureter. Bar, 1 
mm. [From Bach and Bridges (1985).]
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nephrotoxic effects (Kaump, 1966). Some o f these drugs and their metabo­
lites also have marked toxic effects on the proximal tubule (Green et a i ,  
1969; Calder et al., 1971; Crowe etal., 1979; N ew ton etal., 1982, 1983a,b). 
While this may be relevant to the clinical situation, overt cortical damage 
has not been a prominent feature o f R PN  in human analgesic abusers. Thus, 
there is a complicating factor that obfuscates the study o f a primary 
medullary lesion if these compounds are used experimentally. More 
importantly, there are a number o f inadequately identified variables that 
have meant that successive sets o f experiments may not be reproducible. 
For example, whereas Molland (1976) showed that aspirin caused R PN  in 
hooded rats, there are reports for other species and strains that contradict 
this toxic effect (Rosner, 1976). Some o f the problems associated with using 
analgesics and N SA ID  to induce R PN  in experimental animals have been 
reviewed (Bach and Hardy, 1985). In general, the use o f analgesics and 
N SA ID  has served to confuse rather than to clarify the pathogenesis o f  
chemically induced RPN. There are, however, a number o f chemical 
“probes” that target very selectively for the medulla, and provide model 
systems that are preferable for studying the development o f RPN and its 
secondary sequelae.
C . N o n t h e r a p e u t i c  C h e m i c a l  P r o b e s  f o r  I n d u c i n g  R e n a l  
P a p i l l a r y  N e c r o s i s
The ethos o f many studies in experimental pathology has been to use 
model toxic agents to induce rapidly a lesion o f interest. The advantages o f  
inducing lesions over a short time course greatly outweigh the study o f  
chronic lesions (where other factors may obscure the cascade o f pathologi­
cal changes), but there is always the question o f validity in extrapolating 
data from an acute animal model to a chronic lesion that develops in 
humans. D espite these limitations, most o f our understanding on the 
biochemical mechanisms o f carcinogenesis and other toxic lesions in the 
major organ systems has been built up using this approach.
IV. Use o f Model Papillotoxic Probes to Study 
the Pathogenesis and Secondary D evelopm ent 
o f Renal Papillary Necrosis
The difficulties that have pervaded the use o f therapeutically used 
compounds for inducing R PN  have largely been overcome by the adminis­
tration o f papillotoxins that are chemically unrelated to the analgesics and
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N SA ID . There are also several N SA ID  analogs that have very little 
ulcerogenic effect, and have therefore contributed to our understanding o f  
the pathogenesis o f  RPN.
A. E t h y l e n e i m i n e - I n d u c e d  R e n a l  P a p i l l a r y  N e c r o s i s
The papillotoxicity o f  ethyleneimine, first described by Levaditi (1901), 
has been used to study various aspects o f R PN  (Mandel and Popper, 1951; 
Davies, 1967, 1968, 1970; Davies et al., 1968; Ham and Tange, 1969; 
Sherwood et al., 1971; Ellis et al., 1973; Ellis and Price, 1975; Axelsen, 
1978a). Ethyleneimine caused a dose-related necrosis (Axelsen, 1978a) that 
first affected the interstitial cells o f  the papilla tip, and then other “fine” 
anatomical elements o f  the medulla (Ham and Tange, 1969). At subsequent 
time points (or with higher doses), secondary cortical degenerative changes 
developed (Davies, 1967, 1968). Using colloidal carbon as a contrasting 
agent, the microvasculature was shown to be patent up to and beyond the 
time that necrosis developed (Ham and Tange, 1969). The functional 
changes associated with the ethyleneimine-induced lesion included marked 
polyuria, low specific gravity urine, and enzymuria (Mandel and Popper, 
1951; Ellis et al., 1973; Ellis and Price, 1975).
There are, however, a number o f problems with the use o f  ethyleneimine 
as a m odel papillotoxin. The compound is a powerful alkyating agent and a 
proved mutagen; it is chemically unstable and may also' be explosive 
(Dermer and Ham, 1969), and it is no longer commercially available. Thus, 
over the past decade, the use o f  ethyleneimine as a chemical probe for 
inducing R PN  acutely has declined dramatically.
B. 2 - B r o m o e t h a n a m i n e  H y d r o b r o m i d e - I n d u c e d  R e n a l  
P a p i l l a r y  N e c r o s i s
2-Bromoethanamine (BEA) hydrobromide has largely replaced ethyl­
eneimine as the model papillotoxin. First shown to cause RPN by Oka 
(1913), this compound has a number o f advantages over ethyleneimine. 
BEA is commercially available; it is a stable, water-soluble crystalline 
material, although it is unstable in solution. The.BEA-induced lesion is dose 
related and relatively predictable in its intensity for any dose range in the rat 
(Bach et al., 1983), and has been characterized in terms o f  over 35 
publications on different renal morphological and functional changes (see 
Bach and Bridges, 1985, for full reference list). It must, however, be 
stressed that BEA does cyclize to ethyleneimine in vitro under strong alkali 
conditions (Dermer and Ham, 1969), and this has been proposed as the 
mechanism o f BEA-induced R PN  (Murray et al., 1972). There is, however,
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no evidence to show that ethyleneimine is excreted in urine following the 
administration o f  BEA to rodents (P. H . Bach, unpublished data), although 
this does not preclude the localized formation o f the unstable alkylating 
molecule extrarenally or in the papilla.
1. Morphological Changes
A single 50 m g/kg dose given ip causes R PN  acutely in rats (Wyllie et al., 
1972; Shimamura, 1972; Bach and Bridges, 1982; Bach et a l ,  1983; Gregg 
et al., 1988a,b) and mice (P. H . Bach and N . J. Gregg, unpublished), and 
higher doses cause a lesion (Fig. 2A) up to but not beyond the cor-
FlG. 2. (A) BEA-induced R PN  lesion (100 mg/kg ip after 48 hours) showing limit of 
necrosis affecting the matrix staining. Giemsa staining, x 4 . (B) Medullary interstitial cell 
necrosis at papilla tip 4 hours after a single ip dose o f 100 mg/kg BEA showing pyknotic 
irregular nuclei (arrowheads). Giemsa, l-/rm  resin section, x  100. (C) Dilatation o f distal and 
proximal tubules 48 hours after a single 100 mg/kg ip dose o f BEA. Alkaline phosphatase, 
x20 . (D) Regenerative zone between viable and necrotic tissue in papilla 48 hours after a 
single ip dose o f 100 mg/kg BEA. N ote  mitotic figures in collecting duct (arrow) and loops of 
Henle (arrowhead). Giemsa, l-/xm resin section, x40. (E) Adhesion o f platelets to endothelia 
in area o f interstitial cell necrosis, 8 hours after a single ip dose o f 100 mg/kg BEA. Giemsa, 
1-gm resin section, X 100.
; b
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ticomedullary junction (Bach et al., 1983). Lower doses o f BEA do not 
cause any easily identifiable lesion, and repeated high doses do not 
exacerbate the degree o f RPN. The morphological changes associated with 
the time course developm ent o f  BEA-induced R PN  have been described in 
detail elsewhere (Wyllie et al., 1972; Hill et al., 1972; Bach et al., 1983; 
Gregg et al., 1988a,b) and will only be outlined in brief. Early hydropic 
changes developed in the proximal tubule 4—6 hours after BEA administra­
tion, but these had reverted to normal by 8—12 hours. Within 4 hours o f  
BEA dosing there was a significant collecting duct dilatation which lasted 
for 2 4 -4 8  hours.
Medullary interstitial cells had irregular nuclei at 4 hours and lost their 
cytoplasmic integrity by 8 hours; necrosis spread from the papilla tip to the 
corticomedullary junction from 12 hours (Fig. 2B). Collecting duct epithe- 
lia (and other areas o f  the distal nephron) showed degenerative changes at 
12 hours and cell exfoliation at 18 hours. Cortical changes were confined to 
PAS-positive casts in the collecting duct and loop o f H enle from 8 hours 
and dilatation o f  distal and proximal tubules at 8 and 72 hours, respectively 
(Fig. 2C). There was active repair at the junction between viable tissue and 
the necrotic papilla from 24 hours with mitoses in the collecting ducts and 
loops o f  H enle (Fig. 2D).
Necrotic changes developed as early as 12 hours and had run their course 
by 2 4 -4 8  hours. The earliest degenerative changes following low (50 
mg/kg) doses o f  BEA consistently affected the medullary interstitial cells, 
and the loops o f  H enle and the microvasculature were damaged later. The 
urothelial cells covering the papilla and the collecting ducts were left intact 
with minimal signs o f injury. The kidneys taken from animals given higher 
doses o f BEA showed similar early changes, but these were also associated 
with subsequent total necrosis which included loss o f all o f the cellular 
elements which make up the inner medulla.
Eosinophilic casts were present in the collecting duct from 24 hours, at 
which time reparative changes were evident at the interface between 
necrosed and normal areas. There was distal tubular dilatation from 8 hours, 
but this occurred in the proximal tubules after 72 hours. Endothelial 
platelet adhesion was first noticeable at 8 hours, was very marked at 18 
hours, and continued up to 144 hours; but only the capillaries in necrotic 
regions were affected, and not those in other parts o f the kidney or 
urothelial tract (Fig. 2E).
2. Histochemical Changes
Normally, the renal medullary matrix stains strongly with colloidal iron, 
Toluidine Blue, and Giemsa (Bach et al., 1983; Gregg et al., 1988a,b).
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Following BEA administration there were marked changes in the medullary 
matrix staining. The earliest changes were an increased staining intensity 
and a granular appearance around the interstitial cells at the papilla tip 2—4 
hours after BEA dosing. The increased staining became diffuse after 8 -1 2  
hours, and was progressively-lost from those areas where necrotic changes 
were taking place between 12 and 24 hours. The necrosed areas had totally 
lost the histochemical staining o f the matrix from 24—48 hours (Fig. 3). 
There was also an increase in PAS-positive material at the tip o f the papilla 
4 - 6  hours after BEA, which increased to a maximum at 48 hours, but at this 
stage the PAS staining in the mid-medulla was decreased. Even when there 
was reepithelialization o f  the affected area the mucopolysaccharide matrix 
was not reestablished, probably due to the absence o f  medullary interstitial 
cells.
Changes in the matrix staining have also been associated with R PN  in 
humans, where both increases (Burry et al., 1977; Burry, 1978) and 
decreases (Gloor, 1978) have been reported. It is tempting to suggest that 
these are similar to the early and late changes in the acutely induced BEA 
model. Rats given aspirin chronically also developed R PN  and a dense 
fibrillary network o f  PAS-positive material, which became irregular with 
more deeply PAS-staining fibers and bodies in the interstitium (Molland, 
1978). Recently, these histochemical changes have been confirmed bio-
Fig . 3. N ecrotic papilla 48 hours after 100 mg/kg BEA, showing loss o f matrix staining in 
extreme tip where tissue integrity has been lost. Giemsa, 1-g.m resin section, x3 .2 .
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chemically as demonstrated by the loss o f radiolabeled and covalently 
bound sulfate from the medulla following BEA administration; in addition, 
there was a marked perturbation o f urinary proteoglycans and glycosamino- 
glycans (Bach et al., 1988a).
3. D ista l Tubular Changes .
Tamm—Horsfall glycoprotein (THG) is produced by the ascending thick 
limbs o f  the loop o f H enle and lines the epithelium o f that segment and the 
distal tubule, where it is thought to prevent water reabsorption but still to 
facilitate N a+ transport (Lewis et al., 1972). -I-t forms the basic matrix 
material for tubular casts.
T H G  staining remained unchanged for 6— 8 hours after BEA administra­
tion, but during the development o f  the papillary necrosis this glycoprotein 
was lost from the distal nephron (Bach et al., 1988b), and small casts were 
found in the collecting ducts. From 12 hours there were more frequent and 
marked deposits o f heavily stained intraluminal material in the inner 
medullary collecting ducts, some o f which appeared to form aggregates 
against the epithelial cell walls. Only later, when the medullary mucopoly­
saccharide staining had been lost, were large casts o f THG-positive material 
deposited in the collecting ducts and ducts o f Bellini (Fig. 4), where they 
were associated with cellular debris (Bach et al., 1988b). The nephrons that 
appear to feed blocked collecting ducts were generally dilated. Tubular 
dilatation became more marked at 24 hours, when there were THG- 
positive casts in the ducts o f Bellini. These cast-filled ducts appeared to 
drain those regions o f  the cortical nephron where tubular dilatation was 
most marked. Between 24 and 123 hours the cortical staining pattern was 
essentially unchanged, but there was more extensive tubular dilatation. The 
number o f THG-positive casts— containing significant quantities o f cellular 
debris— increased, and T H G  staining in the distal nephrons decreased. 
Some o f  the THG-positive material was also extravasated (Bach et al., 
1988b). Many o f the superficial glomeruli thus affected have THG-positive 
material in Bowman’s space; this finding may be related to glomerular 
sclerosis (Arruda et al., 1979; Sabatini et al., 1982, 1983) that developed 
after some weeks. The most marked cystic dilatation o f cortical nephrons 
were associated with the most extensive deposits o f TH G  in the ducts o f  
Bellini, and there were also deposits o f THG-positive material around the 
glomeruli (in Bowman’s spaces) o f the superficial nephrons, following 
high-dose BEA.
Perturbation o f T H G  distribution does not appear to play a primary role 
in the development o f RPN, but may be important in the pathogenesis o f  
the related polyuria and the secondary tubular changes that follow the 
BEA-induced lesion.
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Fig . 4. Casts of Tam m -H orsfall glycoprotein-positive material deposited in collecting ducts 
(arrowheads). Immunoperoxidase, wax section, X10. [From Bach and Bridges (1982).]
4. Enzyme Histochemical Changes in the Proximal Tubule and the 
Suburothelial Capillaries
The staining o f a number o f enzyme markers has been monitored during 
the development o f a BEA-induced RPN. There were no changes in the 
proximal tubular marker enzymes alkaline phosphatase, y-glutamyl trans­
peptidase (GGT), and adenosine triphosphatase (ATPase) before 8 hours, 
from which time there was a time-related progressive loss o f staining up to 
144 hours, when GGT was almost undetectable (Fig. 5A). Alkaline 
phosphatase and GGT (from 12 hours) and ATPase (from 18 hours) 
staining material occurred in the proteinaceous, PAS-positive casts in the 
loops o f  H enle and the collecting ducts (Fig. 5B). Lysosomal acid phospha-
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Fig . 5. (A) Alkaline phosphatase staining o f proximal tubule brush borders 4 hours after 
100 mg/kg BEA ip. 1-ju.m resin section, x 4 . (B) ATPase-positive staining in proteinaceous 
casts in necrotic region o f papilla 24 hours after 100 mg/kg BEA ip. l-/tm  resin section, x  10. 
(C) ATPase-positive staining o f endothelial lining in a ureteric capillary showing almost total 
occlusion o f capillary lumen (arrowheads), 144 hours after 100.mg/kg BEA ip. l-yum resin 
section, X100.
tase staining was increased in the pelvic urothelial cells at 12 hours and in 
the proximal tubules from 12 hours, up to 48 hours.
There was a marked increase in the staining o f the pelvic, ureter, and 
bladder endothelial alkaline phosphatase, and especially ATPase, at 12 
hours. The intensity and area o f microvascular ATPase staining increased 
progressively in these regions from 18 hours, and by 144 hours the capillary 
lumens were almost occluded in the worst affected areas (Fig. 5C). Capillary 
sclerosis has been described in the kidneys o f  human analgesic abusers 
(Mihatsch et al., 1978, 1984) and is thought to be a specific change which 
has not been described in any other types o f renal disease.
5. L ipid Histochemical Changes
The medullary interstitial cells have a very high lipogenic potential and 
contain numerous lipid droplets rich in long-chain polyunsaturated fatty
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acids (Bojesen, 1974). Oil Red “O ” (ORO) stains the lipid droplets in these 
cells heavily, but not other parts o f the kidney (Bach et al., 1988c). 
ORO-positive lipid material accumulates in kidneys o f  analgesic abusers 
(Munck et al., 1970; Burry et al., 1977; Burry, 1978), and similar changes 
occur in aspirin-induced (Molland, 1976) and essential fatty acid-deficient 
diet-induced R PN  (Molland, 1982). Recent studies have shown that in an 
acutely induced papillary necrosis, early lipid changes take place in the 
capillaries, followed by a marked accumulation (Fig. 6) o f lipid in the 
epithelial cells. Normally there is no ORO-positive lipid material in these 
cells. The epithelial accumulation o f lipid material extends into those areas 
o f the outer medulla which were not affected by the papillotoxin and 
appeared to be normal by routine hematoxylin and eosin staining (Bach et 
al., 1988c). Other chemically induced lesions, such as those caused by 
hexachlorobutadiene, aminoglycosides, m-platin, and polybrene, do not 
produce these ORO lipid changes (Bach et al., 1988c), which suggests that 
the capillary and epithelial deposits o f lipid material may be pathognomonic 
o f  RPN.
Biochemically, the lipid changes in the BEA-induced RPN represent a 
phospholipidosis, in which phosphatidyl- and lysophosphatidyl choline, 
-inositol, and -ethanolamine were increased (M. J. Duffy and P. H. Bach, 
unpublished data). The increase in urinary free polyunsaturated fatty acids
Fig. 6. Lipid droplet accumulation in papilla covering epithelium cells following single ip 
dose of 100 mg/kg BEA. ORO stain, fixed fro2en section, X32.
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with C i8, C20 and C22 suggests a large precursor pool for the synthesis o f  
eicosanoid-related products (D. J. Scholey and P. H. Bach, unpublished 
data).
6 . Microvascular Changes
The subtle control o f  kidney microvasculature and the shunting o f blood 
to (or from) different regions o f  the medulla and cortex represent a most 
fundamental process in normal renal function. This may be altered in 
nephrotoxic lesions that have been linked to ischemic injury. The introduc­
tion o f  exogenous particulate material into the renal microvasculature gives 
some indication o f  the patency o f the vessels or the presence o f occlusion. 
Colloidal carbon has been used to show the loss o f medullary microvascular 
filling at an advanced stage o f ethyleneimine- and aspirin-induced RPN. 
The introduction o f  this foreign particulate material for assessing vascular 
filling may, however, present some difficulties. While India ink has been 
used as the common source o f colloidal carbon, it contains a variety o f  
additives, including phenols and adhesives (Vernon-Booth, 1972), to 
enhance its drawing properties. In addition, the colloidal nature o f this 
material also imparts a substantial oncotic pressure. Both o f  these problems 
(which may cause artifacts in assessing microvascular filling), can be 
overcome by using India ink that has been dialyzed against isotonic saline. 
Colloidal carbon prepared thus has been used to follow the time course o f  
microvascular changes in animals treated with BEA. There was an early shift 
o f  microvascular filling from the cortex to the outer medulla (2—4 hours 
after dosing), and later (at 8—26 hours) the filling o f the inner medulla was 
more pronounced (Fig. 7 A), but at the expense o f the microperfusion o f  the 
outer part o f  the medullary plexus. These changes coincided with the 
development o f RPN. By 48 hours, when necrosis was complete, the 
damaged medulla was virtually avascular. During the course o f develop­
ment o f  RPN , however, the microvasculature was patent in the medullary 
tissue beyond the regions in which necrosis had occurred (Fig. 7B). These 
data were interpreted as showing that an acute medullary necrosis can occur 
without capillary occlusion (Bach et al., 1983). These observations have also 
been confirmed by high-resolution microscopy, where platelet adherence 
and microvascular changes did not occur until late in the development 
o f RPN.
The colloidal carbon method cannot identify “leaky” capillaries, an 
endothelial defect that could play a very important role in disrupting renal 
compartmentalization. Monastral Blue B is a water-insoluble, nontoxic 
colloid; it has an uniform size distribution, high contrast for thin and thick 
sections, an obvious appearance under electron microscopy, and is com-
Fig. 7. (A) Microvascular distribution o f colloidal carbon in the corticomedullary regions of 
(top) control and (bottom) BEA-treated rat kidneys (50 mg/kg at 2 hours). Unstained 100-yu.m 
celloidin section, x 4 . [From Bach etal. (1983).} (B) Aggregates o f colloidal carbon at the tip of 
a necrosed papilla (arrows) 26 hours after 50 mg/kg BEA. Hem atoxylin-eosin, x25. [From 
Bach et al. (1983).}
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Fig. 7. (B) (continued)
mercially available (Joris et al., 1982). Recently, this colloid has been used 
to assess microvascular integrity in the genesis o f RPN, where semithin 
methacrylate sections showed the vascular labeling o f glomeruli and 
capillaries in the pelvic basal epithelia. N o  Monastral Blue B was present in 
the papillary matrix (Fig. 8), suggesting that changes in capillary integrity 
(and the leakage o f material into the interstitium) were not involved in the 
pathogenesis o f  R PN  (Gregg et al., 1988b).
7. Interaction between 2-Bromoethanamine and Analgesic and 
Nonsteroidal Antiinflammatory Drugs
It has been generally assumed that the mixed analgesics are more 
papillotoxic than the individual components singly (Nanra and Kincaid-
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Fig . 8. Monastral Blue-labeled kidney from tissue embedded in glycolmethacrylate resin 
block. N ote  lack o f label in necrotic papilla tip, 24 hours after 100 mg/kg BEA ip. X 1.6.
Smith, 1972; Duggin, 1977), but there has been very little experimental 
evidence to substantiate chemical interactions exacerbating RPN. Recently, 
this question has been addressed using the interactions between a sub­
threshold dose o f BEA < 2 5 —35 mg/kg ip, which does not normally cause a 
discernible lesion), and various analgesics (Bach et al., 1988b). These 
investigations were undertaken in an attempt to develop a short-term 
screening method for evaluating and comparing the papillotoxic potential o f  
analgesics and other compounds. Whereas two doses o f aspirin and 
acetaminophen, in the range o f 0.1 to 5.0 mmol/kg, had no morphological 
effect on their own, there were interactions when BEA was given. Aspirin 
(0.1 m m ol/kg and especially 0.5 mmol/kg) plus BEA caused papillary 
necrosis more severely and frequently, with marked cortical tubular 
dilatation and very heavy deposits o f THG-positive material in the col­
lecting ducts and the remaining interstitium o f the medulla. On occasion, 
THG-positive material was present in Bowman’s spaces o f the superficial, 
but not juxtamedullary nephrons, in those kidneys where papillary necrosis 
was most extensive, and tubular dilatation very marked. By contrast, 
animals pretreated with 2.0 and 5.0 m m ol/kg aspirin, before BEA adminis­
tration, showed no difference from controls.
Pretreatment o f rats with 1.0 m m ol/kg o f acetaminophen greatly exacer­
bated the response to BEA. There was more extensive necrosis, marked
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tubular dilatation, loss o f  T H G  from the distal nephron, and heavy casts in 
the ducts o f Bellini and some in Bowman’s spaces o f the superficial 
glomeruli. By contrast, there were very few changes in animals pretreated 
with 0.5 m m ol/kg o f  acetaminophen. Increasing the pretreatment doses o f  
acetaminophen from 1.0 to 5.0 m m ol/kg dramatically exacerbated the 
necrotic lesion, the tubular dilatation, and the changed TH G  distribution. 
There were large casts in collecting ducts (associated with other cellular 
debris) and loss o f T H G  from the distal nephron. The presence of 
THG-staining material in Bowman’s spaces o f  superficial glomeruli was 
most frequently seen in animals pretreated with 1.0 and 2.0 mmol/kg o f  
acetaminophen (Bach et al., 1988b).
These data are difficult to interpret because o f the unique pharmacolog­
ical and toxicological properties o f aspirin and acetaminophen (Lovejoy, 
1978; Plotz et al., 1981), differences which are further exemplified by the 
complex dose—response curves that were associated with each compound 
when BEA was also administered. These data do, however, strongly suggest 
that significant synergistic interactions may take place between chemicals in 
the genesis o f  RPN.
8. Functional Changes
There are marked similarities between the renal functional changes and 
the pathomorphological progression o f the lesion following BEA adminis­
tration and those reported for the analgesic-associated lesion in both 
experimental animals and humans (Bach and Bridges, 1982, 1985; Bach and 
Hardy, 1985). Prominent among these is the loss o f urinary concentrating 
ability (Fauwa and Waugh, 1968; Wyllie et al., 1972; Murray et al., 1972; 
Shimamura, 1976; Sabatini et al., 1981, 1983; Vanholder et al., 1981; Bach 
et al., 1983), loss o f nephron function, and severe cortical degeneration 
(Sabatini et al., 1981, 1983; Bach and Bridges, 1982). Loss o f other urinary 
electrolytes (N a+, Cl- , PO4- , and Ca2+) has also been reported following 
BEA-induced RPN (Arruda et al., 1979; Sabatini et al., 1981). The 
measurement o f  urinary acidification capacity and electrolyte handling 
could therefore offer a simple way o f  monitoring for R PN  in toxicology 
screening programs. Arruda et al., (1979), however, failed to find any 
differences between control and BEA-treated rats studied 24 hours after 
dosing, and Sabatini et al., (1982) found neither an acidosis nor a defective 
urinary acidification in response to N H 4CI loading 1 month after dosing 
with BEA.
Wilks et al., (1986) studied the renal functional changes within 3 hours o f  
BEA administration. Their data showed that the excretion o f urea increased 
(from 30 minutes), osmolality decreased (from 90 minutes), and N a +
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excretion increased at 3 hours, but potassium excretion was unchanged. 
Glomerular filtration rate and the clearance o f the organic anion, p- 
aminohippurate, decreased over the period o f investigation. These data 
reflect early functional abnormalities, and suggest that BEA may be less 
target selective for the medullary interstitial cells than has previously been 
thought. This is supported by the enzyme histochemical changes in the 
proximal tubular brush border that may reflect subtle injury to the cortex. 
Alternatively, these changes may represent aspects o f the complexity in the 
renal response to injury, and they may reflect a rapid homeostatic conse­
quence caused by perturbation o f the medullary cells.
C . E t h y l e n e i m i n e  a n d  2 - B r o m o e t h a n a m i n e  A n a l o g s  f o r  
I n d u c i n g  R e n a l  P a p i l l a r y  N e c r o s i s
Recently, propyleneimine has been shown to cause RPN at doses as low  
as 20 yLtl/kg (Halman et al., 1986). Multiple doses o f  bromopropanamine 
hydrobromide, 2-chloro-N,N-dimethylethanamine hydrochloride, or 2- 
chloroethanamine hydrochloride (Powell et al., 1985a) also cause this 
lesion, but each is either less effective and/or more toxic than BEA, and 
propyleneimine has many o f the limitations o f ethyleneimine.
D . N - P h e n y l a n t h r a n i l i c  A c i d - a n d  
D i p h e n y l a m i n e - I n d u c e d  R e n a l  P a p i l l a r y  N e c r o s i s
The biphenyls are structural analogs o f the fenamic acid N SA ID , but 
have the advantage o f  a lower ulcerogenic potential. Hardy (1970a,b, 1974) 
has shown that a number o f  these compounds (Table V) produce RPN, but 
the most useful experimental models were induced by N-phenylanthranilic 
acid (N-PAA) and diphenylamine (DPA). Both compounds did, however, 
also produce necrosis o f the S3 region o f the proximal tubule and marked 
splenomegaly in the case o f  D PA (Powell eta l., 1983).
1. Morphological Changes in N-Phenylanthranilic Acid-Induced Renal 
Papillary Necrosis
N-Phenylanthranilic acid is a potent papillotoxin which targets very 
selectively for the medulla and causes a marked papillary urothelial 
hyperplasia Hardy (1970a,b, 1974; Hardy and Bach, 1984), but has little 
extrarenal toxicity (Powell et al., 1983).
The administration o f  N-PA A  to rats for 14 days caused a dose-related 
lesion from focal R PN  (at low doses) to total RPN, and marked cortical 
changes follow high doses o f  the biphenyl (Hardy, 1970a,b). The renal
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TABLE V
Pa p i l l o t o x i c  P o t e n t i a l  o f  B i p h e n y l s  a n d  N S A ID  a n d  
t h e  R e l a t iv e  A m o u n t  o f  PG E I n h i b i t i o n *
Biphenyl N SAID 
and their analog
R PN  induced 
in rats
Inhibition o f PGE* 
synthesis
Diphenylamine .+ +  +  + +  +  +  +
Flufenamic acid +  +  + +  +  +  +
N-Phenylanthranilic acid +  +  + +  +
Diphenyl + +  +
Diphenylmethyl alcohol +  +  + +
Diphenyl-2-carboxylic -
acid
* From T. L. Hardy (unpublished data). 
h PGE =  prostaglandin E2.
interstitial cells, the microvasculature, and the loops o f H enle at the apex o f  
the papilla were affected at the low doses (0.5-1 mmol/kg); and a 
progressive destruction o f  the collecting ducts and epithelium covering the 
papilla at higher doses (1— 2 mmol/kg), and there were also morphological 
changes in the outer medulla and cortex at the highest dose levels o f 3—5 
m m ol/kg (Hardy and Bach, 1984)..
The histochemical changes associated with the N-PAA- and DPA- 
induced R PN  have not been fully described, but include loss o f the 
mucopolysaccharide (MPS) staining from the medullary matrix in those 
areas where necrosis has occurred. THG-positive material was lost from the 
distal nephron and progressively accumulated in casts in the necrotic 
collecting ducts (Powell et al., 1983).
There are some important morphological differences between the N - 
PAA-induced lesions, which develop subacutely, compared to an acutely 
induced R PN  (Bach and Hardy, 1985). The lesion caused by N -PA A  was 
apex limited and affected no more than 30% o f the medulla (i.e., only the 
papillary tip) for multiple doses o f  3 -5  m m ol/kg o f N-PAA in Sprague— 
Dawley rats, but the lesion was diffuse in Wistar rats. Ethyleneimine 
(Axelsen, 1978a) and BEA (Axelsen, 1978b; Bach et al., 1983) cause a 
lesion which varied from an apex-limited focal necrosis (at low doses) to 
total ablation o f  the medulla.
2. Functional Changes in N-Phenylanthranilic Acid-Induced Renal 
Papillary Necrosis
The N-PAA-induced R PN  decreased urine osmolality and increased 
urine volume, but only at dose levels o f  2.0 mmol/kg or more. There were
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no changes in the urinary acidification after an oral dose o f ammonium 
chloride in animals treated with doses o f N-PAA less than 5 mmol/kg. If the 
urinary chloride excretion was studied between 0 and 2 hours after 
ammonium chloride dosing, there was a dose-related decrease in the 
concentration o f  chloride ions that was significantly different from controls 
at the lowest dose o f 0.5 m m ol/kg N-PAA. The importance o f choosing an 
appropriate window in time through which to monitor the dynamics o f the 
renal response to chemical perturbation is clearly shown by the fact that 
similar changes were not apparent in urine collected from 2 - 4  hours 
(Hardy and Bach, 1984). Increased urinary protein, sodium, potassium, and 
chloride excretion have also been reported in animals treated with DPA, 
but N -PA A  caused a proteinuria only (Powell et al., 1985b).
Y. B iochem ical Interpretation o f  the Pathogenesis and 
Secondary C onsequences o f Renal Papillary N ecrosis
M e c h a n i s m  o f  R e n a l  P a p i l l a r y  N e c r o s i s
A variety o f mechanisms have been proposed to explain RPN. There is 
little evidence from studies using animal models and clinical material to 
support the suggestion that R PN  is mediated by an immunological injury 
(Gault et al., 1971; Murray and Von Stowasser, 1976). Similarly, most o f  
the evidence to suggest that analgesics alter intermediary metabolism (see 
Shelley, 1978) was based on data using renal cortical tissues, which are 
biochemically very different from the medulla. A role for anoxic injury and 
microvascular degeneration is not supported by the acute-model lesion, as 
assessed by vascular filling data and morphology (Ham and Tange, 1969; 
Bach et al., 1983; Gregg et al., 1988a,b). N either the colloidal carbon nor 
the Monastral Blue method differentiates between stasis and high flow rate 
areas. Solez et al., (1974) have shown, however, that the clearance o f  
radiolabeled albumin was faster after BEA, thus there is no impaired 
papillary blood flow or hemostasis as evidence to support a contributing 
factor in the development o f RPN. Vascular changes appear to follow the 
lesion. W hile it has been argued that the ubiquity o f analgesics in inducing 
R PN  could be linked to depressed prostaglandin (PG) synthesis and 
vasoocclusion (see Shelley, 1978; Bach and Bridges, 1985), the evidence 
against this is extensive (Bach and Bridges, 1985). An active increase in the 
concentration o f  papillotoxic compounds by countercurrent concentration 
could militate in favor o f the lesion, but the loss o f concentrating ability 
occurs well before a lesion is histologically apparent (Wilks et al., 1986).
N one o f  the theories that have been postulated (Rosner, 1976; Shelley, 
1978; Prescott, 1982) to explain the molecular pathogenesis o f RPN have
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so far defined the factors underlying the development o f  the primary 
necrotic lesion, nor have they addressed themselves to the progressive 
secondary cortical changes which result in the degeneration o f nephron 
function. In the absence o f  a hypothesis to explain the genesis o f the lesion, 
it has been suggested that the metabolic activation o f analgesics, N SA ID , 
and carcinogens could play a very important role in cell injury, and be an 
essential factor in the genesis o f  both R PN  and upper urothelial carcinoma. 
The absence o f  medullary and urothelial cytochrome P-4 50 has precluded 
this metabolic process from direct involvement in the local formation o f  
putative reactive intermediate(s) that could cause the toxic effect. It is 
unlikely that a reactive product formed in the cortex (where there is 
cytochrome P-4 50 activity) would be transported to the papilla and upper 
urothelial cells and cause injury, because these reactive products are highly 
labile and their short-lived nature would preclude this “mechanism” (see 
Bach and Bridges, 1984, 1985).
Recently, the hydroperoxidase activity present in the PG synthase system  
(and other peroxidative enzymes) have been shown to convert the two 
major metabolites o f phenacetinj^-pheflebdine (Andersson et al., 1983; 
Ross et al., 1985) and acetaminophen (Joshi et al., 1978; Zenser et al., 
1979a,b; N elson et al., 1981; Mohandas et al., 1981a,b), to reactive 
intermediates. This is highly relevant to the medulla and upper ureter, 
where PG synthetase is very active (Mori and Mine, 1981). Only unstable 
chemical intermediates formed by these enzymes will act locally (at the 
medulla or ureter) to produce toxic effects, possibly via lipid peroxidation 
(see Bach and Bridges, 1984, 1985). D espite the attractiveness o f this 
hypothesis, neither acetaminophen nor ^-phenebdine causes RPN, and 
there are no published data to suggest their role in the development o f  
upper urothelial carcinoma in rodents. Long-term phenacetin feeding (over 
24 months) does, however, cause a marked pelvic hyperplasia (see Section
VI»9-Histochemically, the enzymes associated with PG synthesis are distrib­
uted in different regions o f the kidney. For example, the cyclooxygenase is 
localized to the medullary interstitial cells, endothelial cells o f all arteries 
and arterioles, the collecting ducts, and glomerular epithelial cells o f  some 
species (Smith and Wilkin, 1977a,b; Smith and Bell 1978). Prostaglandin 
antibodies demonstrated PGE2 and PGF2a in cortical and medullary 
collecting ducts, the medullary interstitial cells, both glomerular mesangial 
and epithelial cells, and endothelial cells o f the arteries and arterioles (Mori 
and Mine, 1981). More PGA2 has also been shown in the tubular cells o f  
the renal medulla compared to the cortex (Perez and McGuckin, 1972). 
N one o f  these methods serves to measure other types o f peroxidative 
activity, but total peroxidative enzyme activity can be measured by the 
diaminobenzidine method. There is more peroxidase activity in the col­
lecting duct compared to the medullary interstitial cells, but the absence o f
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activity in glomeruli suggests that this method does not demonstrate PG  
hydroperoxidase (Janszen and Nugteren, 1971, 1973; Litwin, 1977; Al-Ani 
and Fourman, 1979).
The ubiquitous distribution o f the PGs and cyclooxygenase and other 
peroxidase activities in different parts o f the kidney fail to explain why 
papillotoxic chemicals target selectively for the medullary interstitial cells 
and do not affect regions such as the collecting ducts or the glomeruli, that 
have similar enzymes. It has been suggested that the sensitivity o f the 
interstitial cells to these chemicals relates to the presence o f both an 
enzyme-activating system and high levels o f polyunsaturated fatty acids. 
This would predispose to lipid peroxidation and the associated cellular 
degenerative changes selectively in the interstitial cells (Bach and Bridges, 
1984).
The importance o f  the prostaglandins in the peroxidative activation o f  
potentially papillotoxic chemicals remains to be established. Recent studies 
have shown that cultured rat medullary interstitial cells are sensitive to BEA 
(Benns et al., 1985), but not to those nephrotoxins that target for the 
glomeruli or proximal tubule. These isolated interstitial cells contain lipid 
droplets and peroxidase activity. Interestingly, 3T3 and M DCK cells have a 
very high PG synthase activity (Hassid and Levine, 1977), whereas this 
enzyme has a low level o f activity in HaK cells (Hull et al., 1976). The 3T3 
cells also contain lipid droplets; the other two cell types are essentially free 
o f lipid material. The 3T3 are very sensitive to BEA and show pronounced 
cytotoxicity at levels o f  0.2 mAf over 2—4 hours. By contrast, the MDCK  
and HaK cells are resistant to BEA and appear to be unaffected by exposure 
to 2.0 m M for 24 hours. This observation also points to the increased BEA  
cytotoxicity in those cells with both peroxidative activity and lipid droplets 
(Bach et al., 1986). It must, however, be stressed that at present there are 
no data available to establish if the lipid droplets in the 3T3 cells are 
polyunsaturated, nor is there any information on differences in the 
intracellular activities o f protective factors such as catalase and superoxide 
dismutase.
W e have shown that N -PA A  undergoes peroxidative conversion to 
biologically reactive intermediates (Feldman and Bach, 1988). Horseradish 
peroxidase and PG synthase from pig seminal vesicle and medullary 
microsomes, in the presence o f  hydrogen peroxide or hydroperoxyeicose- 
noic acid (the precursor o f  PG formed from exogenous arachidonic acid), 
activate N -PAA. The biologically reactive intermediate(s) bind to protein 
and nucleic acid, an effect that is quenched by nucleophilic sulfhydryl- 
protecting agents such as glutathione (Feldman and Bach, 1988). The 
quantities o f N -PA A  that are bound to protein and nucleic acid (Feldman 
and Bach, 1988) are o f  a similar order o f magnitude to those o f several 
established carcinogens (Kadlubar et al., 1982).
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VI. Renal Papillary N ecrosis and Upper 
Urothelial Carcinoma
The relationship between R PN  and upper urothelial carcinoma in human 
analgesic abusers has been the topic o f  much debate and continued 
speculation, although the two are very strongly associated (McCredie et al., 
1982a,b, 1983; Bach and Bridges, 1985). Thus, the exact pathogenesis o f  
these malignancies in humans is uncertain; there have been no data on 
which factors exacerbate or ameliorate the development and/or the pro­
gression o f  the tumors, and under what circumstances they metastasize 
most readily. Normally the lesion is diagnosed at such an advanced stage, 
and with such widely disseminated metastases, that surgical resection may 
only be palliative (Hultengren et al., 1965; Mihatsch and Knusli, 1982).
A. R o l e  o f  U r o t h e l i a l  H y p e r p l a s i a  i n  t h e  
D e v e l o p m e n t  o f  U p p e r  U r o t h e l i a l  C a r c i n o m a  i n  
H u m a n  A n a l g e s i c  A b u s e r s
The progression o f  hyperplasia, through dysplasia, to malignancy is now a 
widely accepted series o f  changes in the development o f  carcinoma in 
epithelial cells in a number o f different organs (Faber and Sporn, 1976). 
Such events may occur in the genesis o f analgesic-associated carcinoma. 
There are well-documented foci o f hyperplastic ureteric epithelia, in 
addition to malignancies, in patients with upper urothelial tumors (Lomax- 
Smith and Seymour, 1980a,b) and in analgesic abusers with RPN, but no 
diagnosed malignancies (Blohme and Johansson, 1981). These data, taken 
in light o f  the already established very high incidence o f  upper urothelial 
carcinoma in analgesic abusers (Bengtsson et al., 1968, 1978) and the strong 
association between the two (McCredie et al., 1982a,b, 1983), highlights 
the possibility o f these proliferative changes in the pelvic and ureter 
epithelial cells as being premalignant.
B. A n i m a l  M o d e l s  o f  U p p e r  U r o t h e l i a l  C a r c i n o m a
There are several animal models o f  bladder and renal parenchymal 
carcinoma (Hicks, 1980, 1983; Cohen etal., 1983; Hard, 1987), but to date 
there has been relatively little research on experimentally induced upper 
urothelial carcinoma.
Many o f  the early investigations into the cause o f upper urothelial 
carcinoma concentrated on the role o f phenacetin and mixed analgesics 
(Johansson, 1981; Johansson and Angervall, 1976a,b; National Cancer
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Institute, 1978; Isaka et al., 1979; Nakanishi et al., 1982). While several o f  
these studies reported tumors at a variety o f renal and extrarenal sites, the 
only regular and reproducible effect on the kidney was urothelial hyperpla­
sia (Johansson and Angervall, 1976a,b). In the absence o f urothelial 
malignancies, the general conclusion has been adopted that there was 
sufficient evidence in animals that phenacetin was carcinogenic, but that this 
was limited for analgesic mixtures containing phenacetin (IARC, 1980, 
1982).
The early studies on bladder malignancies caused by feeding animals 
with 0.188%  N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) also 
showed the presence o f  upper urothelial malignancies in a few rats after 46  
weeks (Erturk et al., 1967). Subsequently, over half the 35 rats fed with
0.188%  FANFT for 46 weeks were shown to have severe pelvic hyperpla­
sia, and 4 cases o f upper urothelial carcinoma were also reported (Erturk et 
al., 1969). The FANFT-induced upper urothelial carcinoma has been  
shown to be exacerbated by phenacetin feeding, by mechanical perforation 
o f the renal pelvis (Anderstrom et al., 1983; Anderstrom and Johansson, 
1983), and by sustained Escherichia co//-induced urinary tract infection (L. 
Van Schultz, personal communication). There are also data to show that the 
administration o f  phenacetin for a period o f 30 weeks, after the urothelia 
had been initiated with N-butyl-N-(4-hydroxybutyl)-nitrosamine (HO- 
B B N ), caused a significantly higher incidence o f bladder tumors (Nakanishi 
et al., 1978).
These data suggest that upper urothelial carcinoma could be induced 
experimentally with a total carcinogen such as FANFT and/or the combina­
tion o f  initiation and promotion with any agent that causes a hyperplasia o f  
the papilla or pelvic urothelial cells. N one o f these investigations has, 
however, adequately addressed the question o f the interrelationship be­
tween R PN  and upper urothelial carcinoma. There is no evidence to 
suggest that FANFT causes RPN, and where phenacetin was administered 
after H O -B B N  there were no data to suggest that papillary necrosis had 
been caused by either chemical. In addition, there are several other 
manipulations such as mechanical injury to the renal pelvis (Anderstrom et 
al., 1983; Anderstrom and Johansson, 1983), high-salt diets (Lalich et al., 
1974), and saccharin feeding (Murasaki et al., 1982) that also cause pelvic 
hyperplasia in the absence o f RPN.
C . U p p e r  U r o t h e l i a l  H y p e r p l a s i a  i n  C h e m i c a l l y  I n d u c e d  
R e n a l  P a p i l l a r y  N e c r o s i s
Upper urothelial hyperplasia has, in fact, been a common consequence o f  
many papillotoxic chemicals, and varies from mild, following aspirin
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(Molland, 1976) or BEA (Bach et al., 1983), to a florid hyperplasia 
following substituted indeneacetic acid N SA ID  analog (Bokelman et al., 
1971). N -PA A  often caused hyperplasia in the renal pelvic epithelium  
adjacent to the necrosed papilla. A group o f rats dosed with 5.0 mmol/kg 
N-PAA for 5 days showed significant epithelial changes, which varied from 
a mild columnar hyperplasia, with minimal inflammatory cell infiltration, to 
a florid hyperplasia at the papillary apex (Fig. 9), associated with moderate 
subapical tissue necrosis (Hardy and Bach, 1984).
The protracted period required to induce RPN experimentally with the 
therapeutically used analgesics or N SA ID , and, especially, the variability in
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Fig . 9. Apex-limited urothelial hyperplasia following five daily doses o f 5 m mol/kg N-PAA. 
Hem atoxylin-eosin, x5 . [From Hardy and Bach, (1984).]
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the extent o f  the lesion caused by these agents (Rosner, 1976; Bach and 
Bridges, 1984; Bach and Hardy, 1984), have so far precluded the experi­
mental investigation o f  the relationship between R PN  and upper urothelial 
carcinoma. The acute nature o f the BEA-induced RPN, without extrarenal 
toxicity and with limited effects on the renal cortex, offers a less compli­
cated m odel to study pelvic urothelial changes and the factors that may 
exacerbate the process.
D. U p p e r  U r o t h e l i a l  H y p e r p l a s i a  f o l l o w i n g  
2 - B r o m o e t h a n a m i n e - I n d u c e d  R e n a l  P a p i l l a r y  N e c r o s i s
After BEA treatment the upper urothelia showed marked proliferative 
changes at the edge o f  the epithelia covering the papilla (i.e., at the junction 
between the normal and necrotic part o f  the papilla). This was five cells 
thick (whereas it is normally one cell thick in most parts o f  the urothelia, 
except for the ureter, where it is four cells thick) at 24—48 hours (Fig. 10A). 
Hyperplasia was especially marked at the mouth o f  the ureter (which was 
seven cells thick) at 18 hours and in the pelvis opposite the region o f  
necrosis, which was seven to eight cells thick at 18 hours (Fig. 10B). This 
had only partially resolved by 144 hours.
The ureter and the bladder showed minimal histological changes up to 
144 hours. There were few morphological changes in the upper urothelia 
before 24 hours, after which a progressive and very marked hyperplasia was 
present in the pelvic urothelia (adjacent to the necrosed papilla tip and up 
to the fornix), in the urothelia covering the papilla (at the junction with the 
injured area), in the collecting ducts, and at the origin o f  the ureter. The 
increased thickness o f  the urothelia was most marked at 72 hours and 
continued as such in all o f the upper urothelia (except the pelvis opposite 
the region o f papillary injury) for 144 hours after BEA. There were 
disproportionately fewer mitoses compared to the degree o f urothelial 
thickening (Gregg et al., 1988c).
E. U p p e r  U r o t h e l i a l  K i n e t i c s  f o l l o w i n g  
2 - B r o m o e t h a n a m i n e - I n d u c e d  R e n a l  P a p i l l a r y  N e c r o s i s
W e have used autoradiography to study cell kinetics in different regions 
o f the upper ureter following BEA-induced RPN.
Fig . 10. (A) Marked proliferative changes in papilla covering epithelium at leading-edge 
junction of normal and necrotic parts o f papilla. Toluidine Blue, l-/im  resin section, x40. 
(B) Hyperplasia o f pelvic epithelia opposite denuded papilla covering epithelium indicative of 
necrotic region, 24 hours after 100 mg/kg BEA ip. Toluidine Blue, x40.
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The cell kinetics in different parts o f the kidney, pelvis, and ureter were 
based on the incorporation o f [3H]thymidine, infused from a subcutane- 
ously implanted miniosmotic pump at a zero-order rate for 144 hours. This 
method provides data on the total accumulated turnover o f epithelial and 
urothelial cells for the period under investigation. The labeling index for 
normal cell turnover was highest (and similar) in the proximal and distal 
tubules, less in the epithelia covering the papilla and the adjacent pelvis, 
even lower in the ureter and collecting duct, and lowest in the pelvic fornix. 
Compared to the baseline cell turnover, there was a 2- to 3-fold increase in 
all the areas 144 hours after BEA, except for the collecting duct (8-fold) and 
the pelvic fornix, which showed a 16-fold increase (Gregg et al., 1988c). In 
absolute terms the most active regions o f cell division after BEA were the 
collecting duct, the pelvic fornix (opposite the papilla tip and the margin of 
papillary injury), and the origins o f  the ureter. The urothelia at the margin 
o f  papillary injury were apparently the least actively dividing cells. Both the 
proximal and the distal tubules responded to BEA-induced RPN with a 
markedly increased rate o f  cell division compared to controls.
These data show that the upper urothelia is very responsive to an acutely 
induced RPN, particularly as assessed by autoradiography, which was the 
most sensitive means o f demonstrating proliferative changes. Renal tubular 
epithelia and urothelia each had their own normal cell turnover, and the 
response o f  each to the papillary injury differed. The delayed development 
o f  urothelial changes for the first 24 hours after the necrosis o f the papilla 
suggests that the upper urothelial hyperplasia may be a consequence 
o f RPN.
F. C h a n g e s  i n  t h e  U p p e r  U r o t h e l i a l  H i s t o c h e m i s t r y  
f o l l o w i n g  2 - B r o m o e t h a n a m i n e - I n d u c e d  R e n a l  
P a p i l l a r y  N e c r o s i s
Carbohydrate granules have been noted in the epithelial cells associated 
with R PN  induced by aspirin (Molland, 1976) and BEA (Gregg et al., 
1988a). The aspirin-induced lesion was associated with an accumulation o f  
dense fibrils o f PAS-positive material in the interstitial matrix. There was 
also an accumulation o f PAS-positive granules in the cells o f the collecting 
duct and the covering epithelium in BEA-treated animals (Fig. 11). These 
granules appeared before cell necrosis and may therefore have been part o f  
the autophagic process responding to the release or breakdown o f the 
Extracellular matrix. The presence o f similar granules in pelvic and upper 
urothelial cells 21 weeks after the induction o f an acute papillary necrosis 
suggested that this change was a long-term aberration o f cellular function,
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Fig . 11. PAS-positive staining granules in superficial layer o f upper ureter urothelium 21 
weeks after single ip dose o f 100 mg/kg BEA. l-/rm  resin section, X100.
especially considering that they were most marked in those regions where 
the urothelium was most hyperplastic or dysplastic. Similar changes have 
been described in the upper urothelial carcinoma epithelial cells, and in 
cells that had metastasized from these regions (Tucker et al., 1959), and in 
bladder malignancies in humans (Hukill and Vidone, 1965). The presence 
o f  these granules could be related to changes in the glycocalyx, which has 
been linked to tumorigenesis and neoplasia (Iozzo, 1985) and to foreign cell 
recognition (Smets and Van Beek, 1984). The granules may also represent 
premalignant changes, although similar staining has been reported in 
rodents with lithium-induced nephropathy (McAulliffe and Olesen, 1983).
There are a number o f enzyme histochemical changes in the urothelial 
cells following a BEA insult. For example, there was a marked increase in 
alkaline phosphatase in the pelvic urothelial cells adjacent to the necrosed 
papilla at 8 hours, that subsequently included other hyperplastic upper 
urothelial regions (Fig. 12). This pattern was maintained for up to 24 hours 
and then declined to give a mosaic o f staining that was, nevertheless, still 
strong in the pelvis adjacent to the necrosed papilla at 144 hours.
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Fi g . 12. Marked alkaline phosphatase staining in hyperplastic pelvic urothelium opposite 
necrotic papilla at 8 hours after 100 mg/kg BEA ip. 1-g.m resin section, X100.
G . U r o t h e l i a l  I n i t i a t i o n  w i t h
H y d r o x y d i b u t y l n i t r o s a m i n e  (H O -B B N ) F o l l o w e d  b y  
t h e  I n d u c t i o n  o f  R e n a l  P a p i l l a r y  N e c r o s i s
Pretreating rats with H O -B B N  for 5 weeks, to a toal dose o f  800 mg per 
rat, followed by BEA, produced early diffuse hyperplasia (similar to that 
described in humans with RPN), which progressed to focal proliferative 
changes, up to eight cells thick (Fig. 13A) and discrete lesions with 
pleomorphic, atypical, and disorganized cells (many o f which had irregular 
and bilobular nuclei, and some o f which were multinucleated). These also 
included papillary PI tumors (Fig. 13B) and several flat carcinomas in situ 
that were invasive PI into the submucosa (Fig. 13C) or showed early 
invasion into muscle P2 (N .J . G regget al., unpublished). These features are 
similar to those o f  the tumors reported in human analgesic abusers 
(Johansson and Wahlqvist, 1977; Mihatsch et al., 1980c).
Animals treated with H O -B B N  followed by BEA and those treated with 
BEA alone, for up to 21 weeks, showed the same mosaic pattern o f alkaline
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phosphatase staining in the hyperplastic urothelia. Those areas o f the 
urothelium in the HO-BBN-pretreated animals that appeared to be 
invasive (PI stage) lacked alkaline phosphatase staining, and looked similar 
to foci o f  “normal” urothelium (Fig. 14A). Some o f  the hyperplastic cells in 
both the H O -BBN /BEA -treated and the BEA-treated animals had super­
ficial acid phosphatase staining (Fig. 14B), suggesting an autophagic re­
sponse. Whereas staining for GGT was effective on the brush border, there 
were no foci o f  this activity in the hyperplastic or dysplastic cells at any time 
point following BEA treatment.
By contrast, however, there are focal and irreversible losses o f  alkaline 
phosphatase from otherwise histologically and cytologically normal rat
Fig. 13. (A) Atypical, disorganized urothelium with multinucleated cells and potential 
invasive focal lesions following 5 weeks pretreatm ent with H O -B B N  and 13 weeks after a 
single dose o f 100 mg/kg BEA ip. Giemsa, l-/u,m resin section, x40 . (B) Papillary P I tum or in 
upper ureter following 5 weeks pretreatm ent with H O -B B N  and 13 weeks after a single ip 
dose o f 100 m g/kg BEA. N ote  invasive finger into submucosa (arrowhead). Toluidine Blue, 
1-gm resin section, X20. (C) Early invasion in muscle layer o f ureter from flat carcinoma in 
situ, seen as an invasive finger in B. Toluidine Blue, l-/tm  resin section, X100.
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Fig . 14. (A) P I invasive urothelium showing (arrowheads) negative alkaline phosphatase 
staining compared to hyperplastic urothelium. Gomori alkaline phosphatase method, l-/r,m 
resin section, X 32. (B) Acid phosphatase staining in superficial layer of urothelium following a 
single BEA 100 mg/kg dose at 30 weeks. Acid phosphatase Napthol AS-B1 method, l-/rm  
resin section, x32.
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bladder urothelial cells following di-N-butylnitrosamine, H O -B B N , or 
FANFT treatment (Kunze, 1979; Kunze et al., 1969, 1973; Kunze and 
Schauer, 1971; Stiller and Rauscher, 1971; Ito et al., 1973). The alkaline 
phosphatase-free foci are considered to be preneoplastic cells. GGT- 
positive cells are a well-established marker for premalignant changes in 
hepatocarcinoma (Hanigan and Pitot, 1985). Foci o f GGT-positive cells 
are present in otherwise normal urothelia after exposure to H O -B B N  
(Ozono et al., 1985), a feature that has been present in nodulopap- 
illary hyperplasia and carcinoma that subsequently developed. There is also 
some evidence to suggest that GGT may not be a pathognomonic indicator 
o f premalignant changes, but rather identifies only advanced carcinoma and 
large papillomas (Vanderlaan et al., 1982). These data suggest that the 
histochemical changes that take place in the upper urothelia differ from 
those that occur in the bladder, and raise the possibility that there may be 
subtle aspects in the pathomechanism that are unique to lesions in different 
parts o f the urinary tract.
The combination o f H O -B B N  and BE A did not produce any other 
obvious gross histopathological changes in the heart, lungs, liver, spleen, or 
pancreas up to 21 weeks. Similarly, there were no changes in the high- 
resolution light-microscopic features in the kidney, pelvis, ureter, or 
bladder associated with the use o f H O -B B N  only.
Thus the combination o f  H O -B B N  initiation followed by the promotion 
o f hyperplasia in the upper urothelial cells by a BEA-induced lesion appears 
to offer a very rapid model for the induction o f upper urothelial dysplasia. 
This experimental approach may provide a superior model for studying the 
genesis and development o f  RPN-associated malignancy. Furthermore, this 
system offers the potential to improve the diagnosis and management o f  
similar changes in human analgesic abusers. More importantly, these data 
suggest that the development o f upper urothelial carcinoma may represent 
a classical two-stage model o f cancer. If this is the case, and it is relevant to 
the condition in humans, there is a very important need to establish which 
o f the carcinogens that humans are exposed to represent the initiating 
agents. While the elucidation o f these agents requires very careful study, 
and cannot at this stage exclude analgesics or N SA ID , it is noteworthy that 
smoking was also very strongly associated with the development o f upper 
urothelial carcinoma in analgesic abusers in Australia (McCredie et al., 
1982a,b, 1983). Benzo{7z]pyrene is one o f the potent carcinogens that is a 
component o f  all smokes, and is thought to be a major risk factor in bladder 
cancer (Mommsen and Aagaard, 1983). Interestingly, the peroxidative 
enzymes o f  the type that may be involved in the metabolic activation o f  
analgesics, N SA ID , FANFT, and other carcinogens (Rapp et al., 1980; 
Mattammal et al., 1981; Zenser et al., 1983a,b) also convert benzoM pyrene  
to the highly reactive 7,8-diol epoxide (Marnett et al., 1978).
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VII. Summary o f the Pathogenesis o f  
Experim entally Induced Renal Papillary Necrosis 
and Upper Urothelial Carcinoma
The morphological, histochemical, and functional data presented above 
support several distinct series o f  pathological changes following the admin­
istration o f  BEA. The earliest histochemical changes take place in the 
medullary matrix, which appears to undergo depolymerization. The renal 
medullary interstitial cells are the first cell type to undergo degenerative 
change, which is rapidly followed by damage to the “delicate” elements 
(endothelium and loops o f  H enle) o f the medulla. The collecting ducts and 
endothelial changes are late and generally follow the necrosis o f  other 
anatomical regions o f  the medulla. The lipid changes in the medulla are not 
at present well understood, but they are similar to those already reported in 
human analgesic abusers.
The early subtle degenerative changes in the proximal tubule do not 
appear to be central to the development o f  the papillary lesion, but the 
subsequent exfoliation o f the brush border and proximal tubular cells are 
important components o f the protein casts that begin to form in the distal 
nephron. These subsequently appear to play at least some role in the 
development o f  functional changes that cause marked proximal tubular 
dilatation.
The intense alkaline phosphatase staining that develops in those regions 
o f  the upper urothelia suggests that hyperplasia is a secondary response to 
papillary injury. Similarly, the increased pelvic, ureter, and bladder endo­
thelial staining for ATPase suggests that there is a progressive suburothelial 
microangiography, similar to that described in human analgesic abusers, 
associated with R PN , but also show that this is a consequence o f the other 
changes that are taking place in the kidney.
The proliferative changes in the urinary tract epithelia were assessed by 
the number o f  mitoses and the urothelial thickness. The total number o f  
cell'divisions that occurred in the epithelia following BEA was measured by 
the continuous infusion o f {3H]thymidine and autoradiography o f  the 
semithin sections. Importantly, autoradiography also showed that there is 
marked regeneration in the proximal and the distal tubules, although 
routine histology failed to show these changes. Hyperplasia o f  the upper 
urothelial cells appears to be a secondary consequence o f papillary necrosis 
in this acute-model lesion.
The time course o f  the major pathophysiological changes associated with 
the development o f  R PN  and its secondary consequences o f  cortical 
degeneration and upper urothelial hyperplasia are presented schematically 
in Fig. 15. These data show that there are discrete series o f pathological
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Fig . 15. Schematic representation o f the cascade o f degenerative morphological and 
histochemical changes associated with BEA-induced renal papillary necrosis. RMIC, Renal 
medullary interstitial cells. G G T = Gamma-glutamyltranspeptidase; ATPase =  Adenosine 
triphosphatase.
changes that appear to start on the medullary interstitial cells, and the 
degenerative changes then go on to affect a variety o f other cell types in 
different parts o f the kidney. While much o f the effort in understanding 
nephrotoxicity has been directed at the physiology, morphology, and 
biochemistry o f  the primary renal lesion, there is obviously an equally 
important role for establishing the cascade o f  degenerative changes that 
follow a primary lesion. The complexity o f the kidney is such that it is 
unlikely that any one cell type can be damaged without there being 
repercussions in the rest o f  the organ and probably extrarenally.
VIII. Remaining Questions
It is now obvious that a variety o f chemicals, in addition to the analgesics 
and N SA ID , have the propensity to cause renal papillary necrosis. The 
study o f  R PN  and upper urothelial carcinoma therefore is no longer to be
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regarded as being purely the consequence o f long-term analgesic abuse or 
therapeutic N SA ID  exposure. In humans RPN may also be a consequence 
o f exposure to industrial and environmental chemicals. There is also some 
evidence to show that the papillotoxic chemicals and analgesics and/or 
N SA ID  may interact synergistically to produce RPN. Despite the large 
number o f  pathophysiological similarities between the acute and subchronic 
models o f  R PN , and between these and the chronic analgesic disease in 
animals and in humans, it would not be wise to extrapolate all o f the 
pathophysiological changes reported in the rat model to other species. 
Instead, there is an important need to develop more subtle criteria to 
interrelate the cascade o f degenerative changes and to develop better 
experimental techniques to allow a progression from acute, through 
subacute, to chronic animal models to be followed. Similarly, it is likely that 
studies on a number o f  different species can help address the question o f  
anatomical and functional differences between humans and animals. Upper 
urothelial carcinoma may be a consequence o f a total carcinogen, or it may 
more likely represent an initiation o f the upper urothelial cells (due to their 
endogenous peroxidative activity or medullary enzyme activation), and 
subsequently the development o f RPN and the associated injury to the 
upper urothelial cells and/or the associated functional changes that act as a 
promoting factor.
A number o f  questions still need to be addressed to understand more 
fully the pathogenesis o f  R PN  and particularly the sequence o f events that 
lead from a primary lesion in the medullary interstitial cells to the secondary 
degenerative loss o f cortical parenchyma and urothelial abnormalities. One 
area that needs to be addressed in particular is the dichotomy between 
morphology and cell biochemistry that will describe the lesion in terms o f  
molecular changes, in both animals and humans.
The major questions that still need to be answered can be formulated 
here:
1. By what mechanism are the degenerative changes in the renal 
medullary interstitial cells caused, and are the changes in the other cell 
types (e.g., loops o f H enle, urothelial cells) a consequence o f  chemical 
injury or a result o f  the medullary interstitial cell degeneration?
2. If peroxidative metabolism o f papillotoxic chemicals is a key factor in 
the generation o f  reactive intermediates, what is the role o f the lipid 
droplets in the medullary interstitial cells? While the central role o f such 
peroxidative activation can explain target toxicity associated with aceta­
minophen, N-phenylanthranilic acid, and other analgesics and N SA ID , at 
present there is no known role for this mechanism in the genesis o f the 
BEA-induced lesion.
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3. What are the interactions that occur between analgesics and other 
therapeutic substances (and/or environmental chemicals) that may exacer­
bate or ameliorate the development o f  renal papillary necrosis, or affect its 
progression to chronic renal failure or to upper urothelial carcinoma?
4. What is the clinical significance o f chemicals other than analgesics and 
N SA ID  in causing renal papillary necrosis and upper urothelial carcinoma 
in humans? Ethyleneimine is a very good example o f a chemical that was 
used extensively in industry long before there was a focus on occupational 
health and hygiene.
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UPPER UROTHELIAL CARCINOMA, USING N-BUTYL-N-(4-HYDROXYBUTYL)-NITROSAMINE 
AND AN ACUTE PAPILLARY NECROSIS
N.J. Gregg, P. Ijomah, E.A. Courtauld and P.H. Bach
Nephrotoxicity Research Group, Robens Institute, University of Surrey, 
Guildford, Surrey, GU2 5XH, UK
INTRODUCTION
Upper urothelial carcinoma (UUC) in analgesic abusers has been closely 
associated with renal papillary necrosis (RPN) since it was first reported 
(1). UUC has only rarely been induced in animals using analgesics (2), 
thus a "cause-and-effect" relationship has not been established (3). The 
underlying mechanism of RPN is not fully understood and animal models of 
analgesic-induced lesion are difficult to study because of the:-
i) long latent induction time of the lesion using analgesics
ii) large biological variation in extent of the lesion, and
iii) extra-renal toxicity e.g. gastric ulceration and perforation 
associated with the prolonged inappropriately high non-clinical doses of 
analgesics.
In view of these limitations, a rapidly induced model of RPN would be 
useful to help elucidate and identify factors contributing to secondary 
renal changes, the association between RPN and UUC and the pathomechanism 
of UUC. 2-Bromoethanamine (BEA) hydrobromide has no structural
relationship to the analgesics, but it is an ideal model probe that 
induces an acute, dose-related RPN within 24-48 hr after a single 
injection. This lesion has been widely studied (see 3) and one of its 
secondary consequences is a simple hyperplasia localised to the pelvis, 
ureter and the epithelium covering the papilla, but this change does not 
progress to carcinoma (4).
Previous research using a 2-stage initiation-promotion model has 
established that bladder hyperplasia may develop into tumours (5). We have 
developed such a model by initiating the urothelium with a urothelial 
specific carcinogen; N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) and 
then "promoted" urothelial cell proliferation by inducing RPN with BEA. 
BBN was chosen as the carcinogen to facilitate controlled oral dosing 
(6), to reduce the exposure risk to personnel and because of its greater 
specificity with no benign extra-urothelial tumours induced.
METHODS
Two groups of male Wistar rats (University of Surrey strain) weighing 12Og 
were oral dosed twice weekly for 5 weeks with BBN (MRI, Kansas City,
411
Missouri, USA) to a total dose5 of '800 mg.’ Each dose was administered in a
0.5 ml volum^;^rf| aA20;80’iethahSl^a£elfC(6).." After one weeks respite, one
of these groups w a s ; f s i p g i ^ V , d o s e  of freshly prepared BEA
(Aldrich, Poole', Dorset, UK) at i00 mg/kg (7) in physiological saline. A 
control group received a 0.5 ml volume of the ethanol:water solution twice 
weekly for 5 weeks, and then after one weeks respite received a single ip 
dose of BEA.
Animals were allowed food and water ad libitum, monitored daily and groups 
of animals (n = 3) were sacrificed periodically up to 40 weeks after BEA.
Kidney, bladder and ureter tissues were dissected and fixed for 24 hr at 4
°C in 4% (v/v) formaldehyde:1% (w/v) calcium chloride fixative.
Transverse slices of the kidney containing the papilla tip, bladder and 
the upper 2 cm portion of the ureter were embedded in glycolmethacrylate 
resin (JB-4, Polysciences, Northampton, U K ) . Semi-thin sections (1 urn) 
were stained with Haematoxylin and Eosin (H&E), Giemsa, Toluidine blue, or 
PAS (4). RPN and urothelial changes were graded according to Burry (8), 
and Mostofi (9) respectively.
RESULTS
Control urothelium epithelial layer is typically 2-4 cells thick (Fig. 
la). Six weeks after BBN/BEA treatment there was papillary and nodular 
hyperplasia in the ureter (Fig. lb) and aggregates of mast cells within 
the lamina propria. Within the superficial layer of epithelium dysplastic 
cells with basophilic nuclei were present.
Thirteen weeks after BBN/BEA both papillary and nodular hyperplasia was 
present along the entire length of the ureter (Fig. 2a), together with 
foci of nodular hyperplasia that appeared to invade the lamina propria and 
with multinucleated cells in the superficial layer (Fig. 2b). Dysplasia 
and "invasive" P2 foci were in the lamina propria and approaching the 
muscularis layer (Fig. 2c).
Thirty-four weeks after BBN/BEA treatment dysplastic changes were more 
frequent, extensive and advanced and a large tumourous mass was found in 
the pelvis, adjacent to the truncated papilla stump of one kidney (Fig. 
2d). This tumour arose from the pelvic wall in which there were numerous 
mitotic figures.
Forty weeks after BBN/BEA treatment dysplasia in the pelvis and ureter was 
more advanced and another kidney had a nodular tumourous mass filling the 
upper ureter and extending into the pelvis. The tumour was dysplastic, 
with the loss of cellular polarity and it was extremely difficult to 
differentiate between the laminae propria and muscularis, suggesting an 
"invasive" stage.
Bladder tumours were present in the BBN/BEA treated animals, after 21 
weeks, but not in BBN only (up to 30 weeks) or BEA only treated animals 
(up to 40 weeks).
DISCUSSION
Compared to the BEA only and BBN only control groups, animals from the 
BBN/BEA group had more severe urothelial abnormalities. Tumours in the 
renal pelvis and upper ureter were only found in the BBN/BEA treated 
animals, and bladder tumours appeared earlier and were usually larger 
with more dysplasia and cellular atypia than in the BBN only. The finding 
in this study that "nodular" invasive hyperplasia and nodular tumour 
tissue lacks any positive staining for this enzyme suggests the existence
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Figure 1. a Control urothelium from Wistar rat showing three distinct 
layers; e = epithelium, lp = lamina propria, lm = lamina muscularis. 
Giemsa stain. Bar = 40 urn. b Nodular and papillary hyperplasia in 
ureter from animal 6 weeks after BBN initiation and BEA promotion 
(BBN/BEA). Many areas are dysplastic with extremely basophilic nuclei 
sloughing into lumen. Giemsa. Bar = 25 um.
Figure 2 a. Disorganised hyperplastic ureteric urothelium from animal 13 
weeks after BBN/BEA treatment. Giemsa. Bar = 80 um. Inset b shows
nodular 'invasive' area (arrow) and,large multinucleated cells (arrow­
head) . Giemsa. Bar = 20 um. c. Papillary and nodular hyperplasia in 
ureter, 13 weeks after BBN/BEA treatment. Toluidine blue. Bar = 20 um. d.
Macroscopic photograph of tumour found in pelvis 40 weeks after BBN/BEA
treatment. Bar = 1 mm.
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of premalignant and malignant cell populations within the urothelium of 
animals that had been initiated before an acute RPN was induced. These 
data suggest that a BBN initiated urothelium can be promoted to pre­
neoplastic and neoplastic cells by an acute RPN. This classical 2-stage 
process suggests that analgesic-associated RPN may be a key factor in 
producing a proliferative population in a pelvic or ureteric epithelial 
cells that had already been initiated. These proliferating cells could 
then progress to localized upper urothelial dysplastic foci and with time 
a carcinoma. It is presently uncertain how valid a 2-stage model is for 
human analgesic abusers. Many of these patients have, however, been 
exposed to potential urothelial initiating agents by a high incidence of 
cigarette smoking which has been associated with an increased incidence of 
urothelial malignancies and carcinomas (10).
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SUMMARY
End-stage renal failure (ESRF) due to analgesic nephropathy is still a common clinical condition in 
several countries, but the prevalence in dialysis patients shows large geographical differences. The fre­
quency of ESRF of unknown aetiology is the inverse of that linked to analgesic abuse, and data suggest 
that the occurrence of analgesic nephropathy may be underestimated. The study of analgesic 
nephropathy is difficult because the earliest damage to the kidney is a renal papillary necrosis (RPN), 
which cannot easily be diagnosed. Continued analgesic abuse generally leads to a progressive secondary 
cortical degeneration which is easier to diagnose. If  analgesic abuse is stopped at an early enough stage 
in nephropathy, clinical symptoms stabilize or improve, and ESRF may be averted. A  high incidence of 
upper urothelial carcinoma (UUC) is also observed in individuals with a history o f analgesic abuse, but 
it is still not clear if the two have a related pathogenesis.
Study o f the mechanism o f RPN in animals administered analgesics and nonsteroidal anti­
inflammatory drugs (NSAID) has been difficult owing to their extrarenal toxicity. Several model com­
pounds cause identical clinical changes and have as their selective target the renal medullary interstitial 
cells; subsequently, other changes (including cortical and glomerular degeneration) develop as a secon­
dary cascade. A  number o f mechanisms have been proposed to explain RPN (e.g., counter-current con­
centrating mechanism, ischaemic injury, altered prostaglandin metabolism, immunological changes), but 
peroxidative metabolism of papillotoxic chemicals within the interstitial cells seems to be the most likely 
cause.
Analgesic abuse is a costly socioeconomic condition for which there is currently no clinical treatm ent. 
If  it is diagnosed early enough, severe renal degeneration can be prevented. Additional epidemiological 
inform ation is needed to establish the causative role of analgesics and other chemicals, in order to deter­
mine the relative risk o f each. Additional animal experiments are needed in order to clarify the molecular 
pathogenesis of RPN and UUC, to differentiate the stages in progression to ESRF and to develop more 
sensitive and selective diagnostic criteria.
142
INTRODUCTION
Renal papillary necrosis (RPN) was first described as a frequent consequence of 
the abusive intake o f mixed analgesics in which phenacetin was a common compo­
nent. This observation led to the incorrect description o f RPN as ‘phenacetin 
kidney’. It has since become apparent that a variety o f analgesics, nonsteroidal anti- 
inflammatory drugs (NSAID) and industrial and environmental chemicals can cause I
RPN and interstitial nephritis [1-6].
During the last decade, phenacetin has been removed from most proprietary i-
analgesic mixtures on the basis o f decisions taken by the pharmaceutical industry 
and regulatory agencies; however, after such action in Australia, the number o f  
deaths from RPN was not reduced significantly although analgesic abuse continued 
[7], In Belgium, the sale o f phenacetin-containing analgesics declined dramatically 
from 1972 to 21% of intake in 1976 and 9% o f intake in 1983; nevertheless, the 
prevalence o f analgesic nephropathy in dialysis patients remained at the same level 
between 1979 and 1984. A  prospective study in Belgium has shown decreased renal 
function in analgesic abusers who never took analgesic mixtures containing 
phenacetin [8]. Paracetamol (acetaminophen, which largely replaced phenacetin in 
analgesic mixtures), other therapeutic agents and industrial and environmental 
chemicals are assumed to be involved in the pathogenesis o f  RPN [1].
The aetiology and epidemiology o f RPN has been complicated by poly-pharmacy, 
failure to document the intake o f nonphenacetin analgesics, ignorance o f the role 
o f other analgesics, NSAID and other chemicals in causing papillary necrosis and 
the difficulty in diagnosing RPN. In addition, most patients deny analgesic abuse.
Most o f the epidemiological data that have become available over the last 30 years 
reflect the intake o f phenacetin and not o f other agents which could be implicated.
Estimates o f the amount o f analgesic required to produce papillary necrosis vary 
from <  1 to 35 kg o f phenacetin, but information is not available on the quantities 
o f other analgesics taken or on exposure to other papillotoxic chemicals.
Attempts to explain analgesic abuse [1-3] include addiction to caffeine and the 
misguided use o f these drugs to increase productivity and reduce strain in the work­
ing environment. Only a minority o f patients take the drugs for genuine indications, 
and the origins o f abuse are usually psychosocial. Patients are neurotic, dependent, 
immature, introverted, anxious or depressed, and up to 20% may have psychiatric 
illnesses and other addictive habits such as smoking, alcoholism and the use of  
psychotropic drugs and sleeping tablets. The majority o f the patients are women 
over 30 years o f age from lower socioeconomic and educational groups, with a 
history o f heavy consumption o f analgesic mixtures over five to 30 years. Several 
environmental factors such as dehydration, high temperatures and bacterial infec­
tion have been implicated in the development o f the renal lesions [9]. The prognosis M
for patients who continue to abuse analgesics after RPN has been diagnosed is poor, 
but those who stop taking these substances show stabilization of, or improvement
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in, renal function, and progression to ESRF may be prevented [3]. Apart from these 
renal lesions, there are also increased incidences o f anaemia, gastric ulcers and cor­
onary heart disease [10].
PREVALENCE OF ANALGESIC NEPHROPATHY
There are very marked differences in the incidence o f analgesic-associated end- 
stage renal failure (ESRF) between countries (Table I). The disease has apparently 
disappeared in some o f the high-incidence countries due to legislation on analgesics 
restricting over-the-counter sales; however, despite withdrawal o f phenacetin in 
Switzerland, Belgium and the Federal Republic o f  Germany, analgesic abuse still re­
mains one o f  the main causes o f ESRF.
The overall incidence o f  ESRF in any one country may, however, be misleading, 
since high concentrations o f analgesic abusers occur in specific geographical loca­
tions, such as the Winston-Salem area o f the U .S .A . and in northern Belgium and 
the Federal Republic o f Germany. In Belgium, the epicentre o f the high-frequency 
abuse area is situated in the northern part o f the country, where a prevalence o f up 
to 51% is observed (Fig. 1), while analgesic nephropathy remains at a markedly 
lower level in the southern part o f the country [8], Similarly, in the Federal Republic 
o f Germany (Fig. 2), there are high prevalences in West Berlin (up to 50%), Ham­
burg and Bremen [12].
Several studies indicate that the prevalence o f this disease is underestimated. 
Whereas Pommer et al. [12] showed a 13% prevalence o f analgesic-associated end- 
stage nephropathy in the Federal Republic o f Germany, the European Dialysis and 
Transplant Association found no more than 6%. The proportion o f nephropathies
TABLE I
PREVALENCE OF ANALGESIC NEPHROPATHY IN  PATIENTS W ITH END-STAGE RENAL 
FAILURE IN DIFFERENT GEOGRAPHIC REGIONS
Region Prevalence (% )
South Africa (1978) 22
Switzerland (1980) 20
Belgium (1984) 18
Australia* (1985) 15
F.R . Germany (1983) 13
Canada* (1976) 3
Scandinavia* (1979) 3
France (1979) 2
U.K. (1979) 1
Italy (1979) 1
Spain (1979) 0.4
* The prevalence declined in these regions after legislation on analgesics: Australia, 1978-1981, Canada, 
1973 and Scandinavia, 1961.
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Fig. 1. Analgesic nephropathy as a cause of end-stage renal failure in Belgium (1984). From Ref. 11. 
Population, 10 million; area, 30 515 km2; chronic dialysis units ( • ) ,  54; total numbers of patients under 
chronic dialysis, 2334; (O) and number, patients with end-stage renal failure caused by analgesic 
nephropathy expressed as % o f patients treated in the dialysis unit(s).
o f  unknown aetiology noted in the registry o f the Association for the dialysis 
population o f the European countries (1980-84) may also be indicative o f the 
underestimation o f analgesic nephropathy. This observation is supported by the in­
verse relationship seen between the established prevalence o f analgesic nephropathy 
and nephropathy o f unknown aetiology, which is low in Switzerland and Belgium, 
more than 10% in the Federal Republic o f Germany, France and Italy, and more 
than 20% in Portugal [13].
CLINICAL SYMPTOMS AND DIAGNOSIS OF RENAL PAPILLARY NECROSIS IN MAN
The diagnosis o f analgesic nephropathy is difficult because o f its silent progres­
sion over a long period. Usually, the symptoms are nonspecific or minimal until 
secondary damage affects the cortex and advanced renal failure occurs. One early 
clinical sign o f analgesic nephropathy is the loss o f urine-concentrating capacity 
[10,14,15], but this may be a consequence o f several renal and extrarenal causes. 
Analgesic nephropathy is also associated with electrolyte disturbances, such as 
sodium wastage and hypocalcaemia, and a pronounced defect in urinary acidifica­
tion after ammonium chloride loading [14,15]. Increased blood urea nitrogen or 
serum creatinine levels are indications only o f incipient renal failure, by which time
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Fig. 2. Prevalence of terminal analgesic nephropathy in the Federal Republic of Germany (1986). 
Reproduced, with permission, from Ref. 12; pmp, per million population.
papillary necrosis has long since occurred and the secondary degenerative changes 
have progressed toward ESRF. Irregular shrinking o f the renal tissue and medullary 
calcifications may be identified by radiology and ultrasound, but these represent ad­
vanced degenerative changes. The histological changes in the kidney are confined 
to the medulla, which is generally assessed only at autopsy. Other changes in ad­
vanced renal failure are aspecific, and, while biopsies may show pyelonephritis, they 
will not establish the underlying cause.
Post-mortem studies [1,4-7] have served to confirm an RPN-related disease and 
to establish that ‘early’ degenerative changes begin at the tip o f the papilla and af­
fect interstitial cells, the loops o f Henle, capillaries and the staining interstitial 
ground substance and cause an accumulation o f lipid material, especially in collec­
ting duct cells. Intermediate RPN affects more anatomical elements, including 
atrophy, sclerosis and inflammatory response in the outer medulla, and calcium  
deposits in the necrotic tip, which may have sloughed o ff or remained whole or 
fragmented in the calyces. The papillary stump re-epithelizes. Total RPN affects the
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other medulla to the corticomedullary junction, and cortical changes are 
characterized as chronic interstitial nephritis, tubular dilatation, atrophy, basement 
membrane thickening, sclerosis, fibrosis, inflammatory cell infiltration and vascular 
degeneration. Suburothelial capillary sclerosis appears to be pathognomonic [6]. 
Pelvic, ureteric and bladder urothelium changes include thickening of capillary 
walls, sclerosis o f lamina propria together with altered fat and collagen deposition, 
and, especially, disordered epithelial states, from hyperplasia through to malignan­
cy and tumours [1,4-7].
EXPERIM ENTAL MODELS OF RENAL PAPILLARY NECROSIS
Most o f the studies that describe pathological and histological changes in patients 
with RPN have been retrospective -  performed on autopsied post-mortem tissues. 
The complex heterogeneous structure o f the kidney undergoes rapid autolytic 
degradation after death, which alters the morphology and compromises the inter­
pretation o f the progression o f and interrelationship between degenerative changes. 
In addition, extrarenal complications and disease factors may adversely affect the 
interpretation o f histological data. The best means o f approaching this problem is 
to study the mechanism in animal models o f RPN.
Analgesics such as aspirin, phenacetin and paracetamol may not induce RPN in 
rats, or may do so only after inappropriately high doses given over prolonged 
periods [1,2]. Even then, the biological variation within groups has been unaccep- 
tably high. Further, many therapeutically used NSAID cause death due to extrarenal 
toxicity, such as gastric ulceration and perforation [16]. Thus, rodents are not good 
experimental models for studying the mechanism o f analgesic-induced RPN.
These problems have led to the use o f alternative systems, such as chemicals with 
known papillotoxic potential. There are marked similarities between the renal func­
tional changes and pathomorphological progression o f lesions in several acute 
model systems and those reported for analgesic-associated lesions in both ex­
perimental animals and man [1,17]. The most commonly used chemical agents fall 
into two categories:
(i) Analgesics and N SA ID  analogues: N-Phenylanthranilic acid, an analogue of 
the NSAID fenamate, which has been studied extensively [18,19], causes a dose- 
related apex-limited lesion after oral gavage o f 1-2 m m ol/kg body weight for 14 
consecutive days, or after a single intravenous dose.
(ii) Nonanalgesic-induced renal papillary necrosis: 2-Bromoethanamine hydro­
bromide induces a dose-related RPN within 24-48 h after a single dose [20], as 
reported in more than 35 studies (see Ref. 1 for full list). The tremendous reduction 
in time needed to produce this lesion, compared to those induced using analgesics, 
N SA ID  and their analogues (which may take weeks or months), has several 
logistically important advantages. The histological changes induced in experimental 
R PN follow the same pattern o f early, intermediate and total RPN as has been
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described in man, and are dose- and time-dependent. The earliest morphological 
changes induced by papillotoxins occur in the renal medullary interstitial cells; the 
medullary glycosaminoglycan matrix also undergoes changes, with an increase and 
then a decrease in staining intensity. It is only subsequently that there are platelet 
adhesions, blocking o f blood vessels, degenerative changes in the collecting ducts 
and proximal tubules and the accumulation o f  lipid material in capillaries and 
epithelial cells. At the same time as repair and re-epithelization are taking place, 
there is an increase in the presence o f tubular casts, proximal and distal tubular 
dilatation, and hyperplasia o f collecting ducts and o f covering and pelvic urothelia; 
suburothelial capillaries undergo sclerotic changes. When the repair phase is ad­
vanced or complete there are also degenerative changes in the cortex, including 
fibrosis, glomerular sclerosis and cystic dilatation. The use o f high-resolution light 
microscopy and ultrastructural studies (in conjunction with histochemistry and im- 
munohistochemistry) can help establish the changes in adjacent cells and interrelate 
the cause-and-effect relationship in the sequence o f degenerative events.
MECHANISM OF ANALGESIC-INDUCED RENAL PAPILLARY NECROSIS
Progress in the understanding o f the pathogenesis o f RPN has been assisted by 
use o f model lesions [1], and some o f the factors that may be implicated in the 
molecular changes have been defined. There is no evidence to suggest that the lesion 
has an early immunological basis or that it is a consequence o f renal hypoxia or 
vasoconstriction, and there is no experimental basis to suggest that the altered in­
termediary metabolism is a critical factor [20]. The concept that altered prostaglan­
din metabolism gives rise to vascular (or other) changes is an attractive one, but the 
exceptionally low levels o f these hormones, combined with their instability, has 
made it very difficult to test this hypothesis. The counter-current concentration 
mechanism is an important normal renal function and may be a primary factor in 
concentrating chemicals to toxic levels within the medulla. One o f the earliest 
changes in the development o f RPN, however, is loss o f concentrating processes, 
which detracts from this hypothesis. Furthermore, the concentration o f a compound 
in the medulla cannot explain the molecular mechanism by which it causes RPN [1].
At present, the most attractive explanation for the development o f RPN is related 
to metabolic activation within the kidney. There are two major oxidative systems 
for xenobiotic metabolism in the kidney: the cytochrome P-450 system, localized to 
the cortex, and the prostaglandin hydroperoxidase system, located almost exclusive­
ly to the medulla. The latter has been shown to convert a number o f chemicals, in­
cluding paracetamol, N-phenylanthranilic acid and several carcinogens, to reactive 
intermediates that bind to both nucleic acids and protein [1]. The reasons for the 
selective targetting o f particular chemicals to renal medullary interstitial cells are 
uncertain but may relate either to the absence o f free-radical scavengers or 
nucleophiles or to the presence within these cells o f large numbers o f lipid droplets
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containing polyunsaturated fatty acids. These would form an ideal substrate for ex­
tensive lipid peroxidation within the renal medullary interstitial cells once a reactive 
species had been generated within them.
U PPER  UROTHELIAL CARCINOMA
Upper urothelial carcinoma (UUC) has been associated with RPN and analgesic 
abuse, but a cause-and-effect relationship between the two is not proven [1]. The 
incidence o f UUC among analgesic abusers is very high, especially among women, 
with a female:male ratio o f 2.5:1 [21], in keeping with the ratio o f analgesic abusers. 
Analgesic abusers also develop UUC at a younger age than nonanalgesic abusers 
[22-24], and their distribution in analgesic abusers has a distinct pattern, with 
tumours o f the renal pelvis, ureter and bladder being induced 80 times, 90 times and 
seven times more frequently than in nonanalgesic abusers. Tumours are typically 
multiple, diffuse, poorly differentiated and rapidly spreading [24].
Patients who discontinue abuse o f analgesics are at a greater risk o f developing 
UUC, often after a latent period o f 10-20 years since initiating analgesic abuse. 
Greatly improved dialysis techniques may increase survival o f  analgesic abusers who 
would otherwise develop end-stage renal disease and die [22]. It has therefore been 
suggested that the incidence o f UUC will increase.
The clinical diagnosis o f UUC is difficult because there are only a few nonspecific 
clinical symptoms [1,12,21-28]. The prognosis is poor, and patients with UUC have 
a mean survival time o f only 22 months [22] because o f compromised renal function 
and multifocal sites o f rapidly developing, widespread invasion and metastases [26].
Experimental evidence links exposure to analgesics with the development of  
urothelial tumours [1,21,29]. Although bladder tumours have been studied exten­
sively in animal models, the practical difficulties o f looking for malignancies in the 
ureter and pelvis has limited studies in this area. There is little evidence from long­
term carcinogenicity studies to establish a clear relationship between exposure to 
analgesics and UUC; there is, however, evidence that these carcinomas can be induc­
ed using a classical two-stage initiation/promotion regimen [30]. This suggests that 
localized injury associated with RPN adjacent to urothelium that has already been 
initiated will result in a proliferation o f changes which develop into malignancies.
A t present, the full significance o f these findings in terms o f the human analgesic 
problem is not clear, although a high incidence o f smoking among analgesic abusers 
could be one o f the factors that initiate the urothelium and contribute to the 
development o f this condition after RPN caused by analgesics. Other factors, such 
as loss o f mucoid covering and delayed passage o f urine, would exacerbate any 
pathophysiological change initiated by locally generated reactive metabolites. The 
selective targetting to the upper ureter and pelvis could also be due to the metabolic 
activation o f endogenous or exogenous compounds to reactive intermediates in the 
medulla.
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CONCLUSIONS AND FUTURE OBJECTIVES
RPN and the associated condition, UUC, represent a large economic and health 
burden on the medical services. The recent demonstration that chemicals and drugs 
other than analgesics may also cause RPN warrants special consideration in any 
assessment o f the health significance o f this lesion.
| , More than 30 years after the first publications linking analgesic abuse with
pyelonephritis, ESRF and UUC, the causal relationship remains controversial. It is 
still not clear which analgesics or chemicals are'the causative agent(s), the quantity 
o f each that has to be taken to cause the primary lesion, whether different types of 
papillotoxic chemicals can interact (and, if so, whether additively or synergistically), 
whether chemicals interact with other diseases or what the predisposing factors are 
for the development o f nephropathy and its clinical course. Only when these ques­
tions have been answered will we able to assess the amount o f analgesic that can 
cause RPN and the relative and absolute risks o f developing analgesic nephropathy, 
ESRF and UUC. Additional epidemiological research and long-term prospective 
studies are needed. Elucidation o f the molecular pathogenesis o f RPN and UUC  
would be an important step in developing safer chemicals or in modulating the 
course o f the condition. Furthermore, there is a need to develop more sensitive and 
selective diagnostic criteria for RPN and to define adequately the stages in the pro­
gression o f ESRF in order to identify individuals at risk, monitor renal degenera­
tion, establish the efficacy o f therapeutic and dietary manipulations to prevent 
degenerative changes, and characterize the factors that might exacerbate the 
development o f the lesion and the risk that degenerative changes will progress 
toward malignancy.
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INTRODUCTION
Renal papillary necrosis (RPN) has been associated with an excessive 
consumption of analgesics and nonsteroidal anti-inflammatory drugs (1). 
The course of development of this lesion in man has been documented from 
post mortem tissue, where autolysis, other diseases and marked variability 
in the extent of lesion have made it difficult to determine the 
progression of pathological changes. There is some evidence to suggest 
that the renal medullary interstitial cells are the primary site of toxic 
injury and that microvascular, collecting duct and tubular degeneration 
are secondary changes. 2-Bromoethanamine (BEA) hydrobromide is a
chemical which induces RPN rapidly and has allowed the progression of RPN 
to be studied. There are marked similarities between this acute BEA- 
induced lesion and changes that have been reported in animals dosed 
chronically with analgesics and non-steroidal anti-inflammatory drugs, and 
also the clinical condition in human analgesic abusers (1,2) .
We have re-evaluated the detailed time-course of an acute papillary 
necrosis using semi-thin glycolmethacrylate embedded sections to provide 
detailed pathological changes. Furthermore, the ability to combine 
"routine" staining with selective enzyme histochemistry on serial semi- 
thin (lum) sections enhances the ability to inter-relate changes in 
different cell types during the course of the development of degenerative 
processes that lead to RPN.
MATERIALS AND METHODS
» Male Wistar rats, University of Surrey strain, were injected 
* ip with a single dose of BEA 100 mg/kg body weight (BDH, Poole, Dorset, 
UK) freshly prepared in physiological saline (3) and control animals were 
injected with vehicle only.
Animals were sacrificed by cervical dislocation in groups of 3 at 2, 4, 6, 
8, 12, 18, 24, 48, 72 and 144 hr and pairs of control animals were
similarly sacrificed at 12, 48 and 144 hr. All tissue processing was
performed at 4°C. The right kidney, ureter and the inflated bladder were 
immersion fixed in formal calcium fixative (4% v/v formaldehyde:1% w/v 
calcium chloride). After 24 hr fixation 1-2 mm thick slices of kidney 
including the papilla tip, cortex, and a longitudinal slice of bladder
n e p h r o t o x ic it y  a  Lo ck
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were cut. Serial semi-thin (lum) sections were cut to include the 
papilla tip, mouth.- of ..the ureter and the cortex and of the bladder using 
glass "Ralph" knives.^ *' 'q v.< ^ . ,..
Sections were stained for with haematoxylirt 'iiTct^ edsin (H & E), Giemsa's 
stain, Toludine Blue and PAS. Enzyme histochemistry was performed to 
show the distribution of alkaline phosphatase (Aik Phos), acid phosphatase 
(Acid Phos), gamma-glutamyl transpeptidase (GGT) and adenosine 
triphosphatase (ATPase) using methods modified by Burnett (4).
RESULTS
Morphology and enzyme histochemistry results are summarised in Tables I 
and II.
Table I. Time course of morphological changes
7
Time Point Morphological Changes
ij
Control Normal with papilla interstitial matrix increasing in volume 
towards tip. Urothelium 2-4 cells thick, paler superficial layer which is 
PAS positive.
2 hr No changes discernible.
4 hr Medullary interstitial cell nuclei becoming acutely irregular and
pyknotic (Fig. la).
6 hr Mild hyperplasia of papilla covering epithelium to 2-3 cells thick.
8 hr Marked pyknosis of interstitial cell nuclei, sloughing of hyper­
plastic covering epithelium. Platelets adhering to endothelium dilated 
distal tubular profiles.
12 hr Leading edge of sloughing covering epithelium showing mild 2-3 
cell thick hyperplasia. Degenerative changes in tubular elements in 
papilla. Hyperplasia in upper ureteric urothelium.
18 hr 50% of papilla affected by RPN. Cytoplasmic granules in 
necrotic collecting duct cells, mitotic figures present. Hyperplasia of 
pelvic urothelium opposite leading edge of covering epithelium (Fig. lb).
24 hr Medulla affected by necrosis, loss of tissue integrity with 
cellular debris and proteinaceous casts in papilla. Casts in dilated 
distal tubules in cortex. Fornix area of urothelium, hyperplastic, 
mitotic figures present.
48 hr Covering epithelium leading edge 5 cells thick, cells very 
irregular nuclei, cytoplasmic granules present. General hyperplasia of 
pelvic and ureteric urothelium (Fig. lc). 1
72 hr 75% denudation of papilla covering epithelium. Tubular
necrosis extending to outer medulla. Marked dilatation of proximal and 
distal tubules.
144 hr 100% loss of covering epithelium, papilla is a mass of necrotic
tubules, (Fig. Id) lymphocytic infiltration. Sloughing of pelvic and 
ureteric urothelium, bladder urothelial superficial layer becoming 
increasingly basophilic. Numerous granules in proximal tubule segments.
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Table II. Time course of histochemical changes 
Time point Histochemical changes
Control Occasion PAS positive granules in urothelium Aik Phos and 
ATPase enzyme staining in proximal tubule brush borders (also GGT), 
intermediate and basal layer of urothelium with superficial layer devoid 
of stain (Fig. 2a).
2 hr No changes discernible.
4 hr Increase in interstitial matrix staining with Giemsa. Slight
increase in ATPase staining around pyknotic nuclei.
6 hr Slight decrease in Aik Phos and GGT proximal tubule brush border
staining.
8 hr Increase in Aik Phos staining in pelvic urothelium opposite denuded 
covering epithelium (Fig. 2b). Acid Phos increase staining in the SI and 
S2 proximal tubule segments.
12 hr Increase interstitial matrix staining at papilla tip. Hyperplastic 
urothelium has increased apical Aik Phos staining and increased ATPase 
staining of endothelium sub-urothelial capillaries.
18 hr Mosaic pattern of Aik Phos and ATPase staining in hyperplastic
urothelium (Fig. 2c). ATPase endothelial staining increase, moderate Acid 
Phos staining of interstitial cells in medulla.
24 hr Decreased interstitial matrix staining, loss of proximal tubular
brush border enzymes Aik Phos, ATPase and GGT coincide with an increase 
of these enzymes in proteinaceous casts in the necrotic papilla. Loss of 
Acid Phos staining from S2 proximal tubule segment.
48 hr PAS positive staining material in proteinaceous casts. Continued 
loss of Aik Phos, ATPase and GGT from proximal tubule brush borders, 
also loss of Aik Phos and ATPase to slight degree from pelvic and 
ureteric urothelium.
72 hr Variable enzyme staining in proteinaceous casts, GGT most pro­
nounced. Urothelial staining in ureter reduced to few Aik Phos positive 
cells, no bladder staining at all. Sub- urothelial capillary ATPase 
staining increased (Fig. 2d).
144 hr Granular Aik Phos and GGT staining in interstitium adjacent to 
hyperplastic fornix urothelium. Increased Acid Phos lysosomal staining in 
proximal tubule segments. Sub-urothelial capillary ATPase endothelial 
staining increase in quantity to occlude lumen.
DISCUSSION
The renal medullary interstitial cells are the first morphological feature 
to be affected in the cascade of degenerative changes that leads to RPN. 
These are followed by loss of the mucopolysaccharide matrix and 
degeneration of the endothelium, distal tubules, collecting ducts and 
loops of Henle.
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Figure 1 a.  Medullary interstitial cell nuclei (arrowheads) becoming 
acutely irregular and pyknotic 4 hr after BEA (lOOmg/Kg). Giemsa. Bar = 10 
urn. b. Hyperplasia of pelvic urothelium (arrowhead) opposite leading 
edge of covering epithelium (arrow) 18 hr after BEA. Toluidine blue. Bar = 
lOOum. c. Hyperplastic pelvic urothelium , 72 hours after BEA (100
mg/kg). Giemsa. Bar = 40 urn. d. Papilla tip is a mass of necrotic 
tissue, with casts in loops of Henle and collecting ducts consisting of 
exfoliated cell debris. Giemsa. Bar = 25 urn.
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Figure 2 a. Alkaline phosphatase (Aik. Phos.) staining in control 
bladder urothelium (arrow). Superficial "umbrella" cell layer devoid of 
stain. Bar = lOum. b. Increased Aik. Phos. staining in pelvic urothelium 
(arrowheads) opposite denuded covering epithelium (arrow) 8 hr after BEA. 
Bar = 20 um. c. Mosaic pattern of Aik. Phos. staining in hyperplastic
urothelium, 18 hr after BEA. Bar = 10 um. d. Sub-urothelial capillary 
endothelium stained with ATPase, thickness increasing to occlude lumen 
(arrowheads). Bar = 10 um.
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The sensitivity of the medullary interstitial cells to BEA may be due to 
one or more of the following:-
The interstitial cells are rich in prostaglandin hydroperoxidase and 
other peroxidases, which have the potential to produced biologically 
reactive intermediates (5).
The medulla has very low levels of glutathione and therefore once 
generated and reactive intermediates would not readily be inactivated (5).
The medullary interstitial cells contain a large amount of lipid 
droplets which are very rich in polyunsaturated fatty acids (5).
Thus the consequence of generating a reactive intermediate could be that 
of a sustained lipid peroxidation that was localized to the target cells, 
but also affected adjacent anatomical elements of the medulla. The
interstitial cells synthesise the mucopolysaccharide ground substance that 
serves to support the delicate elements (loops of Henle and capillaries) 
in the medulla and also acts as a matrix that controls the availability 
and movement of liquid, ions and other molecules between the different 
compartments. Thus an early loss of the mucopolysaccharide matrix will
drastically affect renal function and morphology, and play an important 
role in the cascade of degenerative changes that follows. Furthermore, 
where as epithelial cells have a significant regenerative capacity, the 
medullary interstitial cells do not undergo proliferative changes when 
damaged, nor is there a stem cell population from which to replace "lost 
or damaged" cells (1).
The subtle degenerative changes in the proximal tubule do not appear to be 
central to the development of the papillary lesion. Exfoliated brush 
border enzymes and cells are ,however, important components of the 
proteinaceous casts in the distal nephron.
Hyperplasia, the formation of distal tubular casts and then the proximal 
and distal tubular dilatation all appear to be secondary consequences of 
papillary necrosis, and the delayed increase in Aik Phos staining in 
urothelium support this. The increased ATPase staining of sub-urothelial 
capillary endothelium suggests that there is a progressive microangiopathy 
similar to that described in human analgesic abusers with RPN (6).
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INTRODUCTION
Analgesic abuse leads to the development of renal papillary necrosis (RPN) 
and may cause upper urothelial carcinoma in man. Animal models offer a 
potentially important means by which to define the underlying pathogenesis 
of RPN. Moreover, their use could improve early diagnosis, allowing the 
identification of which analgesic has the greatest papillotoxic potential 
and define what factors exacerbate this lesion (1). Many analgesics 
induce gastro-intestinal toxicity in rats which limits the use of this 
species for studying analgesic-induced RPN (2). The use of the non­
analgesic papillotoxic chemical 2-bromoethanamine (BEA) hydrobromide, has 
helped define the mechanistic basis of RPN, particularly because this 
compound targets selectively for the medulla and causes a lesion in 
rodents within 24-48 hr (1). The BEA-induced RPN in the Wistar rat shows 
most of the pathological changes described in human analgesic abusers (3). 
The primary choice of rodents for nephrotoxicity studies reflects their 
low cost, ready availability, ease of handling and the considerable base­
line data on renal function and toxicity. However, the extrapolation of 
nephrotoxicity data from rodents to man is complicated by the marked renal 
anatomical and functional differences between the two species. In contrast 
the human and pig kidney are remarkably similar in terms of physiological 
and anatomical characteristics (Table I).
Table 1. Comparison of some morphological and functional parameters in 
kidneys of man and pig.
Species GFRa Glomeruli Proximal tubule Maximal % Long
b * c Number Radius Length^ Radius0 Osmolality loops
Man 75 2 x 106 100 16 36 1400 14
Pig 72 2 x 106 83 30 35 1080 3
a = ml/min/m^ b = in both kidneys c = um d = mm e = mOsmol/kg
Data from (5) & (6) .
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Both man and the pig are multipapillate, produce urine of similar 
osmolality, and have GFR values*'" numbers of >glomerurli per kidney and 
nephron dimensions thatt comparable (4-6) The pig is thus an
attractive model 7 ' to . study '/'ciinicaily' ' 1 important nephrotoxicity, 
particularly R^ Ni'" The'se^'prdiimiJlary- ‘^ iridin^’-^liciw that BEA causes a 
RPN in the pig kidney, which is morphologically similar to that in the 
Wistar rat.
METHODS
Four female Large White pigs, six months old (weight 50 kg), were given 
freshly prepared 2-bromoethanamine (BEA) hydrobromide (BDH, Poole, Dorset, 
UK) by a slow iv infusion (over 2-3 minutes) while anaesthetised with a 
mixture of 2-3% halothane, +30% nitrous oxide plus +70% oxygen. BEA was 
given at dose levels of 50 (n = 2) or lOOmg/kg (n = 2). The animals were 
allowed access to food and water and monitored daily for any obvious signs 
of distress.
After 7 days the animals (n = 3) were killed after an overdose of halo­
thane anaesthesia and autopsied. The kidneys, ureters and bladder were 
removed intact. The kidneys were then bisected longitudinally along the 
lateral border through the hilus. All tissues were fixed in calcium: 
formaldehyde (4°C) for 72 hr. Control kidneys and bladder were obtained 
from abattoir material.
The cut interior surfaces of the kidneys were examined macroscopically and 
tissue blocks of renal pyramids were prepared to include the papilla tip 
as described by Lomax-Smith and Seymour (7). Together with pieces of 
ureter and bladder, the blocks were processed and embedded in glycol- 
methacrylate resin (JB-4, Polysciences, Northampton, UK). Semi-thin 
sections (lum) were routinely stained with Haematoxylin and Eosin, Giemsa 
and Toluidine Blue, using modified standard methods (8).
RESULTS
General observations. Neither animal given 50 mg/kg BEA showed any 
signs of distress, but those receiving 100 mg/kg had an emetic response 15 
min after recovering from the anaesthetic. This lasted for several hr, and 
1 animal died (from unknown causes) approximately 24 hr later.
Macroscopic changes. There were prominent casts in the medullary rays, 
and dark areas at the papilla tips from which the epithelium covering had 
exfoliated in pigs given the high dose. There were no pronounced changes 
apparent in the pigs given 50 mg/kg BEA.
Microscopic changes. Interstitial cells, the interstitial cell matrix 
and columnar collecting duct epithelium in control papillae showed no 
abnormal histology (Figure 1). Morphological changes that were concomitant 
with the onset of early RPN were present after dosing with 50 and 100
mg/kg BEA (Figure 2 a-d). These included disruption of interstitial matrix
(Figures 2a,b), focal interstitial cell necrosis (Figures 2b,d),
exfoliation of the papilla covering epithelium (Figure 2c), and necrosis
of collecting duct epithelial cells (Figure 2c,d). These changes were 
more pronounced in the animals given 100 mg/kg BEA.
DISCUSSION
This study shows that BEA causes a dose related RPN in the pig. The 
morphological changes observed were essentially the same as in the rat and 
included foci of interstitial cell necrosis together with disruption of
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Figure 1 Semi-thin section of control papilla tip showing intact 
interstitial matrix and collecting ducts. Giemsa. Bar = 40 um.
Figure 2 a Papilla tip from pig kidney 7 days after single iv 
dose BEA (100 mg/kg) showing disruption of interstitial matrix (arrowhead) 
with a decrease in staining. Giemsa. Bar = lOOum. b Focal interstitial 
cell necrosis (arrowheads) together with disrupted interstitial matrix 
(*) and necrotic collecting ducts (arrows) in papilla tip, 7 days after 
single iv dose of BEA (100 mg/kg). Giemsa. Bar = 40um. c Papilla tip, 
7 days after single iv dose BEA 50 mg/kg showing exfoliated covering 
epithelium and necrotic collecting duct cells with basophilic nuclei. 
Giemsa. Bar = 100 um. d Focal interstitial cell necrosis (arrowheads) 
and necrotic collecting duct epithelial cells (arrow) in papilla, 7 days 
after single iv dose BEA (100 mg/kg). Giemsa. Bar = 25 um.
the extra-cellular matrix, loss of the covering epithelia and necrosis of 
the collecting ducts. In the rat these anatomical elements are also the 
earliest to show degenerative changes, but the lesion was less pronounced 
in the pig compared to Wistar rats given the same dose.
The decreased effects of BEA on the pig medulla may be due to a number of 
causes. The multipapillate anatomy of the pig kidney may be less prone to 
the papillotoxic effects because BEA is not "concentrated" in a single 
papillae as it is in the rat, or because the urine concentrating capacity 
of the pig is less than that of the rat (5). Alternatively, both the 
hepatic and renal metabolism of several chemicals differs in rats and pigs 
(9,10). These and other factors may account for the reduced severity of 
the renal lesion in the pig and serves to illustrate marked species 
differences in the renal handling of nephrotoxic compounds in the multi­
papillate kidney. Thus in conclusion BEA is less papillotoxic to the pig, 
but there is a greater systemic toxicity at high doses.
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THE APPLICATION OF 
HISTOCHEMISTRY A T  THE 
LIGHT MICROSCOPIC LEVEL TO 
THE STUDY OF 
NEPHROTOXICITY
_ ; P.H. BACH, N.J GREGG AND E.D. WACHSMUTH
I. INTRODUCTION
Light microscopy continues to rep re sen t the  major method b y  which 
nephropathies are  identified in chemical safety  assessm ent^ and in 
the clinical situation^. While u ltra s tru c tu ra l stud ies provide a very  
im portant technique for detailed subcellular investiga tions, they  
generally do not contribute to diagnosis or treatm ent. Furtherm ore, 
these specialized methods are  both  time-consuming and  costly . His­
tochemical techniques a t the  ligh t microscopic level provide a broad 
approach to the  s tu d y  of renal in ju ry  th a t cannot, a t p re se n t, be 
investigated  as conveniently b y  electron microscopy or any 
biochemical method. Haematoxylin and eosin (H&E) is the  routine 
histochemical sta in  used  to vizualize cells, cellular s tru c tu re s  and 
changes associated with tissue in ju ry . Once cell changes have been 
identified b y  H&E a host of o ther histochemical techniques can be 
applied to help in te rp re t the  cause(s) of a lesion. There a re , 
however, examples where subtle  or specific cellular changes have 
not been identified by  H&E, and hence more sophisticated  tech ­
n iques are  needed. This full range of "routine" to highly 
"specialized" techniques can all be used  to address the  question of 
the  molecular changes associated with a toxic in su lt.
There is also a need to unders tand  more about the  factors 
involved in the  degenerative changes th a t follow a prim ary renal 
lesion. These often occur in a d iscrete  anatomical region of the 
k idney , and subsequently  lead to the  involvement of o ther a reas. 
Histochemical methods may help to define and in te r-re la te  the  cas­
cade of degenerative changes th a t follow prim ary in ju ry  and 
provide information on morphology, cell constituen ts and 
biochem istry, from which the "final" renal lesion can be u n d e r­
stood.
Normal renal morphology a t the  ligh t microscopic level has 
been repo rted  b y  Moffat^ and Kriz^ fo r the r a t ,  Kaissling and
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Kriz^ fo r the  rab b it and b y  Kriz and Koepsell® for the mouse. This 
chap ter will discuss those applications of renal histochem istry th a t 
have been usefu l in iden tify ing , localizing and understand ing  a 
v a rie ty  of chemically induced renal lesions. Both conventional h is­
tochemical methods and the specific receptor-m ediated techniques 
( e .g . antibody, lectin , radiolabelled chemicals) will be considered. 
Where appropriate  a tten tion  will be focused on how these tech ­
niques can be used to help understand  the prim ary lesion.
A. Nomenclature and inter-relating
histochemical and biochemical changes
This chap ter will use the term  histochem istry to cover those tech ­
niques th a t involve the microscopic assessm ent of tissue 
"biochem istry". Immunohistochemistry is a sub -b ranch  which is 
highly  selective and sensitive . The m icrodissection of material from 
the d ifferen t regions of the  nephron will not be considered.
There is a g rea t deal of d ifficulty  in  in te r-re la tin g  the find­
ings of histochem istry with those from pu re  biochem istry. This is 
not su rp ris in g  because of the difficulties in analysing materials in 
a complex environm ent such  as tissue  sections. Also the mass of 
the  LT.C.tcric.1 available is small and instrum entation to quantify  data 
is ex tended  to its  limits. There are  a num ber of analytical con­
s tra in ts  u sing  tissue sections th a t have been exposed to various 
treatm ents ( e .g . fixation, freeze-d ry in g , embedding, e tc . ) ,  to 
conserve morphological fea tu res .
A nother problem in in te rp re tin g  histochem istry is the  incon­
sistency  in terminology. The often confused nomenclature fo r com­
plex carbohydrates^ has highlighted the need to exercise caution 
in  naming material assessed  by  histochem istry in biochemical term s. 
Similarly, "lipid" material may be a measure of hydrophilicity ; the 
h igh  affinities of a b inding site p resen t on an antibody are  of little 
value if the  antigen is masked; even a monoclonal antibody may 
b ind to non-specific sites and the b inding of lectins may be 
changed b y  a num ber of fa c to rs . It is well established th a t 
proteolytic or cytolytic processes accompany cell damage, and the 
associated changes may destroy  or unmask reactive s ite s , or a lte r 
the  cell’s microenvironment. Histochemical methods may, however, 
cause reproducible a rte fac ts , which are  of value for diagnosis and 
may even lead to the b e tte r  understand ing  of the pathomechanism 
of in ju ry . Validation of each method is needed fo r the  most 
re levan t in te rp re ta tion  of da ta , and several c riteria  have been p u t 
forw ard^. Thus all data derived from histochemical methods should- 
be in te rp re te d  with caution. I t is also necessary  to unders tan d  the 
potential and limitations of each of the  histochemical methods being 
u sed .
B. Frozen or fixed tissue
D ifferent techniques of p reparing  tissue  may affect histochemical 
methods because of the  unique chemical process upon which each 
functional group or biological activ ity  is based . Increasingly , two
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or more histochemical methods are  used  in tandem (either on serial 
sections o r the  same sec tio n ), thus the possibility  can arise  of an 
optimal fixation procedure for one method th a t precludes the use of 
o ther techniques.
II. ENZYMES
Enzymes have been determ ined in nephron segments by  microdis­
section using  fluorim etric or radiochemical assay  m ethods-^- -* ,^ or 
by  incubating^ whole k idney sections with su b stra tes  th a t are 
t specific fo r the  particu la r enzyme (together with a coupling 
reagen t if necessary)13~47 i
Table 1 Typical enzyme activities that can be 
shown in the kidney by several different methods
Enzyme Reference
Acid phosphatase 13-15
Alkaline phosphatase 13,14,16
D-Amino acid oxidase 17
Aminopeptidase 16,18,19
Mg^ +-ATPase 14,20
Carbonic anhydrase 21,22
Cytochrome oxidase 23
Diaphorase 24,25
Glucose-6-phosphatase 26
Glucose-6-phosphate
dehydrogenase 23
p-Glucuronidase 13
Gamma-glutamyl-
transpeptidase 16,27
Glutamic dehydrogenase 28
p-Hydroxybutyric
dehydrogenase 24
Inosine 5'-diphos­
phatase
29
Invertase 30
Lactic dehydrogenase 31
Leucine aminopeptidase 32
Non-specific esterase 13
Succinic dehydrogenase 23,25,33,34
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The final reaction p roduct (FR P), gives data on the d is tr ib u ­
tion and relative activ ity  of the  enzyme if it has adequate con trast 
and is localized to the site of formation. Traditionally enzyme 
histochem istry has been undertaken  in fre sh  frozen or fixed sec­
tions, where the range of enzymic activities th a t have been a s ­
sayed are v e ry  large (Table 1).
Pitfalls in using  the enzyme histochemical approach are 
num erous. For example, lactic dehydrogenase (LDH) isoenzymes 
type A4 (M-LDH) diffuses approxim ately six times slower than  type 
B4 (H-LDH) in m uscle^  and since the molar su b s tra te  tu rn o v er of 
M-LDH is twice th a t of H-LDH it will produce more FRP, even if 
its  concentration a t the  tissue site  had been originally smaller. 
Both of these isoenzymes are  p resen t in the d ifferen t p a rts  of the 
kidney31>36, an(j faiiu re  to d ifferentiate  between the two could lead 
to erroneous conclusions. In tracellu lar peptidases appear to be less - w 
affected bv  pathological changes than  b ru sh -b o rd er membrane 
peptidases^ * >3°, b u t the difference may not become apparen t due 
to intracellu lar enzyme diffusion a rte fac ts .
Table 2 The effects of different classes of lytic enzymes on the normal ex­
pression of renal membrane bound marker enzymes
Renal marker enzymes
51-Nucleo­ ATPase Alkaline Leucyl-p-
tidase phosphat­ naphthyl-
ase amidase
Lipolytic enzymes
Phospholipase C +++ ++ 0 0
Lipase VII 0 0 0 0
Glycolytic enzymes
Neuraminidase ++ 0 0 0
p-Galactosidase ++ 0 0 0
(J-Glucosidase 0 0 0 0
Proteolytic enzymes
Trypsin ++ 0 0 ++
Papain + + 0 ++
Protease ++ + 0 +
a-Chymotryps in 0 0 0 +
8-Chymotrypsin 0 0 0 +
Collagenase 0 0 0 0
0 = No changes, + = slight, ++ = moderate and + + + II strong decrease in ac-
tivity compared to controls.
The in te rp re ta tion  of changes in the  amount of FRP also 
p resen ts  a  problem, where it  is often difficult to be certain  w hether 
the  increased  activities rep re sen t de novo syn th esis , unm asking, or 
the  loss of factors th a t normally inhibit the  reaction. Hardonk et
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al.39 described  the  influence of a  v a rie ty  of lytic enzymes on renal 
membrane-bound m arkers. Exposure of normal renal cryosta t sec­
tions to lipolytic, glycolytic and proteolytic enzymes showed that 
some renal m arker enzyme activities were decreased , while others 
were unaffected  (Table 2). By con trast liver sections showed in­
creased enzyme activ ities. These data illu stra te  the complexity in  
in te rp re tin g  changes induced b y  similar enzymes.
A nother problem th a t pervades enzyme histochem istry is th a t 
cryostat sections less than  4 |jun can ra re ly  be cu t from large pieces 
of tissu e , and more often sections are  8 - 1 0  |un, as a re su lt of which 
microscopic resolution may be unsatisfac to ry . The in troduction of 
the hydrophilic m ethacrylate-based embedding media has facilitated 
production of 1 |un sections routinely . Provided mild fixation 
protocols are  followed (see below) an unknown fraction  of the
original enzymic activ ity  may be maintained, which (if it  is more
than  10%) suffices for histochem istry. Fixation may, however, totally 
change enzyme d istribu tion  compared to frozen sections. The
alkaline phosphatase stain ing  p a tte rn  in  proximal tubules may be
reversed  by  f ix in g ^ . Similarly, aminopeptidase is localized to the 
b ru sh -b o rd er when assessed  in frozen sections b y  the localization of 
FRP and antibodies d irected  against the enzyme-^ > 6^ , b u t the 
cytoplasm of low-tem perature fixed t i s s u e ^ .  A lternatively , o ther en­
zymes such  as human carbonic anhydrase are  not g reatly  
a l te re d ^  > 47 #
A. Frozen sections
The proximal tubules can be identified by  the wide v arie ty  of 
b ru sh -b o rd e r  membrane enzymes, b u t o ther nephron segments (such 
as the  distal tubule or the connecting and collecting d u c ts ) , have 
specific immunologically reactive m arkers (see below). A v arie ty  of 
o ther oxidative e n z y m e s ^  have been characterized  in the  k idney , 
notably the medullary collecting duct and in te rstitia l cells.
LDH has been widely used  as a  u rin a ry  m arker of renal in ­
ju ry , and early  stud ies showed th a t its  d istribu tion  in the  kidney 
was ub iqu itous, although the collecting duct and proximal tubule 
stain  most strong ly . This has been of little use in  the  histochemical 
identification of the ta rg e t of renal in ju ry . The addition of 4 M u rea  
to the incubation system  inhibits LDH isoenzym e(s) and has allowed 
the d istribu tion  of renal LDH to be defined in term s of its  d ifferen t 
activ ities. The th ick  ascending limb and the d istal tubule are  rich  in 
H-LDH, whereas the  convoluted tubules of the inner co rtex , collect­
ing d u c ts , glomeruli and vasa rec ta  contain largely  M -LDH^, a find­
ing th a t is consistant with immunohistochemical d a ta ^ .
H eterogeneity in histochem istry is also evident in  each p a r t  of 
the nephron in d ifferen t s p e c ie s ^ . Figure 1 illu s tra tes  the 
difference of FRP concentrations of th ree  enzymes in the r a t ,  
rab b it, dog, marmoset and baboon kidney. This comparison shows 
th a t none of these enzymes are  ideal m arkers fo r any  nephron 
segment in these species. GGT appears to be the  b es t general 
m arker to identify  proximal tubule segm ents '^ . i n addition to 
species d ifferences, sex-linked , ontogeny and d ifferen tation- 
dependent differences occur.
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Figure 1 Enzyme histochemistry of normal kidney. The concentration of the FRP of a 
given enzyme is different in each nephron segment and the distribution is not the 
same in different species. The FRP pattern also varies with each enzyme. Frozen, 
acetone-fixed serial sections stained for the brush-border enzymes alkaline 
phosphatase (APP) and aminopeptidase (AP), and the mitochondrial enzyme succinic 
dehydrogenase (SDH). Cortex at the top and outer stripe of outer medulla at the 
bottom of each photograph. Arrow head pointing to arteria arcuata. Same magnification 
throughout.
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Figure 1 continued
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For instance, sex differences in P^ and P2  segments of the 
proximal tubule have been described  for various cytoplasmic NAD- 
and NADP-dependent oxido-reductases and some mitochondrial en ­
zymes in the  r a t ^ " ^ .  D ifferential increases of b ru sh -b o rd er 
membrane enzymes and cytoplasmic enzymes du ring  ontogeny have 
also been dem onstrated^1,54 ,55^
Renal lesions can be detected  by  changes in renal (enzyme) 
catalytic FRP following exposure to a v arie ty  of c h e m ic a ls in c lu d ­
ing m e rc u ry ^ »34,23 ,z 6 ,55,56  ^ D -s e r in e ^  and c e p h a lo rid in e^ . In 
general chemical insu lts may be vizualized by  a reduced FRP in the 
area of lesion, b u t it  has been v e ry  difficult to in te rp re t, p a r ­
ticu larly  in relation to changes in u rin a ry  enzymes. Cottrell and 
c o -w o rk e rs^  showed th a t loss of alkaline phosphatase, lactate 
dehydrogenase and leucine aminopeptidase FRP all closely paralleled 
the dose- and tim e-related damage to the renal cortex caused by  
m ercuric chloride and p-aminophenol. By co n tras t, increased 
glucose-6 -phosphatase FRP, in the  inner cortex (where it  is n o r­
mally not de tec ted ), following m ercuric chloride-induced in ju ry , 
was taken  as evidence fo r the utilization of glucose needed for 
energy  production du ring  the rep a ir p h a s e d  26 ? an(j SUpp0r ts  the 
concept of cell regeneration . FRP formed by  the catalytic activ ity  
of succinic dehydrogenase, non-specific e s te rase , and in particu lar 
alkaline phosphatase and aminopeptidase have been shown to be 
valuable indicators of acute nephrotoxicity  a fte r  cephaloridine ad ­
m inistration to ra ts  and rabb its  .
FRP concentrations of a  well chosen enzyme may be suitable 
fo r defining the site and quantify ing the severity  of renal lesions. 
In mice, proximal tubules of the ou ter stripe  of the ou ter medulla 
contain twice the concentration of aminopeptidase compared to the 
cortical t u b u l e s ^ .  Thus the enzyme cannot be used  to dem onstrate 
lesions in the  proximal tubule or the proximal convoluta in general, 
whereas alkaline phosphatase, which does not show th is difference 
in mice and ra ts ,  has proved usefu l. So it can be clearly 
dem onstrated by  means of alkaline phosphatase FRP th a t the  P3 
segments of r a ts ,  bu t not of rab b its , are  affected by  c e f s u l o d i n * ^ -  
62. By co n tras t, cephaloridine was shown to affect mainly the P^ 
and P2  segments in both  s p e c i e s ^ ? .  This can be automated by  
means of television image analysis which compares areas with high 
FRP alkaline phosphatase concentrations (e .g . b ru sh -b o rd e r  
membrane) within areas of low FRP concentrations ( e .g . proximal 
tubule c ro ss-sec tions). The loss of alkaline phosphatase FRP is a 
m easure of the number of proximal tubules with lesions. For in ­
stance , the  area  occupied b y  the proximal tu b u la r m arker 
decreased with increased doses of cephaloridine in ra ts  and ra b ­
b its . P retreatm ent with probenecid p reven ted  the lesion, in ag ree­
ment w ith the  protective effects of th is anion tra n sp o rt inh ib itor, 
and the area  of FRP was closer to c o n t r o l s ^ .
The changes in acid phosphatase and succinic dehydrogenase 
FRP following a single dose of c is-p latin  (Figure 2) dem onstrate 
the  unsu itab ility  of these two sta in ing  techniques fo r quantifica­
tion , because the resolution for the d ifferen t segments is poor, 
and th ere  is no discrimination on the  FRP level between damaged 
tubules and those with natu ra lly  low enzymic ac tiv ity . In th is in ­
stance the use of b ru sh -b o rd er membrane enzymes is b e t t e r ^ .
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Figure 2 Histochemistry showing the loss of enzymic activity and proximal tubular 
cell necrosis in the outer stripe of the outer medulla of the male rat kidney over 
several days after a single i.v. dose of 6 mg/kg cis-platinum. Sections show control 
(dO), and changes after 2 days (d2) and 6 days (d6). Frozen, acetone-fixed sections 
stained for the mitochondrial enzyme succinic dehydrogenase (SDH). Baker-fixed 
frozen sections stained for the lysosomal enzyme acid phosphatase (P). Cortex (C), 
outer stripe (0) and inner stripe (I) of outer medulla. Same magnification 
throughout.
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Figure 3 Enzyme histochemistry in semi-thin sections of fixed renal tissue.
A . Alkaline phosphatase staining of proximal tubule brush-borders in a 1 pm section 
of control kidney embedded in glycol methacrylate. Methyl green pyronin counter­
stain. Insert shows endothelial staining with alkaline phosphatase (arrowheads).
B. Distribution of adenosine triphosphatase (ATPase) in control kidney proximal 
tubule brush border in cortex only, in 1 pm semi-thin section of glycol methacrylate 
embedded kidney. Counterstained with methyl green pyronin. C. Gamma-glutamyl- 
transpeptidase (GGT) staining of proximal tubule brush border in control kidney em­
bedded in glycol methacrylate, counterstained with haematoxylin.
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Figure 3 D. Increased ATPase staining of endothelium (arrow) in basal sub-urothelial 
capillaries 144 h after a single 100 mg/kg i.p. dose of 2-bromoethanamine (BEA). 
Kidney embedded in glycol methacrylate, 1 pm section counterstained with methyl 
green pyronin. E. Alkaline phosphatase staining of proteinaceous casts in necrotic 
loops of Henle (arrows) and collecting ducts (arrowheads) in papilla 144 h after 
single 100 mg/kg i.p. injection of BEA. Kidney embedded in glycol methacrylate coun­
terstained with methyl green pyronin. F. GGT staining in necrotic papilla 144 h 
after single i.p. injection of BEA (100 mg/kg). Kidney embedded in glycol methacry­
late 1 pm section counterstained with haematoxylin.
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Renal enzymic changes may also be associated with abnormal 
kidney physiology in the  absence of an overt lesion. Ammonium 
chloride (0.25 mol/1) given to ra ts  in drinking  w ater over 6  days 
induces acidosis and renal e n l a r g e m e n t ^ . Histochemically, in ­
creased glutamic dehydrogenase FRP was found in the  s tra ig h t and 
proximal convoluted tubu le , whereas in control ra ts  it  was seen in 
the s tra ig h t portion. This finding is compatible with nephron adap­
tation or expression of renal functioned reserve  following exposure 
to in ju ry  or abnormal dem ands, such as the increased ammonia 
production in these NH^Cl-loaded animals^®.
B. Methacrylate-embedded fixed tissue
Glycolmethacrylate has recen tly  been widely adopted for routine - w 
high-resolution microscopy, where it is used particu larly  advan­
tageously for enzyme histochem istry. A large number of fixation 
protocols have been used , b u t the  common factors fo r successful 
use of h igh-resolution enzyme histochem istry has been low tem pera­
tu re  (typically -25 to + 4  °C ), low concentration of fixative 
(typically less than  5% glu taraldehyde, paraform aldehyde an d /o r 
calcium’.form aldehyde) and the minimal period of fixation^® Ex­
cellent ATPase, acid and alkaline phosphatase, GGT (Figure 3 ) ,  
non-specific es te rase , p-glucuronidase, aminopeptidase, and 
cytochrome C oxidase d istribu tion  has been r e p o r t e d 4 ® “ 4 4 , 6 3  and 
changes have been followed in ta rg e t selective renal injuries caused 
by  2 -bromoethanamine, indomethacin, adriamycin, hexachlorobuta-
diene and p o l y b r e n e ® 4 - 6 6 .
Similarly, the same high-resolution enzyme histochem istry has 
been used  to dem onstrate a number of key m arker enzymes in no r­
mal and diseased human renal tissu e . These include a-naph thy l- 
acetate esterase  (ANAE), acid and alkaline phosphatase, and AT­
Pase, all of which are confined to the tubule and collecting^ ducts 
in the normal k idney following paraform aldehyde fixation®^5o8,68a. 
Whereas severely  damaged allographs generally retained th is s ta in ­
ing p a tte rn , there  are histochemical differences in renal malig­
nancies. For example, it  was possible to d ifferentiate 90% of renal 
carcinoma based on reduced reactions fo r acid and alkaline phos­
phatase , and ANAE. By con trast 90% of Wilm’s tumours were weakly 
positive fo r acid phosphatase and ANAE. Other enzyme activities 
(e .g . 5’-nucleotidase) have also been studied in non-renal human, 
tissue using  acetone or periodate-lysine paraform aldehyde fixation 
fo r 4  h  a t 4  °C in calcium: formaldehyde®®.
C. Enzymic changes in parenchymal and 
urothelial malignancies
Renal cell carcinoma accounts for about 85% of all prim ary kidney 
malignancies in m a n ^ , where the histogenesis is thought to be 
from the epithelium of the proximal tubu le . These carcinomas can 
be induced in experimental animals b y  the use of N- 
hydroxyethylnitrosam ine (EHEN) and dimethylnitrosam ine. Jasmin 
and Riopelle^l reported  th a t the enzymic profile of the  tumours
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suggested  th e ir  proximal tubu lar orig ins, although glucose-6 - 
phosphatase, 5’-nucleotidase and alkaline phosphatase stained much 
less in tensely  than  the normal adjacent epithelial cells. Sub­
sequently , there  was little GGT and alkaline phosphatase FRP com­
pared  to the adjacent t i s s u e ^ »73 # p resence Qf pAS-positive
b ru sh -b o rd er on the carcinoma cells also served  to confirm their 
o r i g i n s ^ .  The GGT-FRP is also much reduced in human and ra t  
fetal c e l l s '^  75  ^ Taken together these data suggest th a t the  EHEN- 
induced neoplasia rep resen ts  similar undifferen tia ted  and rapidly
dividing cells 7 2 .
The histochemical changes associated with chemically induced 
urothelial malignancies are  also widely stud ied . K u n z e ‘ 6 - 7 9  and 
others*^ >81 have shown the focal loss of alkaline phosphatase from 
otherwise apparen tly  histologically normal r a t  b ladder urothelial 
cells follows carcinogenic doses of di-N -butylnitrosam ine, N -butyl- 
N -(4-hydoxybutyl)-nitrosam ine (HO-BBN) or N -[4 -(5 -n itro -2 -fu ry l) 
-2-thiazolyl]formamide. The loss of alkaline phosphatase was i r r e ­
versible and occurred a fte r  the discontinuation of the  carcinogen; 
it  could not therefore  be a d irect toxic effect. These alkaline 
phosphatase-free  cells are  considered to be preneoplastic , and 
develop into papillomas and carcinomas (Figure 4).
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Figure 4 Mosaic pattern of alkaline phosphatase staining in bladder papilloma from 
animal initiated with HO-BBN then promoted with BEA and sacrificed 18 weeks later. 
Arrows show "preneoplastic" areas with focal loss of staining. Bladder embedded in 
glycol methacrylate 1 pm sections counterstained with methyl green pyronin.
Ozono^^ has also shown th a t a high frequency  of GGT- 
positive cells is p resen t in otherwise normal urothelia a fte r  ex ­
posure to HO-BBN. GGT-positive cells are already well established 
as m arkers for the prem alignant changes in o ther o r g a n s ^ " ^ .  j t
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has therefore  been generally assumed th a t the presence of foci of 
GGT in the urothelia  is a sensitive and specific m arker of malig­
nancy, especially because these changes are  p resen t in nodular 
hyperp lasia and carcinoma th a t develops a fte r  HO-BBN. These en ­
zymic changes may not be pathognomonic indicators of p re - 
malignant changes under all circum stances. For example, V ander- 
laan e t al.^O suggested  th a t GGT-FRP identifies only advanced 
carcinoma and large papillomas. Similarly, whereas K u n z e ^ - ^  has 
repo rted  a variable reduction in NADPH-diaphorase in about two- 
th ird s  of the  urothelial cells with reduced  alkaline phosphatase ac­
tiv ity , Vanderlaan e t al.^O found increased NADPH-diaphorase in 
focal nodular hyperp lasia, under similar experimental conditions.
III. CARBOHYDRATES
A num ber of d ifferen t types of carbohydrate material predominate 
in d iscrete  anatomical areas of the k idney , and the histochem istry 
of each shows th e ir  unique localization. The basement membrane of 
the proximal tubule , and especially the  glomeruli, are  filled with a 
mucopolysaccharide (MPS) m atrix, the  medulla in terstitium  is very  
rich  in MPS (Figure 5 ), and the d istal tubule is coated with 
glycoproteins and glycolipids. The urothelial cells are also covered 
by  mucin or the g lycocalyx^l.
Figure 5 Mucopolysaccharide (MPS) staining of medullary interstitial matrix 
(arrows) in control kidney embedded in glycol methacrylate 1 pm section, Giemsa.
A. Chemical reactions
The individual classes of carbohydrate may, to some ex ten t, be
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differen tia ted  b y  simple h istochem istry. For example, basement 
membrane, proximal tubule b ru sh -b o rd e r  and surface mucin are 
rich  in poly-vie-glycols and give a h igh -con trast stain  with 
periodic acid and Schiff (PAS) or methanamine s i lv e r^ * 92# some of 
the complex carbohydrates, such as Tamm-Horsfall glycoprotein, 
only stain  weakly by  th is method and immunohistochemistry is much 
more effective (see below).
1. Mucopolysaccharides
Mucopolysaccharides (MPS), which in biochemical terms are con­
sidered to be glycosaminoglycans, and th e ir supram olecular s tru c ­
tu re s , the  proteoglycans, are p resen t in:
(i) the glomeruli, where they  form an essential p a rt  of the 
glomerular basem ent membrane, and (th rough  th e ir  poly­
anionic natu re) impart perm selectivity to the glomerular 
a p p a ra tu s ;
(ii) the medulla, where the v e ry  extensive quantities of MPS re p ­
re sen t a tissue of transition  for binding w ater and cations 
th a t are  in the process of being reabsorbed .
(iii) The binding capacity for both w ater and cations is v e ry  high 
and if the m atrix is d isrup ted  (see below) the homeostasis of 
w ater and electrolyte will be m arkedly a ltered .
A num ber of histochemical methods have been used  to show 
the strong ly  acidic na tu re  of th is m a tr ix ^  > 93 ^  The histochemical 
demonstration of these molecules depends to a significant ex ten t on 
the method used  for fixing t i s s u e ^ , and it may be p referab le  to 
the  use of cetylpyridinium  chloride to insolubilize MPS 95.
Several early  publications reported  th a t the decrease of MPS 
stain ing  by  the addition of magnesium chloride could be used  to 
identify  the type of glycosaminoglycan in biochemical t e r m s 96 . This 
is not the  case. On the o ther hand , selective enzymic 
d i g e s t i o n 9 7  » 9 8  Qf MPS reported  for non-renal tissue  may help 
define the presence of a specific glycosaminoglycan in a  m atrix. 
The autoradiographic d istribu tion  of labelled glycosaminoglycan 
p recu rso rs  may not help substan tia te  the presence of MPS9^, b e ­
cause these molecules are  also taken up into g lycoproteins, and the 
carbohydrates may be extensively  metabolized to o ther molecules.
(a) D isruption of glomerular carbohydrate . The glomerular 
basement membrane is thickened in diabetes and nephrotic 
syndrome when assessed  b y  the PAS stainlOO. The p ro te inu ria  a s ­
sociated with a  num ber of chemical insu lts may be caused by  
damage to the glomerular basem ent membrane, a lte ring  the  foot 
process and the loss of the  polyanionic m atrix. This con tribu tes to 
a loss of perm selectivity and the increased leakage of p ro te in s. For 
example, adriamycin causes a pro teinuria  th a t may resu lt from the 
d isruption  of the basement m em brane-related MPS. B ertan i et a l .- ^ l  
have shown th a t within 3 h  of adriamycin adm inistration the 
polyanionic sites of the glomerular epithelial cell decrease p ro g res-
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sively , a change th a t precedes p ro te inu ria  and u ltra s tru c tu ra l ab ­
normalities .
(b) D isruption of m edullary MPS. The m edullary MPS serves 
as a tissue of transition  for w ater and electrolyte hom eostasis, 
supports  the delicate elements of the  micro vasculature  and loops of 
Henle, and provides some support for the  collecting duc ts . Loss of 
m edullary MPS histochemical stain ing  has been observed in several 
instances. For example, McAuliffe^-*^ has shown th a t the in tensity  
of the  medullary in te rstitia l MPS stain ing  is g rea tly  reduced  in the 
homozygous Brattleboro r a t ,  b u t re tu rn s  to near normal if these 
animals are  trea ted  with an tid iu retic  hormone. Similarly, the  in te r ­
stitia l m atrix MPS stain ing  is g rea tly  reduced  in rodents with . 
lithium -induced nephropathy-*-^. Such observations are  consistent 
with lithium blocking the actions of an tid iu retic  hormone, b u t ap ­
pear to be a secondary consequence of the lithium toxicity  ra th e r  '  ^
than  a cause.
The loss of MPS stain ing  from the medulla has also been 
repo rted  in association with renal papillary  necrosis. Medullary MPS 
stain ing  has been reported  to be both  increased-*-^ and absent-*^ 
in human analgesic ab u sers . Molland^ 0 6  described a dense fib rilla ry  
netw ork of PAS-positive material in animals with an asp irin-induced  
renal papillary necrosis th a t became irreg u la r with deeply stain ing 
fib res and bodies in the  in terstitium  (see below ). Using an acute 
model of renal papillary  necrosis it has been possible to estab lish  
th a t sho rtly  a fte r  chemical in su lt there  is a m arked increase in the 
sta in ing  of the  medullary m atrix , a t the same time as the  earliest 
changes are  tak ing  place in  the  in te rstitia l cel l s-*^» .  Sub­
sequen tly , a tim e-dependent loss of m edullary stain ing  occurs in 
those areas where necrosis develops. About 6  h  a fte r  a  dose of 2- 
bromoethanamine hydrobrom ide th ere  is a more in tense PAS-positive 
m aterial a t the tip  of the papilla, which increased  to a maximum at 
48 h , a t which stage the PAS stain ing  in  the mid-medulla was 
decreased . Even when there  is a  re-epithelialization of the affected 
a rea  th ere  is a failure to re -estab lish  the presence of the MPS 
m atrix , probably  due to the absence of m edullary in te rstitia l cells.
The loss of non-specific stain ing  could rep re sen t e ither masking of 
the  functional g roups, the loss of those chemical moieties respon­
sible fo r colour reactions or m arked physicochemical changes in the 
glycosam inoglycan/proteoglycan. Recent biochemical s tu d ie s -^ h a v e  
shown th a t there  is a  v e ry  m arked loss of sulphate groups from 
the medullary matrix and u rin a ry  macromolecular carbohydrate 
tu rn o v e r showed changes in the  molecular weight polydispersion; 
taken  together these data suggest th a t the  m atrix is increasingly  
d isru p ted , and eventually lost from the medulla. *
(c) Epithelial carbohydrate granu les. Tucker e t a l .H °  and* 
Alroy e t a l . -*■■*"*- have reported  the presence of PAS and Alcian Blue 
positive granules in the  human pelvic epithelial cells, where ca r­
cinoma was p resen t in the up p er u re te r ,  and in  cells th a t had 
m etastasized from these reg ions. A series of similar changes have 
been described  by  Hukill and Vidone^^^ for b ladder malignancies. 
Intracytoplasm ic glycogen or in tercellu lar lakes of mucin were com­
mon. Similar changes have also been noted associated with renal 
pap illary  necrosis induced b y  asp irin -^0 6  and 2 -bromoethanamine 
(F igure 6 )-*-®^ . There is also an accumulation of PAS-positive
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granules in the cells of the  collecting duct and the covering 
epithelium. These granules appear before cell necrosis, and may 
therefore  rep re sen t the  autophagic processes. The p resence of 
similar granules in the pelvic and urothelial cells 2 1  weeks a fte r 
the  induction of an acute papillary  n e c r o s i s - * - ^  suggests th a t this 
change is a long-term  aberration  of cellular function, especially be­
cause they  were most m arked in those regions where the urothelial 
dysplasia was g rea tes t.
Figure 6 PAS-positive granules in the superficial layer of ureteric urothelium from 
animai treated with BEA (100 mg/kg). Ureter embedded in glycol methacrylate 1 pm 
section counterstained with haematoxylin.
The presence of these granules could be rela ted  to the 
glycocalyx, particu la rly  because changes in these complex ca r­
bohydrates have been linked to tumorigenesis-*--*-^, and cell surface 
r e c o g n i t i o n - ^ . These changes in carbohydrate sta in ing  may th ere - 
.fo re  rep re sen t early  or subtle changes in the urothelial cells th a t 
predispose them to abnormal growth p a tte rn s . On the o ther hand 
these changes may not be indicative of malignancy o r hyperp lasia , 
because th ey  also occur in rodents with lithium -induced 
nephropathy^®^, where amylase digestion suggested  the  material 
was glycogen. The marked changes in the medullary m atrix caused 
by  renal papillary  necrosis and lithium toxicity  may therefore  
reflect the shun ting  of simple carbohydrate material (normally used 
for MPS syn thesis) into sto red  glycogen.
2. Glycoproteins
There a re  a  num ber of o ther anatomical regions of the  k idney in
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which the glycoproteins and/or glycolipids predominate. These will 
be considered below, under immuno- and lectin histochemistry, al­
though it must be appreciated that some of the less selective stains 
also demonstrate the presence of these molecules.
B. Affinity techniques with lectins
Lectins bind to well-defined sugar r e s i d u e s - ^  wherever these are 
available; i.e. they occur on glycoproteins, mucopolysaccharides, 
glycolipids, etc. The cell surface, intracellular and interstitial car­
bohydrates in fresh or cryostat sections of one cell type may be 
constant and therefore visualized with specific fluorescent or en­
zyme (e.g. peroxidase-linked) lectins. This unique relationship has 
been reported for both human and animal tissue, where the binding 
of a number of lectins is associated with one or more renal cell 
types!!7"-*-23 (Table 3).
Table 3 Selective staining of nephron segments by lectins
LECTIN Soy bean Winged pea Peanut Luex Dolichos
agglutinin agglutinin agglutinin europeaus biflorus
SPECIES Rat Rabbit Rat Rabbit Man Rabbit Man Man Man
Glomeruli + + - - - - - -
Proximal S-^ + - - + + - - - -
tubule S2 + - - + + - - - -
S3 - - - + + - - - -
Henle loop - - - - - + - - -
Distal tubule + + + - - - + - +
Collecting duct + + + - - + + - +
Vascular - - - - - - - + -
endothelia
The binding of peanut agglutinin to the intercalated cells (or dark 
cells) of the collecting and connecting ducts in cryostat sections of 
rabbit kidneys is particularly n o t e w o r t h y ! ! ^ , because there are 
very few markers for these cells at a light microscopic level. By 
contrast Stoward et al.!2^  reported that peanut lectin bound to the 
brush-border of the rat proximal tubule and collecting ducts, and 
it was variable in the distal tubule. Glomeruli only reacted posi­
tively after sialidase digestion. In the mouse!2^ , however, peanut 
lectin stained Bowman's capsule, the tubules and basement 
membrane and the collecting ducts, but the lectin from Dolichos 
biflorus stained only Bowman's capsule and the collecting ducts. 
Some selectivity also exists in any single species, but this may be 
different in another species (see Table 4 for differences in soy 
bean and winged pea agglutinin). Thus a nephron segment specific
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lectin is not available, nor are there any systematic relationships 
between species, although the mouse, rabbit and man have similar 
lectin staining patterns, which differ from the rat-^ 2. Some lectins 
such as limulinl26 have not yet been studied in a number of dif­
ferent species, and therefore its binding to sialoglycoproteins of 
the rat glomeruli, and to a lesser degree both the proximal and the 
distal tubule, may not preclude its usefulness in studying other 
species.
Table 4 The differentiation between proximal and distal tubules using lectins
LECTIN Species where only one tubule type is stained 
Proximal tubule Distal tubule
Wheat germ guinea pig, quail, frog, 0
Ricinus communis rabbit, guinea pig, frog 0
Soy bean 0 dog, mouse
Peanut 0
guinea pig, rat, frog
dog, rabbit, mouse, man 
0
Ulex europeus 0 dog, rabbit, guinea pig, 
frog
Dolichos biflorus 0 dog, rabbit, guinea pig, 
mouse, quail, frog, 
trout, man
Fixation may drastically alter lectin binding, winged pea ag­
glutinin binds to rat tubular epithelium after fixation in Carnoy 
solution, whereas only vascular structures were seen after 
glu tar aldehyde-^  23 % gy contrast Faraggiana and co-workers 1-27 have 
reported that fixation and wax embedding had little effect on the 
binding profile of lectin-peroxidase conjugates that were used for 
human tissue. The lectin from Lotus tetragonolobus bound ex­
clusively to the proximal tubule, while peanut and soy bean lectin 
were confined to the collecting duct. Wheat germ lectin bound 
.several parenchymal components including the glomerular capillary 
wall and its podocyte cell coat. These workers also unmasked 
glycoproteins using sialidase digestion, after which the glomeruli 
stained with soy bean and peanut lectin. Lectins can also be used 
on normal semi-thin methacrylate embedded sections, where they 
have been used coupled to colloidal gold particles-^ -28 or fluorescent
probes^29>
It is reasonable to assume that a variety of pathological 
processes, such as enzymic degradation of carbohydrates, could al­
ter or destroy lectin receptor sites, whereas loss of lipid or 
protein from complex macromolecules unmasks different binding 
sites. The main problem with the use of lectins is that their stain­
ing pattern can only be related to the availability, masking and 
unmasking of specific sugar moieties, and that further molecular
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interpretation is precluded.
IV. ANTIGENS
A. Application of antigen-based histochemistry
There has been an increasing interest in the use of antibodies 
directed against unique or novel characteristics along the nephron. 
These antigenic determinants may be present on enzymes, 
glycoproteins or other molecules, associated with membranes or 
soluble cytosolic constituents. Many of the monoclonal antibodies so 
far reported react with one or more regions of the nephron and/or 
parts of the celll30)131. There are some major disadvantages to 
using antibodies; their production is time-consuming and their * u 
specificity may be doubtful, only a few antibodies will detect the 
same antigen in an unrelated species, and each antibody is a 
unique entity, the production of which cannot be exactly 
reproduced. Even when taken from the same source, polyclonal 
antibodies may vary in titre between batches, and their production 
depends on the longevity of the animal producing them.
Visualization of the site of antibody binding to the antigenic 
determination is done by labelled antibody, e.g. labelled with en­
zymes, fluorescent dyes or radioactive groups. It is evident that 
proximal tubules can easily and specifically be stained by anti- 
brush-border membranes, and distal tubules by means of antibodies 
directed against tonin-^ 2 and Tamm-Horsfall glycoprotein-^ 33. 
However, not all enzymic antigens present in the brush border 
membrane can be demonstrated histochemically, e.g. whereas 
aminopeptidase binds its a n t i b o d y ^ 3  alkaline phosphatase does 
not^ 3^ , which may indicate hidden antigenic determinants.
Provided the concentration is sufficiently high, the antibody 
will act as a native cross-linking agent in frozen, unfixed 
sections3^  >^ 3^ . The use of high antibody concentrations may, 
however, be inappropriate due to the presence of antibodies 
against undesirable antigens giving rise to misleading staining, if 
the binding site is not specifically monitored. For example, 
monospecific anti-renin diluted 1:1000 not only stained the jux- 
tamedullary apparatus in mice, but also stained the epithelial cells 
of the afferent arterioles and some cells of the proximal tubule and 
collecting duct. A 10-fold dilution resulted in the loss of proximal 
tubule and collecting duct staining, whereas an additional 100-fold 
dilution (i.e. 1:1,000,000) resulted in the disappearance of the ar­
teriole staining. These data were interpreted in terms of the quan­
tity of renin released from the juxtamedullary apparatus and its' - 
uptake by pinocytosis, but equally they may represent decreased 
binding to the biotransformed product angiotensin I^-3®.
1. Polyclonal antibodies
Antisera raised against purified epithelial cells may be useful to 
stain particular nephron segments*37, but may contain antibodies 
with various antigen specificities. If only one of these reacted with
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antigenic determinants shared by cells of other nephron segments 
or the interstitium, the staining is not specific. If, on the other 
hand, the specificity of an antiserum has been established, antigen 
concentrations can be quantified in sections using antibody con­
centrations close to saturation levels^ * 59 ^ This approach is dif­
ferent from the conventional one, which aims at the number of 
antigenic sites by diluting out the antiserum.
2. Monoclonal antibodies
More recently, specific renal antibodies have been produced by 
cloning t e c h n i q u e s - ^ , and appear to be the most promising tech­
nique for detecting specifically defined antigenic determinants in 
renal sections. The applicability of monoclonal antibodies may be 
restricted if the density of antigenic determinants is too low.
Figure 7 Immunohistochemistry of normal male rat kidney showing the different con­
centrations of the cytoplasmic isoenzymes aldolase-A and aldolase-B within and be­
tween nephron segments. Frozen, acetone-fixed serial sections stained for aldolase 
(ALD) activity after treatment of sections with antibody against ALD-A and consecu­
tively with antigen ALD-A (A), antibody against ALD-B and antigen ALD-B (B), and 
both antibodies and antigens (AB). Cortex (C), outer stripe (0) and inner stripe (I) 
of outer medulla and inner medulla (M).
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Figure 8 Enzyme- and immunohistochemical changes in rat kidneys 24 h after a single 
1.3 g/kg i.v. dose of cephaloridine. FRP of enzymes is normally only present in 
proximal tubules, but following cephaloridine insult it is also demonstrated in dis­
tal tubules where it is associated with hyaline casts. Frozen, acetone-fixed sections 
stained for the brush-border enzymes alkaline phosphatase (APP) and aminopeptidase 
(AP), and using immunohistochemistry for the cytoplasmic isoenzymes aldolase-A (A) 
and B (B). Outer and inner stripe of outer medulla, with stained proximal tubules and 
casts (top) and serial sections through distal tubules of inner stripe containing FRP 
of enzymes of the proximal tubule (bottom). Arrowheads point to tubular casts.
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Figure 9 Histochemistry of human hypemephroid carcinoma. The FRP concentration of 
each enzyme is heterogeneously distributed in the tumour cells. Frozen, acetone- 
fixed serial sections immunohistochemistry stained for aldolase-A (A) and aldolase-B 
(B) and using enzyme histochemistry for alkaline phosphatase (APP) and aminopep­
tidase (AP). Tubular lumen (T).
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3. Antibodies to enzymes
The use of antibodies is also of advantage in the investigation of 
enzymes with the same catalytic activity, but different molecular 
properties, i.e. isoenzymes. The mixed aggregation immuno- 
cytochemical technique^ has been used to localize and quantify 
specifically renal isoenzymes of lactate dehydrogenase^ and 
aldolase^  in nephron segments. For instance, during renal matura­
tion aldolase-B monomers increase in the proximal tubules of rats, 
but not in the distal tubules. By contrast, aldolase-A monomers in­
crease in the distal tubules, but not in the proximal tubules^. it 
can be concluded that renal casts in adult rats that contain mainly 
aldolase-B monomers are derived from proximal tubules (Figure 7). 
Similarly, the presence of proximal tubule markers can be shown in 
hyaline casts after a nephrotoxic insult (Figure 8). Moreover, ' w 
isoenzyme determinations may be useful in the study of 
tumorigenesis (see below) and development-^  9, and help established 
tumour cell heterogeneity (Figure 9) with other antisera and
lectins
4. Fixed or frozen sections
Immunohistochemical techniques have been applied to both frozen 
and fixed sections. Increasing use is being made of semi- and 
ultra-thin sections of epon- or methacrylate-embedded materials. 
Ultra-cryostat sections are also being employed, but are beyond 
the scope of this chapter. The literature on the optimal methods 
to be used is not consistent and depends on the technique and 
type of molecule being studied. Generally protease treatment 
reverses the loss of antigen binding sites caused by a variety of 
fixation methods^O. increasingly, however, short fixation of fresh 
tissue is becoming popular, especially at low temperatures for the 
duration of fixing, dehydration and embedding!^.
B . Renal immunomarkers
Immunohistochemical methods have also been used to demonstrate a 
variety of functional protein epitopes in discrete localizations of the 
k i d n e y ! 3 2 , 1 3 3 , 1 3 7 , 1 4 C T - 1 6 2  (Table 5), but very few of these tech- ► 
niques have been applied to help elucidate the mechanisms of neph­
rotoxicity. There are a number of macromolecules that are present 
in the glomerulil63-165 (Table 6), some of which are also present . *
throughout the tubular basement membrane. Under pathological 
conditions a variety of immunodeposits have been observed in a 
large number of glomerulopathies, and immunofluorescence monitor­
ing provides the standard means of diagnosis. Glomerular 
i m m u n o c h a n g e s l 6 6 - 1 6 9  are beyond the scope of this chapter. There 
are several tubular epitopes that warrant special comment because 
of their importance in studying target cell toxicity. The use of an­
tibodies for assessing arachidonic acid metabolites and the enzymes 
responsible for their bioconversion is covered below in Section VI.
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Table 5 The distribution of structural and functional proteins, exogenous filtered 
proteins and enzymes in the kidney as assessed by immunohistochemistry
Characteristic Distribution >. Species References
Albumin Proximal convoluted tubule
basement membrane 
apical vesicles and 
lysosomes
Aminopeptidase IV Proximal tubule brush-border
Na+,K+-ATPase Proximal tubule weak
basolateral
Distal tubule strong basolateral 
Absent intercalated cells
Atrial
natriuretic
factor
Carbonic
anhydrase
Carbonic
anhydrase
isoenzymes
Cathepsin D
Clathrin
Intercalated cells of the 
collecting ducts - homogeneous 
in some and apical in others
Weakly in the proximal tubule 
Strongly in the loop of Henle 
Strongly in the collecting ducts 
Distal convoluted tubule - 
a mosaic of very strong and 
absent in adjacent cells
Only isoenzyme II in the loop 
of Henle and distal nephron
Cortical and medullary 
collecting ducts 
Mesangial cells
Proximal tubule weakly positive
Apical portion of the 
proximal tubule
Enoyl-CoA hydratase
Heat-stable Proximal and distal epithelial
cell mitochondria 
Absent from glomeruli
Heat-labile Proximal tubule epithelial
cells
Ferredoxin* Glomerulus and proximal
convoluted tubule
a-Glucosidase Proximal convoluted tubule
brush-border and loop 
of Henle
Kallikrein Distal tubule cytoplasm
Sometimes vascular poles 
glomeruli and collecting ducts 
Apical regions some distal 
tubules
Reabsorption droplets proximal 
tubules
Some collecting ducts in medulla
Guinea pig 142
Rat 143
Mouse 144
Rat
Rat
Rat
Rat
Rat
Rat
Rat
Chick
Human
Rat
Mouse
145
146
146
147
148
149
149
150
151
152,153
153
43
NEPHROTOXICITY IN THE EXPERIMENTAL AND CLINICAL SITUATION
Table 5 (continued)
Characteristic Distribution Species References
Metallothionein Epithelia of collecting duct 
and distal convoluted tubule 
in controls 
After Cd loading - strong proximal 
convoluted and collecting duct 
epithelia staining in both 
nuclei and cytoplasm 
Weak to moderate staining in 
glomerular mesangial and 
visceral epithelial cells and 
vascular smooth muscle cells 
There was no staining in vascular 
endothelial cells
Rat 154
Renin Juxtamedullary apparatus 
Epithelioid cells of the 
juxtamedullary apparatus
Mouse
Rabbit
Dog
Mouse
155
156
156
157
Epithelioid cells of the 
afferent arteriole in the 
juxtamedullary apparatus
Human 158,159
Cu-Zn superoxide 
dismutase
Tissue
polypep^de
antigen
Thick ascending limb of 
the loop of Henle 
Proximal convoluted tubule
Strongly positive 
lining renal pyramid 
thin segment of loop of Henle 
collecting ducts 
Weakly positive 
parietal cells of Bowman's 
capsule
Dog
Rat
Human
160
161
140
Trehalase Proximal tubule brush-border Rabbit
Rat
162
162
Iron-sulphur part of 25-hydroxy-vitamin-D-3-hydroxylase. 
Also stains most extra-renal tissue.
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Table 6 The distribution of structural proteins in the kidney glomeruli as 
assessed by immunohistochemistry
Structural
protein
Distribution Species Reference
Collagen type IV GBM* laminae densa 
Mesangial matrix
Rat 163
Entactin GBM peripheral 
capillary loops 
Tubular basement membrane
Rat 164
Fibronectin Strongly mesangial matrix 
GBM laminae rara 
at the endothelial- 
mesangial interface
Rat 163
Glycoprotein GP-2 GBM tubular basement membrane Guinea pig 165
Laminin GBM lamina rara 
Mesangial matrix
Rat 163
GBM peripheral capillary 
loops 
Mesangial matrix 
Tubular basement membrane
Rat 164
*GBM = Glomerular basement membrane
1. Cytochrome P-450
The role of oxidative metabolism in the generation of biologically 
reactive interm ediates has received much a t t e n t io n l^ , , and
anti-cytochrom e P-450 has been used  to show the localization to the 
jproximal tu b u le , particu larly  the Po and P3  segm ents, and the  in ­
duction following exposure to dioxnv*-^,173.
. '2. Ligandin and brush border antibodies
Ligandin or glutathione-S-transferase B is located in the proximal 
tubule of both animals and man-^ 4-176 and the thick limb of the 
loop of Henle in man 176,177# Similarly the distribution of anti- 
aminopeptidase to the brush-border has been described for several 
species^>36,59 an(j brush-border antigens in rats-^ ,179^
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3. Tamm-Horsfall glycoprotein and o ther d istal tubu lar 
macromolecules
Tamm-Horsfall glycoprotein (THG) is localized to the  distal neph­
ron , where it  plays an essentia l, b u t not ye t fully understood , 
role in u rin a ry  c o n c e n t r a t i o n ^  3, 180 ^  The d istribu tion  of th is 
glycoprotein is p e rtu rb ed  by  a num ber of nephro tox ins. Potassium 
d i c h r o r n a t e  caused a biphasic release of THG and deposits along
the luminal bo rders  of the epithelial cells within 1 2  h , loss from 
the d istal nephron and an increase in the number and size of casts 
from 48 h  a fte r  dosing. Luminal casts accounted fo r all of the 
THG-positive stain ing  material by  144 h , b u t d istal epithelial THG 
increased from 192 h , and the d istribu tion  was normal by  14 days.
Figure 10 Aggregates of immunohistochemically positive Tamm-Horsfall glycoprotein 
hyaline tubular casts present in medullary collecting ducts 7 days after the induc­
tion of an acute papillary necrosis using 100 mg/kg i.p. of BEA.
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THG is also lost from the d istal nephron a t an early  time 
point during  the course of development of an acutely induced renal 
papillary  necrosis (F igure 10)18! .  Only la te r when the medullary 
MPS sta in ing  had been lost do large casts of THG positive material 
deposit, especially in the collecting ducts and ducts of Bellini in 
the  necrosed a reas , where th ey  are  associated with cellular 
debris^8! .  The nephrons th a t appear to feed blocked collecting 
ducts are  generally  dilated. Some of the  THG-positive material is 
ex travasa ted , and many of the  superficial glomeruli thus affected 
have THG-positive material in  Bowman's space. The presence of 
.THG in Bowman's space may be rela ted  to glomerular sclerosis-*-8^, 
.following an acutely induced m edullary in ju ry . Alkaline 
p hosphatase-, ATPase- and GGT-FRP are  p resen t in these casts , 
which supports  the  idea th a t there  are  proximal tu b u la r changes 
‘du ring  the development, or as a re su lt of renal papillary  
necrosis^®8 .
There are  several examples where the cross-se lectiv ity  of 
antibodies to proteins derived from differen t species has been u se ­
fu l. For example, much of the resea rch  on the changes in animal 
•THG has been based on the use of antibodies raised  to human 
THG. There are  also instances where data th a t are  difficult to in ­
te rp re t  have been generated  from the application of antibodies to 
tissue o ther than  the one of in te re s t. Pich e t a l.-*-8 8  rep o rted  the 
v e ry  s trong  b inding of an anti-hum an casein antibody to the mam­
mary glands and sweat gland, and also the distal tubule and the 
collecting duct. The unexpected renal d istribu tion  of th is pro tein  
suggests th a t it  may be involved in the  control of electro ly te, 
w ater and o ther fluid movement. Identification of the  antigen had 
not been undertaken  and c ro ss-reac tiv ity  with o ther antigens could 
not be excluded.
THG and the an ti-casein  positive material are  not the  only 
proteins th a t function in d ifferen t regions of the  body to modulate 
ion and w ater perm eability and tra n sp o rt. Molin e t al.-^8^ showed 
th a t antibodies to the a -su b u n it of the S-100 pro te in  (originally 
found in the  cen tral nervous system ) also stained the th in  limb of 
the loop of Henle, and the connecting and collecting ducts in the 
r a t .  No o ther p a rt  of the k idney o r urothelium reacted  positively 
to th is antibody, and the antibody to the (3-subunit of S-100 did 
not reac t with the k idney or urothelium . The d istribu tion  of S-100 
in the k idney closely parallels the  d istribu tion  of the  carbonic an- 
hydrase  - isoenzyme C-*-8^. The S-100 protein  has been strong ly  
' implicated in calcium binding, and its  presence in the  d istal p a rt  of 
the nephron suggests  th a t it  p lays some role in  modulating Ca^+ 
reabso rb tion , perhaps similar to the role played b y  THG in Na+ 
-up take . A vitamin D-induced calcium -binding p ro te in  (f irs t  
described  in the  chick in testine) has also been rep o rted  in the 
rab b it, r a t  and chick k i d n e y !  8  ^ 5185a ^  There were some species d i f ­
ferences, b u t in general th is calcium -binding pro tein  appeared  to 
be d is tribu ted  almost identically with th a t described fo r the  S-100. 
The potential pertu rbation  of these novel pro teins b y  chemicals, 
and the resu lting  disruption  of calcium and o ther electrolyte 
hom eostasis, w arran ts fu rth e r  investigation. At p re se n t th ere  are 
no data to confirm th a t the S-100 and vitamin D -dependent calcium- 
binding pro tein  are  the same molecules, and v e ry  little  is known
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about the  relationship of e ither of these to THG.
4. Renin and kallikrein d istribu tion
T here are  a num ber of o ther enzymes th a t play major roles in renal 
hom eostasis, the  most im portant of which are  renin!55-159 an(j 
kallikrein-^ 153. These two enzymes produce essentially  opposite 
functional effects in the  kidney-*-^®. R enin-secreting  cells appear to 
be on the ou ter aspects of the vessel wall, and immunoreactive 
angiotensin II is p resen t in h igh concentrations with ren in  granules, 
and is therefo re  assumed to be excreted  with th e m - ^ . (Drstavik. 
and I n a g a m i - ^ 8  showed th a t the localization of the  individual 
mediators is separa te ; whereas kallikrein is localized in the  thick 
ascending limb of the loop of Henle (up to the  d istal tu b u le ) , re n in ' w 
was always associated quite separately  in the epithelioid cells of" 
the a ffe ren t arterio le . Renin is also localized to th is position in the 
normal human kidney!58,159. More im portantly, in those kidneys 
with ischaemic in ju r y ! ^  5159 or B a r tte r’s syndrom e^® the ren in - 
positive epithelial cells showed increased  stain ing  in tensity , and in 
a ffe ren t arterio les th a t were some distance from glomeruli. The p a t­
te rn  of sta in ing  was normal in  localized parenchymal areas where 
ischaemic in ju ry  had not o c c u rre d !^  and in o ther ty p es of neph­
ropathy , even when plasma ren in  levels were h ig h -^  . This novel 
observation needs to be confirmed in the  experim ental situation, 
where th is  abnormal d istribu tion  may help identify  those injuries 
where chemicals cause a d irec t or ind irect anoxia of the  renal 
parenchym a. It may also give some indication of the  mechanisms in ­
volved and the consequences of renal ischaemic in ju ry .
5. ct2U-Globulin d istribu tion  in the kidney
The development of renal carcinoma in only male ra ts  exposed to 
b ranched-chain  ligh t h y d r o c a r b o n s - ^  has heightened in te re s t in 
the  hepatic syn thesis and renal excretion of a2u -globulin-*-^, in 
the  proximal tubule the reabsorp tion  of th is low molecular weight 
p ro te in  gives rise  to the  hyaline droplet th a t is the characteristic  
fea tu re  of "old ra t"  and ligh t hydrocarbon nephropathy . Roy and 
R a b e r ^ l  u sed  a rhodam ine-linked a n ti-a 2U-globulin to show the 
d istribu tion  in the  liver (cytoplasmic in  the  parenchym al cells) and 
the  k idney , where it was localized to the  cells of the  proximal ‘ 
tubu le , the  loops of Henle and the distal tubule . The d istribu tion  
of rhodam ine-labelled ct2U-globulin showed the presence of the 
p ro te in  along the length  of the  nephron. More recen tly , Simpson et* 
al.192 USed an ind irect immunoperoxidase assay  and showed th a t 
the  p resence of ct2U-globulin was not confined to the  hyaline 
d rop le ts, b u t was also p resen t in the cytoplasm and lumen of the 
proximal tubule of male ra ts  trea ted  with the branched-chain  
hydrocarbon 2 ,2 ,4 -trim ethy lpen tane. ct2U-Globulin is also sy n ­
thesized  b y  the duct cells of the  subm axillary g land, where it  is 
not un d er sex hormone control, although the nro tein  is immunologi- 
cally identical to th a t produced by  the liver-*-^.
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6. Tumour antigens
Cordon-Cardo et al.194 used a variety of human urothelial and 
renal cancer cell lines to produce monoclonal antibodies which were 
then shown to be selectively associated with different parts of the 
nephron. Each of these antibodies was novel and did not cross- 
react with other previously identified antigens such as THG, 
fibronectin, laminin, etc. There has been some interest in the 
potential use of these regio-specific markers to identify areas of 
renal necrosis using the presence of urinary excreted antigens 
.from damaged cells as a measure of injury.
Monoclonal antibodies raised to cytokeratin polypeptides have 
been shown to react with various renal sites, including the 
proximal and distal tubule and the urothelia-^ 5. More importantly, 
‘the pattern of renal carcinoma and type I and II carcinoma were 
each unique and different from the rest of the kidney and 
urothelial tract-^. Wang and Krueger-*-^  also reported an antibody 
that is selective for rapidly proliferating cells in different regions 
of the body. The identification of rapidly dividing cells could be 
used to show the presence of proliferative bursts of activity that 
were indicative of repair, hyperplasia or malignancy, especially if 
combined with other methods.
The ABO isoantigens normally associated with blood groups 
have also been used to differentiate between normal and non­
in vasive transitional urothelia carcinoma (which stains for the 
tissue isoantigen) from invasive carcinoma which frequently did not
stainl^.
There is also limited clinical data to suggest that anti- 
ligandin reacts with renal adenocarcinoma, but not with undifferen­
tiated carcinoma, papillary adenoma, well-differentiated papillary 
adenocarcinoma and Wilm's tumours in man^ ^^ . Immunoreactive 
renin-containing cells are present in most renal tumours where 
they are also intimately associated with blood v e s s e l s ^ 1?. Another 
series of markers in a very large number of renal tumours is the 
co-presence of the intermediate-sized filaments of cytokeratin and 
vimentin. While cytokeratin is present in other parts of the normal 
kidney, it is never present with vimentin. This suggests that 
vimentin is expressed as part of the neoplastic t r a n s f o r m a t i o n ^  8 .
G. High-resolution immunohistochemistry
Most of the immunohistochemical methods decribed make use of wax 
- sections. Generally these are 5 |im or thicker (often 7-10 jun), but 
*the use of special techniques may facilitate semi-thin sections. For 
example Clyne et al.1^ 9 reported the immunohistochemical tubular 
localization of albumin in those patients with proteinuria, where the 
tissue was freeze-substituted, paraffin-embedded and cut at 
0.5 |im.
The use of low-density methacrylate resins has also opened 
the potential of undertaking immunohistochemistry on semi-thin sec­
tions , which provides vastly improved resolution and precise 
localization of the antigen labelling®^ . There is loss of antigenicity 
as a result of the processes involved in embedding material in
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glycol methacrylate resin. Hemming et al.2®® reported that cryosec- 
tions used an antibody titre that was 1000 more dilute than that 
necessary for semi-thin sections, but the superior morpholgical 
detail seen in the methacrylate material made it most useful. 
Several of the technical difficulties associated with low-temperature 
embedding of tissue have been made more simple by the device 
reported by Wells2®*-.
The most important criterion for successful immunohisto­
chemistry in methacrylate material is the use of low-temperature 
fixation and processing to preserve both morphology and 
antigenicity®^ *141,168,200,202-207^ Protease treatment helps to im-. 
prove the availability of antigens®^  >168, -but these tend to be the 
extracellular binding sites, and etching the resin may be necessary 
to detect intracellular antigens. The double antibody technique2®® 
has been used successfully to contrast antigens in glycol methacry­
late, where the secondary antibody has included immunogold2® *," 
fluorescent labels*-®®’2®®, avidin-biotin-peroxidase®* and
peroxidase-anti-peroxidase2®®. In general, the most successful ap­
plication of immunohistochemical methods to glycol methacrylate has 
been with those antigens that are most resistant to 
fixation®"^  >1®® » 209-211 ^
V. LIPIDS
There are many aspects of lipid histochemistry that require more 
extensive or renewed evaluation, because of the subtle differences 
that may be introduced by fixation and staining properties of the 
different lipid stains. Thus fixation procedures have been 
evaluated for their ability to unmask lipid from lipoproteins2*-2 or 
to stabilize membranes2*-® ^ and several of the approaches have been 
c o m p a r e d 2 * - * * .  While it is generally appreciated that dehydration for 
wax or methacrylate embedding will remove lipid, the remaining 
vacuoles may be interpreted as structures in their own right2*-®. 
Some lipids are also water-soluble and may be leached out of tissue 
that has been subjected to prolonged fixation®**. The other impor­
tant aspect that has to be re-evaluated are the differences between 
adipose fat globlets, fat droplets, the different types of lipid 
material such as membranes, free neutral and fatty acids, sterols; 
the more complex lipids such as lipoproteins, glycolipids and also 
the question of cytoplasmic "lipid domains", which show varying 
degrees of hpophilicity2*-2-2*-®. Depending on the stain used any 
one or more of these different characteristics can be shown2*-®-2*-® 
and various artefacts have been described2*-®. Berg2*-® used the 
now-established carcinogen 3,4-benzpyrene (benzo[a]pyrene) and- 
showed that there was a very strong fluorescence associated with 
the brush-border and basal filaments (probably the mitochondria of 
the proximal tubule) in formaldehyde-fixed frozen mouse kidney. 
Sudanophilicity was also present in these epithelial cells. By con­
trast Oil Red "O" stains the lipid droplets in the interstitial cells 
of the medulla heavily, but not other parts of the kidney2*-®. The 
medullary interstitial cells have a very high lipogenic potential and 
the numerous lipid droplets are rich in polyunsaturated fatty 
acids, especially those with C18 to C24 chain lengths22®. These
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lipid droplets are  also apparen t as osmophilic material in semi-thin
sections ^ 19 #
A. Abnormalities in lipid distribution following chemical insult
While lipid changes are  well described following liver in ju ry  there  
is a  paucity  of data on nephrotoxicity . The ou tstanding  histo- 
chemical changes in patien ts with analgesic abuse-rela ted  renal 
papillary  necrosis is the  accumulation of ve ry  large quantities of 
Oil Red "O" positive lipid material^-*-. Similar changes have also 
been repo rted  in experimentally induced papillary  necrosis following 
a s p i r i n and a prolonged essential fa tty  acid-deficient d ie t^ ^ .  
More recen t stud ies have shown th a t these changes also occur in 
an acutely induced papillary  necrosis (F igure 11), where the ea r­
liest changes took place in the  capillaries.
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Figure 11 Accumulation of lipid in collecting duct epithelial cells in papilla from 
rat 48 h after single i.p. injection of BEA (100 mg/kg). Fixed-frozen section 
stained with Oil Red "0". Insert shows lipid accumulation in proteinaceous casts in 
loops of Henle and covering epithelium of papilla (arrows).
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There was also a marked accumulation of lipid in the 
epithelial cells (normally there is no lipid material in these cells as 
assessed by Oil Red "O"). The epithelial accumulation of lipid 
material extended into those areas of the outer medulla which were 
not affected by the papillotoxin and appeared to be normal by 
routine H&E staining2^ . A comparison with a variety of other 
nephrotoxic lesions, such as those caused by hexachlorobutadiene, 
aminoglycosides, cis-platin and polybrene, suggest that the capil­
lary and epithelial deposits of lipid material are pathognomonic for 
renal papillary necrosis224. chemical assay of the medullary tissue 
has recently suggested that these histochemical changes repre­
sented a phospholipidosis22^  # The greatly increased levels of lipid 
material in the hyperplastic urothelia may be pathognomonic of, or 
associated with, malignant or premalignant changes. These have 
been described in other malignant tissues222 an(j in exfoliating 
urothelial cells227.
Other published data suggest that the development of renal 
lipid changes is associated with specific types of nephrotoxicity. 
Aminoglycosides cause a proximal tubule p h o s p h o l i p i d o s i s 2 2 8  f which 
in common with other renal lesions caused by chromium2 2 9} carbon 
tetrachloride222} tetracycline2 3 1  and aflatoxin222, 2 3 3  a j s o  c a u s e ( i  a  
localized increase in Oil Red "O" staining. Puromycin amino- 
nucleoside targets selectively for the glomeruli and causes an ac­
cumulation of Oil Red "O" material22^ . The rubeanic acid method 
has also been used to show the increased free fatty acid levels in 
the nephrotic syndrome222. Recently, there has been a report that 
the immunosuppressive cyclosporin causes an accumulation of Oil 
Red "O" positive lipid material in cultured proximal tubular 
cells222, although there appears to be no published evidence from 
histochemical studies on animals treated in vivo to show that similar 
changes are associated with this nephrotoxicity.
At present there is very little information to explain the in­
creased staining of lipid material in these damaged cells. In the 
case of aminoglycoside nephrotoxicity the phospholipidosis has been 
explained on the basis of decreased degradation and lysosomal ac­
cumulation of phospholipids as a result of membrane turnover227, 
but obviously other "lipid" changes may represent lipid unmasking, 
degradation of membranes, and/or accumulation of lipid material 
due to increased synthesis or decreased utilization in those in­
stances where it is changed2^ 2"222.
VI. PROSTANOIDS
The importance of the prostaglandins (PGs) in normal renal func­
tion, and their controversial role in the development of a variety 
of nephropathies such as nephrotic syndrome, renal papillary 
necrosis and hydronephrosis, have been widely studied222>240^ 
Much of the information on the distribution of prostanoid metabo­
lism has come from biochemical studies on medullary and cortical 
tissue slices, isolated glomeruli and cultured cells, and by the use 
of classical microdissection studies. For example, the presence and 
distribution of NAD- and NADP-15-hydroxyprostaglandin dehydro­
genase, and other enzymes related to arachidonic acid metabolism,
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has been established using tissue fragments from cryostat 
sections2^ !. It is important to stress that the absence of a par­
ticular PG or one of the enzymes that metabolize arachidonic acid 
from any one cell type does not exclude the potential for the cell 
to produce the arachanoid of interest. Three distinct approaches 
have been used:
A. Antibodies raised to the enzyme
• Smith and W i l k i n 2  ^  2 used an anti-cyclo-oxygenase to show that the 
„ * distribution of cyclo-oxygenase was confined to the medullary in­
terstitial cells and the collecting ducts in the rat, rabbit and 
. guinea pig, and in the cow and sheep242a»243 jn h^e cortex2^ 2 
- - cyclo-oxygenase antigenicity was localized in the endothelial cells of 
all arteries and aterioles, and the collecting ducts in the rat, rab­
bit, guinea pig, cow and sheep. This enzyme was also present in 
glomerular epithelial cells of the rabbit, cow and sheep.
B. Antibodies raised to the prostaglandins
Mori and Mine2^  used antibodies raised to each of the prostaglan­
dins, and showed the PGE2 and PGF2a were present in the cortical 
and medullary collecting ducts, the medullary interstitial cells, 
both glomeruli, mesangial and epithelial cells and endothelial cells 
of the arteries and arterioles. By contrast PG-6-keto-F^ a (the 
stable metabolite of PGI2) was localized in both mesangial and 
epithelial glomerular cells, and the endothelial cells of arteries and 
arterioles. The tissue localization of PGA2 has also been shown to 
be more marked in the tubular cells of the renal medulla compared 
to the c o r t e x 2 ^ 2 , but there was no discrete localization. These data 
suggested that PGA2 was localized to the cell membrane rather than 
the cytoplasm as appears to be the case for the other PGs.
C. Substrate oxidation to a chromophore
Janszen and N u g t e r e n 2 ^  > 2^ 7 based their histochemical method on 
cyclo-oxygenase-mediated arachidonic acid oxidation of diaminoben- 
- . zidine (using cyanide as a blocking agent for mitochondrial 
oxidation). They showed intense staining of the secretory epithelia 
of seminal vesicles, and especially the renal collecting ducts and 
•medullary interstitial cells. It has proved difficult to confirm that 
this colour change relates to the enzyme PG cyclo-oxygenase, al­
though the distribution parallels were described by S m i t h 2^ 2 ’2^2 . 
Treating animals with analgesics or non-steroidal anti-inflammatory 
drugs, or the addition of these inhibitors of PG synthesis to the 
incubation medium, did not alter the intensity or formation of 
polymerized benzidine reaction product2^ 2-2^ . Litwin2^ 2 »2^ 2 has 
suggested that the colour reaction represents "total" peroxidative 
enzyme activity, based on the fact that diaminobenzidine oxidation 
is blocked by 3-amino-l,2,4-triazole, a well-established inhibitor of 
catalase and peroxidase. This was supported by the fact that the
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renal enzymic activity, demonstrated by this method, was the same 
with hydrogen peroxide and arachidonic acid (there was no reac­
tion with unsaturated fatty acids), it is heat-stable and the pH op­
tima parallel other peroxidases. Also, whereas glutathione abolished 
the colour reaction, catalase had no effect. The main question that 
remains to be resolved is which of the several possible different 
peroxidases can be visualized by this method, especially because of 
the recent importance that has been accorded the role of metabolic 
activation by these enzymes^Oa^ Litwin^S > 249 suggested that the 
activity was "a special peroxidase related to PG synthesis". This 
suggests PG hydroperoxidase, which together with cyclo-oxygenase * 
forms PG synthase, or a lipoxygenase. Unfortunately the higher * „ 
activity in the collecting duct compared to the medullary interstitial 
cells, and the fact that no activity was reported for glomeruli, - 
does not support the biochemical data already available for these - - 
enzymes in the different regions of the kidney^S, 240 ^
D. Perturbations of prostanoid metabolism in response 
to nephropathy
Despite the implicated pathophysiological role for these lipids (and 
their related products) in several nephropathies, and the number 
of techniques available to study prostanoid metabolism, only very 
limited published material is available. Smith et al.251 showed that 
there was a time-related increase in cyclo-oxygenase staining in 
the cortical collecting tubule and the loops of Henle of rabbits with 
surgically induced hydronephrosis. Contrary to expectations there 
were no vascular or glomerular changes, nor were there any 
changes in the medullary staining for this enzyme. Hydronephrosis 
is associated with p h o s p h o l i p i d o s i s ^ ^ ^  and the very marked in­
crease in thromboxane A2 s y n t h e s i s , which suggests that a full 
understanding of this change may only come from the application of 
histochemical, microdisseetion and other techniques.
VII. OXIDASES AND ANTI-OXIDANTS
The presence of oxidative enzymes includes a series of mixed func­
tional oxidase systems such as the cytochrome P-450 enzymes, the
distribution of which is shown by immunohistochemistry-*-^, 173 (see . -
above). The distribution of cytochrome P-450 can also be shown by 
direct microspectrophotometric m e a s u r e m e n t ^ 4} but this approach 
does not appear to have been applied to the kidney. There are* ^ “ 
other oxidase systems in the kidney. Large numbers of peroxisomes 
are localized in the P3 portion of the proximal tubule, but they are 
absent from the glomeruli and the distal nephron. There are 
highly selective methods for their v i z u a l i z a t i o n ^ S , 2 5 6 , a n ( j  their 
origins and d e v e l o p m e n t ^  7 , 2 5  8 j n  the metanephric kidney have 
been well documented. The full renal functions of the peroxisomes 
remain ill-defined. It is generally assumed that urate oxidase is 
responsible for the conversion of uric acid to u r e a ^ 5 7 .  i n  addition 
to urate oxidase, these organelles also contain catalase, and D- 
amino acid oxidase^S. D-amino acid oxidase activity has been
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demonstrated in fixed and fresh renal proximal tubules using D- 
proline or D-alanine, peroxidase and diaminobenzidine (among other 
methods )!?, but the physiological function of the enzyme is far 
from certain. R e d d y  2^ 6 has speculated on the role of D-amino acid 
oxidase in the genesis of the highly localized necrosis to the P3 
region of the nephron following the administration of D-serine. 
There is also evidence that oxalate and polyamines are oxidized in 
the proximal tubule p e r o x i s o m e s 2 ^ * ) .  The presence of these two 
oxidases is particularly important during incipient renal failure 
when the filtered load of oxalate and polyamines is known to be 
high.
The level of catalase is greatest in the proximal tubule, less 
in the distal tubule and very low in the glomeruli (there were no 
data on the medulla) in Syrian hamsters. Furthermore, the catalase 
levels in the proximal tubule were reduced at the same time as 
diethylstilboestrol-induced renal adenocarcinomas. Subsequent 
progesterone treatment reversed the carcinogenic e f f e c t 2 ^ !  and also 
restored the catalase levels to normal.
Using the controlled staining of frozen sections with mercury 
orange, Ashgar et al.^ 62 showed that glutathione (GSH) was local­
ized to the proximal convoluted tubule. Recently, Chieco and 
B o o r  ^ USed low temperatures to decrease the diffusion of the 
mercury glutathione complex, which also reduced the colour inten­
sity, but this decreased sensitivity was partially offset by the 
fluorescence of the complex. The "Prussian blue" method of Smith 
et al. 263a forms much more rapidly that the mercury orange com­
plex and will therefore show better localization. It has been used 
for determining GSH in liver, but produces an artefactual GSH dis­
tribution in the kidney, where the medulla stains very intensely. 
This probably represents staining of the medullary mucopolysac­
charide matrix by colloidal iron 264. There is little histochemical 
data on the distribution of other molecules that are likely to 
protect the cell from the effects of reactive intermediates.
The distribution of superoxide dismutase has recently been 
established using immunohistochemical techniques, which showed 
marked species differences in the dog-^ O and rat-^ l (see above). 
There are, however, at least three distinct types of superoxide 
dismutase, and until the distribution of each is defined it will be 
difficult to relate the absence of enzymic activity to target cell in­
jury in the kidney.
VIII. CATECHOLAMINES
A significant proportion of the control of renal blood flow is resi­
dent in the nervous system, and the presence of catecholamine- 
containing neurons has been shown in many areas of the 
kidney2®^ . These data are generally based on the fluorescence 
complex formed between formaldehyde and catecholamines using the 
Falck-Hillarp method2®6, but this fails to differentiate between 
chemically distinct representatives within this group. Recently, 
Dinerstein et al.26? showed that norephinephrine-fluorophore fades 
very rapidly on exposure to HC1 vapour, but the dopamine- 
fluorophore does not. The presence of dopaminergic elements in as­
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sociation with the  vascular poles of the glomeruli, supports a role 
for the  neuronal control of renal haemodynamics, the release of 
ren in  and the rela ted  renal changes26^.
IX. HEAVY METALS
A num ber of heavy metals a re  poten tly  nephrotoxic. While 
au toradiography (see below) has been an im portant method for 
s tudy ing  metal d istribu tion , histochem istry can also be used . 
Recently the localized renal d istribu tion  of m ercury to the 
lysosomes of the proximal tubule has been shown by  the silver 
amplification of the  m ercury sulphide2^ .  This silver amplification 
technique could also be applied to o ther heavy metals, including 
gold. There are  also a num ber of sensitive chromogenic chelating 
ag en ts , such as benzothiazolylazophenol derivatives tha t bind cad­
mium v ery  selectively2^ .
Changes in metallothionein levels are  a  frequen t consequence 
of heavy metal exposure. The d istribu tion  of metallothionein has 
been shown b y  immunohistochemical m e th o d s-^  (see above). There 
are  a num ber of histochemical methods th a t have been used  to 
dem onstrate the  presence of macromolecular th io ls . Morselt et 
ai.270,271 showed a dose- and tim e-related increase in histochemi- 
cally stainable macromolecular disulphide granules in the  proximal 
and distal (h igh dose only) tubules of ra ts  trea ted  with CdCF^. 
Based on the h igh disu lphide:pro tein  ratio  these granules were a s­
sumed to be cadmium-thionein. U ltras tru c tu ra l studies and X -ray 
microprobe analysis supported  high su lphur and cadmium levels and 
showed th a t these "granules’’ were in  fact lysosomes.
X. AUTORADIOGRAPHY
One of the major advantages of autoradiograpy is the  wide varie ty  
of tra c e r  molecules th a t are  available, the ability to s tu d y  both  
w ater-diffusib le and "fixed" molecules, and the fact th a t the  tech ­
nique can be used  in  tandem with o ther histochemical m ethods. 
Furtherm ore, the d istribu tion  of a host of potentially nephrotoxic 
radiolabelled molecules can be assessed  a t both  a whole-body and a 
microscopic level2^2. The technique can be g rea tly  s treng thened  by  
the  use of an appropriately  labelled p rec u rso r, where some degree 
of ce rta in ty  can be maintained on the natu re  of the molecule, and 
b y  the selective adm inistration of the  label, where localized in fu ­
sion ( ra th e r  than  the systemic rou te) will label a tissue  of choice. 
Many of the  advantages of au toradiography can be fu rth e r  en ­
hanced b y  the use of sem i-thin sections, particu larly  because it is 
then  possible to use ^4C-labelled material and still maintain very  
good localization of d istribu tion  a t the light microscopic level2^2a. 
The in te rp re ta tion  of autoradiography has been covered in  several 
te x ts 2^^>274, b u t may still need careful controls and intelligent 
consideration. For example the binding of -*-2^I-insulin  to the apical 
su rfaces of the proximal tubule rep re sen ts  the normal handling of 
filte red  peptides and not a hormone recep to r2^ .
Most of the histochemical techniques have the disadvantage of
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dead end-poin t m easurem ents. In o rder to obtain kinetic informa­
tion i t  is necessary  to in troduce m arkers into the animals which 
will be incorporated  into renal cells, i .e .  radioactively labelled 
p recu rso rs  of DNA (mostly 3H -thym idine), and of carbohydrates or 
p ro te ins. While there  are  a large num ber of studies th a t have used 
the autoradiographic d istribu tion  of nucleic acid p rec u rso rs , i t  has 
not been generally  recognized th a t th e ir  incorporation shows some 
degree of tissue-specific ity , th a t may depend on the d istribu tion  of 
enzymes involved in purine salvaging. For example, the incorpora­
tion of urid ine (as assessed  a t the  whole-body level) has been 
repo rted  to be fa r  g rea te r in the  k idney than  d e o x y t h y m i d i n e ^ ? ^ .
I t is possible to obtain information on the duration of S- 
phase cell cycling in a tissue specimen using  the double isotope 
pulse-labelling  t e c h n i q u e ^ ? ? .  The two D N A-precursors 3H- and
- - ^ C - thymidine are  pulse-labelled a few hours ap a rt. All the cells in
S-phase a t the time of both  pulses will be dual labelled, while the 
cells th a t a re  a t the  end of S-phase when the f ir s t  pulse is given 
will only be labelled b y  the f ir s t  isotope and not the second. Con­
verse ly  those cells th a t are  in S-phase when the second label is 
given will only c a rry  th a t isotope. The duration of the  S-phase can 
be estim ated from the time between pu lses, and the proportion of 
cells th a t have the th ree  d ifferen t combinations of labelled nuclei. 
As ye t there  are  no published data on the use of th is technique in 
relation to nephrotoxicity , b u t it would be appropriate  to give an 
in sigh t into regeneration  in d ifferen t regions of the  k idney . Dual 
labelling has also been used  to s tu d y  the dynamics of m etal-protein 
complex handling by  the k idney. Murakami and co -w orkers^ '3 , 278a 
showed th a t while - ^ C d  and -^I-labelled metallothionein en te r the 
cell to g e th e r, the -*-^ 3Cd is lost a t a v e ry  early  stage .
The effect of some polycyclic aromatic hydrocarbons consists 
of an inhibition of thymidine incorporation^?** and th a t following 
H gC ^-induced nephrotoxicity  the incorporation of amino acids in ­
creased , consisten t with the morphological c rite ria  of reg en er- 
ation^SO. Similarly, an increased incorporation of thymidine into 
DNA has been described for HgCl2  n e p h ro to x ic ity ^ . Using the 1-h 
3H-thymidine pulse labelling technique it has been possible to show 
th a t the  proliferative ra te  of tubu lar cells is low in adult ra ts  (8 
weeks or o lder), b u t about twice th is ra te  in 5-week-old ra ts .  In 
both  age groups the area of h ighest proliferative ac tiv ity  is th a t of 
the inner s tr ip e , which is about twice th a t of the  r e s t  of the  k id-
- . ' ney . Severe proximal tubule damage 24 h a fte r  a single dose of
cephaloridine is associated with a slight pro liferation , and increases 
up  to 4 days with rep a ir (F igure 12). Regeneration is fa s t , and
“ * similar a fte r  a single dose or a fte r  multiple daily doses. B a l a z s ^ l
has already draw n attention to the resistance of regenera ted  cells 
to fu rth e r  toxic in su lt. Conventional light microscopy of the 
cephaloridine-induced lesion did not show any dose-dependent ab ­
normalities a t  the end of the chronic s tu d y , b u t hyperp lasia  could 
be assumed on the basis of an increase in organ w eight. By con­
tra s t  chronic dosing with gentamicin produces a  dose-re la ted  in­
crease in proliferation and severity  of the lesion. Thus 3H- 
thymidine pulse labelling allows those nephrotoxic effects where 
cells develop resistance  to multiple insu lts to be d ifferen tia ted  from 
toxins th a t repeated ly  damage cells. Similar resu lts  were obtained
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by  L aurent e t a l.^82} using  homogenate analyses in a 14-day 
toxicity  stud ies with gentamicin.
4 8 h A P PV-24hAPP<:.
Figure 12 Autoradiography of the rat kidney 24 h and 48 h after a single 0.8 g/kg 
i.v. dose of cephaloridine and a 1 h i.p. pulse of JH-thymidine. The number of 
labelled (proliferating) cells is greatly increased 24 h after the nephrotoxin and 
is largest in the regenerating tubules by 48 h. Frozen, acetone-fixed sections 
stained for alkaline phosphatase (APP), Camoy fixed, PAS-stained autoradiographs in 
darkfield illumination (R). Arteria arcuata (arrowheads) and some labelled cells 
(arrows). Note the reduced distribution of FRP in necrotic tubules at 24 h, which is 
increased in the regenerated tubules at 48 h.
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While pulse labelling gives information of the ex ten t of 
p ro liferative change a t a single time po in t, i t  does not give a 
measure of tissue  regeneration . Such information can be obtained 
b y  assessing  the total num ber of new cells formed over a period 
du ring  which ^H-thymidine is continuously infused  from a mini- 
osmotic pump, or o ther device. Using th is technique it is possible 
to show the marked increase in cell labelling within 24 h  of a 
nephrotoxic in su lt. More im portantly, while there  is no recognizable 
renal pathology 5-8 days a fte r  a single dose of cephaloridine, the 
trem endous labelling of cell nuclei shows th a t the proximal tubule 
rep resen ts  almost totally  repa ired  tissue (F igure 13). O ther tech ­
niques cannot identify  the  regeneration  of relatively  re s is ta n t cells 
and there  is a need to estab lish  where similar changes escape con­
ventional techniques used  in subchronic and chronic toxicity 
s tu d ie s .
Figure 13 Autoradiography can show the total cell proliferation that has occurred,
O
using JH-thymidine continuously infused s.c. from a mini-osmotic pump 2 to 5 days 
cifter the insult, and the rat killed on day 7. There is limited cell proliferation 
in control rats (A), whereas heavy nuclear labelling occurred after 0.8 g/kg i.v. 
cephaloridine, (B). Darkfield illumination, G shows glomeruli.
It is also possible to s tu d y  the kinetic response of d ifferen t 
renal cell types in response, to renal in ju ry . C ontralateral h y p e r­
trophy  (in  response to uninephrectom y) is up to 4-fold more 
marked in  the  cortex compared to the medulla, and th is response 
to the release of renotropic facto r is suppressed  b y  water
deprivation^*^.
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Figure 13 continued (C) Conventional histology fails to identify the presence of 
regenerated cells (left side) despite the extensive silver grains above regenerated 
cells (right side). Camoy fixed, PAS-stained autoradiographs: darkfield photographs 
of the juxtamedullary junction, showing glomeruli (G), some labelled cells (arrows). 
Transmitted light for conventional histological evaluation (left side) and the same 
field in darkfield illumination for demonstration of the labelled nuclei (right 
side).
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A utoradiography of sem i-thin, m ethacrylate-em bedded sections 
showed th a t normally the tu rnover of epithelial cells (infusing ^H- 
thymidine a t zero o rder from an implanted mini-osmotic pump for 
144 h) d iffered  in the major regions of the k idney. The cell tu rn ­
over was similar in the proximal and distal tubu les, the urothelia 
covering the papilla and the adjacent pelvic epithelia. A lower 
labelling index was observed in the u re te r  and the collecting duct 
and the lowest was the pelvic fo rn ix . Following an acutely induced 
papillary  necrosis there  was a 6-fold increase in the  pelvic fornix 
adjacent to  the  papillary in ju ry  and a 2- to 3-fold increase in the 
tu rnover in all o ther r e g i o n s 2 9 ^ .
XI. OTHER HISTOCHEMICAL METHODS FOR 
ASSESSING THE KIDNEY
A. Renal haemodynamics, glomerular permeability and filtration
Assessment of the renal haemodynamics and glomerular filtration 
generally includes examination of the  whole k idney b y  blood flow 
monitoring^ 8 5 or gross anatomical d istribu tion  of a  labelled 
m aterialise > 287  ^ These methods measure regional flow or total 
clearance and give no data on the d istribu tion  within the medulla 
and cortex . They cannot therefore  be used  to s tu d y  the subtle  and 
focal changes th a t may rela te  to ta rget-selec tive  in ju ry . Several 
histochemical methods are  available to assess these changes, al­
though these have not been used  to follow the time course of those 
renal in juries where such information would be valuable.
1. Nephron perfusion and m icrovascular control
The subtle  control of k idney m icrovasculature and the shun ting  of 
blood to (o r from) d ifferen t regions of the  medulla and cortex 
p resen t a  most fundamental process in normal renal function. This 
may be a ltered  in nephrotoxic lesions th a t have been linked to is ­
chaemic in ju ry . The in troduction of exogenous particu late  material 
into the renal m icrovasculature gives some indication of the  patency 
of the vessels an d /o r the presence of vasoconstriction/occlusion. 
The morphological methods described  below cannot d ifferen tia te  be ­
tween stasis  and high flow ra te  a reas , nor can th ey  generally  iden­
t i f y  "leaky" capillaries, an endothelial defect th a t could p lay  a 
v e ry  im portant role in d isrup ting  renal compartm entalization.
Colloidal carbon has been used  to show the loss of medullary 
m icrovascular filling a t an advanced stage of ethyleneimine-288 and 
asp irin -induced299 re nal papillary  necrosis. The in troduction  of 
th is material for assessing  vascular filling may p re se n t some dif- 
ficu ties. India ink has been used  as the  common source of colloidal 
carbon, a varie ty  of additives (phenols, shellac and fish  g lue)290 
used  to enhance its draw ing p ro p ertie s , and the colloidal n a tu re  of 
th is material imparts a substan tia l oncotic p re s su re , bo th  of which 
may cause arte fac ts  in assessing  m icrovascular filling. These c ir­
cumvent u sing  India ink th a t has been dialysed against isotonic 
saline-*-0^ . Colloidal carbon p rep ared  thus has been used  to follow 
the  time course of m icrovascular changes in animals tre a te d  with 2-
61
NEPHROTOXICITY IN THE EXPERIMENTAL AND CLINICAL SITUATION
bromoethanamine. There was an early  sh ift (2-4 h  a fte r  dosing) of 
m icrovascular filling from the cortex  to the  ou ter medulla, a fte r  
which the filling of the inner medulla was more pronounced, b u t a t 
the  expense of the ou ter p a rt  of the m edullary plexus a t 8-26 h . 
These changes coincided with the development of renal papillary  
necrosis. By 48 h  when necrosis was complete the damaged medulla 
was avascular. D uring the course of development of RPN, however, 
the  m icrovasculature was p a ten t in  the  m edullary tissue beyond the 
regions in which necrosis had occurred . These data were in te r­
p re ted  as showing th a t an acute medullary necrosis can occur 
without capillary o c c lusion-^ . These observations have also been 
confirmed b y  high-resolution microscopy where p latelet adherence 
and m icrovascular changes did not occur un til late in the develop­
ment of the  lesionl08.
The inheren t difficulties associated with using  colloidal 
carbon as a  suitable particu late  material fo r in travascu lar filling 
prom pted Joris e t a l . ^ l  to use Monastral Blue B (a copper 
phthalocyanine), the advantages of which are  w ater-insolubility , 
non-toxicity , uniform size d istribu tion , commercial availability, and 
high con trast fo r th in  and th ick  sections. Recently, th is method 
has been used  to address the possible role of m icrovascular occlu­
sion or leakage in the  genesis of renal papillary  necrosis. The d is­
tribu tion  of vascular labelling in sem i-thin m ethacrylate sections 
showed th a t glomeruli and pelvic basal epithelia were well labelled 
(F igure 14). No Monastral Blue B was p resen t in the papillary
m atrix , data th a t suggest th a t the capillary in teg rity  was in tact
and the leakage of material into the interstitium  was not involved
in the pathogenesis of renal papillary  n e c ro s is^ ^ .
Figure 14 Distribution of Monastral Blue B vascular label throughout kidney. 
Photomicrograph from en bloc kidney embedded in glycol methacrylate.
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E rythrocytes also offer a na tu ra l m arker fo r study ing  vas­
cular filling, and can be isolated, w ashed, form aldehyde-fixed and 
tagged with a fluorescent or radiolabelled m a rk e r^  2} b u t it  has 
been suggested  th a t labelling the ery th rocy te  impairs its  
flexibility , and may a lte r its  normal d istribu tion . It is , however, 
possible to make use of the  endogenous e ry th ro cy tes, because of 
several of th e ir  unique stain ing  p ro p ertie s . Early studies made use 
of the benzidine stain ing technique, and showed the marked blood 
filling changes in the k idney following 5-hydroxytryptam ine 
(serotonin) e x p o s u r e 2 9 3 } which were consistent w ith the shun ting  
of blood away from the cortex to the juxtam edullary a rea . It is 
„ ’ generally assumed th a t th is shun ting  of blood plays an essential 
role in the  development of the  ischaemic proximal tubu lar necrosis 
th a t commonly follows high doses of serotonin. The established car- 
v' - cinogenic p roperties of benzidine preclude its  u se , b u t e ry th ­
rocytes can be contrasted  by  the p resence of enzymes such  as es­
te ra se , glucose-6-phosphate dehydrogenase, acid or alkaline 
phosphatase; the high levels of phospholipids shown by  the  Sudan 
black method; by  a v arie ty  of routinely  used  stains such  as 
Masson's trichrom e, Toluidine b lue, Giemsa^2}93 an(j the high 
macromolecular thiol levels b y  the diazotized N -(4-am inophenyl)- 
maleimide m e th o d ^ ^
2. Glomerular filtration
Total glomerular filtration may be unchanged in those neph­
ropathies (e .g . renal papillary  necrosis) 182 where single nephron 
glomerular filtration  ra tes  are  reduced . While it  is possible to 
measure single nephron glomerular filtration  ra te s  in  superficial 
nephrons by  m icropuncture, th is technique is v e ry  slow and gives 
no information on the juxtam edullary nephrons. The "Hanssen 
technique" makes use of the localization of glomerular filte red  
ferrocyanide to the tubu lar lumen (which is not reabsorbed  or 
se c re te d ) , th a t has been precip ita ted  b y  fe rric  chloride (in  the 
frozen kidney) as P russian  blue*95-297# Many w orkers have then  
m icrodissected whole nephron segments and studied  the d istribu tion  
of P russian  blue in relation to nephron leng th , to tal glomerular 
filtra tion  ra te  and in the d iuretic  versus normal a n d /o r an tid iu retic  
s t a t e s 2 9 6 , 2 9 7 > This approach has also been quan tita ted  using
- . radiolabelled f e r r o c y a n i d e ^ 2  #
There are  few repo rts  using  th is technique to describe the 
degree of glomerular filtration  in nephrons exposed to chemicals.
w Normally only 7 5 % of the nephrons are  actively f i l t e r i n g ^ a n  ob­
servation th a t supports  the functional reserve  th a t is p rese n t in 
the  nephron . The num ber of non-filtering  nephrons increases in 
animals in which hydronephrosis has been induced b y  u re te r  liga­
tion , probably  in those nephrons where there  is cast formation and 
tubu lar dilatation. This does, however, need confirmation using  the 
Hanssen technique and suitable m arkers for luminal c a s ts . This 
may be relevan t in renal papillary necrosis where the  p resence of 
Tamm-Horsfall glycoprotein casts has been linked to tu b u la r d ilata­
tion and subsequen t glomerular sclerosis and sc a rrin g  of the 
c o r t e x - L B l  > 1 3 2 , 299T
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There is p resen tly  in te re s t in the  marked hyaline droplet 
formation th a t occurs in male ra ts  exposed to branched-chain  
h y d r o c a r b o n s  139 ~192 ^  These can be shown by  Mallory's Heidenhein 
s ta in , th e ir  eosinophilia or the  use of antibodies to a.2 U-globulin. 
The heterogeneity  of hyaline droplet formation highlights several 
questions:
( i) . which nephrons are  filte ring , those with or without the 
pro tein  over-load; and
( i i ) . is sw itching off the  filte ring  nephrons a way of giving the 
re s tin g  nephron a chance to remove th is material?
Ferrocyanide does, however, b ind to protein^®® and th e re ­
fore will give h igher values in male ra ts  (because of the  sex h o r­
mone rela ted  p ro te in u ria ), in those circum stances where glomerular 
perm selectivity is a lte red , as a re su lt of glomerular damage and 
when the proximal tubule pro tein  reabsorb tive capacity has been 
decreased .
3. Changes in glomerular pro tein  filte ring  and 
proximal tubule uptake
Glomerular perm selectivity and the proximal tubu lar up take of a 
num ber of filte red  proteins is a v e ry  im portant indication of normal 
renal function. The peroxidative activ ity  of several low molecular 
weight enzymes (such  as ho rserad ish  peroxidase, myeloperoxidase 
and myoglobin) have been used  to s tu d y  glomerular perm eability 
and pro tein  uptake by  the proximal tubule^^"^® ^. The horserad ish  
peroxidase (HRP) is taken up into apical vacuoles or phagosomes in 
the proximal tubule th a t merge with lysosomes, and slowly u n ­
dergoes degradation. The clearance of HRP can be a ltered  by  a 
saline or mannitol d iu resis , which decreases cellular up take . Man- 
nitol in particu la r produced a large number of vesicles which were 
assumed to be involved in fluid tra n sp o rt a t the expense of HRP 
uptake^O^. The adm inistration of these exogenous protein  m arkers 
is no t, however, without the adverse  effect of vascular leakage, a 
response th a t can be inhibited  by  histamine and serotonin 
antagonists 305. There is also some evidence to suggest th a t
arachidonic acid metabolites may be involved in the hypotensive ef- . - 
feet caused by  the adm inistration of HRP, because th is can be 
p reven ted  b y  indomethacin and a s p ir in ^ ^ . Despite the  potential 
value of these methods there  appears to be a paucity  of published ”
data  on th e ir  application to s tudy ing  chemical induced p ro te inu ria .
B. Fluorescence vizualization of chemicals
Many chemicals with nephrotoxic potential fluoresce strong ly  (Table 
7 ), and therefo re  offer the potential to vizualize th e ir d istribu tion  
a t a  cellular and subcellular level (an objective most often achieved 
b y  au to rad iog raphy ). Some of these chemicals also show spectral 
changes as a re su lt of metabolism, a p ro p erty  th a t ensu res th a t
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more information can be atta ined  from th is method than  from 
autoradiography, which m easures total d rug -derived  material only. 
One of the  major problems with the use of fluorescent monitoring is 
the  significant tissue  autofluorescence th a t may be p re se n t. Thus 
it is essential to screen control tissue  to ensure  th a t the  choice of 
f ilte r combinations maximizes the visualization of the chemical of in ­
te re s t.
Table 7 Nephrotoxic 
chemicals with fluores­
cent properties
Actinomycin
Aflatoxins
Aminoglyco s ides
Anthracyclines
Biphenyls
Catecholamines
Tetracyclines
For example, the fluorescence of streptom ycin has provided 
data on its d istribu tion  in the inner ear^®^, an approach th a t could 
also be applied to the k idney. The anthracycline antibiotic 
adriamycin (doxorubicin) and its  analogue daunomycin are  rapidly  
taken up by  the kidney and cleared from the cytoplasm to leave 
only the nuclei showing the presence of these chemicals a fte r  60 
min d08. These data closely paralleled the renal pharm acokinetics of 
the an th racyclines, b u t failed to help explain why th is compound 
ta rg e ts  selectively for the glomeruli-^-*-.
XII. CONCLUSION AND FUTURE TRENDS IN THE USE 
OF HISTOCHEMICAL TECHNIQUES
The applications of histochem istry and immunohistochemistry are 
many, and the topics we have covered rep re sen t only a partial 
_ overview of how fundamental questions can be add ressed . More im­
po rtan tly , despite the  problems th a t may be experienced from time 
to time in reproducing  these techniques they  have several v e ry  im­
po rtan t advantages:
1. They provide the most cost-effective way of b ridg ing  the 
dichotomy between renal s tru c tu re  and function , and may 
give information th a t rela tes d irectly  to a subcellu lar or 
molecular level.
2. Even when the bases fo r histochemical change are  empirical 
(as many still a re ) , they  are  discrim inatory and help vizual- 
ize renal heterogeneity  and focal lesions.
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3. M icrospectrophotometry and fluorim etry, w ith computer 
manipulation of the extensive data th a t have been generated , 
and the automation of slide scanning, are  increasingly 
provid ing  objective means of handling large quantities of 
m aterial.
4. The indication th a t a "general" histochemical change has oc­
cu rred  ( e .g . loss of a carbohydrate  matrix or glycoprotein, 
lipid change, e tc .)  is a fa r  more logical s ta r tin g  point for 
specific and specialized studies (e .g . biochemical, immuno­
logical assessm ent, u ltra s tru c tu ra l evaluation, e tc .)  than  can 
cu rren tly  be rationalized from o ther experim ental protocols.
5. There are  instances where h isto- and immunohistochemical 
methods give information th a t is usually  only otherwise avail­
able from u ltra s tru c tu ra l s tud ies , b u t provide m arkedly 
la rg e r areas of tissue and offer the potential for more rap id  
assessm ents.
6 . Histochem istry gives data  on the kinetics of cell damage and
its  rep a ir , in relation to associated cell types th a t may not 
be damaged. A nother approach is the determination of 
proliferative and regenerative  capacity of renal cells by
means of e ither the frequency  of mitotic figures or counting 
labelled cells a fte r  infusion with 3H -thym idine. Such tech ­
niques may be helpful in the detection of specifically affected 
sites and in the quantify ing of pathological changes, and may
even shed light on mechanisms of toxicity .
7. The tre n d  in toxicology has sh ifted  from descrip tive pathol­
ogy to one with a molecular focus th a t will provide a rational 
basis for sa fe r d ru g  design , b e tte r  treatm ent of disease and 
more reliable hazard  assessm ent. The transition  between 
"organ toxicity" and the focal lesions of " ta rg e t cell toxicity" 
must begin with light microscopic evaluation, and p rogress to 
a biochemical level in which the iden tity  of the  morphologi­
cally damaged cell must be maintained.
Histology is still the  basis for defining renal lesions in 
toxicology, while u rine  and serum  analyses can be of help in
determ ining the sequences of events in  individuals. For detectioh 
of te s t  com pound-related renal lesions in animals with vary ing  
background pathology, it  is advantageous to supplem ent the  con­
ventional sta in ing  techniques. The following problems have to be 
encoun tered :
1 . extensive cell in ju ry  may have caused the loss of the specific 
ch arac te ris tic ;
2 . regenera ting  cells may not ye t have acquired the specific 
ch a rac te ris tic ;
3. the  method used  may be based on minor d ifferences and may 
not readily  discrim inate between cells;
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4. residual compound may in te rfe re  with the histochemical
reaction;
5. sampling e rro r  may be large , e .g .  in the case of focal
lesions;
6 . species differences in morphology and reactiv ity  will be
encoun tered ;
7. special investigations have to be arranged  as an essential
p a r t  of the  s tu d y  protocol and can cause logistic problems if 
used  for routine toxicity  te s ts .
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